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Abstract
In recent years it has become apparent that the proportion o f elderly people in 
the Western World is rising. There are a number o f variables that can adversely 
affect cognitive function such as illness, drug treatment and nutritional status. 
Based on this idea, it was hypothesised that improved nutritional status would 
result in improved cognitive function. In order to assess this hypothesis, it was 
important tests to assess cognitive function.
The first method for assessing cognitive function was with the use o f a 
subjective rating scale to assess activities o f daily living (ADL). It was reported 
that elderly subjects were unaware of any problems with cognitive function. The 
second method for the assessment of cognitive function was with the use of  
objective tests. A test battery was identified and examined for the effects o f age 
and sex on performance. It was reported that a number o f the tests were age 
sensitive. Having identified a test methodology, the effects o f improved 
nutritional status were investigated.
239 healthy community dwelling elderly volunteers received multivitamins 
daily for 36 weeks. It was reported that supplementation with multivitamins had 
no effect on performance of the tasks. In terms of deficiency 30% of the sample 
were at a high risk of deficiency o f vitamin B6 and 10% at a high risk of 
deficiency o f vitamin B2. Risk of deficiency had no effect on psychometric task 
performance, however it was reported that risk o f deficiency affected mood, 
subjects with a moderate risk of deficiency reported higher anxiety rates than 
subjects with either a low or high risk of deficiency.
16 healthy community dwelling elderly volunteers received Ginkgo Biloba 
(lOOmg) daily for eight weeks. It was reported that supplementation with 
Ginkgo Biloba had no effect on performance of the tasks.
24 healthy community dwelling elderly volunteers received an acute dose o f
ii
glucose (50g) and placebo (saccharin 23.7 mg). Cognitive performance was 
assessed at baseline, 30 and 50 minutes post dose. It was reported that 
supplementation with glucose had no effect on performance of the tasks. It was 
questioned whether glucose tolerance was associated with differences in mood 
and task performance. It was reported that subjects with falling blood glucose 
levels showed improved performance on the Sternberg memory task and 
reported feeling more vigorous and less fatigued than subjects with rising blood 
glucose levels.
The results of these experiments would seem to indicate that the test methods 
selected for assessment of cognitive function may not be suitable for the 
assessment of cognitive enhancement in a healthy elderly population. Based on 
the findings, implications for future gerontological intervention research were 
discussed.
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1 Chapter One: An Ageing Society
1.1 Chapter Outline
This chapter discusses society's trend towards increased longevity and 
implications o f this. The chapter discusses the variables that affect cognitive 
function and highlights the need fo r alternative treatments fo r  elderly ailments, 
especially memory problems. One major factor that affects cognition is 
nutritional status. The chapter addresses the incidence o f nutritional deficiency 
in the elderly population and outlines methods for the assessment and treatment 
o f cognition.
1.2 Introduction
In recent years, it has become apparent that the proportion o f elderly people in 
the Western World is rising, this rise is possibly due to improved sanitation, 
nutrition, better living conditions, advances in medicine etc. At the turn o f the 
century, life expectancy was 49 years, today life expectancy is exceeding 70 
years (current population reports). The rise in numbers o f elderly persons is 
even greater in the oldest age group. Green and Davis (1993) report that persons 
aged over 85 years, represent the fastest growing proportion o f society. It is 
predicted that subjects over 80 will rise from 2.1% to 5% o f the total population 
from the years 1980 to 2030 (OCED, 1987). In 1980, 12% of the population 
were aged over 65 years, by 2030 it is estimated that this figure will rise to 22%, 
an estimated 55 million people (OCED, 1987). This represents a continuing 
trend towards an increasingly aged population.
The implications o f increased longevity are that greater numbers o f subjects are 
at risk o f the diseases associated with ageing such as dementia, diabetes, 
Parkinson's and Alzheimer's disease etc. illnesses that will exacerbate cognitive 
decline in subjects who due to their age, will already be experiencing a certain 
degree o f cognitive decline.
Increases in life expectancy will inevitably mean that the elderly person will be 
exposed to more and more drug treatments for specific ailments. The elderly as 
a group are the most frequent users o f psychoactive drugs (Whittington, 
Petersen, Dale and Dressel, 1981) and are the group most sensitive to the 
unwanted side effects. Psychotropic drug use has been associated with 
unwanted side effects such as performance impairment which can be 
detrimental to the elderly population increasing the potential for accidents both 
in and around the home.
In a sector o f the population already prone to age related deficits in cognitive 
performance, society needs to take measures that will limit drug usage in this 
population, hence the search for alternatives to drug treatment would be 
specifically useful for this age group.
There are a number o f variables that affect the elderly making them more 
susceptible to decrements in cognitive function, these variable include, drug 
usage, concurrent illness and nutritional status.
It is quite difficult to limit the cognitive deficits associated with age associated 
illnesses and drug therapies, however it is possible to improve nutritional status 
which may in turn help to limit some of the cognitive decline.
The elderly, for a variety of reasons are vulnerable group in society, prone to 
vitamin and mineral deficiencies. Ageing is accompanied by a variety of 
changes, e.g. social, economic, and psychological that can compromise 
nutritional status. A number o f physical changes associated with ageing also 
affect the elderly persons needs for certain nutrients. For example, ageing 
decreases the skin's capacity to produce vitamin D, age related decline o f  
vitamin B2 , Eta B 12 and folic acid are common occurrences in the elderly, 
mainly due to reduced enzyme activity, impaired absorption o f vitamins in the
gastric system and disease states common in the elderly such as respiratory 
conditions, diabetes, hypertension and Parkinson's disease.
Numerous physiological factors place the elderly at risk of nutritional decline, 
such as a decline in the sense of smell (Chauhan, Hawrysh, Gee, Donald and 
Basu, 1987), and taste (Murphy, Cain and Hegsted, 1989), dental problems 
which can limit the type of food eaten, e.g. the elderly often avoid fresh fruit 
and vegetables due to poor, ill-fitting dentures (Me Gandy, Russell, Hartz, 
Jacob, Tannenbaum, Peters, Sahyoun and Otradovec, 1986). The natural ageing 
process also places the elderly at risk of vitamin and mineral deficiency, 
changes in the gastric system often mean that foods are malabsorbed due to a 
decrease in gastric acid secretion, or as a result of interactions with medications 
Suter, Golner, Goldin, Morrow and Russell, (1991) suggest that as many as 30% 
of persons over the age o f 65 are affected. Neurological impairments can 
decrease mobility and affect the purchase and preparation o f food (Roe, 1988; 
Smiklas-Wright, 1990).
A number of life changes affecting the elderly such as retirement from paid 
employment, the loss of a spouse, and social isolation all effect the nutritional 
state of the elderly. For example people are more reluctant to prepare food for 
one, and hence often eat snack type foods or ready prepared meals rather than 
prepare fresh meals daily. A reduction in daily food intake and the tendency o f  
the elderly to repeatedly eat the same foods place the elderly at risk o f vitamin 
and mineral deficiency. Economic factors affect the nutritional state o f the 
elderly they often cannot afford to purchase foods rich in essential nutrients 
(Stitt, O’Connell and Grant, 1995), or they cannot afford to travel to shopping 
centres to purchase fresh foods. The sedentary life style o f an elderly person 
decreases the need for energy and hence results in reduced food intake, thereby 
increasing the risk of nutritional deficiency.
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One important question for researchers is, "how common are vitamin 
deficiencies in the elderly?" A number of studies have highlighted the fact that 
the elderly are a sector of society particularly vulnerable to sub-clinical vitamin 
and mineral deficiencies.
Researchers identify vitamin deficiency with the use o f three popular methods, 
dietary diaries, structured interviews with nutritionists or dieticians and 
assessment of actual blood vitamin level.
The use of dietary diaries, is a common method adopted by research teams to 
examine the vitamin content of subjects diets. Subjects have to weigh and 
record all food consumed over a three or five day period. This method has been 
used by a number o f researchers (Me Clean, Weston, Beaven and Riley, 1976; 
Ortega, Andres, Redondo, Zamora, Lopez-Sobaler, and Encinas-Sotillos, 1995; 
Ahrari and Kimiagar, 1997). Yearick, Wang and Pisias, (1980), combined 
analysis o f dietary diaries with comprehensive interviews with a nutritionist. 
Both methods have identified multivitamin deficiencies in elderly populations 
(See Table 1).
T yj$y§3X a Showing the vitam in deficiencies determ ined via dietary diaries.
Author Age n A B, b 2 b 6 C E
McClean et al. 1976 72-96 35 34% 34%
Yearick et al. 1980 63-96 100 22% 16% 10%
Oretga 1995 65-89 60 46% 15% 21% 58% 11% 83%
Ahrari 1997 70-87 100 85% 94% 2% 49%
Another method to determine vitamin deficiency, possibly a more accurate
method than dietary diaries, is to assess actual blood vitamin level. In this
method, blood samples are taken and assayed to determine blood vitamin
concentration. These levels can be compared with tables o f vitamin deficiency
cut o ffs, hence a more accurate picture o f blood vitamin status can be
determined. This method was adopted by Goodwin, Goodwin and Garry,
(1982); Vannucchi, da Cunha, Bemardes, and Unamuno, (1994); Tolonen,
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Halme and Sama, (1988); Monguet, Galan, Preziosi, Keller, Bourgeois, Amaud, 
Favier and Hercberg, (1996). A number of multivitamin deficiencies in elderly 
populations have been identified through this method.(see Table 2).
Table 2: Showing the vitam in deficiencies determ ined via assessm ent o f  blood vitam in
level.
A uthor Age n A fit b 2 b 6 C E
Goodwin et a l  (1982) 60-94 260 23% 1%
Vannucci et al. (1994) 102 13% 34% 56% 25%
Tolonen e ta l. (1988) 64-96 243 25%
Monguet eta l. (1996) 66-103 756 14% 65%
All three methods have been used to identify vitamin deficiency amongst 
elderly populations world-wide. These studies provide clear scientific evidence 
that vitamin deficiencies are common occurrences among elderly populations.
These tables reveal that vitamin deficiencies are quite common even amongst 
free living healthy elderly subjects. In some cases these deficiencies affect more 
than 50% of the population sampled.
If as the previous research would indicate, the elderly are susceptible to 
nutritional deficiencies and this in turn effects everyday cognitive functioning, 
then this leads gerontologists and cognitive psychologists alike to ask a number 
of questions. In particular, what happens to cognitive functioning as a result of 
age, can we directly measure or observe these changes either with the use of 
psychometric assessments, or self rating questionnaires, and more importantly 
can we intervene with dietary supplements to try and slow down the rate o f 
cognitive decline?
Chapter two will discuss and consider why a deficiency in certain multivitamins 
results in performance decrements. The multivitamin review reports that poor 
diet can adversely affect cognitive functioning especially in healthy elderly
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subjects. With this information in mind, the following two chapters examine 
how researchers can assess changes in cognitive function.
Chapter three assesses perceived cognitive function with the use o f a self rated 
activity of daily living (ADL) questionnaire that aims to identify problems with 
aspects o f cognition encountered in the day to day living o f a healthy elderly 
sample.
Chapter four examines the role o f objective cognitive tasks as assessment tools 
for measuring changes in actual cognitive functioning. The tasks assessed 
include the Syndrom Kurtz Task (SKT), the Critical Flicker Fusion task (CFF), 
Choice Reaction Time (CRT) and the HPRU Sternberg Memory Task (SMT).
Having identified a battery o f subjective and objective tasks for the assessment 
of cognition in healthy subjects, there will follow three experimental chapters 
examining the efficacy of compounds thought to have cognitive enhancing, 
properties, in the hope that they would slow down the rate o f cognitive decline. 
The compounds/supplements examined include multivitamins, ginkgo biloba 
and glucose.
Chapter five details the results of an a parallel placebo controlled double-blind 
study in which 250 subjects were randomly allocated to received either a 
multivitamin or placebo preparation for 36 weeks. Assessments were made at 
baseline, week 12, 24, and 36 weeks using the Critical Flicker Fusion task 
(CFF), Choice Reaction Time (CRT), HPRU Sternberg memory task (SMT), 
the Syndrom Kurtz Task (SKT), Ravens Standard Progressive Matrices 
(RSPM), Cognitive Failures Questionnaire (CFQ), the Hospital Anxiety and 
Depression Scale (HADS).
Chapter six details the results o f a crossover placebo controlled double-blind 
study in which 16 subjects were randomly allocated to received both ginkgo
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biloba (100 mg daily) and placebo for 8  weeks, with a 4 week washout period 
between treatments. Cognitive assessments were made at baseline, week 2, 4, 6 , 
7 and 8  using the Critical Flicker Fusion task (CFF), Choice Reaction Time 
(CRT), HPRU Sternberg Memory Task (SMT), the Syndrom Kurtz task (SKT), 
Milford Memory Task (MMT), and the Cognitive Failures Questionnaire 
(CFQ).
Chapter seven details the results of an a crossover placebo controlled double­
blind study in which 24 subjects were randomly allocated to receive acute doses 
of glucose (50g) and placebo saccharin (23.7 mg). Cognitive assessments were 
made at baseline, and 30 minutes post dose using the Critical Flicker Fusion 
task (CFF), Choice Reaction Time (CRT), HPRU Sternberg Memory Task 
(SMT), the Syndrom Kurtz task (SKT), a word list task (WLT) and the profile 
of mood states (POMS).
Chapter eight is the discussion chapter that will attempt to pull together all the 
findings reported in this thesis, and more importantly will discuss the 
implications of this research for future gerontological intervention research.
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2 Chapter Two: Vitamins and their Dietary 
Importance
2.1 Chapter Outline
Micronutrients
Vitamin A (retinol)
Vitamin B] (thiamine)
Vitamin B2  (riboflavin)
Vitamin B3 (niacin)
Vitamin B5 (pantotenic acid)
Vitamin B$ (pyridoxine)
Vitamin Bn (cyancobalamin)
Vitamin C (ascorbic acid)
Vitamin E (alpha tocopherol)
Vitamin K  
Biotin 
Folic Acid
Minerals
Iron (Fe)
Calcium (Ca)
Chlorine (Cl)
Magnesium (Mg)
Manganese (Mn)
Molybdenum (Mo)
Selenium (Se)
Bioflavinoids (vitamin P)
Zinc (Zn)
The Role o f Multivitamins in the Central Nervous System 
Neurotransmitter Synthesis 
Antioxidant Protection
The Release o f Energy From Foods
The Effects o f Vitamin Supplementation on Aspects o f Cognition, Mood and 
Behaviour.
This chapter discusses the importance o f nutritional status and its role in 
determining cognitive function. This is especially important fo r  elderly subjects, 
who due to their age, may already be suffering from cognitive decrements that 
may be exaggerated by poor nutritional status.
2.2 Vitamins and their dietary importance
The importance o f micronutrients in the diet was not realised until the early part 
of the 20th Century. Before this time, it was believed that the only components 
of a diet essential for adequate health and functioning were proteins, fats and 
carbohydrates. However, it soon became evident that a certain amount of trace 
elements were required for adequate health. These essential elements were 
termed vitamins from the Latin ‘vital’ ‘amines’ as it was incorrectly thought all 
were amines.
The importance o f vitamins in the diet was a discovery made early this century. 
Hopkins (1912) demonstrated scientifically that animals required a diet o f more 
than just fat, protein and carbohydrates for normal growth. Hopkins postulated 
that animals needed one or more “accessory factors” present in certain natural 
foods that were necessary for nutrition of animals.
In the same year Casimir Funk obtained a concentrate o f an amine from rice 
husks and polishings that alleviated the symptoms o f the disease beri beri. Funk 
coined the name vitamine, denoting an amine essential for life - however many 
of the substances classed as vitamins are not amines. It soon became clear that
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there must be several vitamins vital for the normal growth and functioning of 
animals.
Vitamins are classified into two large groups these being water soluble and fat 
soluble. Water soluble vitamins include vitamin Bi (thiamine), B2 (riboflavin), 
B3 (niacin), B5 (pantotenic acid), B6 (pyridoxine), vitamin B 12 (cobalamin), folic 
acid, biotin and vitamin C (ascorbic acid).The fat soluble vitamins include 
vitamins A (retinol), D, E (alpha tocopherol) and vitamin K. Most of the water 
soluble vitamins function as necessary building block components of a number 
of different co-enzymes important in central metabolic pathways. As well as 
vitamins there are also trace elements and minerals that play important roles in 
the body. These include iron, calcium, chlorine, magnesium, manganese, 
molybdenum, selenium, bioflavinoids and zinc.
Vitamins are defined as organic compounds present in foods in extremely small 
concentrations. Vitamins are essential for normal health and growth and when 
absent from the diet or not properly absorbed cause a specific disease 
deficiency. Vitamins cannot be synthesised by the person and hence have to be 
obtained exclusively from the diet. Each o f the vitamins outlined above will be 
considered in greater detail in the following section.
2.3 Vitamins
2.3.1 Vitamin A (retinol)
Vitamin A is one of the fat soluble vitamins from a group o f compounds 
including retinol, retinal, carotene and caroteniods. Retinol is the form of 
vitamin A found in animal products and the carotenes are found in fruit and 
vegetables. Retinol is the main active form of vitamin A, the chemical structure 
of which was determined by Paul Karrer in 1931. The carotenes are precursors 
to vitamin A and when ingested they get converted in the liver to vitamin A. 
The active form of vitamin A is the aldehyde retinal which is vital for the proper
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formation o f rhodopsin - the light sensitive pigment in vertebrate rod cells in the 
eyes. Deficiency of vitamin A leads to a whole number o f complications such as 
night blindness, defective development o f the teeth, stunted growth, various 
skin eruptions, problems of the mucous membranes and reduced defence against 
infections. Vitamin A is often thought of as the anti infection vitamin as it plays 
an important role in maintaining the immune system. Vitamin A is stored in the 
liver and it has a half life o f 200-300 days therefore, the vital balance is only 
disturbed if  the intake of vitamin A is too low over a period o f months.
2.3.2 Vitamin (thiamine)
Vitamin Bi is one o f the B complex water soluble vitamins. Vitamin Bi cannot 
be stored in the body in large quantities as there is only a small reserve in the 
liver, heart and brain, any excess is therefore excreted in the urine. The 
chemical structure of vitamin Bi was discovered in 1936 by Robert Williams. 
Deficiency o f vitamin Bi has been associated with a whole range o f symptoms 
including anxiety, irritability, depression, loss o f weight and appetite, sleep 
disturbances, inactivity, malaise, forgetfulness and poor co-ordination (Brin, 
1962; Wiliams et al, 1942). Long term deficiency leads to a condition known as 
beri beri, a deficiency state where the patient suffers nerve inflammation, 
muscular weakness and eventually heart failure. It is thought that about half the 
population of western industrialised countries suffer from minor long term 
vitamin Bi deficiency. Marginal deficiency in thiamine is quite a common 
occurrence in elderly populations, and is quite difficult to recognise clinically 
because the effects o f deficiency are non specific. Vitamin Bi is required for 
glycolysis in the conversion of Pyruvate to acetyl coenzyme (Co A) which then 
enters the citric acid cycle, where the acetate is further oxidised to carbon 
dioxide and water in reaction involving pantotenic acid, thiamine, riboflavin and 
nicotinamide. One o f the first responses to a thiamine deficient diet is an 
inability to concentrate, confusion of thought, uncertainty o f memory, anorexia, 
irritability and depression (Williams et al, 1942). When thiamine is
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reintroduced into the diet, dramatic changes occur, appetite is restored and 
personality changes for the better (Brozek and Guetzkow, 1957).
2.3.3 Vitamin B2 (riboflavin)
Vitamin B2 is known as riboflavin, it is another water soluble B complex 
vitamin. Vitamin B2 was first detected in 1879 by Blyth and it's chemical 
structure was isolated in 1935 by Paul Karrer and Richard Kuhn. Riboflavin is 
largely stored in red blood cells and reserves in the human body seem to be 
fairly stable, with any excess being eliminated in the urine. Vitamin B2 
deficiency can result in inflammation of the tongue and lips, scaly scalp, 
eczema, hair loss, dizziness, insomnia, hacks to the comer o f the mouth and 
over sensitivity to light. It is estimated that vitamin B2 deficiency is one of the 
commonest deficiencies, affecting some 20% o f the population. Riboflavin has 
an important role in the energy release from carbohydrates and is also involved 
in the production of the brain neurotransmitters serotonin, noradrenaline and 
acetylcholine.
2.3.4 Vitamin B3 (niacin)
Niacin is a water soluble vitamin that can be produced in the body from the
essential amino acid tryptophan. It is found in two different forms, nicotinic
acid and nicotinamide. The vitamin has a number o f beneficial actions in the
body, including the breakdown of glucose. In the Krebs cycle it is used
biosynthetically to derive the co-enzyme nicotinamide adenine dinucleotide
(NAD) which is essential to a number o f oxidation reduction reactions that
occur in the breakdown of glucose and fatty acids. Niacin is also used for the
maintenance o f the nervous system, normal functioning o f the gastrointestinal
tract, maintenance of healthy skin and the synthesis o f sex hormones. Niacin
expands arteries and hence aids efficient blood circulation and removal o f low
density lipoprotein cholesterol from the blood. Niacin is used for a number of
complaints including the treatment of dizziness, bums, sleeping disorders,
schizophrenia and migraine. Deficiency of niacin results in a disease state
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known as pellagra which results in diarrhoea, dermatitis, confusion, delirium 
and dementia. Mild deficiency produces symptoms such as muscle weakness, 
fatigue, loss o f appetite, nausea, skin eruptions, headache, depression and 
insomnia.
2.3.5 Vitamin B5 (pantotenic acid)
Vitamin B5 is a water soluble vitamin required for the efficient functioning of 
the body. The structure was first isolated by J. R. Williams in 1940. Vitamin B5 
is essential for the metabolism of sugars, fats and proteins, as it forms part of  
co-enzyme A, which plays an important role in the transfer o f acetyl groups 
from various compounds in the Krebs cycle. Vitamin B5 is important in the 
formation and growth of new hair and skin and in the production o f essential 
fatty acids. It is critical for the production o f antibodies. Deficiency o f vitamin 
B5 is extremely rare and is normally only observed in experimental conditions 
where subjects receive diets free o f vitamin B5, under such conditions, 
symptoms include asthma, muscle cramps, insomnia, fatigue, reduced antibody 
production and increased susceptibility to allergy and infection.
2.3.6 Vitamin B6 (pyridoxine)
Vitamin B 6 is another water soluble vitamin part o f the B complex vitamins.
The structure o f vitamin B6 was deduced by Richard Kuhn in 1939. The vitamin
is essential for maintaining healthy skin and nerves and in the formation o f red
blood cells providing general resistance to disease and to stop premature ageing.
The major function of vitamin B6 includes enzyme reactions, the formation of
brain hormones, the formation o f haemoglobin and the maintenance of
homeostatic balance of sodium and potassium in the body. Vitamin B6 improves
the activity of both B and T lymphocytes in our immune system and this in turn
helps in the prevention of diseases such as cancer, asthma, arthritis, coronary
heart disease, various allergies and circulatory disorders. Pyridoxine is essential
for the formation o f the haem rup in haemoglobin, it also has a hormonal
function acting to stop the aggregation o f blood platelets in blood vessels which
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commonly cause blood clots. Deficiency o f vitamin B6 can result in loss of 
appetite, anaemia, emaciation, depression, fatigue, general apathy, nervousness, 
insomnia and poor memory. Vitamin B6 is involved in a number o f crucial steps 
in the synthesis of several neurotransmitters, in the decarboxylation of glutamic 
acid into gamma amino butyric acid (GAB A). GAB A is an inhibitory 
transmitter substance that helps to control the neuronal firing in the brain, hence 
controls seizures.
2.3.7 Vitamin B12 (cyanocobalam in)
Vitamin B 12 is another one of the water soluble B complex vitamins. The 
vitamin was first isolated in 1948. Deficiency o f vitamin B 12 affects nearly all 
tissues in the body. Symptoms of vitamin Bi2 deficiency include fatigue, 
irritability, loss of appetite, diarrhoea, stomach complaints, problems with the 
circulation and heart, and yellowing o f the skin. Long term deficiency leads to a 
condition known as pernicious anaemia which is associated with a number of 
mental problems including loss of concentration, depression, paranoia and 
irritation. Long term deficiency can lead to brain damage and degeneration in 
the nervous system such as loss of sensation and poor co-ordination. Vitamin 
B 12 deficiency leads to a whole range o f symptoms such as depression, 
agitation, irritability, negativism, bipolar disorder, confusion, memory loss, 
disorientation, concentration and apathy. (Dommisse, 1991). Deficiency in 
vitamin B 12 is more common than generally thought, Dommisse (1991) reports 
that the deficiency may be responsible for a number o f psychiatric disorders. 
The human body needs the B complex vitamins to be able to utilise the energy 
in the diet. The B complex vitamins are particularly useful for the brain and the 
nervous system, there is a possibility that the lack of B vitamins may also 
contribute to confusion in older people.
2.3.8 Vitamin C (ascorbic acid)
Vitamin C is a water soluble vitamin, which was first isolated in 1932 by
Charles Glen King. Deficiency o f vitamin C can lead to the disease state scurvy,
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a condition where the gums get inflamed and bleed leading to loss o f teeth. 
Over time the deficiency results in anaemia, mouth ulceration and induration of 
leg muscles. Vitamin C is essential for the formation o f collagen and connective 
tissues it is also important for maintaining the strength o f capillary walls and 
aiding the absorption of iron. Vitamin C is important as it improves the bodies 
ability to fight infection and helps fight diseases such as cancer, high blood 
pressure and arteriosclerosis, by improving the function o f phagocytes and 
activating white blood cells and antibodies. Vitamin C has an important 
function in the brain as it protects against the effects o f ischaemia or oxygen 
deficiency, mainly due to its antioxidant properties.
2.3.9 Vitamin E (alpha tocopherol)
Vitamin E is a fat soluble vitamin first discovered in 1923. Vitamin E is 
essential for muscle development and is important for the production o f red 
blood cells. The most important action of vitamin E is as a lipid-soluble 
antioxidant protecting cell membranes from free radical damage. The vitamin 
also acts as an anticoagulant preventing the formation o f blood clots and 
cataract formation. Vitamin E is useful in the treatment o f cancer, coronary 
heart disease and has also been found to be useful in the treatment of 
Parkinson's disease. Alpha tocopherol interacts with cell membranes, traps free 
radicals and interrupts the chain reaction that damages cells. In animal models, 
alpha tocopherol reduced the degeneration of hippocampal cells after cerebral 
ischemia (Hara, Kato and Kogure, 1990). In hypoxic cultured neurons alpha 
tocopherol reduced cell death associated with beta amyloid protein.
2.3.10 Vitamin K
Vitamin K is a fat soluble vitamin that exists in three forms Ki
(a yellow substance produced naturally by plants), K2 (a pale yellow substance
synthesised by micro-organisms that live in the gastrointestinal tract in humans)
and K3 (of synthetic origin). Vitamin K is a member o f the quinone group
essential for human health. The vitamin was first discovered by Henrik Dam in
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1935. It is very important in the synthesis o f coagulation factors such as 
prothrombin. As well as being used in the blood clotting process, vitamin K is 
involved in two components of energy metabolism, the electron transport chain 
and oxidative phosphorylation.
2.3.11 Biotin
Biotin also known as vitamin H, is another o f the water soluble B complex 
vitamins. Biotin was first identified by Albert Szent-Gyorgyi, Vincent Du 
Vigneaud and co-workers in 1940. Biotin is an active compound that 
participates in many enzymatic reactions. One o f its main uses is in the 
production o f energy from dietary glucose and the production o f energy from 
non glucose source. It is a co-enzyme in the synthesis o f fatty acids and purine 
in the body. Biotin is also used in the production of antibodies and increases the 
effectiveness of the immune system. Deficiency of biotin leads to loss of 
appetite, infections of the mucous membranes, depression, insomnia, muscle 
pain, rashes, discomfort and increased level o f cholesterol in the blood.
2.3.12 Folic Acid
A deficiency o f folic acid is thought to be associated with a whole range of
problems including neurological problems (Reynolds, Rothfield and Pincus,
1973) and psychiatric disorders (Carney, Williams and Sheffield, 1979; Abou-
Seleh and Coppen, 1986). Abou-Seleh and Coppen (1986) believe that folic
acid deficiency might be responsible for some o f the depressions noted in
society. When the deficiency is advanced it can lead to megalobastic anaemia.
Deficiency o f folic acid may also result in reversible dementia (Lishman, 1978).
Botez, Botez and Maag (1984) described a group o f patients with low serum
folic acid levels whose intelligence scores increased by over 9 points following
supplementation with folic acid. The role o f folic acid in the biochemistry of
cognitive function is unknown, but it is believed that folic acid is important for
the synthesis o f neurotransmitters serotonin, noradrenalin and dopamine all o f
these neurotransmitters are thought to be important modulators o f attentional
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and higher order memory functions (Wolkowitz, Tinklenberg and Weingartner, 
1985).
2.4 Minerals
2.4.1 Iron (Fe)
Iron occurs in three forms, haem iron (derived from meat), non heam iron 
(derived from vegetables) and non haem iron that is added to food stuffs. Iron is 
needed by the body for the production of red blood cells and the transport of 
oxygen around the body. Iron is also used in the formation o f many enzymes 
required for energy production in the cell, it is essential for the metabolism of B 
vitamins and the functioning of T-lymphocytes. Iron deficiency results in 
anaemia, the symptoms of which include fatigue, pale skin, breathlessness, loss 
of strength, feeling weak, susceptibility to illness and infection due to a 
weakening o f the white cell defence system.
2.4.2 Calcuim (Ca)
Calcium allows the uptake of vitamin B 12 from the intestines. In babies and 
small children, calcium is required for healthy teeth and bone growth. Calcium 
is required for the transmission of nerve impulses, maintaining the fluid balance 
and muscle contraction, coagulation of the blood and cardiac activity. 
Deficiencies o f calcium are rare but can occur, when it does it results in the 
deficiency state rickets.
2.4.3 Chlorine (Cl)
Chlorine is essential for the formation of digestive stomach acids. It is also 
required for the correct functioning of the carbon dioxide transport system in the 
blood. Chlorine regulates the acid-base balance, the fluid balance and the 
osmotic pressure in the blood.
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2.4.4 M agnesium (Mg)
Magnesium is found in the intracellular fluids o f the body. It is required for the 
production and activation of many enzymes that regulate the metabolism of 
proteins, carbohydrates, lipids, nucleic acids and nucleotides. Magnesium is 
also required for the proper functioning o f neurochemical transmission, is vital 
for normal muscle function, cell division, healthy bones and teeth, proper nerve 
function, plays a role in cell and antibody mediated immune response and 
prevents increases in blood pressure. Magnesium deficiency leads to muscle 
weakness, fatigue and in extreme cases cardiac arrhrythmia. Symptoms of 
deficiency include anxiety, loss of appetite, hormonal disorders, insomnia, 
hypoglycaemia, muscle weakness, muscle cramps and pre-menstrual tension.
2.4.5 M anganese (Mn)
Manganese possess antioxidant properties, it is used for the formation o f strong, 
healthy bones, healthy nerves and muscles and for the control o f growth. 
Manganese is also important for the metabolism of carbohydrates and fats. 
Deficiency o f manganese results in reduced hair growth, rashes and emaciation.
2.4.6 Molybdenum (Mo)
Molybdenum is a metallic element whose role in the human body is unknown. It 
is thought to be essential for the formation o f at least 3 enzymes that act to 
neutralise toxic sulphur compounds. Molybdenum is also thought to be 
important for the production of haemoglobin and helps prevent dental caries.
2.4.7 Selenium (Se)
Selenium was first discovered in 1817 by Jons J. Berzelius. Selenium has a 
number o f different tasks in the human body. It acts as an antioxidant 
preventing peroxidation of lipids in the cell, it boosts the immune system by 
improving the operation of the T-lymphocytes and macrophages. Selenium also
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helps to inhibit the toxic effects of heavy metals such as mercury, cadmium, 
lead and arsenic.
2.4.8 Bioflavinoids (vitamin P)
This is the name given to a group of naturally occurring pigments produced by 
plants. They are used by the body to strengthen the walls o f blood capillaries to 
prevent bleeding into tissues. They are essential for the absorption o f vitamin C, 
and are used to help healing of muscles, sprained joints and chafed skin.
2.4.9 Zinc (Zn)
Zinc is a metallic element that is very important for good health. Zinc forms 
part o f the active site o f around 2 0 0  enzymes used to form bone tissue, heal 
wounds and sores, produce protein and regulate carbohydrate metabolism, and 
required for the synthesis of ribosomes and ribonucleic acids. Zinc helps boost 
the immune system. Zinc also forms part o f the enzyme that allows the release 
of insulin from the pancreas. Zinc deficiency results in the body being unable to 
utilise vitamin A, which causes problems with the skin, can reduce healing of 
wounds. Zinc deficiency can also result in decreased alertness, poor appetite, 
susceptibility to infection and injury, hormonal disturbances and fatigue.
2.5 The role of multivitamins in the Central Nervous 
System (CNS)
Numerous lines o f research have shown that vitamins and their derivatives play 
important roles in the nervous system.
2.5.1 Neurotransm itter syn thesis
Many trace elements such as vitamins Bi, B2 , B6 , Bu and folate are involved in 
the metabolic pathways that lead to the synthesis of neurotransmitters such as 
dopamine, acetylcholine, noradrenaline, serotonin and GABA.
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Ascorbic acid is necessary for the synthesis o f noradrenaline, dopamine and 
acetylcholine.
Vitamin E&6 is a cofactor in the irreversible synthesis of several essential 
neurotransmitters including adrenaline, noradrenalin, serotonin and y- 
aminobutyrate.
Folic acid and vitamin B 12 are important coenzymes for the breakdown of 
catecholamines.
2.5.2 Antioxidant protection
The beneficial effects on cognition may also be due to the fact that many 
micronutrients possess antioxidant functions. For instance, vitamins C, E and 
beta carotene help to protect the cerebral lipids and neurotransmitters from 
oxidation (Di Mascio, Murphy and Sies, 1991; Halliwell and Gutteridge, 1989; 
Stocker and Frei, 1991) whilst antioxidants also help to protect brain function 
by inhibiting arthrosclerosis (Gey, 1994).
2.5.3 The release of energy from foods
Vitamin Bi is an active component necessary for the enzyme responsible for the 
metabolism of carbohydrates. Vitamin B2 is a component o f coenzymes 
necessary for oxidation-reduction of fatty acids pyruvate and amino acids, and 
are also needed in the process o f electron transport. Vitamin B 12 is essential in 
the nutrition of higher animals and coenzyme B 12 is essential for the transfer o f 
hydrogen atoms between adjacent carbon atoms. Biotin is the prosthetic group 
of certain carboxylases responsible for the carrying of carbon dioxide. Folic 
acid is a precursor for a coenzyme responsible for the enzymatic transfer of 
certain one carbon compounds.
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Vitamins are also required for the metabolism of neurotransmitters e.g. vitamin 
Bj is essential for the breakdown of glucose, nicotinamide and vitamin B2 play 
important roles in energy production.
2.6 The effects of vitamin supplementation on aspects 
of cognition, mood and behaviour
Changes in cognitive function can have detrimental effects on everyday 
functioning, these changes can be a result of a whole range variables such as 
illness, drug treatments and nutritional status. Declines in cognitive function are 
especially a problem for older subjects, who simply because o f their age are 
already exposed to disruptions in cognitive function.
A number o f studies were conducted in the 1940’s whereby the micronutrient 
content o f diets were restricted by omitting certain important nutrients which 
resulted in dramatic changes both behaviourally and psychologically.
Berryman, Henderson, Wheeler, Cogswell, Spinella, Grundy, Johnson, Wood, 
and Denko (1947) reported that consuming diets deficient in certain B vitamins 
(vitamin Bi, B2 , B6 , nicotinic acid, folic acid, pantotenic acid and biotin) was 
associated with changes in personality (higher self reporting o f hysteria, 
depression and hypochondriasis) and poor motor performance. When the 
subjects were supplemented moderate improvements in psychometric test scores 
were noted.
Williams, Mason, Smith and Wilder (1942) reported that consuming diets 
deficient in vitamin Bi resulted in an inability to concentrate, confusion of 
thought, uncertainty o f memory, anorexia, irritability and depression.
Farmer (1944) reported that a diet low in vitamin C is associated with poor 
reaction times, severe fatigue and changes in personality (Kinsman and Hood,
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1971). Low levels of dietary vitamin B2 , folic acid and vitamin C have been 
linked to feelings of tiredness, fatigue, confusion and depression (Bell, Edman, 
Morrow, Marby, Mirages, Perrone, Kayne and Cole, 1991; Brozek and 
Guetzkow, 1957; Sterner and Price, 1973; Kinsman and Hood, 1971). Low 
levels of niacin, vitamin Bi, vitamin B 12 and folic acid have been associated 
with psychiatric syndromes including depression and dementia (Strachan and 
Henderson, 1967; Hunter, Jones, Jones, Matthews, 1967; Abou-Saleh and 
Coppen, 1986; Sommer and Wolkowitz, 1988; Deijen, van der Beek, Orlebeke 
and van der Berg, 1992). Low levels of vitamin B6 have been associated with 
sleep disturbances, insomnia and irritability (Brin and Bauemfeind, 1978), pre 
menstrual tension (Abraham and Hargrove, 1980). Low levels o f vitamin Bi, 
vitamin C and folate are associated with poor mood (Heseker, Kubler, 
Westenhofer and Pudel, 1991). One of the most important things to note is that 
many of the above symptoms are evident long before clinical symptoms of 
deficiency are observed.
Vitamin B 12 deficiency presents a wide variety of symptoms including, 
parasthesia, ataxia, mood disturbance, delusions and paranoia. Vitamin B6 
deficiency is reported to produce peripheral neuropathy and convulsions in 
humans.
Folate deficiency has been associated with irritability, forgetfulness and 
paranoia a high incidence of folate deficiency has been observed in patients 
with psychiatric disorders including depression, dementia, schizophrenia and 
epilepsy.
It is important to note that many of these studies were conducted during the war, 
and as well as vitamin deficiency, these subjects were suffering from a whole 
range of social and emotional problems that may have contributed to such 
changes. Despite this minor criticism, these studies highlight the fact that diet,
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more importantly an inadequate diet can have a profound effect on aspects of 
cognitive and psychomotor performance.
Since vitamins play such a vital role in the nervous system, vitamin deficiency 
is likely to affect human cognition and behaviour. We should not assume that 
sub-clinical malnutrition is not present simply because o f the absence of 
physical signs and symptoms. Nutritionists have calculated a person’s everyday 
requirements for multivitamin nutrition, these requirements are termed 
Recommended Daily Allowances (RDA’s), however current definitions of 
adequate nutrition (RDA’s) are based on physical conditions rather than mental 
function. Hence what is adequate to prevent physical signs and symptoms may 
not be adequate to prevent impaired mental function.
Nutritionists maintain that micronutrient deficiencies rarely occur in Western 
industrialised societies, they have been virtually eradicated due to better 
standards o f living and improved nutritional awareness.
Despite the fact that nutrition and health care have improved over the years, the 
previous chapter reports that subclinical or ‘marginal’ nutritional deficiencies 
do exist, however, the extent and impact of these subclinical deficiency states 
are largely unknown. Evidence does seem to indicate that there are vulnerable 
sectors in the population particularly young children, teenagers and the elderly.
If nutritional deficiency results in a disturbance o f cognitive function, then 
research teams must endeavour to adopt appropriate assessment methods 
designed to detect declines in cognitive performance. Without such methods, 
then it would not be possible to assess what aspects o f cognitive function are 
affected when a nutritional deficiency exists, and more importantly, it would not 
be possible to detect improvements in performance as a result o f improved 
nutritional status.
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There are two methods available for the assessment o f cognitive function. 
Firstly, assessment with the use o f subjective rating questionnaires and secondly 
assessment of actual cognitive function with the use o f valid and reliable test 
measures. Two chapters will be dedicated to the assessment o f cognitive 
function in healthy elderly volunteers. Chapter three will consider the role of an 
activity of daily living scale (ADL) for the subjective assessment o f human 
cognitive function. Chapter four will examine cognitive function with the use of 
objective test measures.
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3 Chapter Three: What problems do the
elderly face in regard to the performance of 
everyday activities as assessed using An 
Activity of Daily Living Scale (ADL)?
3.1 Chapter Outline
The use o f rating scales for the assessment o f cognition and everyday 
activities in the elderly.
Analysis o f self reported activity o f daily living in the elderly 
Identifying groupings within the ADL questionnaire -  Principal 
Components Analysis
Two Factor Solution 
Four Factor Solution
Three Factor Solution (Attention, Orientation/comprehension, 
Memory)
Analysis o f the tasks that cause the elderly problems 
Analysis o f factor scores
The effects o f age and gender on attention factor score 
The effects o f age and gender on orientation factor score 
The effects o f age and gender on memory factor score 
Analysis o f mean scores
The effects o f age and gender on attention mean score 
The effects o f age and gender on orientation mean score 
The effects o f age and gender on memory mean score 
Analysis o f tasks that subjects no longer perform
The effects o f age and gender on attention factor score 
The effects o f age and gender on orientation factor score 
The effects o f age and gender on memory factor score 
Analysis o f tasks that subjects have never performed
The effects o f age and gender on attention factor score
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The effects o f age and gender on orientation factor score 
The effects o f age and gender on memory factor score
This chapter considers the assessment o f cognitive function with the use o f a 
subjective rating scale-an Activity o f Daily Living Scale (ADL) comprising 59 
items. The chapter aims to identify cognitive decline in a sample o f 160 healthy 
drug free elderly volunteers. Answers to the 59 questions were analysed using a 
principal components analysis in order to identify cognitive groupings within 
the scale, so as to determine the effects o f age on the separate cognitive 
groupings.
3.2 Introduction : The use of rating scales for the
assessment of cognition and everyday activities 
in the elderly
Chapter two would seem to indicate that cognitive function is adversely affected 
by a number of variables such as age, poor nutritional status and poor health etc. 
Decrements in cognitive function can have profound effects on performance in 
everyday life, increasing the risk of accidents in and around the home.
One important question arises, if  the elderly suffer from decrements in cognitive 
function, then how can these changes be detected or measured, and more 
importantly do these changes in cognitive function adversely affect the 
performance of everyday activities.
Gerontologists and psychologists commonly use two methods for assessing 
cognitive function in the elderly. Researchers can use objective psychometric 
tests to assess actual cognitive function, or alternatively they can use subjective 
rating scales/questionnaires designed to evaluate what the person feels is 
happening to cognitive function.
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The assessment of cognitive function with the use of performance tests is a well 
documented and respected method for the assessment o f age related change, 
known to be valid, reliable and sensitive to both age and drug related change. 
Objective test measures are often the preferred choice for assessing functional 
and cognitive abilities in elderly subjects. However, several drawbacks have 
been associated with these measures namely, the relationship o f such tasks to 
everyday life is questionable, they are time consuming and often expensive and 
they also require space, specially trained staff and technical equipment. Due to 
these constraints such measures are only suitable for the assessment o f small 
numbers o f subjects, therefore many elderly people who are experiencing 
problems with their functional ability may never get tested. Another drawback 
of psychometric tests are often compromised by ailments suffered by the elderly 
such as poor hearing, eyesight, problems with motor ability and many drugs 
used to treat disorders can preclude performance on some psychomotor tests 
e.g. benzodizepines, old generation antidepressants and antihistamines etc.
3.3 Subjective rating scales for the assessment of 
cognitive function
A less expensive method for assessing cognitive function is with the use of  
subjective rating scales. Generally two types o f subjective ratings are available, 
self rating and informant rating scales (completed by the subjects close relatives 
or carer). The use of subjective rating scales is very popular in the assessment of  
elderly persons, as if  you want to know what is happening to cognitive function 
as a result o f age, then the most direct way, is to ask an elderly person what 
problems they are experiencing.
The use of rating scales in psychological research is becoming a popular method 
of assessment, as the scales are quick and easy to administer, relatively 
inexpensive compared with the cost o f using psychometric assessments. Rating 
scales are not compromised by drug treatment and illness, they can be
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administered to large numbers of the population, generate large amounts o f data 
in a very short time duration, they can be completed in the comfort of the 
subjects home, and hence are less daunting than a laboratory situation. Self 
rating questionnaires are an innocuous way of obtaining large amounts o f data 
from subjects and can be used to examine a wide spectrum of cognitive 
performance/behaviour in everyday life.
The use o f rating scales in psychogeriatric research is not a new method for 
assessment. There are numerous scales available for the assessment of cognitive 
function. Assessment o f self reports, and in particular problems with the 
performance o f everyday living is a very important factor for determining 
quality o f life. For example if  the elderly person is unable to prepare meals, 
dress themselves, operate household appliances, or manage their finances, then 
there is a strong possibility that they will lose their independence and be taken 
into a residential home or nursing home for the elderly.
Self reports are very important for giving an overall picture o f what is 
happening to the elderly person and can be especially useful when used to 
assess functional change in Alzheimer's Disease. As Kaplan (1979) points out 
"Almost never is a senile first identified as a result o f poor performance in a 
psychological test. Sometimes the complaint presented when an older person or 
his family seeks professional advice is the loss of a long practised skill 
involving both short term and long term memory, such as the ability to dial a 
telephone number accurately or to tell the time correctly. Deterioration in self 
care is often associated with developing dementia. Such losses may indicate 
serious impairments since they relate to abilities that have been practised for 
many years" ( pp 45-77).
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3.4 The history of ADL self rating scales
There are numerous rating scales for the assessment of everyday activities in the 
elderly. However the development of these scales rests heavily on the earlier 
scales developed for the assessment of functional change in patient populations, 
hence their utility in the everyday world with apparently healthy subjects is 
limited.
Functional ability is essentially defined as the ability to perform basic activities 
of daily life without support, this being the key factor for determining overall 
independence and quality o f life. Functional ability has long been the 
cornerstone o f rehabilitation. There are many instruments for functional ability 
assessment namely the Barthel ADL index (Mahoney and Barthel 1965); the 
Disability Impairment Interview Schedule (DISS) (Bennett, Garrard and Halil, 
1970); Disability Rating Scale (Akthar, Broe, Agnes, Crombie, Andrews and 
Caird, 1973); the GERRI- The Geriatric Evaluation by Relatives Rating Scale 
(Schwarz, 1983); the Ward Function Inventory (Norton, Romano, and Sandifer, 
1977) to name but a few.
There are two main types o f functional assessment instrument, the Activity of 
Daily Living scale (ADL self report questionnaire) and the Instrumental 
Activity o f Daily Living scale (IADL self report questionnaire). The Activity o f  
Daily Living scale (ADL), assesses capability to perform basic activities such as 
dressing, bathing, toileting, feeding etc. -  basic skills essential for self 
maintenance. One of the most popularly used ADL scales is Katz, Ford, 
Moskowitz, Jackson and Jaffee (1963) Activities o f Daily Living scale (ADL).
The second type o f self report assessment is the Instrumental Activities o f Daily
Living scale (IADL). Instrumental activities o f daily living focus on higher
order activities which enable a person to adapt to the environment and to live
independently in the community. These IADL scales assess tasks such as
housekeeping, shopping, handling finances, managing medication, using the
telephone and wider mobility such as using public transport etc. IADL's are
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more sensitive than ADL scales in detecting modest functional loss. One o f the 
most widely used IADL scales is the Lawton and Brody (1969) Instrumental 
Activities o f Daily Living (IADL).
3.5 Criticisms of ADL self rating scales
World-wide there are more than 200 published scales for the assessment of 
ADL and IADL, however many o f these scales have not been validated and are 
not suitable for the assessment of functional impairment in normal, healthy 
elderly populations. Each country tends to rely on their own culturally specific 
scales for the assessment of elderly persons, the advantages o f this are that each 
country is able to detect their elderly persons specific needs, and therefore the 
people are not being questioned about activities that they do not perform. 
However the disadvantage of cultural specific scales is that research teams are 
unable to make cross cultural generalisations, therefore when such scales are 
included in clinical trials researchers are unable to compare results across 
cultures. This is major criticism of many o f the scales used today. Another 
general criticism of many of the scales is they often yield a single global score, 
which makes it very difficult to identify specific aspects o f cognitive decline. It 
is possible that a person is experiencing problems with memory function rather 
than any other aspect o f cognitive ability, this information would be lost when 
assessing cognitive change in terms o f a single global score.
There are a number of rating scales available to identify specific aspects of 
cognitive function e.g. memory. Memory questionnaires have proved very 
popular in psychology, as instead of trying to observe a person's success or 
failure at a memory task, the questionnaires describe a prototypical memory 
situation and ask respondents to rate their memory performance in terms o f the 
situation.
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Worries about decline in memory are particularly prevalent in aged subjects. 
Poon (1985) reports that "Middle-aged and elderly persons universally complain 
about the fact that their ability to remember and retrieve information is not as 
good as it used to be" (p 427-462). Guttman (1980) reported that after 
arthritis/rheumatism, memory loss was the second most frequent problem 
described by elderly Canadians.
One o f the most fundamental issues in terms o f the use o f questionnaires for the 
assessment o f cognitive function in aged subjects is, are the subjective 
complaints o f change in cognitive efficiency with age accurate? Do these 
subjective impressions reflect real changes in their cognitive performance, or 
rather are they manifestations of other variables such as general state o f health, 
depression, self esteem etc?
A number o f researchers have tried to assess the validity o f self reports in aged 
subjects, either by comparing answers to such questions with young subjects, 
assessing changes in memory with age, or by comparing subjective answers 
with objective task performance.
3.6 The use of subjective rating scales for the
assessment of cognitive function in the elderly
Zarit (1982) assessed memory in a sample o f 79 healthy elderly persons aged 
50-82 years (mean age 66.5 years) with the use of a structured interview. The 
interview consisted of 1 1  questions assessing ability to remember information 
from a few minutes ago, days and years ago, remembering names, facts, words, 
directions, the locations of household items and daily tasks. Subjects were also 
asked to make a global rating of memory. It was reported that most subjects 
reported having some difficulty with memory. Twenty five percent o f the 
sample reported that they had a lot o f trouble remembering recent events and 
events that happened a long time ago; 61% percent of the sample reported
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problems with remembering names. Subjects were also asked to rate their 
memory when they were young and at the present time using a 10 point scale. 
They rated memory when they were young to be 8.11 and this fell to 5.73 when 
they were old.
Jorm, Christensen, Hendersen, Korten, Mackinnon and Scott (1994) assessed 
cognitive complaints in elderly subjects aged greater than 70 years. Subjects 
were asked to answer 4 questions. "Overall do you feel you can remember 
things as well as you used to?", "Does this interfere in any way with your daily 
life?", "Do you feel you can think and reason as clearly as earlier in life?" and 
"Does this interfere in anyway with your day to day life?". It was reported that 
60% of subjects sampled believed that their memory was worse than in earlier 
life, whereas only 6% felt that the decline in memory interfered with their daily 
life. 30% of the subjects felt that they could not think and reason as well as in 
earlier life, only 5% felt that this interfered with their life.
Hultsch, Hertzog and Dixon (1987) designed a metamemory in adulthood 
questionnaire to gain information on memory beliefs o f older subjects. They 
reported that older adults gave lower estimates of their memory capacity, 
reported more decline in memory function with increased age, and were less 
inclined to believe that they had any control over their own memory capacity.
Johansson, Allen-Burge and Zarit (1997) assessed memory complaints in a 
sample of 267 elderly subjects (172 women, 95 men) aged 84-90 years (mean 
age 86.85 years). Subjects were asked to rate their memory, by answering 4 
questions. "On the whole, do you think that your memory is good or poor?", 
"Do you think you have problems with your memory that make your life more 
difficult?", "Do you think that your memory has gotten worse during the last 2 
years?" and "On the whole, do you think that you have problems remembering 
things that you want to do or say?".
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Subjects also completed a depression scale (CES-D, The center for 
epidemiological studies depression scale). They reported that subjects who had 
reported that their memory had declined had significantly lower self evaluation 
scores.
Maylor (1990) compared average scores on Broadbent's Cognitive Failure's 
Questionnaire (CFQ) obtained from 3509 subjects aged 50-86 years with 
average scores obtained from 475 young subjects collected by Matthews (1990). 
They reported that older subjects reported fewer lapses than young subjects on 
all except four questions. Older subjects reported that they forgot people's 
names, forget whey they went from one part o f the house to another, find they 
experience "tip of the tongue" and forget what they wanted to buy in shops 
more frequently than younger subjects. It was also reported that female subjects 
aged 50-86 years, reported more memory lapses than male subjects.
3.7 Drawbacks of subjective rating scales
Martin (1986) conducted a study to examine whether self ratings were different 
for different age groups. Two groups of subjects 30 young subjects (aged 18-30 
years, mean age 22.9 years); and 30 elderly subjects (aged 60-78 years, mean 
age 66.3 years) completed an Everyday Memory Questionnaire (EMQ), an 
Everyday Attention Questionnaire (EAQ) and the Cognitive Failures 
Questionnaire (CFQ). It was reported than there were no significant differences 
between the mean scores on any o f the questionnaires between the age groups. 
However, there were differences between the groups when separate questions in 
the questionnaires were examined. In the Everyday Memory Questionnaire 
(EMQ), older subjects reported more problems with names, faces and telephone 
numbers, however the older subjects were better than younger subjects at 
remembering appointments, colours, paying bills and taking medication. On the 
Cognitive Failures Questionnaire (CFQ) older subjects were more likely to 
report forgetting names than younger subjects, however were less likely to
report conversational failure, day dreaming, word misuse, laterality errors, 
reading distraction and colliding. This experiment highlights the fact that global 
scores may mask any problems, as analysis of global scores revealed that there 
were no significant differences between the groups, and the differences were not 
apparent until actual questions were analysed. The experiment also highlights 
the fact that it is often the case that younger subjects report more problems with 
memory and cognitive function with the use o f a questionnaire than older 
subjects. A number of researchers have reported that younger subjects report 
having poorer memories than older subjects.
Tenney (1984) administered a lost and found questionnaire to 281 young 
subjects (aged 17-26 years) and 153 old subjects (50-92 years) to examine 
incidents in which objects were misplaced and recovered. There was no 
significant difference between the number o f incidences reported by the young 
(31.3%) and old subjects (26.1%). More old than young subjects reported 
finding the object in plain sight, in its proper place, and in a place already 
searched, suggesting a tendency with age to overlook objects in obvious places. 
It was expected that the elderly subjects would report more incidences of  
misplacing objects, however it was reported that young subjects reported more 
instances. This in itself is not surprising, after all young subjects are usually 
leading busier lifestyles than the elderly therefore the scope for forgetting is 
much greater.
A similar finding was reported by Rabbitt and Abson (1991) they assessed 
cognitive failure in a sample of 322 subjects aged 50-96 years, using 
Broadbent's cognitive failures questionnaire (CFQ), they found that subjects 
aged 50 reported more lapses of memory than subjects aged 60-70 years.
Herrmann (1982) reviewed the properties o f 14 questionnaires (including the 
Cognitive Failures Questionnaire, the Inventory o f Learning Processes, and the 
Memory Change Questionnaire, Everyday Memory Questionnaire) developed
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independently to assess people's beliefs about their memory performance in 
natural circumstances. They were assessed in terms o f their reliability in 
reporting what is happening to memory, by comparing the results given on 
them, with actual memory performance. It was reported that very few o f the 
questionnaires correlated with actual memory performance, and even when 
there was a correlation, it was very small. Research has found that responses to 
these questionnaires are reliable but that they correspond only moderately with 
a person's memory performance. Apparently beliefs about their memory 
performance are stable but not accurate. Research also has found that responses 
to memory questionnaires vary with several variables: the kind o f memory 
failure, susceptibility to cognitive failures under stress, confidence in memory 
performance, age o f subjects and the medical and emotional status of the 
subject. Thus, although memory questionnaires are only moderately successful 
indicators o f memory performance, they may nevertheless elucidate the 
properties o f beliefs that underlie performance. Perhaps the most interesting 
finding is that out of all 14 questionnaires examined, only five o f the 
questionnaires were found to correlate with objective performance tasks, and 
even when they were correlated, the correlations were very small indicating that 
memory questionnaires cannot be used as a substitute measure o f memory 
performance.
Rabbitt and Abson (1990) assessed self ratings of memory in elderly subjects 
and reported that they are useful sources o f information, however they do not 
portray a true reflection of the elderly persons cognitive functioning. The 
authors propose a number o f reasons to try and account for this. Firstly one of 
the main drawbacks of self rated questionnaires is that it is not possible to 
validate a persons response on a self rated questionnaire, as Hermann (1982) 
reported, responses on subjective questionnaires do not correlate with objective 
performance tasks. Many of the self rated questionnaires report a global score 
(which is gained by summing results on all questions). This method tends to 
obscure the results, as two people with different failures in cognitive function
may get the same global score, indicating that the subjects had similar problems 
with cognitive function. However, it is possible that one subject was suffering 
problems with memory, whereas the other person had problems with 
attention/concentration.
Another problem with self rating questionnaires are that they probe the number 
and variety o f lapses, but not the reasons why people make them, which may 
prove to be misleading. For example, it has been reported young subjects often 
report more lapses with memory than older subjects (Martin, 1986; Rabbitt and 
Abson, 1991; Tenney 1984) which could be taken as evidence that younger 
subjects experience more decline than older subjects. However, when you 
examine the life styles o f the subjects, it become apparent that younger subjects 
lead busier lives than older subjects and hence they experience more occasions 
in which to forget/lapse than older subjects.
Other problems with self rated questionnaires are that individuals with poor 
memories may 'forget that they forgot' and so under report their lapses, The 
reverse is also possible. Older subjects may exaggerate the rate o f decline 
simply because they are complying to a self fulfilling prophesy, as they believe 
that as they get older they will experience more decline and hence they will 
mistakenly attribute occasional absentmindedness to age related decline (Kahn, 
Zarit, Hilbert andNiderehe, 1975).
Nisbett and Wilson (1977) report that people have limited conscious access to 
their own cognitive processes and hence have to rate their ability by comparing 
it with other people, or in terms of their success in coping with the particular 
demands that their lives place on them. This often means that the results 
obtained are unreliable. Older people suffering from a reduction in the speed of 
information processing may be unable to allocate sufficient resources to monitor 
performance adequately and hence may be unable to achieve awareness o f their 
lapses/errors. Results on self rating questionnaires often reflect differences in
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confidence, self regard and mental state (i.e. depression) rather than actual 
cognitive function.
3.8 Conclusions
Despite the caveats, cognitive gerontologists regard self assessment 
questionnaires as unique useful tools to discover what changes in cognitive 
efficiency people experience as they grow old, and how these changes affect 
their daily lives. It is important to recognise that self reports can be informative 
even if  they are 'invalid’ in the sense that they cannot be validated against 
objective test measures. Despite the caveats, self ratings are useful in the fact 
that they simultaneously tell us a variety o f very different things, they are 
indicators o f cognitive decline and offer clues about the person's abilities, 
strengths and weaknesses as well as information about self esteem, confidence, 
anxiety, depression, knowledge and intelligence etc.
3.9 Aims of the present chapter : Analysis of self 
reported activity of daily living in the elderly
In the previous chapter, it was noted that nutritional deficiency can predispose 
subjects to cognitive decline. However before we can examine the role of 
improved nutritional status on cognitive functioning we must first identify the 
types o f behaviour that decline with age.
This chapter details the use of an activity o f daily living scale (ADL) for the 
detection o f cognitive decline in healthy elderly subjects. The scale was a draft 
version o f the Bayer International ADL scale for the assessment o f elderly 
subjects world wide regardless of their cognitive status.
The chapter aimed to firstly identify relationships between the different 
questions posed, in the hope that rather than gain a global score, it would be
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possible to identify groupings contained within the questionnaire. Therefore 
enabling the effects o f age on different aspects o f cognitive decline i.e. memory 
and attention to be ascertained. Secondly, having identified separate groupings, 
the effects of age and gender will be examined on each o f the groupings.
3.10 Methods
3.10.1 Subjects
160 elderly subjects (70 males, and 90 females) aged 61-84 years, mean age 
70.25 years, (mean age for males was 75.86 years and mean age for females 
was 65.59 years). All subjects were community dwelling elderly volunteers in 
good health and were free from current drug usage.
3.10.2 Procedure
In order to assess problems that the elderly are experiencing with the 
performance of everyday activities, a sample o f 160 healthy non-drug taking 
elderly subjects completed an activities o f daily living questionnaire containing 
59 questions. The questionnaire was sent to 250 elderly subjects, 64% of the 
questionnaires were returned.
Answers to the questionnaire were analysed using principal components 
analysis to determine relationships between questions, and more importantly to 
identify what aspects of cognition were causing the elderly the greatest 
problems.
The ADL includes codes which reflected increasing difficulty with task (0-3), 
but also used codes 4 and 5 for cases where the individual no longer performs 
the task (4), and never performed the task (5). The tasks that are posing 
problems (i.e. those rated 0-3) were analysed together, tasks no longer 
performed (rated 4) and tasks never performed (rated 5) were analysed 
independently.
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3.10.3 A ssessm en t
All subjects completed a draft version of the Bayer International Activities of 
Daily Living Scale (ADL). The original scale consisted of 63 questions, 
however for this analysis only 59 questions were analysed (4 o f the questions 
were removed from the analysis as they were questions about current 
employment and were not responded to). The questions aimed to identify 
problems that elderly persons were experiencing with the performance o f their 
everyday tasks, such as housework, operating household appliances, the use of 
the telephone, shopping, travelling and visiting friends, managing finances and 
medication etc.
The questionnaire aimed to address all behaviours thought to reflect aspects of 
cognitive performance such as memory, attention, concentration, orientation, 
comprehension etc.
Subjects were required to rate how often they have experienced a problem with 
the performance o f each task during the last four weeks.
Subjects had to answer each question using the scale
0 = The task has never posed a problem
1 = The task sometimes posed a problem
2 = The task often posed a problem
3 = The task always posed a problem
4 = I no longer perform this activity
5 = 1 have never performed this activity
3.11 Results : Identifying groupings within the ADL 
questionnaire -  principal components analysis
The 59 items were subject to a principal components analysis using Statistica. 
Factors with Eigenvalues equal to or greater than 1 were retained for a oblimin
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rotation. When test items loaded on more than one factor, they were included in 
a factor according to their maximal weighting. Factor scores were calculated for 
each subject by summing the raw scores on each of the individual items in each 
factor. This produced 18 factors for the assessment of functional capacity with 
Eigenvalues greater than or equal to 1 (see Table 3 and Figure 1).
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Figure 1: Showing the scree plot from the principal.
Table 3: Showing the results of the principal components extraction (Eigenvalue,
the percentage of variance accounted for by each factor, and the cumulative percentage) 
for 18 factors.
Factor Eigenvalue % variance Cumulative %
1 9.3 15.8 5.8
2 4.7 8.0 23.8
3 2.6 4.5 28.3
4 2.2 3.8 32.2
5 2.1 3.5 35.8
6 1.9 3.3 39.2
7 1.9 3.2 42.4
8 1.6 2.7 45.2
9 1.5 2.6 47.8
10 1.4 2.4 50.3
11 1.3 2.3 52.7
12 1.3 2.2 54.9
13 1.2 2.1 57.0
14 1.2 2.0 59.1
15 1.1 1.9 61.0
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Factor Eigenvalue % variance Cumulative %
16 1.1 1.8 62.9
17 1.0 1.8 64.7
18 1.0 1.7 66.4
Overall, 18 factors account for a total of 66.4% o f the variance o f the ADL 
scale. However, as their are only 59 questions in the scale, many of the factors, 
particularly the last few factors may only consist o f one or two questions per 
factor. It is unlikely that one or two questions could be classified as a reliable 
index of everyday activity therefore a more economical solution was sought.
The 18 factor solution can be seen in appendix 2.
Examination of the scree plot would seem to indicate that the data could be 
reduced to either 2, 3 or a maximum of 4 factors.
3.11.1 Two Factor Solution
Principal components extraction was repeated to obtain 2 factors. When 2 
factors were extracted the factors seemed to relate to familiar actions/behaviours 
and unfamiliar actions/behaviours. Factor one (familiar actions) factor 
accounted for 15.8% of the variance, and the second factor (unfamiliar actions) 
account for approximately 8 % of the variance. Therefore accounting for a total 
of 23.8% of the variance (see Table 4).
Table 4: Showing the results of the principal components extraction (Eigenvalue,
the percentage of variance accounted for by each factor, and the cumulative percentage) 
for 2 factors.
Factor Eigenvalue % variance Cumulative %
1 9.3 15.8 15.8
2 4.7 8.0 23.8
The 2 factor solution can be seen in appendix 3.
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3.11.2 Four factor solution
A four factor solution was also examined. Extraction o f four factors revealed 
that the factors accounted for a total of 32.2% of the variance (see Table 5).
Table 5: Showing the results of the principal components extraction (Eigenvalue,
the percentage of variance accounted for by each factor, and the cumulative percentage) 
for 4 factors.
Factor Eigenvalue % variance Cumulative %
1 9.3 15.8 15.8
2 4.7 8 . 0 23.8
3 2 . 6 4.5 28.3
4 2 . 2 3.8 32.2
When the data was extraction to 4 factors, interpretation o f the factors appeared 
to be quite difficult, it was possible to identify 2  quite distinct factors (attention, 
orientation) the third and fourth factors were more difficult to interpret, and 
appeared to be similar to each other, both were comprised of memory type 
questions. Consequently a three factor solution was imposed on the data.
The four factor solution can be seen in appendix 4.
3.11.3 Three factor solution
A three factor solution was examined. Extraction o f 3 factors accounts for 
28.3% of the total variance. The first factor accounted for 9.3% o f the variance, 
this factor was termed the attention/concentration factor. Factor 2 accounted for 
4.7% of the variance and was termed the orientation/comprehension factor, and 
the third factor accounted for 2 .6 % of the variance and was termed the memory 
factor (see Table 6  and Table 7).
Table 6: Showing the Eigenvalue, percentage of variance and cumulative
percentage of the three factor solution.
Factor Eigenvalue % variance Cumulative %
1 9.3 15.8 15.8
2 4.7 8 . 0 23.8
3 2 . 6 4.5 28.3
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Table 7: Showing the results of the principal components extraction (Eigenvalue,
the percentage of variance accounted for by each factor, and the cumulative percentage) 
for 3 factors.
ADL Questions Factor One 
(Attention)
Factor Two 
(Orientation)
Factor Three 
(Memory)
1 .24 .09 .18
2 .29 . 2 1 .28
3 .29 .15 .40
4 .19 . 1 0 . .45
5 .48 . 1 2 .25
6 .41 .25 . 0 2
7 .35 .13 . 0 0 1
8 .30 .17 .45
9 .36 .34 .13
1 0 - . 1 0 .89 .05
1 1 - . 1 1 .92 .06
1 2 -.06 .93 .07
13 -.07 .87 .09
14 -.08 .93 .05
15 .05 .17 . 1 2
16 .28 .43 .04
17 . 2 1 .32 .25
18 .27 .27 - . 0 2
19 . 1 1 .009 .19
2 0 .47 .15 .09
2 1 .18 .17 . 0 2
2 2 .15 .18 -.003
23 .05 .24 . 1 0
24 . 2 1 . 1 1 .51
25 . 0 0 . 1 1 .65
26 -.04 .06 .74
27 -.14 .03 .65
28 .60 .07 .05
29 .58 .18 .06
30 .44 .05 .18
31 .27 . 1 0 .16
32 .45 - . 0 2 . 1 2
33 .44 .008 . 2 1
34 .54 .007 .03
35 -.18 -.13 .24
36 .50 . 0 2 .16
37 .35 .08 .15
38 .06 .14 .19
39 .23 . 1 0 - . 2 2
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ADL Questions Factor One 
(Attention)
Factor Two 
(Orientation)
Factor Three 
(Memory)
40 .41 . 1 2 .16
41 .40 -.09 .28
42 .51 -.05 - . 0 1
43 . 2 2 -.05 .41
44 .43 .07 -.19
45 .36 .41 .05
46 .35 . 2 2 . 1 0
47 .28 .14 .24
48 .43 .13 .26
49 .51 .05 -.05
50 .38 -.03 .15
51 .30 .33 . 0 1
52 .48 .06 .03
53 .43 . 0 1 - . 0 1
54 . 2 2 .48 -.03
55 .32 .04 .29
56 .49 .05 .05
57 .52 . 1 2 .18
58 .52 .08 . 1 1
59 .43 .13 . 1 1
The 3 factor solution.
The questions contained in each of the three factors (attention, orientation and 
memory).
3.11.4 Factor 1 - A ttention/Concentration
52. Do you experience difficulty “doing two things at the same time?”
58. Is it difficult for you to keep your mind on a task when several other things 
are going on around you?
30. Do you have problems concentrating on conversation?
29. After reading a chapter or a few pages in a book or in an article, do you have 
difficulty describing what you have just read?
36. Do you experience problems concentrating on reading leisure material?
37. Do you have difficulty reading the newspaper thoroughly?
59. Do you put off things because you have difficulty getting them organised?
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28. Do you need to read the same passage or part o f a book (or other reading 
material) several times in order to remember it?
57. If you are interrupted whilst speaking, do you tend to forget what you were 
going to say?
34. Are you easily distracted whilst reading leisure reading material?
56. If you have to wait your turn to speak, do you have trouble keeping in mind 
what you were going to say whilst listening to someone else talk?
5. If you are interrupted during an activity o f chore, do you have difficulty 
continuing where you left off?
32. Do you forget point in the middle of a conversation?
33. Do you have difficulty finding the correct word to use when speaking?
42. Do you forget names o f people who have just been introduced to you?
49. Do you search for personal belongings?
6 . Do you experience difficulty learning new directions regarding how to use 
simple household appliances (e.g. coffeemaker, iron, toaster)?
7. Do you experience difficulty learning new directions regarding how to use 
complex household appliances (e.g. microwave oven, vacuum cleaner, 
washing machine)?
9. When travelling to new places do you sometimes become overwhelmed 
with new information?
20. Do you find it difficult to complete forms?
40. Do you repetitively go from one room into another in order to do or get 
something but then forget what you wanted to do?
41. Do you have problems remembering important dates and events?
44. Do you have difficulty remembering telephone numbers which you 
frequently dial?
46. While counting something up, do you need to recount it several times?
47. When making telephone calls do you dial the wrong number?
48. Do you loose important things?
50. Do you forget anniversaries or birthdays you have always observed in the 
past?
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53. When looking up an unfamiliar telephone number, do you have to refer back 
to it whilst dialling?
55. Do you forget to turn off the stove, turn out the lights, or lock the door when 
you should?
3.11.5 Factor 2 Orientation/Com prehension
17. Do you have difficulty touring an unfamiliar city or place on your own?
54. Do you have trouble following a map to a new place?
9. When travelling to new places do you sometimes become overwhelmed 
with new information?
16. Do you have difficulty reading a map of an unfamiliar city or place?
14. When driving a car, do you become unsure or uncertain about which exits to 
take to get to a familiar place?
11. When driving a car do you have problems recognising landmarks that would 
help you know where to turn?
12. When driving a car, do you have problems recalling landmark that would 
help you know where to turn?
10. Do you have difficulty driving from one familiar spot to another without 
preparation i.e. without carefully going over the route?
3.11.6 Factor 3 Memory
3. Do you forget about what you have just done (e.g. locking the door, pulling 
out a plug on an appliance)?
26. Do you go to social or cultural events on the wrong day or at the wrong 
time?
25. Do you invite friends or relative and forget that you have invited them?
43. Do you buy greetings cards, birthday or anniversary cards for close friends 
or relatives and forget to mail them?
19. If you use public transportation for a route you have never taken before, do 
you feel uneasy and uncertain about what you do?
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4. Do you begin an activity or chore and then forget the steps or sequence of 
behaviours necessary for the completion o f the activity?
27. Do you purchase tickets for an event only to find that you have booked 
tickets for a wrong date or time?
8 . Do you become confused whilst performing several simple activities around 
the home at the same time?
24. Have you started to avoid discussions/conversations because o f difficulty 
finding the correct word to use?
3.11.7 Validity of the factors
In order to determine the validity of the factors, split half reliability rates were 
calculated for each factor using Cronbach’s alpha.
Questions in each of the factors were divided into two groups (questions were 
allocated to two groups, alternate questions to group 1 , answers to questions in 
group 1 were correlated with answers from group 2 ).
Table 8: Showing the split half reliability rate and standardised itemised alpha
score for each of the three factors (attention, orientation and memory).
Attention Orientation Memory
Split half reliability r = 0.77 r = 0.80 r = 0.77
Standardised itemised alpha r = 0.83 r = 0.82
l—
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All questions within each of the factors correlate very highly, therefore the 
factors have internal reliability.
Having identified three distinct factors (attention, orientation, memory) it is 
possible to determine the effects o f age and gender on the factors, in the hope 
that it would be possible to identify age and gender differences within the 
factors.
47
3.12 What are the tasks that cause the elderly 
problems?
This set of analysis refers to the individuals who are still performing the tasks 
(items rated 0-3).
3.12.1 Analysis of factor sco res
A factor score was calculated for each subject on each o f the three factors 
(attention, orientation and memory). These scores were analysed to determine 
gender and age differences.
3.13 Effects of age and gender on new ADL factors
The interaction with age and gender was examined using a two way analysis of 
variance with two between subjects factors, (age band and gender) compared 
with each of the three factor scores (attention, orientation and memory).
3.13.1 Attention factor sco res
There was no main effect o f age (F (4 , 153) = 1.25; p>0.05) factor scores were 
comparable across the ages. There was a tendency for female subjects to report 
more problems with tasks assessing attention, more frequently than males, 
however this failed to reach statistical significance (F (i, 153) = 0.39; p>0.05). 
There was no interaction between gender and age (F (4) i53) = 0.75; p>0.05).
3.13.2 Orientation factor sco res
There was no main effect o f age (F (4j 153) = 0.27; p>0.05) factor scores were 
comparable across the ages. There was no main effect o f gender (F (i, 153) = 
0.003; p>0.05) factor scores were comparable for male and female subjects. 
There was no interaction between gender and age (F (4j 153) = 1.25; p>0.05).
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3.13.3 Memory factor sco res
There was no main effect of age (F (4 , 153) = 0.66; p>0.05) factor scores were 
comparable across the ages. There was no main effect of gender (F (i, 153) = 2.28; 
p>0.05) factor scores wee comparable for male and female subjects. There was 
no interaction between gender and age (F (4 , 153) = 1.59 p>0.05).
3.13.4 Conclusion
Based on the analysis of the factor sores (attention, orientation and memory). It 
appears that the ADL is insensitive to the effects of age and gender. Subjects of 
all ages reported similar rates in terms of the difficulty experienced with the 
performance of everyday tasks regardless of gender.
3.14 Analysis of subjects mean scores
A mean score was calculated for each subject by averaging the results of 
questions that subjects rated as causing them problems, i.e. any questions that 
subjects answered with either as causing a problem some of the time, often and 
always. Mean scores as well as factor scores were calculated because when 
mean scores are calculated, all the questions are weighted equally, however 
when factor scores are calculated, the fact that each item is not equally weighted 
is accounted for. The subjects mean score was analysed in relation to age, 
ageband and gender to determine whether subjects report more problems as age 
increases, or whether there are any differences between the types o f problems 
reported by male and female subjects.
3.15 The effects of age and gender on new ADL factors 
analysis of subjects mean scores
The interaction with age and gender was examined using a two way analysis of 
variance with two between subjects factors, (age band and gender) and mean 
score for each of the factors as the dependant variable.
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3.15.1 Attention factor
There was no main effect o f age (F (4 , 150) = 0.96; p>0.05) the ages are 
comparable in terms o f reporting problems with tasks assessing attention. There 
was no main effect o f gender (F (i, 150) = 0.18; p>0.05) factor scores were 
comparable for male and female subjects. There was no gender age interaction 
(F (4, 150) = 0.80; p>0.05).
3.15.2 Orientation factor
There was no main effect o f age (F (4 , 151) = 0.94; p>0.05) or gender (F (i, 151) = 
0.18; p>0.05) and there was no age gender interaction (F (4 , 151) = 0.80; p>0.05). 
The reporting o f problems with orientation tasks was the same for all age and 
gender.
3.15.3 Memory factor
There was no main effect o f age (F (4 , 153) = 0.51; p>0.05) or gender (F (i, 153) =
0.68; p>0.05) and there was no gender age interaction (F (4 , 153) = 0.26; p>0.05). 
The reporting of problems with memory tasks was the same for all age and 
gender.
3.16 Correlation between mean scores and factor 
scores
Mean scores and the factor scores for each of the subjects were correlated to 
determine whether there was a relationship between mean scores and the factor 
scores (see Table 9).
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Table 9: Showing relationship between subjects mean scores and subjects factor
scores (Pearson product moment).
Attention factor Orientation
factor
Memory
factor
Mean attention score 0.54* -0.64* 0.29*
Mean orientation 
score
0.27* -0.23* 0.38*
Mean memory score 0.23* -0.34* 0.65*
* level of significance p<0.05
As the attention and memory factors are positively correlated with the mean 
scores for both memory and attention, a higher factor score means the same as a 
higher mean score, i.e. the higher the factor score the more problems 
experienced. However as the orientation factor score is negatively correlated 
with the orientation mean score, a higher factor score is indicative o f fewer 
problems with the task, and a lower factor scores is indicative o f more 
problems.
3.17 Correlation between mean scores and the factor 
scores with actual age
The analyses reported above show that age groups differ little in terms o f the 
difficulties they report. This issue was also addressed by examining the 
correlation between actual age and self reported difficulties. In order to do this 
mean scores and factor scores were correlated with actual age using Kendall's 
tau (see Tables 10 and 11).
Table 10: Showing the correlation between factor scores and actual age.
Factors Kendall's tau p level
Attention - . 1 0 p>0.05
Orientation - . 0 0 p>0.05
Memory .08 p>0.05
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Table 11: Showing the correlation between mean scores and actual age.
Factors Kendall's tau p level
Attention -.06 p>0.05
Orientation -.008 p>0.05
Memory -.07 p>0.05
These correlational analyses confirm the results obtained from the earlier 
analyses. Using the three factor method of scoring the ADL, self reported 
difficulties in attention, orientation and memory do not alter with age.
3.17.1 Sum m ary
The results so far, would seem to indicate that there is no evidence of 
differences between age groups, or o f gender, on self reported difficulties in 
attention, orientation and memory, whether the data were analysed using 
subjects mean scores on the questions, or by the more precise measure of 
calculating factor scores for each o f the three factors. As discussed above, these 
analyses reflect the difficulties with activities which individuals still perform, it 
may be however that gender and age differences do emerge in terms of the 
activities people no longer perform.
3.18 Analysis of the tasks that subjects no longer 
perform
As with the previous analysis o f tasks that cause subjects difficulties, mean 
scores were calculated for tasks that subjects reported that they have given up 
(no longer perform), items rated 4.
3.19 Analysis of subjects mean scores for tasks that 
subjects no longer perform
The questionnaire also provided information to identify the tasks that subjects 
were no longer performing. Mean scores (i.e. numbers of activities referred to in
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questions no longer performed) were analysed to assess any gender and age 
differences.
3.20 The effects of age and gender on new ADL factors
Data were analysed using a two way analysis o f variance with age band and 
gender as between subjects factors, and mean score (attention, orientation and 
memory) as the dependant variable.
3.20.1 Attention factor
There were no significant main effects o f age (F (4 , 150) = 1.65; p>0.05) mean 
scores were comparable across the ages. There was no main effect o f gender (F 
(i, 150) = 0.38; p > 0.05). There was no interaction between gender and age (F (4 , 
150) = 1.16; p>0.05).
3.20.2 Orientation factor
There was a significant main effect o f age (F (4 , 152) = 6.45; p<0.0001). There 
was a significant effect of gender (F (i, 152) = 18.04; p<0.0001). There was a 
significant interaction between gender and age band (F (4 , 152) = 2.34 p=0.05). 
Post hoc testing revealed that the greatest divergence is in the highest age band
i.e. very elderly women have given up more orientation tasks than very elderly 
men. (It may be that the difference in male and female longevity means that the 
weaker males die and hence the older males may be a more selected sample) 
(see Figure 2).
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Figure 2 : Showing the incidence of orientation tasks that subjects no longer
perform.
3.20.3 Memory factor
There was no significant main effect of age (F (4 , 153) = 0.41; p>0.05) the mean 
scores were comparable across the ages. There was no main effect o f gender (F 
(i, 153) = 1-37; p>0.05) i.e. males and females report similar rates o f giving up 
memory type behaviours. There was no interaction between gender and age (F 
(4, 153) = 0.45; p>0.05).
3.21 Correlation between subjects mean scores and 
actual age
Analysis o f the effects of ageband on tasks that subjects no longer perform 
report no differences for attention and memory tasks, whereas older subjects 
frequently reported that they no longer performed orientation type tasks 
compared to their younger counterparts. This issue was addressed by examining 
the correlation between actual age and the reports o f no longer performing tasks 
of everyday activities (see Table 12).
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Table 12: Showing the correlation between mean scores and actual age.
Factors Kendall's tau p level
Attention -0.07 p>0.05
Orientation 0.10 p>0.05
Memory 0.20 p>0.05
The correlational analysis with actual age and subjects mean scores for tasks 
that they no longer perform reported that there was no relationship between a 
subjects actual age and no longer performing attention, memory and orientation 
type tasks.
3.21.1 Sum m ary
Unlike the self report data for tasks that subjects do perform, there were a few 
significant differences between the age groups and the genders in the data for 
tasks that subjects no longer perform.
In particular there were significant age and gender differences between subjects 
for reporting that they no longer perform orientation type tasks. Older subjects 
tended to report that they no longer performed orientation type tasks more 
frequently than younger subjects. Female subjects were also more likely to 
report that they no longer performed orientation tasks more frequently than 
male subjects. There was a significant interaction between gender and age, in 
that older female subjects reported that they no longer performed orientation 
type tasks significantly more frequently than older male subjects.
The data would seem to indicate that orientation type tasks pose more o f a 
problem to the ageing population than tasks assessing attention and memory to 
the extent that older subjects no longer perform such activities.
It is possible that gender and age differences may also emerge when the 
activities that subjects have never performed are considered.
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3.22 Analysis of the tasks that subjects have never 
performed
The activity o f daily living self rating questionnaire also provided information 
relating to the types o f tasks that subjects have never performed, items rated 5.
3.23 Analysis of subjects mean scores for tasks that 
subjects have never performed
As with activities no longer performed mean scores were calculated for the 
three types o f behaviour and were analysed.
3.24 The effects of age and gender on new ADL factors
The data were analysed to assess differences between the age groups and gender 
in terms o f tasks that they have never performed. The interaction with age and 
gender was also examined using a two way analysis o f variance with two 
between subjects factors, (age band and sex) compared with each o f the three 
mean scores (attention, orientation and memory).
3.24.1 Attention factor
There was no main effect o f age (F (4 , i50) = 1.39; p>0.05) subjects o f all ages 
reported similar rates for attention type tasks that they have never performed. 
There was no main effect of gender (F (i, 150) = 3.00; p>0.05) males and females 
report similar rates for attention type tasks that they have never performed. 
There was no interaction between gender and age (F (4 , 150) =1.71; p>0.05).
3.24.2 Orientation factor
There was a main effect of age (F (4 , 153) = 4.50; p<0.001) and a main effect of  
gender (F (i, 153) = 13.35; p<0.001. There was a significant interaction between
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gender and age (F (4 , 153) = 2.35; p<0.05), older female subject were more likely 
to report that they have never performed tasks assessing orientation (see figure
3).
Incidence of orientation type tasks never performed
Male
Female
Figure 3: Showing the incidence of orientation tasks that subjects have never
performed.
3.24.3 Memory factor
There was a significant main effect of age (F (4> i53) = 3.16; p<0.01), older 
subjects were significantly more likely to report that they have never performed 
memory type tasks, than younger subjects (see Figure 4). There was no main 
effect o f gender (F (i, 153) = 0.001; p>0.05), males and females had similar 
reports of memory tasks that they have never performed. There was no 
interaction between gender and age (F (4j 153) =1.16; p>0.05).
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The main effect of age on memory tasks never 
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Figure 4: Showing the incidence of memory tasks that subjects have never
performed.
3.25 Correlation between subjects mean scores and 
actual age
Analysis o f the effects of age on tasks that subjects have never performed report 
no differences for attention tasks, whereas older subjects frequently reported 
that they never performed orientation and memory tasks compared to their 
younger counterparts. This issue was addressed by examining the correlation 
between actual age and the reports o f never performing tasks o f everyday 
activities (see Table 13).
Table 13: Showing the correlation between mean scores and actual age.
Factors Kendall's tau p level
Attention -.07 p>0.05
Orientation 0.10 p<0.05
Memory 0.20 p<0.05
The correlational analysis confirm the results obtained from the earlier analysis. 
Using subjects mean scores as a method for scoring the ADL, self reported 
ratings o f no longer performing attention tasks do not alter with age. Whereas 
actual age was correlated with both memory and orientation type tasks.
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3.25.1 Sum m ary
There were main effects found o f both age and gender on tasks that subjects 
have never performed. It was found that older subjects were more likely to 
report that they have never performed orientation and memory tasks than 
younger subjects. Female subjects were also more likely to report that they have 
never performed orientation type tasks than male subjects.
These differences between the ages and genders reflect past societal norms. 
Older subjects and female subjects had fewer opportunities to perform 
orientation type tasks e.g. driving. Fifty years ago, it was considered 
unnecessary for a woman to learn to drive, as driving was perceived as a 
predominantly male task.
3.26 Discussion
This chapter aimed to identify the types of behaviours that pose a problem in the 
everyday living o f elderly persons with the use o f a subjective rating scale, an 
activity of daily living scale (ADL). All subjects completed the questionnaire, 
rating the degree to which certain behaviours caused them problems on a day to 
day basis during the previous 4 weeks. The answers to the questionnaire were 
analysed using a principal component analysis to extract separate factors within 
the scale. It appeared that a 3 factor solution provided the optimal way of 
describing the questionnaire. The 3 factors related to tasks assessing attention, 
orientation and memory.
A mean score and a factor score were determined for each o f the subjects. The 
mean scores and the factor scores were analysed in order to assess the influence 
of variables such as age, age band and gender on performance.
The reason for analysing with both mean and factor scores is that the two scores 
can give different results. When mean scores are calculated, all the questions are
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weighted equally. However when factor scores are calculated, the fact that each 
item is not equally weighted is accounted for. Therefore some questions will 
hold more weight than others, and will account for more variability. As a result 
of this, it is possible that analysis with the factor score may be more 
representative than the mean scores.
Analysis o f the data in terms of mean scores and the factor scores revealed that 
there were no significant gender or age differences between the reporting of 
what tasks cause the elderly problems on a day to day basis.
The questionnaire also provided information relating to what tasks the subjects 
were no longer performing i.e. the tasks that subjects had given up. Mean scores 
for tasks that are no longer performed were analysed in terms o f age and gender. 
There were no significant differences between the rates o f giving up for males 
and females o f all ages for tasks assessing aspects of attention and memory. 
However, there were significant differences between the ages and gender in 
terms o f giving up orientation type tasks. It was found that females were 
significantly more likely to report giving up tasks assessing orientation than 
male subjects, and older subjects were more likely to report that they had given 
up tasks assessing orientation when compared with younger subjects.
As well as being able to assess the types o f tasks that subjects no longer 
perform, the questionnaire was also able to provide information relating to tasks 
that the subjects had never performed. Mean scores for tasks that have never 
been performed were analysed in terms of age and gender. The results o f this 
mirror the results reported for tasks that subjects were no longer performing. It 
was found that there were no significant differences between the attention tasks 
that subjects have never performed. However there were significant age 
differences reported for tasks assessing memory, it was found that older subjects 
were more likely to report that they have never performed memory tasks more 
frequently than younger subjects. This could reflect the fact that the older
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subjects are less likely to have performed memory tasks or simply it could 
reflect the fact that older subjects had forgotten what tasks they had performed.
There were also significant differences between the ages and gender in terms of 
orientation tasks that subjects have never performed. It was found that females 
were significantly more likely to report never having performed tasks assessing 
orientation than male subjects, and older subjects were more likely to report that 
they had never performed tasks assessing orientation than their younger 
subjects.
The results of the subjective rating scale for subjects who are currently 
conducting tasks involving attention, orientation and memory, would seem to 
indicate that age does not affect the rates at which subjects report problems with 
current performance o f the tasks. However, there is a vast literature available to 
provide evidence that ageing results in a decline in aspects o f cognitive 
function, especially aspects o f attention, memory and the speed o f information 
processing. Therefore the results of this experiment would seem to suggest that 
subjective ratings do not provide researchers with a true representation o f what 
is happening with cognitive function as a result of age. Researchers have 
proposed a number o f reasons why older subjects cannot accurately rate 
cognition.
Nisbett and Wilson (1977) noted that individuals cannot inspect their own 
cognitive processes, but can only make inferences about them from received 
social opinion, or by observing the overt effects o f their behaviour on the 
external world. Hermann (1982) and Rabbitt and Abson (1990) have found that 
self rating questionnaires do not predict performance on everyday tasks and 
have suggested many logical and methodological reasons why we should not 
expect them to do so. Rabbit and Abson (1991) note that age differences in 
peoples answers to self rating questionnaires may strongly reflect changes in 
their general levels of confidence and their attitudes towards themselves rather
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than actual changes in their objective abilities. Self reports are often very 
difficult to interpret because people’s answers to such questionnaires often tell 
us a variety o f different things. For example, they offer an explanation of 
peoples competencies and weaknesses, but they also give us information about 
subjects self confidence, anxiety and depression, as well as the extent o f their 
knowledge and insight about subjects abilities, knowledge and beliefs about 
how their memories work.
It is speculated that the elderly show a tendency to exaggerate or underestimate 
the frequency of problems relating to aspects of cognition, as many elderly 
persons believe that the results of such questionnaires may be used against them 
e.g. if  they express that they are experiencing problems with the performance of 
their daily activities they are admitting that they can no longer fend for 
themselves, and that they may be placed into sheltered accommodation or into a 
home for the elderly. Therefore, many researchers believe that the results o f self 
reports should be treated with caution.
The absence o f age differences in the current analysis o f the self-reported 
difficulties of the elderly may be due to such unreliable reporting, but may 
equally reflect the absence o f difficulties. Therefore one o f the best ways in 
which to assess cognitive function and more importantly decline with age, is to 
assess actual decline with the use o f reliable, validated objective test measures. 
Chapter four will detail the results o f psychometric test performance using a 
battery o f cognitive tasks designed to assess declines in cognitive function, in 
the same sample o f drug free healthy elderly volunteers, to determine actual age 
related declines in cognitive function.
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4 Chapter Four: What problems to the elderly 
experience with regard to actual 
performance and do these changes relate to 
subjective ratings?
4.1 Chapter Outline
The relationship between subjective and objective test measures
Subjective ratings that correspond with objective measures.
Subjective ratings that do not correlate with objective measures.
Analysis of objective task performance in a healthy elderly population.
Tasks assessing aspects of attention.
Tasks assessing aspects of orientation.
Tasks assessing aspects of memory function.
Tasks assessing the speed of information processing.
The effects of age and gender on the Syndrom Kurtz Task (SKT)
The effects of age and gender on the CFF, CRT and SMT task 
Relationships between the cognitive function tasks:
Principal components analysis
Age and gender differences in performance of the SKTfactor scores. 
Principal components analysis of the performance data.
The effects of age and gender on the 5 performance factor scores
Performance factor correlations with actual age
ADL factor correlations with actual performance factors
The chapter details the assessments of cognitive function using a battery of tests 
designed to assess aspects of attention, memory, orientation and the speed of 
information processing.
The chapter considers the effects of age and gender on actual task performance, 
aims to identify relationships between the tasks in order to assess different
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aspects of cognitive function, and finally considers the relationship between 
subjective and objective measures.
4.2 Introduction: Assessment of cognitive function in 
the elderly
In the previous chapter, 160 drug free healthy elderly subjects completed a 
subjective rating scale assessing cognitive problems encountered in everyday 
living. Analysis of the data would seem to indicate that the elderly were not 
aware of many of age related changes in day to day cognitive function.
Cognition comprises the mental processes through which knowledge in the 
world can be attained, retained and used, namely the so called higher order 
mental activities such as attention, memory, thinking, reasoning, problem 
solving, perception and language. The term cognition is derived from the Latin 
"cognoscere", meaning to know or have knowledge of. It is generally assumed 
that ageing is associated with a number of changes in cognitive function, on 
some but not all aspects o f cognitive function. Generally, normal ageing is 
associated with a decline in certain aspects o f memory, a general loss of 
processing resources and attention, decreases in problem solving ability, naming 
and fluency, whereas tasks involving language and other verbal skills remain 
relatively unaffected by age.
The effects of age on cognitive function have been described in terms of a 
computer analogy. "The cognitive system is much like a decaying computer 
which gradually looses memory and processing power and so progressively 
becomes unable to run more and more of a set of programmes, still perfectly 
preserved on floppy discs, which it could previously use with no trouble" 
(Rabbitt, 1993 p385-434).
The previous chapter raised a doubt on the credibility o f self reports, there is 
some debate as to whether self rating questionnaires accurately depict problems
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with cognitive function, especially memory. To examine this, research teams 
have asked subjects to rate their memory problems using a self rating 
questionnaire, and perform a battery of psychometric tests designed to 
objectively measure decrements in memory and cognitive function. Direct 
comparisons of the two methods should enable researchers to determine 
whether answers given on self reports accurately depict current cognitive status. 
If self reports are correlated with objective task performance, then answers on 
such rating scales could be regarded as reliable. However, if  answers on rating 
scales do not correlate with actual task performance, then the accuracy of the 
self rating is somewhat doubtful, or rather the real world tests that feature in 
subjective ratings are different to those assessed in psychometric tests.
Numerous research teams have tested cognitive function in healthy elderly 
subjects with the use of both subjective rating scales and objective performance 
tasks.
4.3 Subjective ratings that correlate with objective 
measures
A number o f researchers have reported correlation's between subjective ratings 
and objective test measures.
Johansson, Allen-Burge and Zarit (1997) assessed the relationship between self- 
evaluations, and cognition, in a sample o f 267 subjects (mean age 86.85 years), 
taken from a longitudinal, population-based panel of the oldest old in Sweden. 
Subjects completed self-report measures on memory, and a comprehensive 
battery o f structured behavioural, social, and biomedical assessments.
The self rating o f memory consisted o f 4 questions, subjects had to answer them 
using a Likert type response, the questions asked were "On the whole, do you 
think that your memory is good or poor?"; "Do you think that you have
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problems with your memory that make your life more difficult?"; "Do you think 
that your memory has gotten worse during the past 2 years?" and "On the 
whole, do you think that you have problems remembering things that you want 
to do or say?". Cognitive performance was assessed using a battery of 5 tests, a 
memory in reality test (subjects had to place 1 0  objects in a model house, they 
then had to recall where all 1 0  items had been placed, and actually replace all 
the items in the house); prose recall task (subjects had to provide immediate 
recall o f a story); clock test (subjects had to draw a clock and set the hands to a 
certain time, set the hands on a wooden clock with no numbers on the face, and 
had to state the times of the clocks); coin test (subjects were given 10 Swedish 
coins, they were asked to choose the least number o f coins that added up to four 
pre selected totals); MMSE (Mini Mental State Examination).
Results indicated that overall cognitive ability, was associated among other 
things with self-reports o f memory for the entire sample. The MMSE was 
significantly correlated to self evaluations, better performance on the MMSE 
was associated with fewer complaints. Self evaluations were also highly 
correlated with depression, less depressed subjects had a more positive 
evaluation o f their memory. Self reported decline correlated with actual decline 
(as measured using the MMSE) and predicted decline correlated with 3 tests of 
memory, the coin task, prose recall and the memory in reality task although the 
magnitude o f the relationship was small (.22, .34 and .32 respectively). The 
authors concluded that self reports of memory cannot substitute for objective 
assessment, however they may prove useful as detection tools for "at risk" 
subjects who would warrant for a complete objective assessment.
Zarit (1982) assessed memory complaints and actual memory in a sample o f 79 
elderly persons aged 50-82 years (mean age 66.56 years). Subjective ratings of 
memory were assessed in a structured interview, subjects were asked to give a 
global evaluation of memory, rate ability to remember information from a few 
minutes ago, days ago and years ago, ability to remember names, words, facts,
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directions, daily tasks and the location o f household items. Memory was 
assessed using a 15 item word list, recall o f famous faces task, shopping list 
task, list o f daily activities task, giving directions, a names and faces task and 
visual recall o f a scene. The authors reported that subjective reports of 
difficulties with memory were associated with actual performance on the word 
list task, the shopping list task, daily tasks and tip o f the tongue experiences on 
the famous faces task. It was reported that subjects with poor task performance 
reported more difficulty on the subjective memory interview.
Schofield, Marder, Dooneief, Jacobs, Sano and Stem (1997) investigated the 
relationship between memory complaints and cognitive performance among 364 
healthy community-dwelling elderly subjects. Memory complaints were 
recorded as present or absent at the baseline evaluation. After 1 year, 169 o f the 
subjects were re-evaluated. At baseline, 31% of the normal subjects and 47% of 
those with cognitive impairment had memory complaints. Subjects with 
memory complaints had higher Hamilton depression scale scores than subjects 
without memory complaints but equivalent scores on a measure o f total recall. 
At follow-up, the subjects with baseline memory complaints had significantly 
greater decline in memory and cognition than subjects without memory 
complaints.
Jorm, Christensen, Henderson, Korten Mackinnon and Scott (1994) conducted a 
community survey in 877 elderly Australian subjects (aged 70+ years) to 
determine decline in memory and intelligence. 431 female and 446 male 
subjects and their informants (a close relative or friend) were asked to rate 
memory decline and intellectual decline, they were asked such question as "do 
you feel you can remember things as well as you used to?"; "Do you feel you 
can think and reason as clearly as earlier in life?"; "Does this interfere with your 
everyday life?" and "How long ago did this change start?". Everyday memory 
was also assessed, subjects were asked to answer questions such as "Do you 
have more trouble remembering things that have happened recently?"; "Are you
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worse at remembering where your belongings are kept?"; "Do you have troubles 
recalling conversations a few days later?". Actual cognitive function was 
assessed using the Mini Mental State Examination (MMSE); the National Adult 
Reading Test (NART); symbol letter modalities test (test similar to the digit 
symbol substitution test and the symbol modalities test, where letters and 
geometric shapes are associated, subjects have to state which letter is associated 
with each shape) three-word recall and name and address recall, face 
recognition and figure reproduction. Scores on all 4 tests were summed to give 
an overall episodic memory score. Anxiety and personality were also assessed 
using an anxiety and depression questionnaire and the Eysenk Personality 
Questionnaire (EPQ). It was found that both informants and subjects commonly 
reported cognitive decline, intellectual decline was less frequently reported than 
memory decline, in most cases the decline was not seen as interfering with daily 
life. Answers relating to cognitive decline did correlate reliably with actual 
memory performance, however the correlation’s were very small (MMSE -
0.13, Symbol-letter modalities -0.12 and episodic memory -0.12). When 
responses from subjects and informants were compared, agreement was found 
to be poor. For subjects, reports of cognitive decline were correlated with 
anxiety and depression symptoms and with trait neuroticism, self reports did not 
correlate with age. In contrast, informants' reports were correlated with the 
subjects cognitive test performance and age, but also with the informants own 
anxiety and depression symptoms, suggestion that informants ratings may be 
contaminated by the affective state of the informant. These findings cast doubt 
on the reliability of informants interpretations o f cognitive decline in their 
partners or close friends.
4.4 Subjective ratings do not correlate with objective 
measures
While the above studies have reported that complaints o f poor memory are 
typically considered to reflect actual functioning, several studies have found
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discrepancies between subjective reports o f poor memory and test scores. It is 
often the case that persons perform better on objective tests than their self 
ratings would seem to indicate (Perlmutter, 1978; Rabbitt and Abson, 1991; 
Jorm, Christensen, Korten, Henderson, Jacomb and Mackinnon, 1997)
Perlmutter (1978) assessed memory function with a questionnaire containing 60 
questions and actual memory performance (incidental associative orienting task, 
recall and recognition o f these words and recall and recognition o f a word list 
task, and fact memory task). Sixty four subjects aged 20-25 years (mean age 23 
years) and 60-65 years (mean age 62 years) completed the tasks. It was found 
that older subjects reported more memory problems than younger subjects, and 
they expected that their memory would get worse with age. However in terms of 
the actual performance tasks, older subjects performed better than younger 
subjects on the fact recall and recognition task. This study highlights the 
discrepancy between subjective and objective measures.
Rabbitt and Abson (1990) assessed subjective ratings and objective task 
performance in 422 subjects (330 women, 92 men) aged 50-80 years (mean age 
63 years). Subjects completed the Cognitive Failure's Questionnaire (CFQ), the 
Memory Failure's Questionnaire (MFQ) and the Lost and Found Questionnaire 
(LF), and the Alice Heim AH4 intelligence task, the Mill Hill vocabulary task, 
30 item word list and a cumulative learning task containing 15 items. They 
reported that there was no correlation between any o f the subjective ratings and 
obj ective measures.
Rabbitt and Abson (1991) questioned whether elderly persons were able to 
gauge performance on memory tasks. In the experiment 322 subjects aged 50- 
96 years rated their memory performance using Broadbent's Cognitive Failures 
Questionnaire (CFQ), Memory Failures Questionnaire (MFQ) and they also 
completed the Beck Depression Inventory (BDI). Subjects ratings were 
compared with actual performance on a digit span task, recognition memory for
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40 drawings, cumulative learning task containing 15 words, and a free recall 
task containing 30 words. No correlations were reported between subjective and 
objective measures hence Rabbitt and Abson concluded that subjects were 
unable to accurately rate memory performance.
Jorm, Christensen, Korten, Henderson, Jacomb and Mackinnon (1997) assessed 
whether cognitive complaints predict future or reflect past cognitive decline 
using data from a 2-wave longitudinal study o f 70+ years old. Cognitive 
complaints were assessed on 2 occasions 3.6 years apart. The first assessment 
was made in 1990-1991 using 721 subjects and the second set o f interviews 
were conducted in 1993-1994 in a total o f 507 subjects. Results showed 
cognitive complaints did not predict future cognitive change on the Mini-Mental 
State Examination.
4.4.1 Conclusions
The discrepancy between subjective ratings and actual task performance would 
seem to indicate that, in order to gain an accurate representation of cognitive 
decline in aged samples, researchers should not rely on subjective ratings alone 
and should assess cognitive function using valid and reliable objective 
measures.
4.5 Aims of the chapter: Analysis of objective task
performance in a healthy elderly population
This experiment aims to identify age related decrements in cognitive function 
using a battery o f cognitive tasks. The tasks include the Syndrom Kurtz Task 
(SKT), Critical Flicker Fusion Task (CFF), Choice Reaction Time (CRT), and 
the HPRU Sternberg Memory Task (SMT).
As well as identifying age related decrements, this chapter questions whether 
there are any relationships between the cognitive and psychomotor tasks. The
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relationships between tests will be identified with the use o f a principal 
components analysis.
Finally having identified the relationships between the tests, the cognitive 
factors will be compared with the subjective (ADL) factors identified in the 
previous chapter. The analysis will aim to determine whether the performance 
factors relate in any way to the ADL factors.
4.6 Methods
4.6.1 Subjects
160 elderly subjects (70 males, and 90 females) aged 61-84 years (overall mean 
age 70.25 years, mean age for males was 75.86 years and mean age for females 
was 65.59 years) participated in the study as a whole. All subjects were in good 
physical and mental health and were free from current drug usage. Subjects 
were recruited from the general public via the IIFRU data base or responses to 
adverts in the local press.
4.6.2 Procedure
All 160 drug free healthy elderly subjects completed a test battery assessing 
overall cognitive function consisting of the Syndrom Kurtz task (SKT), the 
Critical Flicker Fusion task (CFF), Choice Reaction Time task (CRT), and the 
HPRU Sternberg Memory task (SMT).
Performance on all measures were analysed with respect to gender, increasing 
age and interaction between gender and age.
4.6.3 A ssessm en ts
The tasks included in thesis can be considered in terms o f the cognitive sub­
groupings identified in the ADL chapter (attention, orientation, memory). In
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addition to the three ADL groupings, an additional group entitled the speed of 
information processing was also identified.
In terms o f the cognitive groupings the tasks assessing attention include 
Syndrom Kurtz subtests VI (counting symbols) and subtest VII (reverse naming 
task).
Tasks assessing orientation include SKT subtest IV (arranging blocks) and SKT 
subtest V (replacing blocks).
Tasks assessing memory included the HPRU Sternberg memory task (SMT), 
SKT subtest II (immediate recall), SKT subtest VIII (delayed recall), SKT IX 
(recognition memory).
Tasks assessing the speed o f information processing include SKT subtests I 
(object naming), SKT subtest III (numerical naming), the Critical Flicker Fusion 
task (CFF) and the Choice Reaction Time task (CRT).
4.7 Tasks assessing aspects of attention
Attention is an important component o f human performance, as the ability to 
remain alert and to select appropriate information from the environment is often 
a limiting factor especially in aged subjects.
Attention can be viewed as the capacity and limitations o f an individual to 
select and process sensory information from the environment, as well as the 
ability to concentrate on information despite distracting stimuli or over long 
periods of time.
It is generally assumed that attention is not a single entity, rather it can be 
regarded as manifesting itself in a number of forms, these are usually defined as
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sustained attention or vigilance, selective or focussed attention, and divided 
attention. It is possible that certain aspects of attention are disrupted with age, 
whereas others are spared. Research would seem to indicate that ageing disrupts 
selective attention and divided attention, whereas sustained attention (vigilance) 
is relatively well preserved with age (Salthouse, 1982).
The test battery used throughout this thesis contains two selective attention 
tasks. The tasks are SKT subtests VI (counting symbols) and SKT VII (reverse 
naming task).
4.7.1 SKT Sub test VI (a counting sym bols task)
In the SKT subtest VI subjects are asked to count the number of symbols 
contained on a card. The card contained seven rows of different symbols e.g. 
flowers, circles, squares and triangles, the subject was asked to count aloud the 
number of circles seen on the card. The time taken to complete the task was
l  tZLsL /f LIC-U,.
This task, is essentially a selective attention task, whereby the subject has to 
attend to one symbol (e.g. the circles) whilst ignoring all other symbols, the task 
is very similar to a visual search task. There is also a speed element to the task, 
the slower the subject is at performing the task, the higher the penalties they 
incur. Hence a selective attention task with such a reliance on speed would be 
expected to show decrements with age.
Rabbitt (1965) assessed visual search in two groups o f subjects, young subjects
(mean age 19 years) and elderly subjects (mean age 67.4 years). Rabbitt
reported that the elderly subjects were significantly slower at the visual search
task, mean search time for the elderly groups was 27.8 seconds, compared to
only 20.8 seconds for the younger subjects. Scialfa, Esau and Joffe (1998) used
a visual search task to assess selective attention in which younger and older
subjects had to find a single target in both feature and conjunction search
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conditions. Display size varied between 2 and 8  items, and target distractor 
similarity ranged from low to high levels. It was reported that older adults had 
difficulty detecting the target in high similarly conjunction search displays 
containing a large number o f distractors. Reaction times were also much longer 
for older subjects. The results were taken to indicate that there were age 
differences in selective attention, and older subjects suffer from an age-related 
slowing.
4.7.2 SKT VII (a reverse naming task)
Subtest VII is an interference test for the assessment of cognitive rigidity, it 
assesses the ability to adapt to change in well trained reactions. Subjects are 
presented with two rows of letters e.g. ABBAAB. The subject is required to 
mentally reverse the letters e.g. if they read the letter A they have to respond B, 
and if they read the letter B they have to respond A. Time taken to complete the 
task was recorded.
The reverse naming task is selective attention task, whereby subjects have to 
selectively attend to one aspect of the task whilst at the same time ignore certain 
aspects o f the task (see the letter A, mentally reverse the letter and respond with 
the letter B).
This task has similar properties to the Stroop task, where subjects have to attend 
to all the information (coloured word written in another coloured ink) and 
selectively attend to only one aspect o f the information (i.e. ink colour). 
Performance on the Stroop task has been shown to decline with age. Cohn, 
Dustman and Bradford (1984) administered the Stroop colour word test to 80 
healthy males aged 21-90 years. They reported significant age effects on the 
task, performance in subject's aged 61-70 and 71-90 was significantly slower on 
the task than younger subjects. Similar results were reported by Comalli, 
Wapner and Wemer (1962); Hartley (1993); Uttl and Graf (1997).
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The reverse naming task (SKT VII) is also similar to the digit substitution task 
(DSST), whereby the subject is presented with a digit and an associated 
symbol/pattern. The subjects have the list o f digits and symbols in front of them 
and are given a certain amount of time in which they have to complete the task. 
The subjects have to attend to the digit, whilst at the same time associate the 
digit with the designated symbol. Bryan and Luszcz, (1996) assessed selective 
attention using the digit symbol substitution task in two groups o f subjects, 36 
older adults (mean age 73 years) and 36 younger adults (mean age 21 years). 
Older subjects had poorer scores on the DSST than younger adults. Park, Smith, 
Lautenschlager, Earles, Frieske, Zwahr and Gaines (1996) assessed cognitive 
function using the digit symbol substitution task in a sample o f 301 subjects 
aged 20-90 years. They reported significant declines in performance on this task 
with age. Similar results were reported by Gilmore, Royer and Gruhn (1983).
4.7.3 Sum m ary
i  • . ,i /"v* , p 1 j* t i t *  * ,1 n . 1Researcn mio me enecis oi age on selective attention using me stroop tasK, 
visual search task and the digit symbol substitution task (DSST) would seem to 
indicate that ageing is associated with significant declines in performance 
(Rabbitt, 1965; Scialfa et al., 1998; Comalli et al., 1962; Cohen et al., 1984; 
Hartley, 1993; Uttl and Graf, 1997; Luszcz, 1996; Park et al., 1996; Gilmore, 
Royer and Gruhn, 1983).
Based on this evidence, age related declines in performance would be expected 
on both SKT VI (counting symbols) and SKT VII (reverse naming task).
4.8 Tasks assessing aspects of orientation
4.8.1 SKT IV (arranging blocks) and SKT V (replacing blocks)
There is some evidence to suggest that elderly subjects report problems with 
orientation type tasks, in particular they report problems with driving, giving
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directions, following directions, map reading, orientation to time and location 
etc.
SKT subtests IV (arranging blocks test) and SKT V (replacing blocks) can 
loosely be regarded as orientation type tasks, as to perform the task, subjects 
have to be able to place 10 numbered blocks e.g. 23, 45, 96, 54 etc. into 
ascending order (SKT IV) and then replace the blocks in their original starting 
positions (SKT V). Subjects were not required to remember the spatial location 
of the blocks as it was clearly marked on the board, however if  they were able 
to roughly remember the spatial location of the blocks then they would perform 
the task faster than subjects who were unable to remember the spatial locations 
There is some evidence that memory for spatial information declines with 
increased age (Light and Zelinski, 1983).
Moore, Richards and Hood (1984) assessed spatial memory in a sample of 
subjects aged 19-76 years, subjects had to remember the spatial locations of 
wooden shapes, they reported that there were significant declines in the ability 
to recall spatial locations in aged subjects. Evans, Brennan, Skorpovich and 
Held (1984) conducted a study in which subjects had to recall the spatial 
location o f buildings in their home town and place models o f the buildings onto 
a map. It was reported that older subjects were poorer at the task than younger 
subjects, even though they had lived in the area longer than younger subjects. 
Both SKT IV and V rely heavily on speed as well as orientation/spatial 
information, the subjects have to place the blocks in the correct spatial locations 
as fast and accurately as possible, as the tasks rely heavily on speed, and age is 
known to result in slowing in performance, declines with increased age would 
be expected (Lindenberger et al., 1993).
4.8.2 Sum m ary
Based on the above experimental evidence that elderly subjects have problems
with orientation/spatial tasks (Light and Zelinski, 1983; Pezdek, 1983; Evans et
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al., 1984; Moore et al., 1984), and that performance slows with advanced age 
(Lindenberger et al., 1993) significant age effects would be expected on SKT 
subtests IV (arranging blocks) and V (replacing blocks).
4.9 Tasks assessing aspects of memory function
A common finding in ageing research is that older subjects seem to have poorer 
memories than younger subjects (Dixon, Simon, Nowak and Hultsch, 1982). 
The elderly often report that problems with memory are one o f the greatest 
problems they face with everyday living (Lowenthal, Berkman, Beuhler, Pierce, 
Robinson and Trier, 1967). Older people frequently express concern about 
failing memory. Lowenthal et al., (1967) reported that in community studies, 
more than half the persons aged 60+ reported serious memory problems.
Salthouse (1980) likened older memory to "the running o f a voluminous library 
by an increasingly frail librarian" (47-65). This view helps summarise the 
effects of age on memory, however this opinion is not held by all researchers. 
Many believe that some elderly subjects do not experience such a dramatic 
decline in memory function, so it can be argued that Salthouse's opinion may 
paint a rather negative picture. The types o f memory complaints commonly 
reported include problems with remembering names and faces, important 
events, appointments, telephone numbers and remembering where they have 
placed personal belongings such as their spectacles.
The tasks assessing memory that have been used in this thesis include the 
HPRU Sternberg memory task (SMT), SKT subtest II (immediate recall), SKT 
subtest VIII (delayed recall) and SKT subtest IX (recognition memory).
4.9.1 The HPRU Sternberg Memory Task (SMT)
The HPRU version o f the SMT task is presented in computerised format using a 
personal computer and software from the HPRU test battery. Subjects responses
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are made using a mouse, where one button is the “yes” response and the other 
button the “no” response. To complete the task subjects sit at a 75 cm desk with 
the computer screen 50 cm in front o f them at eye level. All responses are 
recorded by the computer.
Subjects are required to memorise a series o f target digits, ranging from single 
digits, sets of 3 digits and sets o f 5 digits, these are termed the stimulus set (or 
target digits). These are presented at a rate of 800 ms per digit. One second after 
the presentation of the final digit an auditory warning signal (750 ms duration) 
sounds, followed by a series of 12 single probe digits. In the original Sternberg 
Memory Task, memory scanning ability was assessed by presenting a single 
digit probe (Sternberg, 1966, 1975). Subjects respond to the probes by pressing 
the “yes” button if  the probe digit was contained in the stimulus set, or the “no” 
button if  it is not. There are an equal number o f positive and negative probe 
digits in each probe set. Subjects are presented with 6  stimulus sets, (two single 
digits, two 3 digit presentations and two 5 digit presentations). The computer 
records the subjects reaction times for all presentations. A total SMT score is 
derived by averaging responses to all stimuli.
Since memory is known to decline with advanced age, and speeded responses 
decline with age, then age related declines in performance would be expected 
on the HPRU version of the Sternberg memory task.
4.9.2 SKT su b te s t II (an immediate recall task)
In SKT II subjects were required to give an immediate recall of the 12 pictures 
in 60 seconds. Pictures had previously been seen and named in SKT subtest I. 
The number of forgotten items were recorded.
The immediate recall o f objects task is a task thought to be affected by age
Marguerie De Rotrou, Le Poncin Lafitte and Lafitte (1986) assessed memory
performance in 37 elderly subjects using a paired associate word list task, it was
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reported that memory recall declined with age, subjects with the poorest 
performance had a mean age o f 75.5 years and subjects with superior 
performance had a mean age o f 65.7 years.
Ferris et al (1980) assessed memory function in a sample o f normal elderly 
subjects aged 60-88 years, and young subjects aged 17-39 years using a 
paragraph recall task, and a paired associate task, subjects were required to give 
immediate recall o f the test material. It was reported that there were marked 
declines in immediate recall on the paragraph recall and the paired associate 
task with age, namely, older subjects recalled fewer items than younger 
subjects.
Delbecq-Derouesne and Beauvois (1989) conducted a word recall task in 
subjects aged 20-86 years. Immediate mean recall of 15 words was found to 
decline as age advanced so that mean recall for subjects aged 20-25 was 8.2 
words, in subjects aged 56-65 mean recall was 6.2 and in subjects aged 65-86 
years mean recall was 5.2 words.
4.9.3 SKT su b te s t VIII (a delayed recall task)
SKT subtest VIII is a delayed recall task (conducted approximately 10 minutes 
after the immediate recall task). Subjects were asked to provide delayed recall 
of as many of the 12 pictures originally seen in SKT subtest I.
Generally performance on a delayed recall task is poorer than performance on
the immediate recall task, as the memories have faded during the passage of
time. Delbecq-Derouesne and Beavois (1989) examined free recall in 75
subjects aged 20-86 years. Mean immediate recall for subjects aged 20-25 years
was 3.97 and in subjects aged 65-86 years was 3.6. Delayed recall remained
relatively stable in subjects aged 20-25, however fell to 1.53 in subjects aged
65-86 years. In particular in this task subjects were unable to rehearse the
material as they had completed SKT subtests III to VII (which essentially act as
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distractor tasks to block rehearsal) therefore delayed recall should be much 
poorer than immediate recall. Based on this information age related decrements 
in performance would be expected on the task.
4.9.4 SKT su b te s t IX (a recognition m em ory task)
In the recognition task (SKT subtest IX) subjects were shown a card containing 
48 pictures of objects and are asked to indicate what objects they have seen 
before i.e. what objects they had previously seen in SKT I. The number of 
forgotten objects were recorded.
Recognition memory tasks are much easier to perform than recall tasks (Erber, 
1974). Generally performance on recognition tasks are relatively unaffected by 
age, as the subjects has external cues to aid recognition (unless the distracting 
stimuli are too similar to the target stimuli, and hence disturb recognition). 
Hence age related decrements are not expected on recognition memory tasks.
4.9.5 Sum m ary
Based on the experimental evidence on memory function in aged subjects, age 
related declines in performance are expected on immediate recall (SKT II), 
delayed recall (SKT VIII) and the HPRU Sternberg memory task. Whereas age 
effects would not be expected on the SKT recognition task (SKT subtest IX).
4.10 Tasks assessing the speed of information
processing
The slowing of behaviour with increased age is generally accepted as a major 
consequence o f age, and is widely documented (Salthouse, 1985; Welford, 
1977). This slowing is expressed in terms of the processing time required to 
perform a particular task (Cerella et al., 1980). Salthouse (1985) suggests that a 
reduction in information processing speed is a marked concomitant o f old age.
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The tasks assessing the speed of information processing, include SKT subtest I 
(object naming), SKT subtest III (numerical naming) the Critical Flicker Fusion 
task (CFF) and the Choice Reaction Time task (CRT).
4.10.1 SKT su b te s t I (an object naming task)
In SKT subtest I, subjects are shown pictures of 12 familiar objects, subjects are 
asked to name the objects aloud, and more importantly try to remember them. 
The time taken to name the pictures is recorded.
4.10.2 SKT su b te s t III (numerical naming task)
In SKT subtest III subjects had to perform a numerical naming task. The task 
was carried out using a board with 10 magnetic disks on it. Each disk is 
numbered with two digits e.g. 23, 45, 96, 54 and 68 etc. Subjects are asked to 
read aloud the numbers as quickly as possible time taken to complete the task is 
recorded.
Both tasks (SKT I, III) rely heavily on speed, subjects have to name the 
objects/numbers as quickly and accurately as possible. Age effects on the object 
naming task would be expected, as not only does the task rely on speeded 
response but it is well documented that many elderly subjects suffer word 
finding difficulties (Burke, MacKay, Worthley and Wade, 1991) which would 
preclude performance on the task.
Numerical naming is essentially a procedural task, a task that is well learned, 
rehearsed and retained during the persons lifetime. Hence age effects would not 
be expected on such a task.
4.10.3 Summary
Age related declines in performance are expected on SKT I (object naming task) 
but are not expected on SKT III (numerical naming).
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4.10.4 The Choice Reaction Time Task (CRT)
The Choice Reaction Time task (CRT) is used as an indicator o f sensorimotor 
performance, assessing the efficiency of the attentional and response 
mechanisms in the information processing chain. The latency of a motor 
response to a stimulus is recorded, but since the stimulus is one of a number of 
alternatives, this enables the measurement of attention. The task allows for the 
measurement of three components, recognition reaction time (RRT) which can 
be regarded as the attentional aspect o f the task, motor reaction time (MRT) 
which is used as a measure o f the efficiency of the response output system, and 
total reaction time (TRT) which is the sum of RRT and MRT.
Reaction time tasks are often used to assess information processing, as response 
time to a stimulus is thought to have three components:-
1. Sensory input
2. Central processing
3. Behavioural output
Welford (1958) notes that as long as the stimulus is strong enough, decrement in 
performance is related to the central processing of the information.
For the task subjects sit at a table positioned to be 75 cm high, the CRT
apparatus is laid flat on the table top 50 cm away from the subjects eye. The
task consists o f a flat box with a home key positioned in the centre and at the
edge closest to the subject. Positioned equidistant in a semi circle around the
home key are six red lights, positioned underneath these are light sensitive
buttons. During the task the subjects are asked to place their index finger of the
preferred hand on the home key and wait for one of the red lights to illuminate,
as soon as this happens they have to remove their finger and place it onto the
button which is positioned directly beneath the illuminated light, once they have
done this they have to return to the home key and wait for the next light
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stimulus. Subjects are presented with 20 such trials, mean reaction times are 
obtained from the average of 20 consecutive trials. The computer automatically 
records recognition reaction times (the time taken for the subject to remove their 
finger form the home key) and motor reaction times (the time taken for the 
subjects to reach the appropriate response button) and total reaction times (the 
sum of RRT and MRT).
Reaction time can be assessed using simple reaction time (SRT) i.e. response to 
one stimuli, or with choice reaction time tasks (CRT) i.e. response to more than 
one stimuli, or choice of responses. The definition of choice reaction time, i.e. 
the subjects has a number o f choices, and the subject must select the appropriate 
response from a number of alternatives, highlights the fact that responses on 
such tasks is slower than responses on simple reaction time tasks.
Changes in the information processing rate can manifest themselves either as 
changes in response speed or o f accuracy. Hence choice reaction time (CRT) is 
often used as a central indicator of information processing. It has been 
suggested that individual differences in choice reaction time may directly reflect 
differences in the efficiency of the central nervous system. The assessment of 
reaction time has real life impact, changes in reaction time o f even a few 
milliseconds can have dramatic consequences in various situations (e.g. driving, 
crossing the road, removing your hand before you slice bread).
Reaction times have been found to decrease as age increases (Lindenberger, 
Mayr and Kliegl, 1993). The literature would seem to indicate that latencies in 
simple reaction time increase by 20% to 26% from age 20 to 60 years. It is 
accepted that responses by the elderly on choice reaction time tasks are 
disproportionately slower on choice reaction time tasks than simple reaction 
time tasks, generally the greater the number o f choices, the more disadvantaged 
the elderly become. Choice reaction time tasks require more processing, as the
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greater the range of choices means that more mental processing has to be done 
before a decision is reached and a response is reached.
Rabbitt and Phillips (unpublished data) assessed choice reaction time in 564 
individuals aged 20 and 79 years. Performance was assessed on a serial, self 
paced 10 choice reaction time (CRT) task. They reported that there were 
definite changes in CRT with age, between the age of 20 and 30 years the 
differences between CRT were small but significant and the rate of change 
progressively accelerates in all subsequent decades. Birren, Woods and 
Williams (1979) note that there is a 20% decrement in performance on the 
choice reaction time task between the ages of 2 0  and 60 years, and this 
decrements is even greater in older subjects. Gottsdanker (1982) assessed 
reaction time to a tone in subjects aged 18-93 years, it was reported that reaction 
times increased with age, by approximately 2 seconds per decade. Coleston and 
Hindmarch (1989) reported highly significant differences between reaction 
times in young and elderly subjects, elderly subjects had significantly slower 
reaction times.
Corpolongo and Salmon (1981) compared reaction times in 20 elderly subjects 
(aged 60-70 years) and 20 young subjects (aged 20-30 years), using 4 different 
reaction time tasks. Simple reaction time (subjects had to press a button when a 
light was illuminated), choice reaction time (subjects had to press the 
appropriate button when one of three lights illuminated), stimulus-response 
translation (in this task, one o f three digits were randomly presented on the 
digital response unit, the subjects had three response buttons each 
corresponding to the digits so that subjects had to press the left button when the 
number 1 was presented, the centre button when number two was presented and 
the right button when the number three was presented) and stimulus-stimulus 
translation (up to three stimulus lights were presented simultaneously, the 
subjects were required to translate the number of lights into a response position 
code, so that subjects had to press the left button when one light was presented,
the centre button when two lights were presented and the right button when 
three lights were presented). Subjects had to complete 30 trials of each o f the 
four tasks. The time difference between the two groups was equivalent for SRT, 
CRT and stimulus-response translation, however on the stimulus-stimulus 
translation (task 4), the elderly showed significantly poorer performance.
4.10.5 The Critical Flicker Fusion Task (CFF)
Critical flicker fusion task (CFF) is regarded as an index o f overall CNS 
activity, the ability o f the central nervous system to process discrete ‘bits’ of 
information Hindmarch (1980). Therefore an increase in CFF thresholds is 
associated with more efficient brain processing i.e. increased alertness and a 
greater capacity for information processing.
In the task subjects are asked to discriminate flicker from fusion, and fusion 
from flicker in a set of four red light emitting diodes (LED’s) set at the comers 
of a 1cm square. Subjects sit lm  from the lights to ensure that the diodes are 
viewed binocularly and in foveal fixation. The diodes flicker on and off at a 
50/50 light-dark ratio according to a square waveform, and at a constantly 
increasing or decreasing rate of 1 Hz/s over a range of 12-50 Hz. Subjects 
responses are obtained via pressing a button that they hold in the preferred hand. 
Individual thresholds are determined via the psychophysical method of limits as 
an average of the responses on three ascending (flicker to fusion) and three 
descending (fusion to flicker) presentations, Woodworth and Schlosberg (1958).
The age related deficit with CFF was first noted in 1940's when data were 
collected from subjects aged 18-80 years (Brozek and Keys 1945; Weekers and 
Roussel 1946; Misiak 1947). Colgan (1954) collected CFF data from 42 
subjects aged 65 and 95 years, they reported a linear age related decline in 
CFFT. Coleston and Hindmarch (1989) notes that a decline in CFF threshold 
begins after 40 years. However Coppinger (1955) notes that the decline was 
only evident in subjects aged 70+ years.
85
4.10.6 Summary
Based on the experimental evidence of a slowing of information processing 
with age, age related declines are expected on the Critical Flicker Fusion task 
(CFF) and the Choice Reaction Time task (CRT).
4.11 The effects of age and gender on the Syndrom 
Kurtz Task (SKT)
The Syndrom Kurtz (SKT) is a short test designed to evaluate memory, 
attention and speed of information processing in elderly subjects. The task 
consists o f 9 subtests assessing memory recall (SKT II, immediate recall, SKT 
VIII delayed recall) and recognition memory (SKT IX, recognition memory), 
verbal fluency (SKT I, object naming, SKT III, numerical naming) and 
attention/concentration tasks (SKT IV, arranging blocks, SKT V, replacing
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takes a maximum of 60 seconds to complete
A total o f 154 (85 female and 69 male) elderly subjects completed the SKT task 
subjects were aged 60-85 years with a mean age o f 70.8 years.
Prior to analysis subjects were classified into one of 5 age groups (60-64, 65-69, 
70-74, 75-79, 80+) Table 1 shows the demographics of the subjects.
Table 14: Showing the gender and ageband split of subjects who completed the Syndrom 
Kurtz Task (SKT).
Age-band Male Female Total
60-64 15 2 0 35
65-69 19 2 1 40
70-74 2 0 2 0 40
75-79 8 16 24
80+ 7 8 15
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Performance on all SKT subtests were analysed to determine whether there 
were any differences between the subjects in terms of age and gender.
The data were analysed using a two way analysis of variance with age band and 
gender as between subjects factors and the SKT subtests I, II, III, IV, V, VI, 
VII, VIII, and IX as the dependant variables.
4.11.1 SKT S ubtest I (object naming).
In SKT subtest I, subjects had to name and try to remember 12 objects. The time 
taken to name all 12 objects was recorded.
On average subjects took 15.67 seconds to name all 12 objects (SD 5.56) (see 
Figure 5).
Scatterplot of Age and SKT I 
(object naming)
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Figure 5: Shows the scatterplot of age on object naming (SKT I).
The main effect of age approached significance (F (4 , 144) = 2.14; p = 0.06). 
There was a non-significant trend for age related changes in performance. In the 
present analysis, subjects aged 75-79 years were faster at the task, (see Table
15).
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Table 15: Showing the mean scores and standard deviations in terms of age on 
performance of SKT I (object naming).
Ageband Mean Time taken to complete the task
60-64 16.47 seconds
65-69 15.06 seconds
70-74 16.80 seconds
75-79 13.00 seconds
80+ 16.77 seconds
There was no main effect of gender (F (i, 144) = 2.16; p >0.05) indicating that 
object naming was comparable for both male and female subjects. There was no 
age and gender interaction (F 144) = 0.90; p >0.05) on performance of SKT 
subtest I.
4.11.2 SKT su b te s t II (immediate recall)
In subtest II subjects had to provide an immediate recall of as many of the 12 
items as possible, the number of omissions acted as the dependant variable.
On average subjects made 5.11 omissions from the list of 12 items (SD 1.57) 
(see Figure 6 ).
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Figure 6: Showing the scatterplot of age on immediate recall (SKT II).
There was a main effect of age band (F (4 , 144) = 2.56 ;p <0.05) indicating that the 
forgetting rate was significantly different across the age ranges. Post hoc testing 
revealed that subjects aged 75-79 years had significantly poorer immediate 
recall than subjects aged 60-64 and 70-74 years (see Figure 7).
There was no main effect of gender (F (i, 144) = 0.02; p >0.05), indicating that the 
amount forgotten for males and females was comparable. There was no age 
band gender interaction (F (4 , 144) = 0.09; p >0.05).
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Figure 7: Showing the main effect of age on immediate recall (SKT II).
4.11.3 SKT S ubtest III (numerical naming)
In subtest III subjects had to name 10 numbered blocks. The time taken to 
correctly name all 10 blocks was recorded.
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Figure 8: Showing the scatterplot of age on numerical naming (SKT III).
On average subjects took 7.88 seconds to name all 10 numbered blocks (SD 
2.84) (see Figure 8 ).
There was no significant main effect o f age (F (4 , 144) = 0.21; p >0.05) indicating 
that numerical naming was comparable across the age ranges (see Figure 8 ). 
There was a main effect of gender (F (i, 144) = 4.18; p <0.05). Female subjects 
were significantly slower at naming the numerals than male subjects (see Table
16). There was no significant interaction between gender and age (F (4 , 144) = 
0.73; p >0.05).
Table 16: Showing the mean time for male and female subjects to name numerals.
Gender Mean Score
Male 7.29 seconds
Female 8.32 seconds
4.11.4 SKT Subtest IV (arranging blocks)
In SKT subtest IV subjects had to arrange the 10 numbered blocks into 
ascending order. The time taken to complete the task was recorded.
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Figure 9: Showing the scatterplot of age on time taken to arrange blocks (SKT IV).
On average subjects took 20.61 seconds to arrange 10 numbered blocks into 
ascending order (SD 6 .6 6 ) (see Figure 9).
There was a significant main effect of age (F (4 , 144) = 4.47; p= 0.001). Post hoc 
testing revealed that subjects aged 75-79 and 80+ were significantly slower at 
arranging the blocks than subjects aged 60-64, 65-69 years (p <0.05) (see Figure 
10).
There was no main effect of gender (F (i, 144) = 1.41; p >0.05) and no age band 
gender interaction (F (4 , 144) = 1.10; p >0.05).
Main effect of age on SKT IV 
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Figure 10: Showing the main effect o f age on SKT subtest IV (arranging blocks)
4.11.5 SKT S ubtest V (rearranging blocks)
In subtest V subjects had to replace the 10 numbered blocks into their original 
position which was clearly marked out on the board. The time taken to complete 
the task was recorded.
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Figure 11: Showing the scatterplot of age on time taken to replace blocks (SKT V).
On average subjects took 14.67 seconds to replace the 10 numbered blocks (SD 
3.35) (see Figure 11).
There was a significant main effect of age (F (4 , 144) = 3.67; p < 0.01). Post hoc 
testing revealed that subjects aged 75-79 and 80+ were significantly slower at 
replacing the blocks than subjects aged 60-64, 65-69 and 70-74 years (see 
Figure 12).
There was a main effect o f gender (F (i, 144) = 4.90; p < 0.05). Female subjects 
were significantly slower at replacing the blocks than male subjects (see Table
17). There was no age band gender interaction. (F (4 , 144) = 1.72; p >0.05).
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Table 17: Showing the mean time for male and female subjects to replace blocks.
Gender Mean Score
Male 14.37 seconds
Female 15.61 seconds
Main effect of age on SKT V 
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Figure 12: Showing the main effect of age on replacing blocks (SKT V).
4.11.6 SKT Subtest VI (counting sym bols)
In subtest VI subjects had to count the number of symbols contained on a card. 
The card contained rows of symbols such as circles, triangles, squares and 
flowers, subjects had to count the number of circles on the card. The card 
consisted of approximately 119 symbols (43 of which were circles). The time 
taken to complete the task was recorded.
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Figure 13: Showing scatterplot of age on time taken to count symbols (SKT VI).
On average subjects took 19.41 seconds to count all 43 symbols (SD 4.30) (see 
Figure 13).
There was a main effect of age (F (4 , 144) = 3.08; p= 0.01). Post hoc testing 
revealed that subjects aged 75-79 years were beginning to show an age 
decrement and performance in subjects aged 80+ was significantly slower than 
performance in subjects aged 60-64, 65-69 years and 70-74 years (p <0.05). As 
age increased, time taken to complete the task increased, so that older subjects 
were slower at counting symbols than younger subjects (see Figure 14).
There was no main effect of gender (F (i( 144) = 0.97; p >0.05), indicating that 
performance of males and females was comparable. There was no interaction 
between ageband and gender (F (4 , 144) = 0.08; p >0.05).
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Figure 14: Showing the main effect of age on counting symbols (SKT VI).
4.11.7 SKT su b te s t VII (reverse naming)
In subtest VII subjects had to perform a reverse naming task, subjects were 
presented with two rows of letters e.g. ABBAABAB, subjects had to mentally 
reverse the letters so that when they saw the letter A they had to respond B and 
vice versa. The time taken to complete the task was recorded.
Scatterplot of Age on SKT VII 
(reverse naming)
60
o  40 +uC/D
b  20 1a4>
S  o
•Mi
60 65 70 75 80 85
Age
Figure 15: Showing the scatterplot of age on the reverse naming task.
On average subjects took 23.01 seconds to perform the reverse naming task (SD 
6.27) (see Figure 15).
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There was a significant main effect of age (F (4 , 144) = 9.79; p= <0.001). Post hoc 
testing revealed that performance in subjects aged 75-79 and subjects aged 80+ 
was significantly slower than performance in subjects aged 60-64, 65-69 years 
and 70-74 years (p <0.05). Older subjects took longer to perform the reverse 
naming task, (see Figure 16)
There was no main effect of gender (F (i, 144) = 1.11; p >0.05), indicating that 
performance of males and females was comparable. There was no age band 
gender interaction (F (4 , 144) = 1.24; p >0.05).
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Figure 16: Showing the main effect of age on the reverse naming task (SKT VII).
4.11.8 SKT su b te s t VIII (delayed recall)
In subtest VIII subjects had to provide a delayed recall of the 12 objects that 
they had seen in subtest I. Delayed recall took place approximately 10 minutes 
after initial presentation. The number of omissions were recorded.
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Figure 17: Scatterplot of age on delayed recall (SKT VIII).
On average subjects omitted 4.55 of the 12 objects (SD 2.00) (see Figure 17). 
There was a main effect o f age band (F (4 , 144) = 2.73; p <0.05). Delayed recall 
was significantly poorer in older subjects. Post hoc testing with Newman Keul's 
revealed that performance in subjects aged 75-79 was significantly poorer than 
subjects aged 60-64 years (see Figure 18).
There was no main effect of gender (F (i, 144) = 0.00; p >0.05), forgetting rates of 
males and females were comparable. There was no age band gender interaction 
(F (4 ,144) = 0.31; p >0.05).
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Figure 18: Showing the main effect of age on delayed recall (SKT VIII).
4.11.9 SKT su b test IX (recognition memory)
In subtest IX subjects had to perform recognition task, they had to identify the 
original 12 objects from a list of 48 objects. Recognition memory was tested 
after approximately 12 minutes had elapsed, during which time subjects had 
completed SKT subtests II to VIII. The number of omissions were recorded.
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Figure 19: Showing the scatterplot of age on recognition memory (SKT IX).
On average subjects failed to recognise 0.59 objects (SD 1.26) (see Figure 19). 
There was no main effect of age band (F (4> 144) = 0.22; p >0.05) indicating that 
recognition memory was comparable across the age ranges.
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There was no main effect o f gender (F (i, 144) = 0.77; p >0.05), performance of 
males and females was comparable. There was no age band gender interaction 
(F (4 , 144) = 1.11; p >0.05).
4.11.10 The effect of actual age on SKT task  perform ance
The SKT data were analysed using the Kendall’s tau to determine whether there 
was a relationship between task performance and actual age.
It was reported that there were significant correlations between actual age and 
performance on SKT II (immediate recall), SKT IV (arranging blocks), SKT V 
(replacing blocks), SKT VI (counting symbols), SKT VII (reverse naming) and 
SKT VIII (delayed recall) (see Table 18).
Table 18: Showing the correlation between SKT task performance and actual age.
SKT Task Kendall's Tau p level
SKT I (object naming) -0.04 p<0.05
SKT II (immediate recall) 0.04 p<0.05
SKT III (numerical naming) -0.03 p>0.05
SKT IV (arranging blocks) 0 . 2 0 p O . 0 0 1
SKT V (replacing blocks) 0.13 p<0 . 0 1
SKT VI (counting symbols) 0 . 1 2 p<0.05
SKT VII (Reverse naming) 0.26 pO.OOOl
SKT VIII (delayed recall) 0.19 p<0.0005
SKT IX (recognition memory) 0.06 p>0.05
4.12 The effects of age and gender on the CFF, CRT 
and SMT tasks
4.12.1 Critical Flicker Fusion (CFF)
In the CFF task, subjects were required to discriminate flicker from fusion and 
vice versa, the mean of 6 presentation (3 ascending and 3 descending) were 
recorded.
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A total of 154 elderly subjects (84 female, 70 male ) aged 60-85 years (mean 
age o f 70.19 years) completed the CFF task (see Table 19).
Table 19: Showing the gender and age-band split of subjects who completed the critical 
flicker fusion task (CFF).
Ageband Male Female Total
60-64 15 2 0 35
65-69 2 0 2 1 41
70-74 2 0 2 0 40
75-79 8 15 23
80+ 7 8 15
Scatterplot of Age and CFF performance
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Figure 20: Showing the scatterplot of age on CFF performance.
The average CFF threshold was 29.20 Hz (SD 3.05) (see Figure 20).
There was no significant main effect of age (F (4 , 144) = 0.70; p >0.05) CFF 
thresholds were comparable across the ages.
There was a main effect of gender (F (i, 144) = 9.16; p < 0.05), indicating that 
female subjects had lower CFF threshold than male subjects, indicative o f  
poorer information processing capacity (see Table 20). There was no age sex 
interaction (F (4 , 144) = 0.27; p >0.05).
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Table 20: Showing the mean CFFT for male and female subjects.
Gender CFF Threshold (Hz)
Male 29.98 Hz
Female 28.38 Hz
4.12.2 Choice Reaction Time (CRT)
In the CRT task subjects had to place their index finger on a home key, as soon 
as a light illuminated (1 of 6), had to move their finger from the home key to 
press a button which extinguished the light. Subjects were requited to respond 
to 20 stimuli.
A total of 126 (70 female and 56 male) elderly volunteers aged 60-85 years with 
a mean age of 70.26 years completed the Choice Reaction Time Task (CRT) 
(see Table 21).
Table 21: Showing the gender and ageband of subjects who completed the choice 
reaction time task (CRT).
Male Female Total
60-64 11 16 27
65-69 17 17 34
70-74 17 17 34
75-79 7 12 19
80+ 4 8 12
4.12.3 Recognition Reaction Time
Recognition reaction time is the time take to realise that a stimulus has been 
presented, the time taken for the subject to remove their finger from the home 
key. It is generally regarded as the attentional aspect of the reaction time task.
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Figure 21: Scatterplot of age on reaction time (RRT).
On average subjects mean RRT was 424.54 ms (SD 74.78 ms) (see Figure 21). 
There was no main effect of age (F (4> n6) = 0.74; p >0.05) indicating recognition 
reaction times were comparable for old and young subjects.
There was a main effect of gender (F (i, n6) = 6.73; p <0.01) male subjects had 
significantly faster recognition reaction times than female subjects (see Table 
22). There was no age gender interaction (F (4, ii6) = 2.07; p >0.05).
Table 22: Showing the mean RRT for male and female subjects.
Gender Mean RRT (SD)
Male 409.10(60.53)
Female 436.85 (82.82)
4.12.4 Motor Reaction Time
Motor reaction time is the time taken to respond to the stimulus (i.e. move the 
finger from the start point to the response button).
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Figure 22: Showing the scatterplot of age on motor reaction time (MRT).
The mean motor response time was 330.22 ms (SD 79.65) (see Figure 22).
There was no main effect of age (F (4 , hq = 0.54; p >0.05) indicating that motor 
reaction time was comparable for the ages.
There was no main effect of gender (F (i; n6) = 0.006; p >0.05), performance in 
males was comparable to females. There was no age gender interaction ( F (4 , n6) 
= 1.29; p >0.05).
4.12.5 Total Reaction Time
Total reaction time is the sum of RRT and MRT It is the time taken for the 
subject to move their finger from the home key, press the appropriate button 
and return back to the home key.
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Figure 23: Showing the scatterplot o f age on total reaction tim e (TRT).
The mean motor response time was 753.60 ms (SD 119.19 ms) (see Figure 23). 
There was no main effect of age (F (4 , n6) = 0.66; p >0.05) total reaction time 
was comparable for the ages.
There was no significant main effect of gender (F (i, n6) = 3.25; p >0.05. There 
was no age gender interaction (F (4 , n6) = 1.39; p >0.05).
4.12.6 The HPRU Sternberg memory task  (SMT)
In the HPRU Sternberg Memory Task (SMT) subjects are required to memorise 
a set of digits (the stimulus set) ranging from single digits to sets of three and 
five digits. Following this sequence, subjects are presented with 12 single digit 
probes, subjects are required to decide whether the probe digits were a part of 
the stimulus set or not.
A total of 125 elderly volunteers (69 female and 56 male) elderly volunteers 
(aged 60-85 years with a mean age of 70.32 years) completed the HPRU 
Sternberg memory Task (SMT) (See Table 23).
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Table 23: Showing the gender and ageband of subjects who completed the Sternberg 
Memory Task (SMT).
Male Female Total
60-64 11 15 26
65-69 17 17 34
70-74 17 17 34
75-79 7 12 19
80+ 4 8 12
Performance
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Figure 24: Showing the scatterplot of age on Sternberg memory performance.
The mean response time was 1258.26 ms (SD 269.62 ms) (see Figure 24).
There was no main effect of age band (F (4 , n 5) = 2.07; p >0.05) indicating that 
there was no significant difference between Sternberg Memory performance 
across agebands. However, there was a trend for older subjects to have slower 
responses on the task (see Table 24).
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Table 24: Showing the ageband mean responses.
Ageband Mean Responses
60-64 1181.87
65-69 1194.73
70-74 1282.35
75-79 1348.08
80+ 1374.73
There was no main effect of gender (F (i, 115) = 0.51; p >0.05), performance of 
males and females was comparable. There was no age band gender interaction 
(F (4 , us)= 0.42; p >0.05).
4.12.7 The effect of actual age on CFF, CRT and SMT
The CFF, CRT and SMT data were analysed using the Kendall’s tau to 
determine whether there was a relationship between actual age and task 
performance. It was reported that there was a significant correlation between 
actual age on recognition reaction time, and Sternberg Memory performance 
(see Table 25).
Table 25: Showing correlation between CFF, CRT and SM T task perform ance and 
actual age.
Task Kendall's tau p level
CFF -0.05 p>0.05
RRT 0.15 p<0.05
MRT 0.48 p>0.05
TRT 0.14 p>0.05
SMT 2.19 p<0.05
4.12.8 Summary
SKT subtests were analysed to determine age and gender effects. It was 
reported that there were main effects o f age on immediate recall (SKT II), 
arranging blocks (SKT IV), replacing blocks (SKT V), counting symbols (VI) 
the reverse naming task (SKT VII), and delayed recall (SKT VIII) older 
subjects were significantly slower at performing the speeded tasks, and had 
poorer memory recall than younger subjects.
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There were no age differences on the object naming (SKT I), numerical naming 
(SKT III), recognition memory (SKT IX) Critical Flicker Fusion task (CFF), 
Recognition Reaction Time (RRT), Motor Reaction Time (MRT), Total 
Reaction Time (TRT) or the HPRU Sternberg Memory Task (SMT).
There were no main effects of gender on any of the SKT tasks, Motor Reaction 
Time (MRT), Total Reaction time (TRT) or the HPRU Sternberg Memory Task 
(SMT) and no gender-ageband interactions.
Main effects of gender were reported on the CFF task, female subjects had 
lower CFF thresholds than male subjects, indicative of poorer information 
processing capacity. There was a main effect of gender on the recognition 
reaction time task, female subjects had significantly slower recognition reaction 
times than male subjects. Main differences between the sexes were also reported 
on SKT V (replacing blocks), and the numerical naming task, female subjects 
were significantly slower than male subjects on performance o f the tasks.
4.13 Relationships between the cognitive function 
tasks
Having identified age related decrements on the performance tasks, a principal 
components analysis was performed on the SKT data to try and identify 
relationships between the SKT subtests. It was hoped that the principal 
components analysis would identify which aspects of human cognition the SKT 
subtests were assessing.
4.14 Principal components analysis
Principal components analysis with oblique rotation, and pairwise deletion of  
missing data were performed on the SKT subtests. Total SKT score was omitted 
from the analysis, as this score is compiled from the scores on each o f the 9
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subtests, hence including total score in the analysis would be regarded as double 
handling data.
Three factors were reported to have Eigenvalues greater than 1 (See Figure 25). 
Together these accounted for 61.0% of the total variance.
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Figure 25: Showing the scree plot from the principal components analysis of the SKT 
task.
4.14.1 Three Factor Solution
A three factor solution was explored, the 3 factor solution accounted for 61% of  
the total variance (see Table 26 and Table 27).
Table 26: Showing the Eigenvalue, percentage of variance and cumulative percentage for 
the 3 factor solution.
Factor Eigenvalue % variance Cumulative %
1 2.73 30.4% 30.4%
2 1.67 18.6% 49.0%
3 1.08 12.0% 61.0%
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Table 27: Showing the factor loadings for the three factor solution.
Factor 1 Factor 2 Factor 3
SKT I 0.15 0.29 -0.74
SKT II 0.29 0.29 0.67
SKT III 0.46 -0.09 -0.57
SKT IV 0.73 0.15 0.05
SKT V 0.78 0.12 0.001
SKT VI 0.63 -0.07 -0.09
SKT VII 0.78 -0.008 0.06
SKT VIII 030 0.60 0.51
SKT IX -0.04 0.84 -0.10
In factor one, SKT subtests IV (arranging blocks), SKT V (replacing blocks) 
and SKT VII (the reverse naming task) are heavily loaded. These tasks are 
attention type tasks hence the factor was termed the attention factor.
In factor two SKT VIII (delayed recall) and SKT IX (recognition memory) were 
heavily loaded, SKT II (immediate recall) also loaded on the factor, hence this 
factor was termed the memory factor.
In the third factor a number of the subtests load quite highly, namely SKT I 
(object naming), SKT II (immediate recall), SKT III (numerical naming) and 
SKT VIII (delayed recall). Essentially these are speed o f naming tasks (I and 
III) and memory tasks (SKT II, SKT VIII). Since recognition memory did not 
load very highly, and the memory subtests load with factor two, this factor was 
termed the speed of naming factor.
Lehfeld, Rudinger, Reitz, Heinrich, Wied, Fomazzari, Pittas, Hindmarch and 
Erzigkeit (1997) conducted a study in which SKT raw data from subjects in 5 
countries were analysed to determine individual factors. Data from the SKT was 
collected in Germany, Chile, Greece, Russia and England.
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The English sample consisted of 193 healthy elderly community dwelling 
subjects (128 female, 64 male) aged 60-97 years (with a mean age of 72.17 
years). The English subjects attended the HPRU in order to complete the SKT.
Lehfeld et a l , (1997) performed a principal components analysis with varimax 
rotation on the English SKT raw data (SKT subtests I-IX). Instead o f factor 
loadings, the authors chose to use a "perfect congruent weights" approach that 
uses maximum similarity of factor weights as a rotation criteria. This method 
was chosen as factor weights are not as dependant on sample characteristics as 
loadings, hence the authors believed that their method would yield more reliable 
results.
The authors reported that three factor solution best explained the data. Lehfeld 
et al (1997) termed the three factors attention, speed of naming and memory.
The subtests that loaded with factor one were SKT subtests IV (arranging 
blocks), SKT V (replacing blocks), SKT VI (counting symbols) and SKT VII 
(reverse naming task). Factor one was termed the attention factor.
Factor two consisted of SKT subtests II (immediate recall), SKT VIII (delayed 
recall) and SKT IX (recognition memory) this factor was termed a memory 
factor. Finally The third factor was termed the speed of naming factor and 
consisted of SKT subtests I (object naming) and SKT III (numerical naming).
Table 28 shows the factor loadings in the German unimpaired subjects (very 
similar results were obtained in the English sample, however the authors do not 
report the English factor loadings.
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Table 28: Shows the factor loadings identified by Lehfeld et al., (1997) using the German 
unimpaired subsection.
Attention Factor Memory Factor Speed of Naming Factor
SKT I 0.09 0.006 0.69
SKT II 0.22 0.78 0.03
SKT III 0.03 -0.02 0.77
SKT IV 0.77 0.13 0.07
SKT V 0.82 0.07 0.09
SKT VI 0.68 0.12 0.10
SKT VII 0.73 0.13 -0.02
SKT VIII 0.37 0.79 -0.01
SKT IX -0.04 0.65 0.01
4.14.2 Conclusion
The three factor solution of the SKT raw data (SKT I-IX) agrees with the results 
obtained by Lehfeldt et al., 1997. Factor one (attention factor) included SKT 
subtests IV, V, VI and VII. In the present analysis of factor two (memory), SKT 
VIII and IX load highly and produce results similar to Lehfeldt et al., 1997. 
However, in the present analysis SKT II did not load very highly with factor 
two. In the present analysis of factor three, SKT I, II and III load very highly 
which again agrees with 1997 analysis (with the exception o f SKT II).
Overall there was high agreement rate between the two sets of analysis, which 
helps to substantiate that the factors are genuine and not just specific to a 
particular sample.
4.15 Age and gender differences in performance of the 
SKT Factor scores
Having identified SKT factor scores (attention, memory and the speed of 
naming) the effects o f age and gender were examined on each of the factors. 
The data were analysed using a two way analysis o f variance with age band and 
gender as between subjects factors and the SKT factor scores as the dependant 
factors.
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4.15.1 SKT Factor 1 (attention)
SKT subtests included in the SKT attention factor included arranging blocks 
(SKT IV), replacing blocks (SKT V), counting symbols (SKT VI) and the 
reverse naming task (SKT VII).
There was no significant main effect of age (F (4 , 144) = 1.45, p>0.05). There 
were no main effects o f gender (F (i, 144) = 1.35, p>0.05) and there was no 
significant gender ageband interaction (F (4 , 144) = 1.32, p>0.05).
4.15.2 SKT Factor 2 (speed of naming )
SKT subtests included in the SKT speed of naming factor included SKT I 
(object naming) and SKT III (numerical naming).
There was no significant main effect of age (F (4 , 144) = 1.15, p>0.05). The speed 
of naming scores were comparable across the ages.
There was no significant main effect of gender (F (i, 144) = 0.14; p>0.05). There 
was a significant gender ageband interaction (F (4 , 144) = 2.85; p<0.05) (see Table 
29).
Table 29: Showing the mean factor scores in terms of age and gender for the speed of 
naming factor
60-64 65-60 70-74 75-79 80+
Male -0.25 0.009 0.30 0.08 0.33
Female 0.17 -0 . 0 2 -0.67 0.17 0.52
4.15.3 SKT Factor 3 (memory)
SKT subtests included in the SKT memory factor included SKT II (immediate 
recall), SKT VIII (delayed recall) and SKT IX (recognition memory).
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There was no significant main effect of age (F (4 , 144) = 0.04; p >0.05) there were 
no differences between the factor scores of subjects. There were no significant 
main effect o f gender (F (j, 144) = 1.06; p >0.05) and no significant gender 
ageband interaction (F (4 , 144) = 0.35; p >0.05).
4.15.4 Summary
There were no age effects for scores on attention or memory, however there was 
a significant gender ageband interaction on the memory factor, suggesting that 
there was a tendency for older female subjects to be slightly slower than male 
subjects on tasks assessing the speed of naming.
4.16 The effect of actual age on SKT factor scores
Analysis of the effects of age band on the factor scores would seem to reveal 
that there were no effects of ageband on any of the factors. However, it is 
possible that splitting the data in terms of age band may have affected the 
results, therefore actual age was correlated with the SKT factor scores using the 
Kendall’s tau (see Table 30).
Table 30: Showing correlation between SKT factor scores and actual age.
Task Kendall's tau p level
attention factor -0.04 p>0.05
memory factor 0.07 p>0.05
speed o f naming factor 0.008 p>0.05
It was reported that there were no significant correlation's between actual age 
and the SKT factor scores.
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4.17 Principal Components Analysis of the 
performance data
Principal components analysis was used in the same way as the SKT principal 
components analysis to determine relationships between all the psychometric 
tests.
The psychometric tests included in the analysis were SKT subtests 1 to 9, CFF, 
SMT RRT and MRT. (Total SKT and total reaction time (TRT) were omitted 
from the analysis as the total SKT scores can be regarded as a the sum of the 
penalties occurred in SKT subtests 1-9, and TRT is the sum of both RRT and 
MRT, including them in the data could be regarded as double counting).
The data were subject to a principal components analysis with oblique rotation, 
pairwise deletion of missing data (see Figure 26).
Plot of Eigenvalues
3.5
2.5
a>
03>
0.5
Number of Eigenvalues 
Figure 26: Showing the Scree plot o f the perform ance data.
Examination of the scree plot would seem to reveal factor solutions consisting 
of five factors. A five factor solution was explored.
4.17.1 A five factor solution
The five factor solution accounted for 64.7 % of the total variance (see Table 31 
and 32).
Table 31: Showing the Eigenvalues and percentage o f variance.
Factor Eigenvalue % variance Cumulative %
Factor 1 3.1 23.8 23.8
Factor 2 1.8 13.8 37.7
Factor 3 1.3 10.1 47.8
Factor 4 1.1 8.6 56.5
Factor 5 1.0 8.1 64.7
Table 32: Showing the factor loadings for each o f  the psychom etric tests on the five 
factors.
Factor 1 Factor 2 Factor 3 Factor 4 Factor 5
SKT I 0.01 -0.10 0.84 0.07 0.09
SKT II 0.10 0.82 -0.13 -0.13 -0.05
SKT III 0.38 -0.09 0.61 -0.09 -0.29
SKT IV 0.65 0.29 0.13 0.10 0.07
SKT V 0.67 0.26 0.20 0.19 0.09
SKT VI 0.71 -0.09 0.04 -0.009 0.08
SKT VII 0.76 0.19 0.05 0.003 -0.03
SKT VIII 0.11 0.86 -0.02 0.08 0.17
SKT IX 0.06 0.14 0.02 0.02 0.86
CFF 0.05 -0.01 -0.38 0.66 -0.08
RRT 0.24 -0.17 -0.16 0.67 0.08
MRT 0.11 0.23 0.04 0.56 -0.47
SMT 0.58 -0.08 -0.25 0.37 -0.20
Examination of the factor loadings revealed that each of the tasks could be 
assigned to a factor, and the factors seemed logical. They were termed attention, 
memory recall, speed of information processing, speed of naming and 
recognition memory (see Tables 33 and 34).
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Table 33: Showing the factors and subtasks included in the 5 factor solution.
Factor Names Subtests
Factor 1 (attention) SKT IV, V, VI, VII, SMT
Factor 2 (memory recall) SKT II, VIII
Factor 3 (speed of naming) SKT I, III
Factor 4 (speed of information processing) CFF, RRT, MRT
Factor 5 (recognition memory) SKT IX
Table 34: Showing the Eigenvalue, and percentage o f variance accounted for by each o f  
the 5 factors.
Factor Tasks in each 
factor
Factor name Eigenvalue % variance cum ulative
%
1 SMT, SKT 4, 5, 
6 ,7
Attention 3.1 23.8 23.8
2 SKT 2, 8 Memory
recall
1.8 13.8 37.7
3 CFF, RRT, 
MRT
Speed o f
information
processing
1.3 10.1 47.8
4 SKT 1, 3 Speed o f  
naming
1.1 8.6 56.5
5 SKT 9 Recognition
memory
1.0 8.1 64.7
4.18 The effects of age and gender on the 5 
performance factor scores
The interaction with age and gender was examined using a two way analysis of 
variance with two between subjects factors (age band and gender) and factor 
score for each of the performance factors as the dependant variable.
4.18.1 Factor 1 - Attention Factor
Factor 1 consists of the HPRU Sternberg Memory Task (SMT), SKT subtest IV 
(arranging numbers), SKT Subtest V, (rearranging numbers) SKT Subtest VI, 
(counting symbols) and SKT Subtest VII, (reverse naming task).
There was no main effect of age F ^  114) = 0.33; p>0.05). There was no 
difference between the attention factor scores in terms o f age. There was no
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significant main effect o f gender (F (i, 114) = 0.72; p >0.05), and there was no 
significant age and gender interaction (F (4 , 114) = 1.67; p >0.05).
4.18.2 Factor 2 -The Memory Recall Factor
Factor 2 consists of SKT subtest II (immediate memory recall) and SKT Subtest 
VIII (delayed memory recall).
There was no significant main effect of age (F (4 , 114) = 0.73; p >0.05) there was 
no difference between the memory recall factor scores in terms o f age.
There was no significant main effect of gender (F (i, 114) = 1.31; p >0.05). There 
was no significant age and gender interaction (F (4 , 114) = 1.09; p >0.05).
4.18.3 Factor 3 - The Speed of Naming Task
Factor 3 consists of SKT subtest I (object naming) and SKT Subtest III 
(numerical naming).
There was no significant main effect of age (F (4 , 114) = 0.53; p >0.05). There was 
no difference between the speed of naming factor scores in terms of age. There 
was no significant main effect of gender (F (i, 114) =. 0.88; p >0.05). There was 
no significant age and gender interaction (F (4 , 114) = 0.23; p >0.05).
4.18.4 Factor 4 - The Speed of Information P rocessing  Task
Factor 4 consists of the Critical Flicker Fusion task (CFF) Recognition Reaction 
Time (RRT) and Motor Reaction Time (MRT).
There was no significant main effect of age (F (4 , 114) = 0.35; p >0.05). There was 
no difference between the speed o f information processing factor scores in 
terms of age. There was a significant main effect o f gender (F (i, 114) = 0.47; p = 
0.001). Female subjects were poorer at information processing tasks than male
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subjects. There was no significant age and gender interaction (F (4 , 114) = 1.00; p 
>0.05).
4.18.5 Factor 5 - Recognition Memory
Factor 5 consists of SKT subtest IX (recognition memory).
There was no significant main effect of age (F (4 , 114) = 1.82; p >0.05). There was 
no difference between the recognition memory factor scores in terms o f age. 
There was no significant main effect of gender (F (i, 114) = 1.85; p >0.05). There 
was no significant age and gender interaction (F (4 , 114) = 1.17; p >0.05).
4.19 Performance Factor correlation's with actual age
Analysis of the effects of ageband on the five performance factors would seem 
to reveal that there was no effect of age band on any o f the five performance 
factors. However, it is possible that splitting the data in terms o f age band may 
have affected the results, therefore actual age was correlated with task 
performance using Kendall’s tau.
In terms of actual age, it would seem that using factor scores, it is possible to 
predict performance on the recognition task (SKT IX) simply in terms o f a 
subjects age. Actual age was not correlated with task performance on any of the 
other performance factors (see Table 35).
Table 35: Showing the results o f the Kendall's tau. The correlation between actual age 
and task perform ance.
N Kendall's tau p Level
Attention 124 -0 . 0 1 p>0.05
Memory recall 124 0.06 p>0.05
Speed of information processing 124 0.006 p>0.05
Speed of naming 124 0.004 p>0.05
Recognition memory 124 -0.15 p<0.05
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4.20 ADL Factor correlations with actual performance 
factors
Having identified performance factor scores, and previously identified ADL 
factor scores, it was questioned whether there is a relationship between ADL 
and performance factor scores.
An important issue for gerontologists is whether there is a relationship between 
what the elderly believe is happening to cognitive function (expressed as a 
subjective rating) and what is happening to them in terms of actual cognitive 
function (assessed with the use of psychometric tests). If subjective ratings were 
reliable, then subjects experiencing actual cognitive decline should "feel" that 
they were experiencing such decline. This is an important issue, as many 
researchers rely on subjective ratings as accurate reflections o f cognitive 
decline.
A correlation was performed to examine the relationship between the ADL 
factor scores and the performance factor scores. There are no significant 
correlations between subjective factor scores (ADL) and the objective factor 
scores (performance factor scores). Therefore, subjects self reports o f what they 
felt was happening to them was not confirmed when they performed objective 
tests, to determine what was actually happening to them as a result o f age. The 
subjects did not feel that they were experiencing changes in cognition as a result 
of age (as expressed in their ADL factor and mean scores). However, it has been 
shown that age related decrements were noted in actual task performance.
Table 36: Showing the correlation matrix between performance factor scores and ADL 
factor scores. Performance factor scores 1-5.
ADL Factors Attention Memory
recall
Speed of 
naming
Speed of 
information 
processing
Recognition
memory
Attention 0.54 0.06 -0.02 0.08 -0.07
Orientation -0.09 -0.09 -0.01 0.01 0.08
Memory 0.10 0.14 0.04 -0.05 -0.05
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These results support previous research where actual task performance did not 
bear any relationship on subjective ratings (Rabbitt and Abson, 1991; Jorm et 
a l , 1997).
Rabbitt and Abson (1990), questioned whether elderly persons were actually 
aware of their everyday performance capabilities. This research raises the 
question 'Should we rely on the self reports o f elderly persons?'. It would appear 
that a clearer picture of age related change in performance are only obtained 
when actual performance is assessed, rather than simply relying on subjective 
self reports. Perhaps the ideal assessment tool would incorporate both subjective 
and objective measures.
4.21 Discussion
This chapter aimed to answer three fundamental questions, 'What are the effects 
o f age on the cognitive and psychomotor tasks?', 'How do the tests used relate to 
each other?' and finally 'Is there a relationship between the subjective and 
objective assessments of human cognitive function?'
A review of the performance literature on ageing reported that age decrements 
in performance would be expected on tasks o f attention, immediate recall and 
delayed recall and tasks relying on the speed of information processing.
In terms of the tests included in this thesis age related decrements were 
expected on SKT I (object naming), SKT II (immediate recall), SKT IV 
(arranging blocks), SKT V (replacing blocks), SKT VI (counting symbols), 
SKT VII (reverse naming task), SKT VIII (delayed recall), the Critical Flicker 
Fusion task (CFF), Choice Reaction Time (CRT) and the HPRU Sternberg 
Memory Task (SMT).
Age related decrements were not expected on SKT IX (recognition memory) or 
SKT III (numerical naming).
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The results indicated that as expected age related decrements were noted on 
SKT II (immediate recall),. SKT subtests IV (arranging blocks), SKT V 
(replacing blocks), SKT VI (counting symbols), SKT VII (reverse naming task) 
and SKT VIII (delayed recall). Age related decrements are noted on tasks 
assessing selective attention (SKT VI and VII), attention-orientation type tasks 
requiring a speeded response (SKT IV and V), and immediate and delayed 
recall (SKT II, VIII).
However age related decrements were not evident on SKT subtest I (object 
naming), SKT III (numerical naming), SKT IX (recognition task), the Critical 
Flicker Fusion task (CFF), Choice Reaction Time (CRT) or the HPRU 
Sternberg Memory Task (SMT).
A number of reasons have been proposed to try an account for the lack o f age 
related decrement.
Age related decrements were not observed on SKT I (object naming). Despite 
the fact that elderly subjects experience word finding difficulties, no age effects 
were reported on the object naming task. It is possible that the task was too 
simple for healthy subjects an did not place them under great cognitive demand, 
given that they only had to name 12 objects. It is possible that age related 
decrements would only be observed in subjects with cognitive decline, or would 
only become evident in healthy subjects when the number o f stimuli were 
increased.
There was also no main effect of age on SKT IX (recognition memory). 
Generally age related decrements are not reported on recognition memory tasks, 
as the material presented acts as a cue to aid recall (unless the material is too 
similar to the stimuli and hence disrupts recognition). The lack o f effect may 
also be attributed to a methodological flaw. In general recognition tasks are 
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tested exclusively (i.e. without previously testing immediate and delayed recall). 
However in the SKT task subjects are asked to recognise the stimuli after they 
have performed both immediate and delayed recall tasks. Therefore, the task is 
not strictly assessing recognition memory per se.
The Critical Flicker Fusion task (CFF) is a measure o f overall central nervous 
system efficiency, essentially it is a measure of how efficient subjects are at 
processing information. As information processing is known to decrease with 
increased age (Salthouse, 1985) age related decrements would be expected on 
the task. A number of previous researchers have reported age related declines in 
performance on the CFF (Brozek and Keys 1945; Weekers and Roussel 1946; 
Misiak 1947; Colgan, 1954). However in this experiment no age effects were 
reported. Age related decrements were expected on the CFF task, especially as 
age related slowing in performance had been observed on SKT subtests IV 
(arranging blocks), V (replacing blocks) and SKT VI (counting symbols), these 
three tests assess aspects of attention and speed. If no age related decrements 
were noted on speeded tasks, then the lack of effect on the CFF would have 
been expected. The lack of an age effect on the CFF maybe due to a failure on 
the subjects part to leam and fully understand the task. However, since all 
subjects had at least 6  practice sessions before taking part in the study, it is more 
likely that the task in it's present form is not age sensitive.
The Choice Reaction Time is a task that has previously been reported as 
sensitive to the effects of age (Birren, Woods and Williams, 1979; Lindenberger 
et al, 1993; Corpolongo and Salmon, 1981). However no age effects were 
reported on the task. It is possible that the methodology o f the task was 
responsible for the lack of effect. This version o f the choice reaction time is too 
simple, subjects only have to respond to one o f 6  stimuli, age effects may have 
been noted if  the number of stimuli had been increased.
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The Sternberg Memory Task (SMT) employed is not the original Sternberg 
Memory Scanning task (1966, 1975). In Sternberg's original task, following 
presentation of the test material, a single digit probe is presented to test the 
ability to scan the memory set. In the present HPRU version o f the task, 12 
single digit probes are presented, so subjects have to scan the memory set 1 2  
times, which is very different from the original Sternberg Memory Scanning 
task. This methodological difference between the tasks may be responsible for 
the lack o f effect o f age.
To conclude, the test battery used in this thesis, contained some tasks that were 
sensitive to the effects o f age these included SKT subtests II (immediate recall), 
IV (arranging blocks), V (replacing blocks), VI (counting symbols), SKT VII 
(reverse naming) and SKT VIII (delayed recall). A number o f tasks that were 
not found to be age sensitive these included SKT I (object naming), SKT III 
(numerical naming), SKT IX (recognition memory), the Critical Flicker Fusion 
task, Choice Reaction Time or the HPRU Sternberg Memory Task.
Having assessed the tasks for age and gender effects, it was then decided to try 
and identify relationships between the tasks using a principal components 
analysis. Clear relationships between the psychometric test were identified. 
Firstly, the SKT task was analysed using the principal components analysis to 
reveal that a three factor solution identified the most sensible relationships 
between the subtests. The three factors were termed attention (SKT IV, V, VI, 
VII), the speed o f naming (SKT I and III) and memory (SKT II, VIII, IX). 
These results mirrored those reported by Lehfeld et al., (1997).
Having identified clear relationships between SKT subtests, a principal 
components analysis was performed on all the psychometric data (SKT subtests 
I, to IX, CFF, RRT, MRT and SMT). A five factor solution was accepted. The 
factors were termed attention (SMT, SKT IV, V, VI and VII), memory recall
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(SKT II, VIII), speed o f naming (SKT I, III), speed o f information processing 
(CFF, RRT, MRT and TRT) and recognition memory (SKT IX).
Finally, having identified five performance factors and previously identifying 
three ADL factors a correlation was performed to determine whether there was 
any relationship between the performance factor scores (attention, memory 
recall, speed of naming, speed of information processing and recognition 
memory) and the ADL factor scores (attention, orientation and memory).
It was reported that there were no significant correlations between subjective 
factor scores (ADL) and the objective factor scores (performance factor scores). 
Subjects self reports o f changes in cognition as a result o f age were not 
confirmed in objective tests.
The subjects did not feel that they were experiencing changes in cognition as a 
result o f age (as expressed in their ADL scores) even though age related 
decrements were noted on some of the objective performance tasks.
These results support previous research where actual task performance did not 
bear any relationship on subjective ratings (Rabbitt and Abson, 1991; Jorm et 
al., 1997). Based on this, it was concluded that self report ADL scales may not 
provide scientists with an accurate picture o f cognitive decline. The ideal 
assessment schedule should include both subjective and objective measures, 
rather than solely relying on subjective ratings.
Having identified, some tasks that are sensitive to the effects o f age, and 
previously noting that nutritional deficiencies may predispose elderly subjects 
to cognitive decline. Three experimental chapters have been devoted to 
assessing the effects o f nutritional/dietary supplements on aspects o f cognitive 
and psychomotor performance in samples of healthy community dwelling 
elderly subjects.
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The nutritional supplements examined were multivitamins, ginkgo biloba and 
glucose.
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5 Chapter Five: The effects of long term 
multivitamin supplementation on aspects of 
cognition in an elderly population
5.1 Chapter Outline
The relationship between multivitamin status and cognitive function in patient 
populations
The effects of nutritional status on cognitive function in elderly populations.
The effects of vitamin supplementation on attention in elderly 
populations
The effects of vitamin supplementation on memory in elderly populations 
The effects of vitamin supplementation on the speed of information 
processing in elderly populations
The effects of vitamin supplementation on intelligence in elderly 
populations
The effects of vitamin supplementation on mood, well being and 
behaviour in elderly populations
The effects of long term multivitamin supplementation on aspects of 
cognitive function 
The change in blood vitamin levels 
Vitamin A 
Vitamin Bj 
Vitamin B2 
Vitamin Be 
Vitamin Bn 
Vitamin E 
Vitamin C 
Biotin 
Folic Acid
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The effects of long term multivitamin supplementation on mood and cognitive 
function in the elderly
The effects of multivitamin supplementation on attention
The effects of multivitamin supplementation on tasks assessing memory
recall
The effects of multivitamin supplementation on the speed of naming 
The effects of multivitamin supplementation on the speed of information 
processing
The effects of multivitamin supplementation on recognition memory ‘
The effects of multivitamin supplementation on intelligence 
The effects of multivitamin supplementation on mood
This chapter details a study assessing the long term effects of multivitamin 
supplementation on cognitive function in a sample of 239 healthy community 
dwelling elderly subjects.
The effects of multivitamin supplementation were examined on objective tasks 
assessing memory, attention, the speed of information processing, intelligence, 
and subjective ratings of cognitive failure, anxiety and depression.
The chapter reviews the previous literature in terms of the effects of 
supplementation on aspects of memory, attention, the speed of information 
processing and subjective mood and general well being in healthy elderly 
samples.
5.2 The relationship between multivitamin status and 
cognitive function
A number of researchers have assessed nutritional deficiencies in samples of 
elderly subjects, it has been reported that in many cases, the deficiency rates 
exceed 50% of the population sampled. With such high incidences of
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deficiency, researchers have questioned whether nutritional deficiency 
adversely affects cognitive function.
Researchers have questioned whether poor nutritional status is associated with 
impaired cognitive function and even psychiatric illness. If the two were linked, 
then it would be expected that subjects with nutritional deficiency would show 
impaired cognitive function or may be suffering psychiatric disorders. In 
chapter two, it was reported that vitamin deficiency was associated with a 
number of dramatic changes in mood, personality and cognitive function. 
Disorders such as depression were linked to deficiency in vitamins Bi, B3 , B6 , 
B 12 and biotin; dementia associated with deficiency in vitamins Bj, B3 , B6 , B 12 
and folic acid, problems with concentration and thought associated with 
deficiency in vitamins Bi, B3 , B 12; and insomnia associated with B3 , B6 and 
biotin.
5.3 Nutritional status in patient populations
To test this hypothesis, researchers have assessed blood vitamin concentration 
in samples of subjects with psychiatric syndromes.
Carney, Ravindran, Rinsler and Williams (1982) examined blood levels of 
vitamin Bi, B2 and B6 in 172 unselected patients admitted to a psychiatric 
hospital. It was reported that a total o f 53% of those admitted were deficient in 
at least one o f the vitamins (41% in one vitamin and 1 2 % in more than one 
vitamin), more importantly 30% of the sample were deficient in vitamin Bi and 
29% of the sample were deficient in vitamin B2 even though none of the 
patients showed any physical signs o f deficiency.
Hancock, Hullin, Aylard, King, and Morgen (1985) examined the nutritional 
status o f 216 elderly women admitted to a psychiatric hospital. It was reported 
that compared to healthy elderly women, the psychiatric patients had lower
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blood levels of vitamins C, B2 and B6. Interestingly the patients with dementia 
had worse protein and vitamin status than patients with depression.
Hunter, Jones, Jones and Matthews (1967) assessed blood levels o f vitamins B 12 
and folate in a sample of 150 psychiatric patients aged 17-86 years. It was found 
that only 3% of the patients had low levels o f vitamin B 12, whereas 50% of the 
patients were found to have low levels of folate.
Spindler and Renvall (1989) tested the hypothesis that poor nutritional status is 
associated with poor cognitive functioning. Blood vitamin status and cognitive 
function were assessed in 73 subjects aged 77-83 years. The authors reported 
that if a decline in cognitive function is associated with poor nutritional status, 
then subjects with cognitive impairment should have lower nutritional status 
than subjects with optimal cognitive function. All subjects kept three day 
dietary diaries so that nutritional status could be estimated. Cognitive function 
was assessed using the Mini Mental Status Examination (MMSE). Subjects 
were assigned to one of two groups on the basis o f their MMSE scores. Group 
one consisted of subjects with MMSE scores between 21 and 25, they were 
classed as having mild impairment. The other group consisted o f subjects with 
MMSE scores less than or equal to 20, these were classed as having moderate 
impairment. Results of the dietary diaries were compared in both groups and 
with a sample o f healthy elderly subjects. A number o f marked differences 
emerged between the three groups. It was reported that subjects with low levels 
of vitamin Bi, B2 , B 12 and folate, had poorer cognitive functioning than those 
with higher levels of nutritional status. Interestingly serum B 12 levels decreased 
with increasing impairment. This study provides tentative evidence that 
nutritional status can adversely affect cognitive function.
Sommer and Wolkowitz (1988) conducted a study that assessed the relationship 
between folic acid levels and cognitive function in a sample o f 13 patients aged 
51-93 years, who had been admitted into hospital as a result o f memory
129
complaints. Ten of the 13 patients had been diagnosed with probable 
Alzheimer’s disease. Cognitive function was assessed using the MMSE, the 
Mattis Dementia Rating Scale, California verbal learning task, Benton naming 
task and the Benton visual retention task. Mean scores on the MMSE were 18.5 
(± 6.3) and it was found that scores on the MMSE were highly correlated with 
folic acid level. Patients with low folic acid levels had poorer MMSE scores 
than subjects with higher folic acid levels, indicative of poorer cognitive 
functioning. It is interesting to note that in this sample folic acid levels were 
found to affect cognitive function, and all patients had folic acid levels in the 
normal range. Despite the small sample size included in the study, the results 
are interesting and warrant further investigations.
Levitt and Karlinsky (1992) examined the relationship between folate, vitamin 
B 12 and severity o f cognitive impairment in patients with Alzheimer's disease. 
Ninety seven patients were assessed (40 patients had probable AD, 31 had other 
dementia’s and 26 had mild cognitive impairment). Blood samples were taken 
to determine blood vitamin levels and patients completed the Mini Mental State 
Examination. In the Alzheimer’s group vitamin B 12 level was significantly 
correlated with MMSE scores, so that subjects with low blood vitamin B 12 
levels had poorer MMSE scores than subjects with higher blood vitamin B 12 
levels. There were no correlations between folate or vitamin B 12 level and 
MMSE in any o f the other subjects. These findings suggest a specific 
relationship between vitamin B 12 levels and the severity of cognitive 
impairment in patients with Alzheimer's disease.
However it is important to note that the causal relationship in the reported 
studies is very difficult to decipher, the vitamin deficiency may lead to mental 
impairments, or the fact that the patient is mentally impaired may lead to poor 
nutritional status simply because the patient forgets to eat or consume a diet 
lacking in the essential vitamins. Reynolds et al. (1979) believe that the two 
could be linked in a vicious circle.
130
A finding common to all the above studies is vitamin deficiency and 
disturbances in either cognitive function, mood or personality. Hence these 
studies would seem to prove tentative evidence that nutritional deficiencies may 
be associated with psychiatric disorders.
131
Ta
bl
e 
37
: 
Sh
ow
in
g 
the
 
re
la
tio
ns
hi
p 
be
tw
ee
n 
nu
tr
iti
on
al
 s
ta
tu
s 
an
d 
co
gn
iti
ve
 
fu
nc
tio
ni
ng
 
in 
pa
tie
nt
 p
op
ul
at
io
ns
.
©w■4^=3o
.3
s3
'o
©Td
vO
0 sCOin
<N
pq
"3©
oUP
©Td
vOo s
OstS
PQ
a
cda 
©
'o >  UP »-H
t3 </5
 ^J§o  v
r o  cd
©>
*0
O
O
©
£Jd
cd
Jd
0s-m
§
Ctf
S
£jd
cddp
1/5
S3
©
&PQ 
«+h S3 
O •£nP w 0s  cd 
O  *3 in >
l+Ho
<D>
©
ndoo
3
£
PQ
00
ooeu
nd
cdPQ
UP
£
.3 2ts °cd (j
Td
PQ
00
s  i
1-H C/3
eu, pq
>
Uho
T3
O
O 'o
3  «
^  ’SsC/5 w
S'? M8 m
C/3 
< PQ
cd
S3
O’+-»
B
§
nd
<L>
PQ
S3
>
t 3
S3
cd
<L>
UP
Td
©
Td
S3
cd
C/5
3
C3
cjabO%->
i
Md
C/5 c/5<L) e3 
C/5 O  
c/5 e d
M PQ 
S'? ^
C/3 S
<  S
cd © c/:
U  PQ 3
©
CJOD
+oo
r-H
Td
©U)
cd
+oo
Td0)
bO
cd
cda)
VOoo coOs
t"
<Nr- VO1—H<N
Oin voCO r-~On
cdCO
□  C/5
5  B
6  a
s . I
i j  C/D
5 E
3  -j§
>5 &
s i cdPh cdP h
IZ)
C/3
 ^ 'S l-H*^’3 a C/3
1 & 4> (U
a >  §a 8 < +-»CCJp .
ShOPPH-»3
CN
00
Os
©
I
U
Moo
3 ov 
K O
r-~
VO
Os
I
a
Osooos
nd cd
.a £CP S 00 P4
<N
Os
Os
B  >>
Cd M
.3 -s>a> cd
►J ^
132
5.4 The effects of nutritional status on cognitive 
function in elderly populations
Based on the above findings where psychiatric disorders have coincided with 
poor nutritional status, a number o f researchers have examined the effect of 
nutritional status on cognitive function by measuring blood vitamin levels and 
cognitive function in elderly populations and comparing the two, or by 
examining the impact o f vitamin supplementation on cognitive function in both 
healthy elderly subjects and patient populations. Researchers have examined the 
effects of nutritional status on aspects of attention, memory, intelligence and the 
speed o f information processing.
5.5 The effects of vitamin supplementation on 
attention in elderly populations
Attention is thought to be one aspect of cognitive function which is particularly 
susceptible to decrements with age (Plude and Hoyer, 1986). Researchers have 
examined the association between nutritional status or the effects of single and 
multivitamin supplementation on aspects of attention in elderly subjects.
Bohnen, Jolles and Degenaar (1992) assessed the relationship between 
nutritional status and cognitive function in a sample o f 80 healthy subjects aged 
17-85 years. Blood samples were taken to determine vitamin B 12 status o f the 
subjects. Cognitive function was assessed using the Stroop task. Subjects were 
required to complete 4 components of a Stroop task. In the first version subjects 
had to name 100 colour words (red, yellow, green and blue). In the second 
version subjects had to name 100 colour spots (red, yellow, green and blue), 
whilst in the third version, subjects had to complete the classic Stroop task, 
where 100 colour words were written in coloured ink, the subjects were 
required to name the colour o f the ink. In the fourth version o f the task, 20 items 
from subtest III were randomly selected, small rectangles were drawn around 
the words, subjects were required to read the word within the rectangle. This
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final version of the task induced greater interference than the classic Stroop 
task. It was reported that subjects with lower blood vitamin levels exhibited 
poorer Stroop task performance than those with higher blood vitamin levels, 
especially on version IV the modified Stroop task with increased complexity.
Deijen, van der Beek, Orlebeke and van der Beek (1992) examined the effect of 
vitamin supplementation on attention in 76 healthy men aged 70-79 years. 
Subjects were supplemented with vitamin B6 or placebo for a period of 3 
months. Attention was assessed using a cognitrone (a task in which 5 display 
fields appear on the screen, 4 at the top, 1 at the bottom. The subjects had to 
compare the figure at the bottom of the screen with the four figures at the top. If 
the figures at the bottom matched one of the figures at the top o f the screen, 
then the subjects had to press the "yes'’ response key, and the "no" response key 
if  the figure did not match). The number o f correct responses and reaction times 
were recorded. The task measured aspects o f selective attention, form 
perception and memory. Performance was assessed at baseline and after three 
months o f treatment. It was reported that supplementation had no effect on task 
performance.
Botez, Botez and Maag (1984) conducted a study in which 49 folate deficient 
patients aged 22-76 years (mean age 42.2 years) were supplemented with folate 
10 mg daily for 7-11 months. Cognitive function was assessed using a digit 
symbol substitution task, a similarities task and a block design task. It was 
reported that supplementation with folate resulted in improved performance on 
all three tasks.
5.5.1 Sum m ary
The Bohnen et al (1992) study, implicated that selective attention was affected 
by nutritional status. Two studies have examined the effects o f vitamin 
supplementation on attention in elderly subjects. Deijen et al (1992) reported 
that short term supplementation with vitamin B6 had no effect on performance
134
of the cognitrone - a task assessing selective attention, form perception and 
memory. Botez et al. (1984) reported that folate supplementation in depressed 
folate deficient patients resulted in significant improvements on the DSST, 
block design and similarities tasks.
Bohnen et al. (1992) observed that Stroop task performance was poorer in 
subjects with lower blood vitamin B 12 levels, the Stroop task is an attention 
demanding task, requiring the subjects to selectively attend to some aspects of 
the task (i.e. ink colour) whilst ignoring other aspects o f the task (i.e. the written 
word) therefore, it is possible that nutritional status may affect performance on 
the task. However to date, no studies have supplemented subjects with 
multivitamins and examined the effects. In the Deijen et al. (1992) study, 
performance was assessed using a cognitrone, this task requires elements of 
attention, speed, form perception and memory, the multi-nature o f the task, may 
result in negative effects simply, because the task requires more than just 
attention in order to complete it.
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5.6 The effects of vitamin supplementation on 
memory in elderly populations
Problems with memory are common complaints among the elderly (Dixon, 
Simon, Nowak and Hultsch, 1982, Lowenthal, Berkman, Pierce, Robinson and 
Trier, 1967).
A number of studies have demonstrated that a deficiency in certain blood 
vitamin concentrations have resulted in decrements in memory performance.
Goodwin, Goodwin, and Garry (1983) assessed the effect o f nutritional status 
on cognitive functioning in 250 elderly subjects aged 60-94 years . Blood 
vitamin levels were assessed and correlated with performance on a memory 
task. Memory was assessed using the paragraph recall task, taken from the 
Wechsler Memory Scale (subjects had to listen to a paragraph read to them by 
the investigator, and were required to give immediate recall o f the paragraph 
and delayed recall some 30 minutes later). It was reported that blood vitamin 
concentration was an important determinant of memory function, in particular 
low concentrations of vitamin Bi, B\2, vitamin C and folic acid were associated 
with poor memory recall.
La Rue, Koehler, Wayne, Chiulli, Haaland, and Garry (1997) conducted a 
follow up to the Goodwin et al. (1983) study in which associations between 
nutritional status and cognitive performance were examined in 137 elderly 
subjects (aged 60-90 years). Cognitive performance was assessed using three 
memory tasks, the WAIS paragraph recall task, WAIS visual reproduction and 
the Rey Osterreith complex figures test. In the paragraph recall task subjects 
had to listen to 2 short stories and were required to give immediate recall and 
delayed recall (30 minutes later).Visual reproduction (subtest from the Wechsler 
Memory Scale) subjects had to study 4 geometric shapes and attempt to draw 
them from memory, immediately and after 30 minutes delay. Subjects also had 
to complete the Rey Osterreith complex figures test which is much the same as
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the visual reproduction task but with greater degree o f difficulty, both 
immediate and delayed (30 minutes delay) reproduction o f the figures were 
required. In this study the researchers examined current nutrition-cognition 
correlations and past nutrition-cognition correlations.
There were several correlations between both current and past vitamin status 
and task performance. Current use o f vitamin C and niacin was positively 
correlated with Rey Osterreith task performance and approached significance on 
the visual reproduction test. There were no associations between current vitamin 
use and paragraph recall. Overall, it was reported that subjects with superior 
cognitive performance had higher nutrition concentrations
The study also looked at performance in subjects currently taking supplements 
and compared to test scores with subjects who were not taking any supplements. 
There was no difference in performance on the logical memory task or visual 
reproduction between supplement users and non users.
Past vitamin use was correlated with current psychometric task performance. 
Past vitamin B users had significantly higher mean scores on the Rey Osterreith 
immediate and delayed recall. Past vitamin C users had higher visual 
reproduction and Rey copying scores. Past vitamin E use was correlated with 
higher scores on Rey copying (immediate) Rey recall (delayed), and visual 
reproduction scores. Current vitamin E takers also had higher Rey recall 
(delayed). Generally higher past intakes o f vitamins A, E, Bg and B 12 were 
associated with better visuospatial recall. The results o f past vitamin intake and 
current psychometric task performance are interesting, however it must be 
remembered that past nutritional/supplement use is only one variable that may 
have affected cognitive function, there are a number o f variables that may have 
effects such as age, current health state, drug use and the time o f delay with 
taking versus not taking vitamins etc. and therefore these results are merely 
speculative. Nonetheless the findings of this study suggest some associations
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between cognitive performance and dietary intake and/or plasma concentrations 
of specific nutrients among normally ageing older adults.
Riggs, Spiro, Tucker and Rush (1996) assessed the relationship between blood 
level o f vitamin B6 and B 12 on cognitive functioning in 70 male subjects aged 
54-81 years. Memory was assessed using a word list task, backward digit span, 
pattern memory and memory for ordered actions. The word list task taken from 
the CERAD test battery, 10 words were presented at a rate o f one every 2 
seconds, immediate recall was required. Three consecutive word lists were 
presented, the total number of words recalled were recorded (maximum 30 
words). Performance on the WAIS-R backward digit span, and memory for 
actions was also assessed. To test memory for ordered actions, subjects were 
given a sheet listing all the tasks they had completed, they were required to 
number the tasks in the order they believed they had completed them. To test 
Pattern memory, a target pattern was presented to the subject, after a brief 
interval 3 patterns are shown to the subjects, the task is to identify the target 
pattern, the number o f correct responses were recorded.
The authors reported that higher blood levels of vitamin B6 were associated with 
improved performance on the backward digit span task and the memory for 
actions task.
The authors also reported a negative finding, there was a trend for subjects with 
higher plasma concentrations of vitamin Bj2 to show poorer recall on the word 
list task. Despite this negative finding, the study provided tentative evidence 
that higher levels o f vitamin B6 facilitated performance on complex sequential 
information processing tasks, i.e. backward digit span (working memory) and 
memory for actions (episodic memory), where as higher levels of vitamin B 12 
resulted in poorer short term memory.
139
Tucker, Penland, Sandstead, Milne, Heck, and Klevay (1990) examined the 
relationship between nutritional status and cognitive function in a sample of 28 
healthy elderly subjects aged 60-87 years. Blood vitamin status was assayed to 
determine blood vitamin status. Cognitive function was assessed using a digit 
span task (both forward and backward) and tonal memory (subjects heard two 
sequences o f tones, the subjects were required to decide whether the tones were 
the same or different, the length o f the tones increased with successive trials, 
subjects were required to decide whether the tones were the same both forwards 
and backwards). Blood vitamin level was correlated with actual task 
performance. It was reported that carotene level was positively correlated with 
backward digit span, higher blood levels o f carotene were associated with 
improved digit span performance. Higher blood levels o f vitamin B2 were 
associated with poorer backward digit span. Higher blood levels o f carotene 
were associated with poorer tonal memory, whereas higher blood levels o f iron 
were associated with better tonal memory performance.
Lauque, Wegner, Ousset, Ghisolfi-Marque, Faisant, Baudoin, Petithory, 
Antoine, Allard, Vellas, and Albarede (1995) conducted a study that suggested 
that poor nutritional status may affect cognitive functioning. Lauque et al. 
(1995) assessed cognitive function using the WAIS picture reproduction task in 
91 elderly subjects (mean age 71 years). Based on the results o f the WAIS test, 
subjects were divided into 2 groups, high score and low score. In the high score 
group, the mean score for women was 55.9 and 55.3 for men. In the low score 
group, the mean score for women was 28.4 and 23.8 for men. Nutritional 
intakes were assessed in all subjects, by assessing the content o f 3 day dietary 
diaries. It was reported that subjects in the high score group, had higher intakes 
of vitamins Bi, B6, C and zinc than subjects in the low score group. The study 
was taken as tentative evidence that insufficient intake o f micronutrients might 
result in cognitive alterations.
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5.6.1 Sum m ary
The studies assessing nutritional status and memory function in healthy elderly 
subjects resulted in a number o f correlations between blood vitamin status and 
cognitive function. In particular it would seem that deficiencies in certain blood 
vitamin levels have resulted in decrements in memory task performance, 
decrements have been observed on the paragraph recall task (Goodwin et al, 
1983; La Rue et al, 1997), memory for geometric shapes -visual memory and 
the Rey Osterreith complex figures test (La Rue et a l , 1997), backward digit 
span (Riggs et al., 1996), and memory for actions task (Riggs et a l, 1996).
Tucker et al (1990) reported that lower blood vitamin levels o f iron and 
carotene were associated with poorer digit span performance and improved 
tonal memory. Lower levels of vitamin B2 were associated with better backward 
digit span.
Lauque et al (1995) reported that subjects with poorer picture reproduction 
scores had lower intakes o f vitamins Bi, E ,^ C and zinc.
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5.7 The effects of multivitamin supplementation on 
memory in elderly populations
Based on the above findings, where poor nutritional status was associated with 
decrements in cognitive function, a number o f researchers have attempted to 
improve nutritional status in healthy elderly and patient populations by 
supplementation with either single or multivitamins, and have observed the 
effects o f improved nutritional status on aspects of memory performance.
Deijen, van der Beek, Orlebeke, and van den Berg (1992) conducted a 12 week 
study to examine the effects of vitamin B6 supplementation on cognitive 
functioning in 38 elderly men aged 70-79 years. Memory was assessed at 
baseline and after 12 weeks using the Sperling whole report task, a paired 
associate word list task, and a short term memory task.
The Sperling whole report task, an iconic/sensory memory task in which 30 
slides o f 12 letters were flashed onto the screen for duration's o f 250, 150 and 
50 ms. Immediately after each flash, subjects had to recall as many letters as 
possible in 6 seconds. In the paired associate word list task, 9 pairs o f words 
were presented onto a computer screen at a rate of one set every 3 seconds. 
After all 9 pairs had been presented with one of the pairs o f words and were 
required to provide its paired word, by pressing the key that corresponded with 
the word, e.g. the words John and grocer were presented, so when presented 
with the name John subjects have to press the grocer key. Recall o f the paired 
word was required immediately and after a delay of one hour. Subjects also had 
to complete a short term memory task, much like the Sternberg memory task, 
but with letters rather than numbers. A memory set o f four letters is flashed on a 
screen for five seconds, following the memory set a number o f 41 trials is 
presented containing two or four letters, placed on the comers o f an imaginary 
square. If a letter from the memory set is flashed onto the screen then subjects 
have to press "yes", and "no" if  the letter was not from the memory set. Deijen 
et al. (1992) found that supplementation with vitamin B6 had no effect on short
term memory, immediate recall o f the paired associate task, the short term 
memory task, or the Sperling whole report task. However supplementation with 
vitamin B6 facilitated delayed recall of the paired associate word list task.
Tolonen, Halme, and Sama (1988) assessed the effect of supplementing 44 
elderly subjects with vitamin E&6 or placebo for 12 months. Memory was 
assessed using the digit span task (forward and backward); paragraph recall 
(immediate and delayed recall) and the clock test ( a visual recognition and 
motor production task). After 12 months o f supplementation, the vitamin B6 
treated group showed performance improvements on the immediate story recall, 
and the clock task, compared to the placebo treated group. Performance in the 
placebo group deteriorated on immediate story recall, and the clock recognition 
task.
Burr, Hurley, and Sweetnam, (1975) assessed blood level o f vitamin C in 828 
community dwelling elderly subjects aged 59-97 years. Two hundred and ninety 
seven of the subjects with low vitamin C level were admitted to a two year 
controlled trial, in which subjects received either placebo or vitamin C for two 
years (150 mg/day for 12 weeks and 50 g/day maintenance dose for the rest of 
the two years). The authors were interested to see whether supplementation with 
vitamin C would affect mental functioning on the Inglis test o f short term 
memory- a paired associate word list task (in which a higher score is indicative 
of poorer memory). It was reported that long term supplementation with vitamin 
C had no effect on performance of the task.
A number of researchers have assessed the effects of vitamin supplementation 
on memory function in patient populations.
Botez, Botez and Maag (1984) conducted a study in which 49 folate deficient 
patients aged 22-76 years (mean age 42.2 years) were supplemented with 10 mg
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folate daily for 7-11 months. Memory was assessed using the digit span task. It 
was reported that performance on the task was significantly improved.
Sram, Binkova, Topinka, Kotesovec, Hanel, Fojtikova, Klaschka, Prosek and 
Gebhart (1990) assessed the effect of supplementation with vitamin C and E on 
memory performance in a sample of 160 subjects from two homes for the 
elderly. Subjects were aged 60-90 years. Subjects were supplemented with 
antioxidant vitamins C and E for a period of 2 years. A sample o f 80 subjects 
completed psychometric tasks to assess the effects o f antioxidant 
supplementation on cognitive performance. Cognitive performance was 
assessed using the digit span task (forward and backward), and paragraph recall. 
Performance was assessed at baseline and after 3, 6, 12, 18 and 24 months. It 
was found that supplementation with vitamin C and E had no effect on the digit 
span or paragraph recall tasks.
5.7.1 Sum m ary
Memory is an aspect of cognitive function that has shown to be sensitive to the 
effects o f nutritional status. Examination of the deficiency studies, report that 
poor nutritional status is associated with decrements in memory performance 
especially on the backward digit span task, paragraph recall task and visual 
memory tasks.
In chapter two, some consideration was given to the role o f vitamins within the 
body and central nervous system. Analysis o f this data would seem to suggest 
that a deficiency in B complex vitamins would result in memory problems, this 
is true for vitamins Bi, B 2 , B 3 , B 6 , B 12 and folic acid as all these vitamins are 
essential for the synthesis of neurotransmitters.
Based on such evidence, a number of research teams have assessed the effects 
of multivitamin supplementation on memory function. The results would seem 
to indicate that supplementation with the B complex vitamins was associated
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with a number of performance improvements, these were evident on delayed 
recall o f the paired associate word list task (Deijen et a l, 1992), immediate 
recall of the paragraph recall task and the clock task (Tolonen et a l, 1988), and 
supplementation with folate was associated with improved digit span (Botez et 
al, 1984).
Two researchers have previously examined the effects o f vitamin C and E on 
memory performance, it would appear that supplementation with vitamin C and 
E had no reported effect on memory function. However, as this conclusion has 
been reached using only two studies, further research is warranted in order to 
resolve the issue.
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5.8 The effects of vitamin supplementation on the 
speed of information processing in elderly 
populations
The speed o f information processing is an aspect o f cognitive function that is 
susceptible to decrements with age (Salthouse, 1985; Welford, 1977; 
Lindenberger et al, 1993). A number o f studies have been conducted to assess 
the effects o f nutritional status or multivitamin supplementation on the speed of 
information processing.
Riggs, Spiro, Tucker and Rush (1996) assessed the relationship between blood 
level o f vitamin Be and B 12 on cognitive function using a pattern comparison 
task and a continuous performance task in 70 male subjects aged 54-81 years. In 
the pattern comparison task subjects had to choose the odd pattern from 3 
similar patterns, the time taken to respond was recorded. In the continuous 
performance task, a string of letters were presented on a computer screen, 
subjects had to press a button every time they saw a capital letter S, response 
times were recorded. It was reported that there was no relationship between 
nutritional status and performance on either task.
Deijen, van der Beek, Orlebeke, and van den Berg (1992) supplemented 38 
healthy men aged 70-79 years, with vitamin B6 for 3 months. Performance was 
assessed using the Vienna task, and a speed o f processing task, essentially a 
multistimuli reaction time unit, optical stimuli in a number o f colours (white, 
yellow, red, green and blue) are represented in 10 different positions. Subjects 
have to respond by pressing one o f 5 reaction keys assigned to each o f the 
colours. Two additional white lamps set apart from the coloured lamps, are also 
illuminated, these lamps were extinguished by stepping on left or right foot 
pedals. Two acoustic stimuli (high/low tone) are assigned to 2 rectangular 
"tone" keys, and had to be pressed when the tone was heard. The number of 
correct, incorrect, delayed and missed responses were recorded.
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In the speed o f processing task - a cross was randomly presented in one o f the 4 
comers o f a screen for 100 ms, subjects had a response key pad with buttons at 
the 4 comers, when an cross appeared in a comer the subjects had to press the 
button diagonally opposite to where the cross appeared. Subjects had to 
complete a total of 51 trials, reaction time and number o f correct responses were 
recorded.
Deijen et al (1992) reported that supplementation with vitamin B6 had no effect 
on performance o f either the perceptual motor skill or the speed o f processing 
task.
Burr, Hurley and Sweetnam (1975) assessed cognitive performance using a 
reaction time task. In the task, subjects had to respond by pressing a button 
when a light illuminated. Performance was assessed in a sample o f 297 elderly 
subjects aged 59-97 years with low blood vitamin levels of vitamin C. Subjects 
were supplemented with oral vitamin C 150 mg for 12 weeks to initially raise 
the blood vitamin levels and then 50 mg daily dose until two years had elapsed. 
After the two year period, performance was reassessed, no performance 
improvements were associated with a rise in blood vitamin C levels.
5.8.1 Sum m ary
In the reported studies, Riggs et al (1996) reported that there was no 
relationship between nutritional status and tasks assessing the speed of 
information processing. Deijen et al (1992) and Burr et al (1975) reported that 
supplementation with vitamin B6 or vitamin C had no effect on tasks assessing 
the speed of information processing.
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5.9 The effects of vitamin supplementation on 
intelligence in elderly populations
Previous research has revealed that supplementation has beneficial effects on 
intelligence scores o f school children and teenagers (Benton and Roberts, 1988; 
Benton and Butts, 1990; Benton and Cook, 1991).
Since the speed o f processing is thought to reflect intelligence and age results in 
decrements in the speed of information processing (Salthouse, 1985; Welford, 
1977; Rabbitt 1965) age related decrements would be expected on tasks 
assessing intelligence. In line with this the effects of supplementation on 
intelligence in elderly subjects would be expected to be similar to the results of 
supplementation on the speed of information processing.
La Rue, Koehler, Wayne, Chiulli, Haaland, and Garry (1997) assessed cognitive 
performance in 137 elderly subjects (aged 60-90 years). Cognitive performance 
was assessed using the abstraction scale from the Shipley-Hartford intelligence 
scale (subjects had to specify missing items in serial logically determined series 
(e.g. AB BC CD D?). This study was a follow up to the Goodwin et al. (1983) 
study, and hence the researchers were able to compare both current use and past 
use of vitamins on cognitive performance. It was found that subjects previously 
taking vitamins A, B6, B 12 and E had better abstract task performance. Higher 
vitamin Bi, B2 and folate levels were positively correlated with abstraction test 
performance, so subjects with higher vitamin Bj, B2 and folate levels had better 
abstract performance. Current vitamin E use was associated with higher mean 
abstraction scores than non users.
Smith, Clark, Nutt, Hayward and Perry (in press) assessed the effects o f anti­
oxidant supplementation on intelligence in healthy elderly volunteers. Two 
hundred and five healthy elderly volunteers aged 60-80 years were 
supplemented with either an anti-oxidant preparation (consisting o f beta 
carotene 12 mg, vitamin E 400 mg and vitamin C 500 mg) or placebo for 12
151
months. Intelligence was assessed using the New Adult Reading Task (NART). 
Blood samples were taken and performance assessed at baseline and after 4, 8 
and 12 months. It was reported that subjects who showed a large increase in 
vitamin C level following supplementation made significantly fewer errors on 
the NART.
Researchers have assessed the effects o f multivitamin supplementation on 
intelligence patient populations using the Mini Mental State Examination 
(MMSE).
Abalan, Mancier, Dartigues, Decamps, Zapata, Saumtally and Galley, (1992) 
conducted a pilot study to assess the impact of nutritional supplementation on 
cognitive function in 29 patients with Senile Dementia o f the Alzheimer Type 
(SDAT). All patients were aged over 66 years, had a score between 2 and 23 on 
Folstein's Mini Mental State Examination (MMSE), and had fulfilled the 
NINCDS-ADRDA criteria of SDAT. Patients were randomised to receive either 
a multivitamin supplement (n = 15) or placebo (n = 14) for a period o f 105 days. 
(The multivitamin supplement consisted of vitamins A, C, E, Bi, B2 , B6, B 12, 
biotin, folic acid, calcium, magnesium, phosphorus, L-tryptophan, iron, zinc and 
a number of trace elements). Cognitive function was assessed using the MMSE 
at baseline, and after 35, 70 and 105 days.
At baseline there was no significant difference between the MMSE scores o f the 
2 groups. However, after treatment for 105 days, the supplemented group 
showed a significant improvement in MMSE sores compared to baseline and 
the placebo group. This pilot study provided tentative evidence for a role o f  
nutrition in the pathogenesis of SDAT.
Blass, Gleason, Brush, DiPonte, and Thaler (1988) noted that a number of 
studies have implicated that the activities o f thiamine-dependant enzymes 
appear to be reduced in the brains of patients with Alzheimer's disease. Based
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on this hypothesis, Blass et al. (1988) supplemented 11 elderly patients (aged 
59-83 years) with vitamin Bi or placebo for a period o f 3 months. All patients 
had a diagnosis of probable senile dementia of the Alzheimer’s type (SDAT). 
The patients received vitamin Bi and placebo for a period of 3 months in a 
crossover design. Performance was assessed using the (MMSE). It was reported 
that supplementation with vitamin Bi scores on the (MMSE) were significantly 
improved.
Cunha, Rocha, Peixoto, Motta, and Barbosa (1995) assessed the effect of 
vitamin B 12 supplementation on performance in 19 demented patients with a 
mean age of 77.5 years who were deficient in vitamin B 12. It was reported that 
16 of the 19 patients continued to show progressive decline during follow up 
visits ( 3 to 24 months). The only patients who showed some improvement on 
the MMSE had mild dementia with a history of less than 2 years. The authors 
concluded that screening for vitamin B 12 deficiency should be considered in 
patients with early of dementia symptoms.
Sano, Ernesto, Thomas, Klauber, Schafer, Grundman, Woodbury, Growdon, 
Cotman, Pfeiffer, Schneider and Thais (1997) supplemented 341 dementia 
patients with selegiline, vitamin E or placebo for a period o f 2 years. Patients 
were randomised to receive selegiline 10 mg daily (n = 87); vitamin E 200 iu a 
day (n = 85); selegiline and vitamin E (n = 85) or placebo (n = 84). Assessments 
were made using the MMSE. After 2 years it was found that the placebo group 
had the highest score on the MMSE and the vitamin E treated group had the 
lowest.
Two studies have reported no effect and even a continued decline in cognitive 
function following treatment with multivitamins or vitamin Bi.
Bums, Marsh and Bender (1989) supplemented 19 geriatric patients (age 76-86 
years) with multivitamins and placebo for 6 weeks in a crossover design. All
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patients were previously diagnosed as having multi-infarct dementia (MID), 
patients were assessed using the MMSE. It was reported that supplementation 
resulted in no changes on MMSE scores.
Nolan, Black, Sheu, Langberg, and Blass (1991) 15 outpatients aged 59-87 
years were enrolled in a study which assessed the effects of vitamin Bi on 
dementia progression in a year long study. Fifteen subjects aged 59-87 years 
were randomly allocated to receive either placebo or vitamin Bi (3g/d) for 12 
months. Cognitive function was assessed using the Mini Mental State 
Examination (MMSE). Cognitive function was assessed at baseline and at 3 
monthly intervals. Ten patients completed the trial (5 from the placebo group 
and 5 from the vitamin Bi group). Cognitive function was found to decline in 
both groups for example MMSE scores fell from 16.6 to 10.4 in the vitamin Bi 
group, and in the placebo group they fell from 16.3 to 12.5 during the 12 month 
trial. This double blind placebo controlled parallel group study did not support 
the hypothesis that vitamin Bi either improves cognition or slows the 
progression of cognitive decline in patients with SDAT. The two studies that 
have failed to show any protective effects on cognition following treatment with 
either mono vitamin or multivitamin supplementation only contain very small 
sample sizes, and it is possible that more positive effects may have been evident 
had the sample sizes been increased. Therefore, the studies do not satisfactorily 
refute the hypothesis that nutritional supplementation affects cognitive function.
5.9.1 Summary
Since choice or complex reaction time is thought to reflect intelligence, it was 
assumed that the effects of supplementation on intelligence would echo the 
results o f supplementation on information processing. However it was reported 
that the effects of supplementation on intelligence in elderly subjects were much 
the same as those reported in children and teenagers.
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It was reported that higher blood levels of vitamins Bi, B2 , folate and vitamin E 
had higher abstraction scores than subjects with poorer blood vitamin status (La 
Rue et al., 1997). In SDAT and MID patients, MMSE scores were found to be 
improved following supplementation with certain vitamins, vitamin Bi (Blass et 
al., 1988); multivitamins (Abalan, et al, 1992); Vitamin B 12 (Cunha et al., 
1995) and Vitamin E (Sano et al., 1997).
Two patients studies reported that supplementation with multivitamins or 
vitamin Bi had no effect on MMSE scores of SDAT or MID patients (Bums et 
al., 1989; Nolan et al., 1991). In the Bums et al. (1989) study 19 patients were 
supplemented with multivitamins for a period of 6 weeks, and in the Nolan et 
al. (1991) study only 15 patients were supplemented with vitamin Bi for 12 
months. It is possible that multivitamins need to be given for longer than 6 
weeks, as it usually takes about 12 weeks to observe increases in blood 
vitamins. Hence if  patients had been treated for longer periods, beneficial 
effects may have been reported. In the Nolan et al. (1991) study, there were 
only 10 evaluable patients at the end of the treatment period, hence it is possible 
that the small sample size may be responsible for the lack of effect.
The results of the supplementation studies in patients report many 
inconsistencies, however this may be due to the fact that the rate o f cognitive 
decline in patients with probable SDAT varies immensely. In the Nolan et al 
(1991) study some patients showed no change on the MMSE, however others 
declined by 12 points. Therefore any results are merely speculative, but the 
mixed results certainly highlight the fact that certain sectors o f society would 
benefit from supplementation.
Many of the above studies have demonstrated the benefits o f obtaining a 
nutritionally balanced diet, providing all the required vitamins and minerals 
necessary for optimal functioning. This chapter has also outlined the fact that 
there are sectors in society particularly elderly persons who do not gain enough
155
nutrients from their daily diet, therefore supplementation may be a way to help 
correct nutritional deficiencies.
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5.10 The effects of vitamin supplementation on mood, 
well being and behaviour in elderly populations
Vitamins are important for the synthesis and production o f neurotransmitters 
especially serotonin, dopamine, noradrenaline and GAB A, hence a deficiency in 
certain multivitamins may result in observed changes in mood and personality. 
A number of researchers have assessed the effects of altered blood vitamin level 
and supplementation with single and multivitamins on aspects of subjective 
mood, general well being and behaviour in elderly subjects.
Chome, Paul, Pudel, Bleyl, Heseker Huppe, and Kubler (1986) assessed mood 
and personality in elderly subjects aged 59-91 years. Subjects were divided into 
2 groups on the basis of nutritional status, a deficient group (which consisted of 
subjects with a deficiency in at least one vitamin) and a control group (non 
deficient subjects). Mood and personality were assessed using the Freiburg 
Personality Inventory (FPI- which assess 12 personality traits) it was reported 
that vitamin deficient subjects had higher depression, fatigue and emotional 
instability scores than control subjects.
Smith, Clark, Nutt, Hayward and Perry (in press) assessed the effects o f anti­
oxidant supplementation on mood and cognitive failure in healthy elderly 
volunteers. Two hundred and five healthy elderly volunteers aged 60-80 years 
were supplemented with either an anti-oxidant preparation (consisting of beta 
carotene 12 mg, vitamin E 400 mg and vitamin C 500 mg) or placebo for 12 
months. Mood was assessed using the Profile o f Mood States (POMS) and 
cognitive failure assessed using Broadbent et al (1982) Cognitive Failure's 
Questionnaire (CFQ). Blood samples were taken and assessments were made at 
baseline and after 4, 8 and 12 months. It was reported that subjects who showed 
a large increase in vitamin C level following supplementation felt significantly 
more composed, elated and confident than subjects who showed small declines 
in their vitamin C level, similarly these subjects reported fewer errors of 
memory, attention and action during their everyday activities.
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Bouchet, Guillemin and Brianpon (1996) assessed the quality o f life (QOL) in 
1896 volunteers aged 35-60 years. Subjects were randomly allocated to one of 
four groups group 1 (n = 180) who were supplemented with a multivitamin 
complex (consisting of vitamins A, C, E, zinc and selenium) for 2 months, 
group 2 (n = 180) received placebo for 2 months and groups 3 (n = 768) and 4 
(n = 768) received no treatments. All subjects were sent a QOL questionnaire 
(The Short Form Health Survey Questionnaire)in December 1993 and again in 2 
months later. It was reported that supplementation with multivitamins had no 
effect on any of the measures of quality o f life which included physical and 
social function, physical role, emotional role, mental health, energy-fatigue, 
pain and general health perceptions.
Sram, Binkova, Topinka, Kotesovec, Hanel, Fojtikova, Klaschka, Prosek and 
Gebhart (1990) assessed the effect of supplementation with vitamin C and E on 
memory performance in a sample of 160 subjects from two homes for the 
elderly. Subjects were aged 60-90 years. Subjects were supplemented with 
antioxidant vitamins C and E for a period of 2 years. A sample o f 80 subjects 
completed psychometric tasks to assess the effects of antioxidant 
supplementation on subjective ratings. Various aspects o f mood were assessed 
including pain fear eating difficulties, sleep disorders, anger, fatigue, memory 
disturbances and motoric difficulties. Subjective ratings were completed at 
baseline and after 3, 6, 12, 18 and 24 months. It was reported that 
supplementation with vitamin C and E significantly improved ratings on the 
scale, especially motoric ability and mood.
Smidt, Cremin, Grivetti, and Clifford (1991) assessed the effects of vitamin Bi 
supplementation on the general health and well being of 80 elderly women aged 
65-92 years with marginal vitamin deficiency. Subjects were treated with either 
vitamin Bi or placebo for a period of 6 weeks. Well being was examined by 
getting the subject to rate a number of mood states using a 10 point scale (where
159
0 = never have the condition and 10 = always have the condition), the 
conditions examined were concentration, tenseness, appetite, soreness/burning 
hands and feet, sleep, general well being (how they felt) and ability to perform 
activities required. It was found that the Bi supplemented group showed 
improved feelings of general well-being, 88% of the vitamin Bi treated subjects 
reported feeling "brighter" and "cheerier" than before supplementation. They 
also felt less fatigued, had improved appetite, showed an increase in activity, a 
reduction in daytime sleep and had improved sleep patterns compared to 
subjects treated with placebo.
Schorah, Newill, Scott and Morgan (1979) assessed the effects of 
supplementation with vitamin C on functional ability using an Activity of Daily 
Living Scale (ADL) in 118 subjects aged 59-97 years. Subjects were 
supplemented with vitamin C for 1 month. They found that supplemented 
subjects showed marginal improvements in their ADL scores, whereas the ADL 
scores of placebo treated subjects declined.
Blass, Gleason, Brush, DiPonte and Thaler (1988) supplemented 11 elderly 
patients (aged 59-83 years) with vitamin Bi or placebo for a period o f 3 months. 
All patients had a diagnosis of probable senile dementia o f the Alzheimer’s type 
(SDAT). The patients received vitamin Bi and placebo for a period of 3 months 
in a crossover design. Behavioural change was assessed using the Blessed 
Dementia Rating Scale and the Haycox Behavioural Rating Scale. It was 
reported that supplementation had no effect on either scale
Clausen, Nielsen, and Kristensen (1989) supplemented 97 elderly patients (aged 
50-94 years) with multivitamins or placebo for a period of 12 months. Cognitive 
ability was assessed using the Gottfries, Brane and Steen rating scale for 
dementia. It was reported that after 12 months treatment, the multivitamin 
supplemented group showed an improvement (that just failed to reach statistical
160
significance) on the dementia scale, whereas the placebo group declined during 
the first 6 months, and only showed a very slight improvement after 12 months.
Sano, Ernesto, Thomas, Klauber, Schafer, Grundman, Woodbury, Growdon, 
Cotman, Pfeiffer, Schnieder and Thai (1997) supplemented 341 dementia 
patients with selegiline, vitamin E or placebo for a period o f 2 years. Patients 
were randomised to receive selegiline 10 mg daily (n = 87); vitamin E 200 iu a 
day (n = 85); selegiline and vitamin E (n = 85) or placebo (n = 84). Assessments 
included the Alzheimer's Disease Assessment Scale (ADAS) and other real life 
measures such as time taken to die, the time taken to be institutionalised, time 
taken to reach a diagnosis of severe dementia (classed as a scores o f 3 on the 
clinical dementia rating scale) and the time taken until the patient could no 
longer perform 2 out of 3 basic activities o f daily living (Blessed dementia 
scale). After 2 years it was found that vitamin E treated group showed a longer 
delay in the need for hospitalisation than any of the other groups. Both 
selegiline and vitamin E delayed the progression of the disease and lengthened 
the time taken for institutionalisation, and hence for this reason, the authors 
believe that both selegiline and vitamin E should be considered for use in 
patients with moderate dementia. This study demonstrates the real world 
approach of clinical trials, as the prolongation of life and the delay in the need 
for institutionalisation is more meaningful to family members and clinicians 
rather than a slight improvement in the scores on a rating scale or psychometric 
test.
Bums, Marsh and Bender (1989) supplemented 19 geriatric patients (age 76-86 
years) with multivitamins and placebo for 6 weeks in a crossover design. All 
patients were previously diagnosed as having multi-infarct dementia (MID), 
patients were assessed using the CAPE behaviour rating scale and the Hachinski 
dementia rating scale. It was found that supplementation had no effect on either 
scale.
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5.10.1 Summary
The effects of multivitamin supplementation on mood and general well being in 
elderly subjects, is somewhat contradictory. It would appear that 
supplementation with certain vitamins has beneficial effects on some aspects of 
well being.
The Chome et al (1986) study would seem to provide evidence that vitamin 
deficiency may result in changes in mood and personality, resulting in higher 
scores o f depression, fatigue and emotional instability.
Schorah et al (1979) reported that supplementation with vitamin C resulted in 
improvements in activity of daily living (ADL) scores. Smidt et al (1991) 
supplemented healthy elderly females with vitamin Bi, supplementation 
resulted in subjects feeling cheerier and brighter, less fatigued, increased 
activity, a reduction in daytime sleep, improved sleep patterns and improved 
appetite. Smith et al (in press) reported that subjects who showed large 
increases in vitamin C reported feeling more confident, elated, composed and 
reported fewer errors on the cognitive failures scale.
Sram, et al (1990) reported that treatment with vitamin C and E for 2 years 
resulted in improvements on a subjective rating scale.
Bouchet et al (1996) supplemented subjects with multivitamins for a period of 
2 months, they reported that supplementation had no effect on subjects quality 
of life. It is possible that the lack of effect reported by Bouchet et al (1996) 
may be due to a design fault, as supplementation for only 8 weeks is unlikely to 
result in any dramatic changes in blood vitamin status, hence would be unlikely 
to result in changes in subjective ratings.
Despite the inconsistencies, it would appear that supplementation with either 
single or multivitamins is likely to result in changes in subjective ratings.
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5.11 Conclusions
From the above evidence it would be expected that long term multivitamin 
supplementation could have profound effects on cognitive function in elderly 
subjects, both healthy and patient populations.
5.12 Aims of the present study: The effects of long 
term multivitamin supplementation on aspects of 
mood and cognitive function in a healthy elderly 
population
The present study aims to assess the effects of long term multivitamin 
supplementation on aspects of cognitive function and mood in elderly subjects. 
The psychometric tasks completed by the volunteers assessed attention, 
memory, intelligence, the speed of naming, the speed o f information processing, 
and subjective ratings of cognitive failure, anxiety, and depression, as used in 
the previous analysis.
Based on the previous literature, poor vitamin B 12 status was associated with 
poor Stroop task performance (Bohnen et al., 1988), and supplementation with 
folate resulted in improvements on the digit symbol substitution task. In terms 
of the tasks assessing aspects of attention in the present experiment, 
multivitamin supplementation would be expected to improve performance on 
the reverse naming task (SKT VII) and the counting symbols task (SKT VI) as 
these tasks are similar to the Stroop task and visual search tasks.
The effects of multivitamin supplementation on the arranging blocks and 
replacing block tasks (SK IV, V) would only be expected to show 
improvements. If multivitamin supplementation had any effects on tasks 
assessing the speed of information processing, as the tasks not only incorporate 
aspects of attention, but also require a speeded element.
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In terms of multivitamin supplementation on the speed o f information 
processing, only a small number of researchers have assessed the relationship 
between nutritional status and the speed of information processing. Based on the 
fact that Riggs et al. (1996) reported no correlation between nutritional status 
and the speed o f information processing, and together with the fact that Deijen 
et al. (1992) and Bums et al. (1989) found no beneficial effects of 
supplementation on tasks o f attention, supplementation with multivitamins 
would not be expected to report any performance improvements on the Critical 
Flicker Fusion task (CFF), the Choice Reaction Time task (CRT), object 
naming task (SKT I) or the numerical naming task (SKT III).
The beneficial effects of supplementation are particularly evident on memory 
tasks. Vitamin deficiency was associated with decrements in paragraph recall, 
backward digit span, visual memory, word list recall and Rey complex figures 
task. Supplementation with both single and multivitamins have been associated 
with improvements on the delayed recall o f the paired associate word list task 
(Deijen et al., 1992), immediate paragraph recall (Tolonen et al., 1988), and 
digit span (Botez et al., 1984).
In terms of the memory tasks included in the present experiment, multivitamin 
supplementation would be expected to improve delayed object recall (SKT 
VIII). Less dramatic effects would be expected on the immediate recall of 
objects (SKT II), as the previous literature would seem to indicate that short 
term memory is relatively unaffected by supplementation with either single or 
multivitamins. Supplementation with multivitamins was not expected to 
produce any dramatic effects on the recognition memory task (SKT IX). 
Therefore, the effects of supplementation would be expected on the immediate 
recall task (SKT II), delayed recall task (SKT VIII), and no effects on the 
recognition task (SKT IX).
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There is quite large amounts of literature reporting that intelligence scores of 
children and teenagers are improved following supplementation with 
multivitamins (Benton and Roberts, 1988; Benton and Butts, 1990; Benton and 
Cook 1991; Schoenthaler et a l , 1991). There have been few studies assessing 
the effects o f multivitamin supplementation on intelligence scores of healthy 
elderly subjects. However there have been a number of studies assessing the 
effects of supplementation on Mini Mental State Examination (MMSE) scores 
of patient populations. Based on these results, and on the fact that the present 
population believed that they were experiencing a certain degree o f cognitive 
decline, it was thought that supplementation with multivitamins for a period of 
36 weeks would result in improvements on the Ravens Standard Progressive 
Matrices (RSPM).
In terms of subjective ratings, Chome et al (1986) reported that vitamin 
deficient subjects had higher depression, fatigue and emotional instability scores 
than non deficient patients. Based on these results, it was speculated that 
supplementation with multivitamins would result in lower reports o f anxiety and 
depression rated using the Hospital Anxiety and Depression Scale. There has 
been one study that has examined the effect of anti-oxidant supplementation on 
cognitive failures (Smith et a l , in press), it was reported that subjects with 
higher vitamin C levels reported fewer errors on the CFQ. Therefore, it was 
speculated that improved vitamin status would result in fewer subjective reports 
of cognitive failure.
5.13 Method
5.13.1 Subjects
239 healthy community dwelling elderly subjects (112 males and 127 females) 
aged between 60 and 82 years, (mean age 69.5 years) were enrolled in the 
study. All subjects were in good physical and mental health. They had no 
significant history of hepatic, renal, respiratory, endocrine, gastrointestinal,
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haematological, central nervous or cardiovascular disorders (determined by 
medical examination). Subjects were recruited form the general public via the 
HPRU data base, newspaper and poster advertisements. For the demographics 
see Table 44.
Table 44: Showing the dem ographics o f the subjects.
Multivitamin group Placebo group Total
Males Females Males Females
age 60-64 15 23 14 19 71
age 65-69 16 16 21 20 73
age 70-74 11 19 14 13 57
age 75-79 10 3 6 8 27
age 80+ 4 2 1 4 11
Total 56 63 56 64 239
5.13.2 Treatm ents
Subjects were randomly allocated, under a double-blind procedure to treatment 
with either the multivitamin supplement or placebo. Treatments were 
administered orally as two soft gelatine capsules each day. The capsules were 
identically packaged. The placebo capsule contained rape seed oil. The vitamin 
preparation contained:- vitamin A, Bi, B2 , E ,^ B 12, vitamin C, vitamin E, folic 
acid, biotin and nicotinamide. The dosing was calculated to provide the 
equivalent of 1 Recommended Daily Allowance of vitamin A, and 10 US 
RDA's for the remaining vitamins (RDA Recommended Daily Allowances, 9th 
edition, 1980 USRDA). All capsules were provided by Roche Pharmaceuticals.
Table 45: Showing the com position o f  the m ultivitam in preparation.
Vitamin Amount USA Recommended Daily Allowance's
Vitamin A 3334IU 1 US Recommended Daily Allowance
Vitamin Bi 14 mg 10 US Recommended Daily Allowance's
Vitamin B2 16 mg 10 US Recommended Daily Allowance's
Vitamin B6 22 mg 10 US Recommended Daily Allowance's
Vitamin B 12 0.03 mg 10 US Recommended Daily Allowance's
Vitamin C 600 mg 10 US Recommended Daily Allowance's
Vitamin E 100 mg 10 US Recommended Daily Allowance's
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Vitamin Amount USA Recommended Daily Allowance’s
Biotin 2 mg 10 US Recommended Daily Allowance's
Folic Acid 4 mg 10 US Recommended Daily Allowance's
5.13.3 Procedure
Prior to participation on the study, subjects were familiarised and trained on all 
psychometric tests. Four test sessions took place (baseline, week 12, week 24 
and week 36).
Subjects entered the unit fasted, underwent a brief medical assessment and a 20 
ml blood sample which was taken by the study nurse. Following a light 
breakfast subjects underwent testing on the psychometric test battery.
5.13.4 Psychom etric A ssessm en ts
Psychometric assessments included the Critical Flicker Fusion Task (CFF); 
Choice Reaction Time (CRT); HPRU Sternberg Memory Task (SMT); the 
Syndrom Kurtz Task (SKT); Ravens Standard Progressive Matrices (RSPM). 
Subjective assessments included the Cognitive Failures Questionnaire (CFQ) 
and Hospital Anxiety and Depression Scale (HADS) Table 46 summarises the 
test schedule.
Table 46: Sum m arising the assessm ent test schedule at each visit.
Baseline W eek 12 W eek  24 W eek 36
Critical Flicker Fusion * * * *
Choice Reaction Time * * * *
HPRU Sternberg Memory Task * * * *
Cognitive Failures Questionnaire * * * *
Ravens Matrices * *
Hospital Anxiety Depression Scale * *
Syndrom Kurtz Task * *
Blood Vitamin Assessment * * * *
5.13.5 Critical Flicker Fusion Task (CFF)
The Critical Flicker Fusion task (CFF) is regarded as an index o f overall CNS 
activity, the ability o f the central nervous system to process discrete 'bits' o f
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information Hindmarch (1980). Therefore an increase in CFF threshold is 
associated with increased alertness and a greater capacity for information 
processing.
5.13.6 Choice Reaction Time Task (CRT)
The Choice Reaction Time task (CRT) is used as an indicator o f sensorimotor 
performance, assessing the efficiency of the attentional and response 
mechanisms in the information processing chain. The task is comprised of three 
components recognition reaction time (RRT), motor reaction time (MRT) and 
total reaction time (TRT).
5.13.7 HPRU Sternberg Memory Task (SMT)
The HPRU Sternberg memory task is a technique based upon a reaction time 
method where subjects are required to memorise a set of target digits. In the 
HPRU Sternberg memory task, the ability to scan the memory set was assessed 
by getting subjects to attend to a series o f digits, then presenting 12 single digits 
and asking the subjects whether that digit was in the original memory set.
5.13.8 Syndrom Kurtz Task (SKT)
The SKT task is comprised of 9 subtasks assessing aspects of attention 
(arranging blocks (SKT IV), replacing blocks (SKT V), counting symbols (SKT 
VI), reverse naming (SKT VII)), memory (immediate recall, (SKT II), delayed 
recall (VIII) and recognition memory (SKT IX)) and the speed o f naming 
(object naming (SKT I) and numerical naming (SKT III)) Erzigkeit (1989).
5.13.9 Ravens Standard Progressive Matrices (RSPM)
The Ravens progressive matrices is a test o f non verbal intelligence (Raven, 
Court and Raven, 1992). The tasks tests a persons capacity to find relationships 
between "meaningless figures" and in doing so develop a systematic method of 
reasoning. The matrices consist o f 60 problems divided into five sets o f 12
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problems (A, B, C, D and E). Subjects are presented with a diagram of a puzzle, 
each puzzle has a part missing, the subjects has to choose (from a set o f 4 or 6) 
the missing part of the puzzle. Each o f the 5 sets start with a puzzle which is, as 
far as possible, self-evident, and develops a theme in the course o f which the 
problems build on the argument of what has gone before and thus becomes 
progressively more difficult.
5.13.10 Cognitive Failures Q uestionnaire (CFQ)
The Cognitive Failures Questionnaire (CFQ) was developed by Broadbent, 
Cooper, Fitzgerald and Parkes (1982). It is a measure of self-reported failures in 
perception, memory and motor function. Subjects are required to answer 25 
questions, rating the frequency o f problems over the past four months, using a 
scale where 0 = never and 5 = very often.
5.13.11 Hospital Anxiety and D epression Scale (HADS)
The Hospital Anxiety and Depression Scale (HADS) was designed by Zigmond 
and Snaith (1983) as a self rating scale for the assessment o f anxiety and 
depression. The scale consists o f 14 items, 7 o f which measure anxiety and 7 
measure depression.
5.13.12 Blood Vitamin Levels
To determine the blood/serum vitamin levels, various assays were carried out. 
To identify levels of Bi, B2 and B6, whole blood was tested. The plasma levels 
of vitamin A, C, C, B 12, Biotin and folic acid were determined.
All biochemical assays were carried out in the laboratories o f F. Hofftnan-La 
Roche. Twnty ml of blood was drawn from fasted subjects and divided into two 
heparinized tubes. A sample of 3-4 ml of whole blood was placed into an 
ampoule containing acid-citrate-dextrose. This was express posted to the 
laboratory where the status o f vitamins Bi, B2 and B6 were assessed using 
apoenzyme tests (Vuilleumier et al, 1983; 1990). The ramaining blood was
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centrifuged and the plasma stored at -20  degrees centrigrade. For vitamin C 
analysis, 0.5 ml o f plasma was added to 4.5 ml o f 5% metaphosphoric solution 
prior to freezing, with plasma concentration being determined using a fluoro- 
metric method (Brubacher and Vuilleumier, 1974). The analysis of vitamin B 12 
and folic acid was carried out using the solid phase no boil vitamin B 12 and folic 
acid radioassay kits (Diagnostic products Corporation). Biotin plasma levels 
were assayed using a microbiological method (Frigg and Brubacher, 1976). 
Vitamins A, E and beta-carotenes were assayed by a high-performance liquid 
chromatography (Vuilleumier et al, 1983; Hess et al, 1991).
5.14 Results
The blood vitamin data were analysed using a 2 way analysis of variance with 
treatment (multivitamin or placebo) and visit (baseline, week 12, 24 and 36) as 
between subjects factors. Any complex significant differences were analysed 
using the Newman Keul's post hoc test.
5.15 The change in blood vitamin levels
The aim of this analysis was to examine whether supplementation with 
multivitamins would affect blood vitamin concentration levels.
5.15.1 Vitamin A
There was no main significant effect of treatment (F ( i? 222) = 0.67; p> 0.05), 
there was no significant difference in the blood levels of vitamin A for either the 
multivitamin supplemented or the placebo group. There was no significant time 
effect (F (3 , 666) = 0.90; p > 0.05) showing that blood vitamin levels did not 
change significantly over time. This was due to the fact that the supplement 
contained vitamin A level equivalent to 1 USA RDA's, as any higher could 
result in toxicity. There was no significant treatment and time interaction, 
however it approached statistical significance (F (3 , 666) = 2.44; p = 0.06).
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5.15.2 Vitamin Bi
There was significant main effect of treatment (F (i, 22 2) = 24.72; p < 0.001), 
with means showing that the treatment group had higher levels o f Bi than the 
placebo group. There was a significant time effect (F (3> 666) = 88.47; p < 0.001) 
with means showing that the multivitamin treated group had blood levels that 
changed significantly over time. There was a significant treatment and time 
interaction (F (3) 666) = 72.24; p< 0.0001) multivitamin treated group showed a 
significant increase in blood levels o f vitamin Bi at week 12. Blood vitamin Bi 
levels remained significantly higher than the placebo condition at weeks 24 and 
36, blood vitamin Bi levels in the placebo group remained stable over time.(see 
Figure 27).
Main effect o f treatment was analysed using post hoc testing, which revealed 
that at baseline there was no difference between the blood vitamin Bi levels of 
the subjects, however at weeks 12, 24 and 36 the multivitamin supplemented 
group had significantly higher blood level of vitamin Bi (pO.OOOl).
The change in blood level of vitamin BI
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Figure 27: Showing the change in blood level of vitamin BI (* pO.OOOl).
5.15.3 Vitamin B2
There was significant main effect of treatment (F (i, 2 2 2) = 52.69; p < 0.001), 
with means showing that the multivitamin treated group had higher blood levels 
of vitamin B2 than the placebo treated group. There was a significant time effect 
(F (3 , 666) = 55.36; p< 0.01) with mean showing that the multivitamin treated 
group had blood levels that changed significantly over time. There was a 
significant treatment and time interaction (F (3 , 666) = 90.39; p < 0.0001) with 
means showing that the multivitamin treated group showed an increase in blood 
levels o f vitamin B2 at week 12. Blood vitamin B2 levels remained significantly 
higher than the placebo condition at weeks 24 and 36. Blood vitamin B2 levels 
in the placebo group remained stable over time, (see Figure 28).
The main effect of treatment was analysed using post hoc testing to revealed 
that at baseline there was no difference between the blood vitamin B2 levels of 
the subjects, however at weeks 12, 24 and 36 the multivitamin supplemented 
group had significantly higher blood level o f vitamin B2 than the placebo group 
(pO.OOOl).
The change in blood level of vitamin B2
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Figure 28: Showing the change in blood level of vitamin B2 (* pO.OOOl).
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5.15.4 Vitamin B6
There was significant main effect o f treatment (F (is 2 22) -  868.59; p < 0.001), 
with means showing that the multivitamin treated group had higher blood levels 
of vitamin B6 than the placebo group. There was a significant time effect (F (3 , 
666) = 955.96; p < 0.001) with mean showing that the multivitamin treated group 
had blood levels that changed significantly over time. There was a significant 
treatment and time interaction (F (3 , 666) = 862.31; p < 0.0001) the multivitamin 
treated group showed an increase in blood levels o f vitamin B6 at week 1 2 . 
Blood vitamin B6 level remained significantly higher than the placebo condition 
at weeks 24 and 36. Blood levels in the placebo group remained stable over 
time (see Figure 29).
The main effect o f treatment was analysed using post hoc testing to reveal that 
at baseline there was no difference between the blood vitamin B 6 level of the 
subjects, however at weeks 12, 24 and 36 the multivitamin treated group had 
significantly higher blood level o f vitamin B6 than the placebo treated group 
(pO.OOOl).
The change in blood level of vitamin B6
n 0
Baseline Week 12 Week 24 Week 36 Placebo
MultivitaminVisits
Figure 29: Showing the change in blood level of vitamin B6 (* p<0.01).
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5.15.5 Vitamin B12
There was significant main effect of treatment (F (i, 22 2) = 21.83; p < 0.001), 
with means showing that the multivitamin treated group had higher levels of 
vitamin B 12 than the placebo treated group. There was a significant time effect 
(F (3 , 666) -  19.80; p < 0.001) with means showing that the multivitamin treated 
group had blood levels that changed significantly over time. There was also a 
significant treatment and time interaction (F (3 , 666) = 38.39; p < 0.0001) the 
multivitamin treated group showed a significant increase in blood levels of 
vitamin B 12 over time (see Figure 30).
Post hoc testing o f the main effect o f treatment revealed that at baseline there 
was no difference between the blood vitamin B 12 levels o f the subjects, however 
at weeks 12, 24 and 36 the multivitamin supplemented group had significantly 
higher blood level o f vitamin B 12 than the placebo group (p<0 .0 0 0 1 ).
The change in blood level of vitamin B12
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Figure 30: Showing the change in blood vitam in level o f vitam in B12 (ng/L)
(p<0.0001).
5.15.6 Vitamin E
There was significant main effect of treatment (F (i, 2 2 2) = 68.61; p < 0.001), 
with means showing that the multivitamin treated group had higher levels o f 
vitamin E than the placebo group. There was a significant time effect (F (3 , 6 66) =
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33.47; p < 0.001) with mean showing that the multivitamin treated group had 
blood levels that changed significantly over time. There was also a significant 
treatment and time interaction (F (3 , 666) = 50.99; p < 0.0001) with the 
multivitamin treated group showing a significant increase in blood levels of  
vitamin E at week 12. Blood levels o f vitamin E remained significantly higher 
than the placebo condition at week 24 and 36 (see Figure 31). Blood levels of 
vitamin E in the placebo group remained stable over time.
Post hoc testing of the main effect of treatment revealed that at baseline there 
was no difference between the blood vitamin E levels o f the subjects. However, 
at weeks 12, 24 and 36 the multivitamin supplemented group had significantly 
higher blood level of vitamin E than the placebo treated group (p<0.0001).
The change in blood level of vitamin E
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Figure 31: Showing the change in blood level o f vitam in E (m g/L) (p<0.0001).
5.15.7 Vitamin C
There was significant main effect of treatment (F (i, 22 2) = 69.52; p < 0.001), 
there was a significant difference in blood levels o f vitamin C between the 
treatment groups, with means showing that the multivitamin treated group had 
higher vitamin C levels than the placebo treated group. There was a significant 
time effect (F (3 , 666) = 14.01; p < 0.001) with means showing that the 
multivitamin treated group had blood levels that changed significantly over
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time. There was also a significant treatment and time interaction (F (3 , 666) = 
17.80; p < 0.0001) the multivitamin treated group showed an increase in blood 
levels o f vitamin C over time (see Figure 32).
Post hoc testing of the main effect o f treatment revealed that at baseline there 
was no difference between the blood vitamin C levels o f the subjects, however 
at weeks 12, 24 and 36 the multivitamin supplemented group had significantly 
higher blood level o f vitamin C than the placebo treated group (p<0.0001).
The change in blood level of vitamin C
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Figure 32: Showing the change in blood level of vitamin C (mg/L) (p<0.0001).
5.15.8 Biotin
There was significant main effect of treatment (F (i, 22 2) = 133.03; p < 0.001), 
there was a significant difference in blood levels of biotin between the treatment 
groups, with mean showing that the multivitamin treated group had higher 
blood biotin levels than the placebo group. There was a significant time effect 
(F (3,666) = 32.43; p < 0.001) with means showing that the multivitamin treated 
group had biotin blood levels that changed significantly over time. There was 
also a significant treatment and time interaction (F (3 , 66 6) = 32.67; p < 0.0001) 
the multivitamin treated group showed an increase in blood levels o f biotin over 
time (see Figure 33).
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The main effect of treatment was analysed using Post hoc testing it was 
revealed that at baseline there was no difference between the blood biotin levels 
of the subjects, however at weeks 12, 24 and 36 the multivitamin supplemented 
group had significantly higher blood level o f biotin than the placebo group 
(p<0.0001).
The change in blood level of biotin
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Figure 33: Showing the change in blood biotin level (nmol/L) (PO.OOOl).
5.15.9 Folic Acid
There was significant main effect of treatment (F (i, 2 2 2) = 896.67; p < 0.001), 
there was a significant difference in blood levels of folic acid between the 
treatment groups, with means showing that the multivitamin treated group had 
higher levels of folic acid than the placebo group. There was a significant time 
effect (F (3 , 666) = 215.92; p < 0.001) the multivitamin treated group had blood 
levels o f folic acid that changed significantly over time. There was also a 
significant treatment and time interaction (F ^  666) = 192.34; p < 0.0001) the 
multivitamin treated group showed an increase in blood levels o f folic acid at 
week 1 2  which remained significantly higher than the placebo condition at 
week 24 and 36. Blood levels o f folic acid in the placebo group remained stable 
over time (see Figure 34).
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Post hoc testing revealed that at baseline there was no difference between the 
blood folic acid levels o f the subjects, however at weeks 12, 24 and 36 the 
multivitamin supplemented group had significantly higher blood level of folic 
acid than the placebo group (p<0.0001).
The change in blood level of Folic Acid
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Figure 34: Showing the change in blood level of Folic Acid (nmol/L) (* p<0.0001).
5.15.10 Blood vitamin sum m ary
The effect o f supplementing diet with a multivitamin preparation resulted in a 
significant increase in blood vitamin level in most cases after only 12 weeks of 
treatment (with the exception of vitamin A, this was due to the fact that the 
multivitamin supplementation consisted of a lower dose o f vitamin A equivalent 
of 1 US RDA was given so to reduce the risk of vitamin A toxicity). What is of 
importance here, is whether a significant increase in blood vitamin level has an 
effect on psychometric performance. The hypothesis was that higher blood 
vitamin levels would result in superior psychometric task performance, and 
lower self reports o f cognitive failure, anxiety and depression.
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5.16 The effects of long term multivitamin 
supplementation on cognitive function in an 
elderly sample
The data were analysed using a 3 way analysis o f variance with treatment and 
age as between subject factors and visit as the within subject factor. The 
performance data were analysed in terms of the cognitive groupings that were 
identified in chapter 4. The groupings included
1. Attention ( HPRU Sternberg memory Task, SKT subtests IV, V, VI, and 
VII).
2. Memory recall (SKT subtest II and VIII).
3. Speed of naming (SKT subtest I and III)
4. Speed o f information processing (CFF, TRT, RRT and MRT).
5. Recognition memory (SKT subtest IX).
The study also examined the effect of multivitamin supplementation on 
intelligence (Ravens Standard Progressive Matrices) and subjective ratings of 
mood and cognitive failure (Hospital Anxiety and Depression Scale (HADS), 
Cognitive Failures Questionnaire, (CFQ).
5.17 The effects of multivitamin supplementation on 
attention in an elderly population
In chapter 4 the effects o f ageing on tasks that assessed attention were 
examined, it was concluded that there was a main effect o f age on SKT IV, V, 
VI and VII, as age increases performance on selective attention tasks declined. 
The purpose of this experiment was to assess the effects o f supplementation on 
attention tasks. In chapter 4 as a result o f a principal components analysis a 
number o f tasks were classed as assessing attention they included SKT subtests 
IV, V, VI, VII and the HPRU Sternberg Memory Task.
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5.17.1 SKT su b te s t IV (arranging blocks)
In this tasks subjects is presented with a 10 numbered blocks arranged in 2 
rows (e.g. 23 45 53 65). Subjects were required to arrange the blocks into 
ascending order. The time taken for the subjects to complete the task was 
recorded.
There was a main effect of age (F (4 , 213) = 8.69 p<0.001). There was no main 
significant effect of treatment (F (i, 213) = 0.56; p > 0.05), there was no 
significant difference in performance for either supplemented or the placebo 
group (see table 47).
Table 47: Showing the treatment means at each visit (seconds).
Baseline Week 36
Multivitamin 20.41 20.42
Placebo 20.29 20.18
There was no significant time effect (F (i, 2 1 3) = 0.33; p > 0.05) there was no 
significant change in performance over time. There were no significant 
interactions between age treatment and visit (F (4 , 213) = 0.43; p>0.05).
Post hoc testing of the main effect o f age using the Newman Keul's test, 
revealed that subjects aged 60-64 years were significantly faster at arranging the 
blocks than subjects aged 70-74, 75-79 and 80+. (See Figure 35).
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Figure 35: The main effect o f age on perform ance on arranging blocks ( SKT subtest
IV).
5.17.2 SKT su b te s t V (replacing blocks)
In subtest V subjects then had to replace the 10 numbered blocks into their 
original starting positions which were clearly marked on the board. Time taken 
to replace the blocks was recorded.
There was a main effect o f age (F (4 , 213) = 8.69 p<0.001). There was no main 
effect o f treatment (F (1,213) = 0.16; p > 0.05), there was no significant difference 
in performance for either supplemented or the placebo group (see Table 48).
Table 48: Showing the treatm ent m eans at each visit (seconds)
Baseline Week 36
Multivitamin 15.35 15.04
Placebo 14.86 14.65
There was no significant time effect (F (i, 21 3) -  2.65; p > 0.05) there was no 
significant change in performance over time. There were no significant 
interactions between age treatment and visit (F (4 ,21 3) = 0.64; p>0.05).
The main effect o f age was analysed using the Newman Keul’s task, it was 
found that subjects aged 60-64 years were significantly faster at replacing the
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blocks subjects aged 70-74, 75-79 and 80+ (p<0.001), performance on the task 
was shown to slow with increasing age. (See Figure 36).
The main effect of age on replacing blocks (SKT V)
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Figure 36: The m ain effect o f age on perform ance on replacing blocks (SK T subtest
V).
5.17.3 SKT su b te s t VI (counting sym bols)
In this task, subjects were required to count symbols. The symbols are printed 
onto a card, which contained 7 rows of 3 different symbols (e.g. circle, star, 
flower). Subjects were required to count the number of circles on the card. The 
time taken to complete the task was recorded.
There was no main effect o f age (F (4 , 2 13) = 1.26 p > 0.05) time taken to count 
symbols was comparable between the age bands. There was no main effect of 
treatment (F (i, 221) = 1-95; p > 0.05), there was no significant difference in 
performance for either supplemented or the placebo group (see Table 49).
Table 49: Showing the treatm ent m eans at each visit (seconds)
Baseline Week 36
Multivitamin 20.18 20.63
Placebo 19.42 19.90
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There was no significant time effect (F (i, 221) = 1-84; p > 0.05) there was no 
significant change in performance over time. There were no significant age 
treatment or time interactions (F (4 ,213)= 1-06; p>0.05).
5.17.4 SKT su b te s t VII (reverse naming task)
In subtest VII subjects had to complete a reverse naming task, subjects were 
required to name a row of letters e.g. AABABBA when subjects read the letter 
'A' they were required to say 'B' and vice versa. The task consisted of 34 letters, 
the time taken to complete the task was recorded.
There was a main effect of age (F = (4, 213) = 10.85 p <0.001) . There was no 
main effect of treatment F = (1, 213) = 0.46; p > 0.05), there was no significant 
difference in performance for either supplemented or the placebo group (see 
Table 50).
Table 50: Showing the treatm ent m eans at each visit (seconds).
Baseline Week 36
Multivitamin 24.30 22.86
Placebo 23.46 22.82
There was no main effect o f time (F = (1, 213) = 2.57; p > 0.05) there was no 
significant change in performance over time. There was a significant age and 
visit interaction (F (4 ,213)= 2.59; p < 0.05).
Post hoc testing of the main effect o f age revealed that on performance on the 
task declines with age (see Figure 37).
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The main effect of age on the reverse naming task
(SKT VII)
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Figure 37: Showing the main effect o f age on the reverse nam ing task  (SK T VII).
Post hoc testing of the age visit interaction revealed that there were no 
significant changes in performance between the baseline and week 36 tests 
point for subjects aged 60-64, 65-69, 70-74 and 80+. Subjects aged 75-79 were 
significantly faster at the reverse naming task at week 36 compared to their 
baseline score (see Figure 38).
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F igure 38: The interaction between age and visit on the reverse nam ing task  (SKT
subtest VII).
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5.17.5 HPRU Sternberg Memory Task (SMT)
Subjects were required to memorise a set of digits (the stimulus set), ranging 
from single digits, sets of three and sets of five digits. Following the series, 
subjects were presented with 12 single probe digits, the subjects were required 
to decide whether the probe digits were a part of the stimulus set or not.
There was a main effect o f age (F (4 , 203) = 4.38; p < 0.01). There was no main 
effect o f treatment F (1,203) = 0.27; p > 0.05), there was no significant difference 
in performance for either supplemented or the placebo group (see Table 51).
However examination o f the treatment means would seem to indicate that 
baseline performance on the task was poorer in the multivitamin group than the 
placebo group.
Table 51: Showing the treatm ent m eans at each visit (m illiseconds)
Baseline Week 12 Week 24 Week 36
Multivitamin 1412.50 1361.52 1281.48 1201.93
Placebo 1137.11 1271.00 1245.82 1196.79
There was a significant time effect (F (3 , 609) = 19.88; p < 0.001). There was a 
significant age and time interaction F (12, 609) = 3.32; p <0.001).
The main effect o f age was analysed using post hoc Newman Keul's it was 
found that performance on the task declines as age increases, older subjects took 
longer to respond to the stimuli. (See Figure 39).
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The significant time effect was analysed using Newman Keul's, it was reported 
that performance on the task got significantly faster over time, possibly 
reflecting a practice/familiarity effect. (See Figure 40)
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Show ing the main effect o f tim e on the H PR U  Sternberg M em ory Task
Post hoc analysis o f the interaction between age and time revealed that 
performance in subjects aged 60-64, 65-69 and 70-74 showed a significant 
improvement in response times over the test period. In subjects aged 75-79 and
80+ there was no improvement in performance until week 36, subjects 80+ 
showed poorer response times at week 12 and 24 (see Figure 41).
The interaction between age and visit on the 
Sternberg Memory Task (SMT)
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Figure 41: The interaction between age and visit on the H PR U  Sternberg M em ory
Task (SM T).
5.17.6 Sum m ary
There were no main effects o f treatment on any o f the tasks thought to assess 
attention, multivitamin supplementation had no effect on attention, other than an 
interesting interaction between age and visit on the HPRU Sternberg Memory 
Task, where subjects aged 60-74 showed a significant improvement in 
performance over time, whereas there was no improvement over time for 
subjects aged greater than 75 years.
In line with chapter 4, main effects o f age were reported on both the arranging 
and replacing blocks task (SKT IV, V); the reverse naming task (SKT VII). In 
the present analysis age effects were also reported on the HPRU Sternberg 
Memory Task (SMT). In general older subjects were slower at performing the 
tasks, and long term supplementation with multivitamins did not help to reduce 
the age related deficit.
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5.18 The effects of multivitamin supplementation on 
memory recall
In chapter 4 the effects o f ageing on tasks that assess memory recall SKT II 
(immediate recall) and SKT VIII (delayed recall) were assessed. It was 
concluded that there were significant main effect of age o f performance of 
memory recall tasks. The purpose o f this experiment was to assess the effects of 
supplementation on memory recall, in the hope that long term multivitamin 
supplementation would reduce the age related deficit.
5.18.1 SKT su b te s t II (immediate recall)
In subtest II subjects were required to provide immediate recall of the 12 items 
(that they had previously seen in subtest I). Subjects only had 60 seconds in 
which to recall the 12 items, the number of omissions were recorded.
There was a significant main effect of age (F (4 , 213) = 3.67; p<0.01). There was 
no main significant effect of treatment (F (i, 21 3) = 1.26; p > 0.05), there was no 
significant difference in performance between the multivitamin supplemented or 
the placebo group (see Table 52).
Table 52: Showing the treatm ent m eans at each visit (num ber o f om issions).
Baseline Week 36
Multivitamin 4.39 4.99
Placebo 4.45 5.15
There was a significant time effect (F (i, 213) = 15.42; p < 0.001) there was a 
significant change in performance on the task over time, subjects forgot more 
items after 36 weeks of treatment.
There was no significant age, treatment and time interaction (F (4 , 213) = 1-64; 
p>0.05).
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The main effect of age was analysed using the Newman Keul's post hoc test, it 
was revealed that immediate memory recall declines as age increases, memory 
recall was poorest in subjects aged 75-79 years (see Figure 42)
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Figure 42: The m ain effect o f age on im m ediate recall (SK T subtest II).
5.18.2 SKT su b te s t VIII (delayed recall)
In subtest VIII subjects were required to provide delayed recall of the 12 items, 
that they had seen some 10 minutes ago. Subjects only had 60 seconds in which 
to recall the 12 items, the number of omissions were recorded.
There was a main effect o f age (F (4 , 21 3) = 5.39; p <0.001). There was no main 
significant effect of treatment (F (i, 213) = 0.05; p > 0.05), there was no 
significant difference in performance for either supplemented or the placebo 
group (see Table 53).
Table 53: Showing the treatm ent m eans at each visit (num ber o f om issions).
Baseline Week 36
Multivitamin 4.09 4.65
Placebo 3.88 4.60
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There was a significant time effect (F (i, 213) = 9.65; p < 0.01) subjects forgot 
more items over time. There was no significant age treatment and time 
interaction (F (4 , 213) = 0.58; p>0.05).
The main effect o f age was analysed using post hoc testing which revealed that 
subjects aged 60-64 years forgot significantly fewer items than older subjects 
(see Figure 43).
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Figure 43: The main effect o f age on delayed recall (SKT subtest VIII).
5.18.3 Sum m ary
In line with chapter 4 main effects of age were reported on both the immediate 
recall task (SKT II) and the delayed recall task (SKT VIII), older subjects 
tended to forget more items that younger subjects.
There was no main effect o f treatment on tasks assessing memory recall, both 
the placebo and the multivitamin group had similar forgetting rates on both the 
immediate (SKT II) and delayed recall tasks (SKT VIII). Supplementation with 
multivitamins did not reduce the age deficit in memory recall.
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5.19 The effects of multivitamin supplementation on 
the speed of naming
In chapter 4 the effects of ageing on tasks that assess the speed o f naming were 
assessed. The tasks considered to assess the speed of naming included SKT I 
(object naming) and SKT III (numerical naming) it was concluded that there 
were main effects o f age on the object naming task, so that older subjects were 
slower at naming the 1 2  objects, however there were no main effects o f age on 
the numerical naming task. This experiment assessed whether the age related 
decrement in object naming could be alleviated with long term supplementation 
of multivitamins.
5.19.1 SKT su b te s t I (object naming)
The subjects is shown a card containing 12 pictures of objects. They were 
required to name the objects as quickly as possible, remembering to try and 
commit the objects to memory as they would have to recall and recognise the 
objects. The number of omissions were recorded.
There was no main effect o f age (F ^  2 1 3) = 1.32; p > 0.05) time taken to name 
objects was comparable for all ages. There was no main significant effect of 
treatment (F (i, 213) = 2.63; p > 0.05), there was no significant difference in the 
time taken to name objects for the supplemented or the placebo group (see 
Table 54)
Table 54: Showing the treatm ent m eans at each visit (seconds).
Baseline Week 36
Multivitamin 13.61 14.37
Placebo 14.77 15.29
There was no significant time effect (F (i, 213) = 0.01; p > 0.05) there was no 
significant change in performance over time. There was no significant age 
treatment and time interaction (F (4 , 213) = 1-36; p >0.05).
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5.19.2 SKT su b te s t III (naming num erals)
The subjects had to name a set of 10 randomly chosen numbered blocks e.g. 24, 
36, 53, 65 etc. The time taken to name all numbers was recorded.
There was no main effect o f age (F (4 , 213) = 0.56; p > 0.05) time taken to name 
numerals was comparable for all ages. There was no main significant effect o f  
treatment (F (i, 213) = 2.64; p > 0.05), there was no significant difference in the 
time taken to name numerals for the supplemented or the placebo group (see 
Table 55).
Table 55: Showing the treatm ent means at each visit (seconds).
Baseline Week 36
Multivitamin 7.57 7.64
Placebo 7.74 8.38
There was a significant time effect (F (i, 213) = 5.80; p < 0.01), subjects got 
slower at naming numerals over time.
There was a significant interaction between treatment and visit (F (i, 2 1 3) = 5.07; 
p < 0.01), subjects in the placebo group showed a decline in performance over 
time, i.e. responses got slower whereas performance in subjects treated with 
multivitamin supplementation remained stable, this could be taken as evidence 
of an effect o f supplementation even though performance in the supplemented 
group did not improve, the supplementation had the effect o f retarding the 
decline that was observed in the placebo condition, acting with a protective 
effect (see Figure 44).
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Figure 44: The interaction between treatm ent and visit on nam ing num erals (SKT
subtest III).
5.19.3 Sum m ary
In chapter 4 a main effect of age was reported on the objects naming task (SKT 
subtest I), however in this sample there were no main effect o f age, subjects of 
all ages were comparable in the time taken to name 12 objects. In line with 
chapter 4 there was no main effect o f age on numerical naming.
There were no main effect o f treatment on tasks assessing the speed o f naming 
(SKT I or III), supplementation did not improve performance on SKT task I 
(object naming), however in SKT III (numerical naming task) supplementation 
seemed to protect against the decrement in performance that was noted in the 
placebo condition over time, whereas in the multivitamin group performance 
remained stable over time.
5.20 The effect of multivitamin supplementation on the 
speed of information processing
In chapter 4 the effects of ageing on tasks that assessing the speed o f  
information processing were examined, it was concluded that there was no main
195
effect o f age on the speed of information processing assessed using the Critical 
Flicker Fusion task (CFF), or the Choice Reaction Time tasks (CRT).
5.20.1 Critical Flicker Fusion (CFF)
Subjects completed 6 trials, 3 ascending and 3 descending trials, the average of 
which was taken as the subjects critical flicker fusion threshold.
There was no main effect o f age (F (4 ,209)= 1-09; p > 0.05) critical flicker fusion 
thresholds were comparable for the ages. There was no main significant effect 
of treatment (F (i, 209) = 0.69; p > 0.05), there was no significant difference in 
critical flicker fusion thresholds for either supplemented or the placebo group 
(see Table 56).
Table 56: Showing the treatm ent m eans at each visit (Hz).
Baseline Week 12 Week 24 Week 36
Multivitamin 28.96 28.68 28.96 28.84
Placebo 29.41 29.48 28.89 29.88
There was no significant time effect (F (3> 627) = 0.23; p > 0.05) there was no 
significant change in critical flicker fusion thresholds over time. There was no 
significant age treatment and time interaction (F (12, 629) = 0.88; p>0.05).
5.20.2 Total Reaction Time (TRT)
Total reaction time was measured using a choice reaction time task, containing 
6 lights, subjects had to respond by extinguishing the lights as fast as possible. 
Total reaction times were obtained from the average of 20 stimuli. Total 
reaction time was defined as the time taken for subjects to remove their finger 
from the home, reach the appropriate response key and return back to the home 
key.
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There was a main effect o f age (F (4; 2 09) = 6.50; p<0.001). There was no main 
significant effect o f treatment (F = (i, 209) = 0.007; p >0.05 ), there was no 
significant difference in total reaction times between the multivitamin and the 
placebo groups (see Table 57).
Table 57: Showing the treatm ent means at each visit (m illiseconds).
Baseline Week 12 Week 24 Week 36
Multivitamin 803.42 813.77 767.44 752.47
Placebo 783.50 791.60 780.29 742.91
There was a significant time effect (F (3, 627) = 13.37; p < 0.001) total reaction 
times decreased over time. There was a significant age and visit interaction (F 
(12,6 27) = 1-96; p <0.05) (see Figure 45).
Post hoc testing of the main effect o f age revealed that performance on the task 
declined with increased age, and younger subjects had significantly faster 
response times than older subjects (see Figure 45)
The main effect of age on Total Reaction Time 
(TRT)
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Figure 45: Showing the main effect o f age on total reaction tim e (TRT).
Post hoc testing of the main effect of time revealed that subjects got faster at the 
task over time, possibly indicating a practice/familiarity effect (see Figure 46)
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Figure 46: Showing the main effect o f tim e on total reaction tim e (TRT).
The significant age and visit interaction was analysed using separate one way 
analyses o f variance, it was revealed that at every visit, there were significant 
differences. All age groups showed significant improvements in reaction times 
over the testing period. However in subjects aged 80+ there was quite a 
dramatic improvement in reaction time by week 36 (see Figure 47).
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Figure 47: The interaction between age and visit on total reaction tim e (TRT).
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5.20.3 Recognition Reaction Time (RRT)
Recognition reaction time was measured using a choice reaction time task, 
containing 6 stimuli, subjects had to respond by extinguishing the lights as fast 
as possible. Recognition reaction time is the time taken for the subject to lift 
their finger from the home key.
There was no main effect o f age (F (4 , 197) = 0.15; p>0.05) there was no 
significant difference between recognition reaction time for the ages. There was 
no main significant effect of treatment (F (i, 197) = 0.25; p > 0.61), there was no 
significant difference in recognition reaction time between the multivitamin and 
placebo group (see Table 58).
Table 58: Showing the treatm ent means at each visit (m illiseconds).
Baseline Week 12 Week 24 Week 36
Multivitamin 445.07 459.61 442.37 470.02
Placebo 455.67 466.99 460.05 454.45
There was no significant time effect (F (3 , 5 91) = 2.16; p>0.05) recognition 
reaction time remained stable over time. There was a significant treatment and 
visit interaction (F (3, 591) = 2.97; p <0.05) (see Figure 48).
Post hoc testing o f the treatment/visit interaction revealed that there was a 
significant difference between the baseline RRT scores for the 2 groups. There 
were significant differences between the multivitamin RRT scores, the baseline 
score was significantly different from week 12 and week 36. There were no 
significant differences between the RRT scores in the placebo group.
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5.20.4 Motor Reaction Time (MRT)
Motor reaction time was measured using a choice reaction time task, containing 
6 stimuli, subjects had to respond by extinguishing the lights as fast as possible. 
Motor reaction time was defined as the time taken for the subject to reach the 
appropriate response button.
There was no main effect o f age (F (4 , 197) = 1.29; p> 0.05), there were no 
significant differences between motor reaction times for the ages. There was no 
main significant effect of treatment (F (i, 197) = 0.30; p > 0.05), there was no 
significant difference in motor reaction time between the multivitamin and 
placebo group (see Table 59).
Table 59: Showing the treatm ent m eans at each visit (m illiseconds).
Baseline Week 12 Week 24 Week 36
Multivitamin 354.13 355.43 329.52 294.44
Placebo 343.60 349.90 315.96 286.86
There was a significant main effect o f time (F (3 , 591) = 21.56; p < 0.001) post 
hoc testing revealed that reaction times got faster over time, motor reaction 
times at week 36 were significantly faster than reaction times at baseline, week
2 0 0
12 and week 24 this possibly reflects a learning/familiarity effect (see figure 
49). There were no significant age treatment and visit interactions (F (12, 591) = 
1.19; p>0.05).
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F igure 49: The m ain effect o f tim e on m otor reaction tim e (M RT).
5.20.5 Summary
In line with chapter 4 there were no main effects of age on tasks assessing the 
speed of information processing (CFF, RRT, MRT,) despite previous literature 
(Coleston, 1989). In chapter four there were no main effects o f age on TRT, 
however in the present analysis, effects o f age on TRT were observed.
There were no main effects o f treatment, supplementation with multivitamin 
had no effect on either Critical Flicker Fusion thresholds or the Choice Reaction 
Time task.
5.21 The effects of multivitamin supplementation on 
recognition memory
In chapter 4 the effects of ageing on tasks that assess recognition memory were 
assessed, it was concluded that there was no main effect o f age on recognition
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memory. In chapter 4 the SKT subtest IX was classed as assessing recognition 
memory. The purpose o f this experiment was to assess the effects of 
supplementation on recognition memory.
5.21.1 SKT su b te s t IX (recognition memory)
In this task subjects were required to recognise the original 12 objects (seen in 
subtest I) from a set of 48 pictures of objects. The number of omissions were 
recorded.
There was a main effect of age (F (4 , 213) = 7.07; p<0.001). There was a main 
significant effect o f treatment (F (i, 213) =5.61; p < 0.01). There was no 
significant time effect (F (i, 213) = 1-07; p > 0.05) there was no significant change 
in recognition memory over time. There was a significant interaction between 
age, treatment and test (F (4 , 213) = 3.77; p < 0.005).
The main effect of age was analysed using post hoc testing with the Newman 
Keul’s test, it was revealed that there was a significant increase in forgetting 
rates as age increased, subjects aged 80+ had the poorest recognition memory 
(see Figure 50)
The main effect of age on SKT IX
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Showing the main effect of age on recognition memory (SKT IX).Figure 50:
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Post hoc testing o f the main effect of treatment revealed that forgetting rates 
were higher in the placebo treated group (placebo = 0.84, multivitamin = 0.51).
Post hoc testing o f the age treatment and time interaction revealed a number of 
significant differences. In the placebo group there was no significant difference 
between the baseline and week 36 test point for subjects aged 60-64, 65-69 and 
70-74. Subjects aged 75-79 years showed a significant increase in forgetting 
rates at week 36 compared to baseline, and subjects aged 80+ showed a 
significant improvement in forgetting rate at week 36 compared to the baseline 
visit.
In the multivitamin treated group, there was no significant difference between 
the baseline and week 36 test point for subjects aged 60-64, 65-69, 70-74 and 
75-79 years. Subjects aged 80+ showed a significant increase in forgetting rates 
at week 36 compared to baseline (see Figure 51).
Treatment, age and visit interaction on recognition 
memory (SKT IX)
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Figure 51: The significant interaction between age treatm ent and test on recognition
m em ory (SKT IX).
5.21.2 Summary
In this sample there was a main effect of age reported on recognition memory, 
in particular the oldest subjects, those aged 80+ had the poorest recognition 
memory. In chapter 4 there were no main effects o f age on recognition memory
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scores. There was an interaction between age treatment and visit, it was 
revealed that in the older subjects (i.e. those aged 75-79 and 80+) there were a 
number o f differences between the treatment groups. In the placebo group 
subjects aged 75-79 showed an increase in their forgetting rates over the test 
period, whereas subjects aged 80+ showed an improvement over time. In the 
multivitamin group, subjects aged 80+ showed an increase in their forgetting 
rate over time.
5.22 The effects of multivitamin supplementation on 
intelligence
Much of the research conducted in this area particularly with teenagers and 
young children would seem to imply that intelligence, particularly non verbal 
intelligence is strongly affected by improved nutritional status. The effects of 
multivitamin supplementation on non verbal intelligence in an elderly sample.
5.22.1 Ravens Standard Progressive M atrices (RSPM)
Subjects completed the Ravens Standard Progressive Matrices, consisting of 60 
problems.
There was a main effect o f age (F (4 , 211) = 5.70; p<0.001). There was no main 
significant effect of treatment (F (i, 211) = 1.13; p > 0.05), there was no 
significant difference in Ravens scores between the supplemented or the 
placebo group (see Table 60).
Table 60: Showing the treatm ent m eans at each visit.
Baseline Week 36
Multivitamin 47.40 48.96
Placebo 47.99 49.13
There was a significant time effect (F (i, 211) = 5.60; p < 0.01) post hoc testing 
revealed that both the placebo and multivitamin supplemented groups showed
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an improvement in Ravens scores over the testing period. There were no 
significant age treatment and time interactions (F (4 , 2 1 1 ) = 1.25; p>0.01).
Post hoc testing revealed that Raven’s mean scores declined as age increased, 
older subjects had lower scores than younger subjects (see Figure 52).
The main effect of Age on the Ravens Task
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Figure 52: The m ain effect o f age on Ravens Standard Progressive M atrices.
5.22.2 Summary
There was a main effect o f age on the Ravens standard progressive matrices, so 
that older subjects had poorer intelligence scores than younger subjects.
Despite previous findings, there was no main effect of treatment on non verbal 
intelligence. Perhaps this effect is specific to children or subjects with poor diet, 
or rather the effect is specific to the test.
5.23 The effects of multivitamin supplementation on 
mood
Subjective mood is another aspect of human functioning that is thought 
particularly susceptible to nutritional deficiencies, in particular deficiencies in 
the B complex vitamins have been associated with mood disturbances, and 
extreme changes in mood such as depression. In this experiment the impact of
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multivitamin supplementation on subjective ratings o f anxiety, depression were 
examined using the Hospital Anxiety and Depression Scale (HADS) and 
cognitive failures, such as slips of the tongue, disturbances in attention and 
memory etc were examined using the Cognitive Failures Questionnaire (CFQ).
5.23.1 The Hospital Anxiety and D epression Scale (HADS): 
Anxiety
Subjects completed Zigmond and Snaith's (1983) Hospital Anxiety and 
Depression Scale (HADS), 7 of the 14 items assess anxiety.
There was no main effect o f age (F (4 , 2ii) = 0.63; p > 0.05) there was no 
significant difference between anxiety scores and the ages. There was no 
significant main effect o f treatment (F (i, 2 11) = 1-11; p > 0.05) there was no 
significant difference in anxiety scores between the supplemented or placebo 
group (see Table 61).
Table 61: Showing the anxiety treatm ent m eans at each visit.
Baseline Week 36
Multivitamin 6.58 6.61
Placebo 5.76 6.05
There was no significant main effect o f time (F (i, 21 1) = 0.00; p > 0.05) there 
was no significant change in anxiety scores over time. There was a significant 
age, treatment and time interaction (F (4 , 2 1 1 ) = 3.12; p < 0.01).
Post hoc testing of the age treatment and time interaction revealed that in the 
placebo group subjects aged 60-64 and 80+ showed a slight fall in anxiety 
scores over time, subjects 65-69, 70-74 showed a slight increase in anxiety 
scores over time. Subjects aged 75-79 years showed a significant increase in 
anxiety scores over time.
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In the multivitamin treated group, subjects aged 60-64 and 65-69 reported no 
differences in their anxiety scores over time. Subjects aged 70-74 showed a 
significant increase in anxiety scores over time. Subjects aged 75-79 showed a 
slight decrease in anxiety scores over time and subjects aged 80+ reported no 
difference in their anxiety scores over time, (see Figure 53)
Anxiety treatment age and time interaction
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Figure 53: The interaction between age treatm ent and visit in anxiety scores.
5.23.2 The Hospital Anxiety and D epression Scale (HADS): 
Depression
Subjects completed Zigmond and Snaith's (1983) Hospital Anxiety and 
Depression Scale (HADS), 7 of the 14 items assess depression.
There was no main effect of age (F (4) 2ii) = 2.22; p > 0.05) there was no 
significant difference between depression scores and the ages. There was no 
main significant effect of treatment (F (i, 211) =2.22; p > 0.05), there was no 
significant difference in depression scores for either the supplemented or the 
placebo groups (see Table 62).
Table 62: Showing the depression treatm ent means at each visit.
Baseline Week 36
Multivitamin 3.86 3.74
Placebo 3.69 3.70
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There was no significant time effect (F (i, 211) = 0.08; p > 0.05) there was no 
significant change in depression scores over time. There was no significant age, 
treatment and time interaction (F (4 , 211) = 0.98; p>0.05).
5.23.3 The Cognitive Failures Q uestionnaire (CFQ)
Subjects completed a self rating questionnaire consisting of 25 questions 
subjects had to rate how frequently they had experienced cognitive failures e.g. 
absentmindedness, forgetting appointments, directions, errands (since their last 
visit).
There was no main effect o f age (F (4 , 20 6) = 0.85; p >0.05) there was no 
significant difference between cognitive failure scores and the ages. There was 
no main significant effect o f treatment (F (i, 2 06) =2.87; p> 0.05), there was no 
significant difference in the cognitive failure scores for either the supplemented 
or the placebo group (see Table 63).
Table 63: Showing the treatm ent m eans at each visit.
Baseline Week 36
Multivitamin 39.80 38.90
Placebo 36.96 37.31
There was no significant time effect (F (3 , 618) = 0.44; p >0.05) there was no 
significant change in the cognitive failure rate over time. There was no 
significant age, treatment and time interactions (F (12, 6 18) = 0.81; p>0.05).
5.23.4 Sum m ary
There was no main effect of age or treatment on either anxiety or depression 
scores. Subjects self ratings o f depression and anxiety were comparable in both 
the multivitamin and placebo groups.
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There was no main effect o f age or treatment on the self reporting o f failures in 
everyday life such as forgetting appointments, conversations, errands, 
directions, absentmindedness, tip o f the tongue experiences and the ability to 
learn. Supplementation had no effect on subjective ratings o f failure.
5.23.5 Blood vitamin sum m ary
The effect o f supplementing diet with a multivitamin preparation resulted in a 
significant increase in blood vitamin level in most cases after only 12 weeks of 
treatment (with the exception o f vitamin A, this was due to the fact that the 
multivitamin supplementation consisted of a lower dose o f vitamin A equivalent 
of 1 US RDA was given so to reduce the risk o f vitamin A toxicity). What is of 
importance here, is whether a significant increase in blood vitamin level has an 
effect on psychometric performance. The hypothesis was that higher blood 
vitamin levels would result in superior psychometric task performance, and 
lower self reports of cognitive failure, anxiety and depression.
5.24 Deficiency in the population sampled
Having analysed the data it became apparent that cognitive decrements should 
only be observed in subjects with a defined vitamin deficiency. In terms o f the 
baseline data there were a number o f subjects who were experiencing vitamin 
deficiency. Roche Pharmaceuticals provided vitamin deficiency cut off rates, in 
terms o f low, moderate and high risk o f deficiency. Table 64 shows the risk of 
deficiency for subjects in the present study.
Table 64: Showing the risk o f deficiency for the present population
Vitamin Low Risk Moderate Risk High Risk
Vitamin A 237 1 0
Vitamin Bi 223 7 0
Vitamin B2 149 57 24
Vitamin B6 120 38 72
Vitamin B 12 222 11 5
Vitamin C 234 0 3
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Vitamin Low Risk Moderate Risk High Risk
Vitamin E 237 1 0
Biotin 194 45 0
Folic Acid 178 60 0
Having identified that the present population did contain a number of subjects 
who were at either moderate or high risk o f vitamin deficiency. It was then 
possible to examine the effect o f the change in vitamin status in subjects with a 
different risk of deficiency. It was possible to compare the effect o f vitamin 
supplementation in subjects with good nutritional status compared with subjects 
with poorer nutritional status.
In order to do this, subjects were classified into one of three groups, low risk 
subjects (n = 97), moderate risk subjects (n = 70) and subjects at high risk (n = 
56). High risk subjects were subjects with at least one moderate and one high 
risk of deficiency.
Table 65: Grouping o f subjects in term s o f the risk o f vitam in deficiency.
N Low risk Moderate
Risk
High Risk Group
50 9 0 0 Low
47 8 1 0 Low
37 8 0 1 Moderate
27 7 2 0 Moderate
28 7 1 1 High
6 6 3 0 Moderate
18 6 2 1 High
3 7 0 2 High
3 5 3 1 High
5 6 1 2 High
2 5 2 2 High
It was hypothesised that subjects with a greater risk o f deficiency would 
’'respond" to a greater extend than subjects with a low risk o f vitamin 
deficiency, i.e. high risk subjects would show a greater degree o f improvement 
of cognitive function than subjects with a low risk o f vitamin deficiency.
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The data were analysed using a three analysis o f variance (ANOVA) with tests 
as the within subjects factor and risk of deficiency (low, moderate and high) and 
treatment (multivitamin, placebo) as between subjects factors. The data were 
analysed to determine whether the risk of deficiency interacted with a change in 
performance.
It was revealed that none of the performance analyses on any of the cognitive 
tasks (CFF, CRT, SMT, SKT, Ravens or the cognitive failures questionnaire) 
showed any reliable involvement of severity in performance changes.
There was an interaction between risk o f deficiency and change in mood, as 
measures using the Hospital Anxiety and Depression Scale. It was reported that 
subjects in the moderate group had higher anxiety levels following 
supplementation that subjects in either the high or low risk groups (F (3 , 2 2 5) = 
4.88; p<0.05). There was a three way interaction between treatment severity and 
tests in terms of the depression scale on the HADS. It was reported that placebo 
treated subjects with a high risk o f deficiency became more depressed over time 
compared to subjects with low of deficiency who became less depressed over 
time (F (12,22 5) = 4.44; p<0.05).
5.25 Discussion
Despite the fact that supplementation with a multivitamin supplement for 36 
weeks lead to a significant increase in blood vitamin levels over time, this 
increase in blood vitamin levels had no beneficial effects in terms o f cognitive 
and psychomotor performance. It was hypothesised that subjects with higher 
blood vitamin levels would show superior cognitive functioning to subjects with 
low blood vitamin levels.
This experiment failed to demonstrate any beneficial effects o f supplementation 
on tasks assessing attention, memory recall, speed o f naming, speed of
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information processing, recognition memory, intelligence or any effects on 
subjective mood ratings or perceived cognitive failures. There was one finding 
that although was not an improvement could be taken as evidence of a 
protection on decline, subjects treated with multivitamins had stable 
performance on the recognition memory task, whereas subjects treated with 
placebo showed a decrement in performance over time.
In terms of deficiency the sample was very well nourished, only 30% of the 
sample were at a high risk of deficiency of vitamin E*6 and only 10% of the 
sample were at a high risk of deficiency of vitamin B2. Data was analysed to 
determine whether subjects with a high risk o f deficiency showed differences in 
performance from subjects with a low risk o f deficiency. It was reported that 
there were no performance differences between subjects in terms o f the risk of 
deficiency. There was a significant difference between the subjects in terms of 
mood ratings. It was reported that subjects with a moderate risk o f vitamin 
deficiency reported higher anxiety levels following supplementation that 
subjects with either a high or low risk of deficiency. In terms of 
supplementation it was reported that placebo treated subjects with a high risk of  
deficiency reported feeling more depressed over time, whereas those with a low 
risk o f deficiency reported feeling less depressed over time. There were no other 
differences reported in terms o f the risk o f deficiency.
In previous studies, there were no effects o f supplementation reported on tasks 
assessing attention. In the present study, there were five tasks assessing 
attention SKT IV (arranging blocks); SKT V (replacing blocks); SKT VI 
(counting symbols); SKT VII (reverse naming); and the HPRU Sternberg 
Memory Task (SMT). SKT subtests IV and V represent spatial tasks, simply 
requiring the subjects to arrange numbers into an order, hence do not place the 
subjects under a great deal of cognitive demand, therefore improvements on 
these tasks, following a nutritional supplement would not be expected. SKT VI 
(counting symbols) is a vigilance/selective attention task, requiring the subjects
212
to concentrate on counting a number o f symbols, contained in a list o f a number 
of symbols. SKT VII (reverse naming) is a fairly complex selective attention 
task similar to the Stroop task, where subjects have to process information and 
respond in another way, e.g. see a letter A and say B. There have been no 
studies examining the effects of supplementation on the Stroop task, however 
Bohnen et al (1992) reported that subjects deficient in vitamin B 12 had poorer 
Stroop task performance than subjects with high blood vitamin B 12 levels. 
Therefore it was thought that supplementation with multivitamins would 
enhance performance on the task.
In the HPRU Sternberg Memory Task, subjects were required to memorise a 
small series o f numbers, the task being very similar in nature to the digit span 
forward task. In terms o f the effects o f supplementation on the forward digit 
span task, previous studies have reported mixed findings. Botez et al (1984) 
reported that treatment with folate for 7-11 months resulted in improved digit 
span performance, whereas Tolonen et al (1992) reported that vitamin B6 had 
no effect on the task. Based on the results from this present study, performance 
improvements following supplementation were expected on the task.
These results as a whole would seem to mirror previous studies, where no 
beneficial effects of supplementation were reported on tasks assessing attention.
Memory is an aspect of cognitive function that is thought to be sensitive to 
nutritional status. In particular, it has been reported that deficiency in certain 
vitamins has resulted in decrements on a number o f tasks e.g. paragraph recall, 
backward digit span and visual memory tasks. In terms o f supplementation, the 
results of experimental work seem somewhat contradictory, Deijen et al (1992) 
reported that the effects o f supplementation with vitamin B6 seemed to have 
dramatic effects on long term memory. However Tolonen et al (1988) reported 
that supplementation with vitamin B6 for one year resulted in improved 
immediate paragraph recall and performance on the clock test. Botez et al
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(1984) reported that supplementation with folate for 7-11 months resulted in 
significant improvements on performance of the digit span task.
In terms o f the immediate and delayed recall memory tasks used in this 
experiment, SKT subtest II (immediate recall) and SKT VIII (delayed recall) are 
age sensitive tasks, that showed a decline with advanced age. It was hoped that 
supplementation with multivitamins would help to eliminate the age related 
decrement. However it would appear that the tasks were not responsive to 
multivitamin supplementation. The recognition memory task (SKT IX) was not 
sensitive to the effects of age, and hence performance could not be expected to 
show any improvements following multivitamin supplementation.
There have been two studies examining the effect o f vitamin supplementation 
on the speed of information processing in healthy elderly subjects (Deijen et a l , 
1992; Burr et al., 1975). Neither study reported any beneficial effect of 
supplementation on the speed of information processing. In line with this, the 
present study reported that multivitamin supplementation had no effect on tasks 
assessing the speed of information processing (CFF, TRT, RRT. MRT).
There have been no studies that have examined the effect o f supplementation on 
the speed o f naming. However, as these tasks are similar to tasks assessing the 
speed o f information processing for which no effect o f supplementation was 
reported. Therefore, no effects o f supplementation were expected on SKT I 
(object naming) and SKT III (numerical naming), and this was found to be the 
case.
Intelligence, particularly non verbal intelligence has been shown to improve 
following supplementation in children (Harrell, 1946; Boggs et al., 1965; 
Schoentahler et ah, 1991; Benton and Roberts, 1988; Benton and Butts, 1990; 
Benton and Cook, 1991). There have been few studies examining the effects of 
supplementation on intelligence in healthy and elderly patient populations, the
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few studies that have assessed aspects of intelligence have reported that 
supplementation had the effect of improving scores. Therefore it is possible that 
the beneficial effects are not just limited to child samples. The present study 
assessed the effect of multivitamin supplementation on performance of the 
Ravens task, a non verbal test of intelligence. However unlike previous studies, 
it was reported that multivitamin supplementation had no effect on Raven's 
scores. The beneficial effects reported in the previous studies have been on the 
abstraction task, a subtask o f the WAIS used for the assessment of intelligence, 
and the Mini Mental State Examination (MMSE). It is possible that these tasks 
measure other aspects of cognitive function, rather than intelligence per se.
Mood was assessed using the Hospital Anxiety and Depression scale, no effects 
of supplementation were observed. In a previous study Chome et al (1986) 
reported that multivitamin deficient subjects had higher depression scores than 
non deficient subjects. Smidt et al (1991) reported that supplementation with 
vitamin Bi for 6 weeks resulted in improved feelings o f well being.
A number o f differences between the present study and earlier research may 
help to explain why this long term intervention study failed to demonstrate any 
beneficial effects on cognitive functioning in the elderly.
The present study did not include any o f the tasks used by previous research 
teams. It is possible that the tasks selected for use in this experiment were not 
sensitive to detect slight performance improvements, even though many o f them 
were sensitive to the effects o f age (SKT II, IV, V, VII, VIII, IX, HPRU 
Sternberg memory task, Total Reaction Time and Ravens Standard Progressive 
Matrices).
It is quite possible that these tasks were not sensitive to the effects o f improved 
nutrition, treatment with an over the counter supplement at best could only be 
expected to produce modest improvements, it is possible that these modest
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improvements were to subtle to be detected by the cognitive and psychomotor 
tasks included in this study.
The age differences between the previous studies and this present study may 
also have contributed to the lack o f effect, although this study included subjects 
aged 60-85 years, the vast majority o f the sample were aged 60-70 years, (the 
mean age o f the subjects was only 69.5 years ) which in terms o f experimental 
studies can be classed as young elderly subjects. The mean age of subjects in 
the previous studies was slightly higher than the mean in this study (see Table 
30 with the exception of Riggs et al, 1997 and Smith et a l, in press), and it is 
possible that the older subjects in the previous studies were experiencing more 
decline in cognitive and psychomotor function than the subjects included in this 
experiment.
Another major difference between the present study and previous studies, 
concerns the sample population size. The present study contained 239 healthy 
elderly subjects, whereas previous studies have sampled much smaller 
populations (with the exception o f Goodwin et a l, 1983; Burr et a l, 1975; 
Smith et a l, in press)
Table 66: Showing the age ranges, and mean ages o f subjects included in previous
studies.
Authors Age Range Mean Age Sample size
Burr et al (1975) above 70 years 78 years 297
Goodwin et al (1983) 60-94 years 71 years 250
Chome et al (1986) 65-91 years not quoted 60
Sram et al (1990) 60-90 years not quoted 80
Tucker et al (1990) 60-87 years not quoted 28
Lauque et al (1995) above 60 years 73 years 91
Riggs et al (1996) 54-81 years 66.1 years 70
La Rue et al (1997) 66-90 years 76.9 years 137
Smith et al (in press) 60-80 years 66 years 205
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Finally the recruitment procedure may have hindered the experiment, all the 
subjects volunteered to take part in the study and were obtained via 
advertisements in Doctors surgeries and local newspapers, or from the HPRU 
data base. When experiments are conducted using volunteer samples, a biased 
sample is generally obtained, consisting o f subjects who are very fit, health 
conscious, eager and highly motivated therefore it can be argued that the sample 
included in this study were probably not suffering from any degree o f cognitive 
decline.
In terms o f future research, it might be more suitable to include tasks that have 
previously proved sensitive to the effect of multivitamin supplementation in 
order to try an clarify whether the effects observed were universal, or use tests 
that assess similar aspects of cognitive function to those found to be sensitive to 
the effects of supplementation. It would also be more representative o f the 
population if  a wider selection of elderly subjects were included as subjects, 
rather than just relying on volunteers, given that it may be the case that 
performance improvements can only be expected in subjects who are already 
experiencing a certain degree o f cognitive decline.
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6 Chapter Six : The effects of repeated dosing 
with Ginkgo Biloba on aspects of cognitive 
function in a healthy elderly population.
6.1 Chapter outline
What is Ginkgo Biloba
The mechanism of action of Ginkgo Biloba
Cognitive enhancing and mood enhancing properties
The effects of GBE supplementation on attention in adult populations 
The effects of GBE supplementation on memory in adult populations 
The effects of GBE supplementation on the speed of information 
processing in adult populations
The effects of GBE supplementation on mood and well being in adult 
populations
The effects of long term supplementation with GBE on cognitive function in a 
healthy elderly population.
The effects of Ginkgo Biloba on attention
The effects of Ginkgo Biloba on memory recall
The effects of Ginkgo Biloba on the speed of naming
The effects of Ginkgo Biloba on the speed of information processing
The effects of Ginkgo Biloba on recognition memory
The effects of Ginkgo Biloba on subjective ratings of ADL
This chapter reviews the literature in which elderly subjects were treated with 
ginkgo biloba and reports an original study which investigated the effects of 
repeated dosing of ginkgo biloba 100 mg daily on aspects of cognition 
(attention, memory recall, speed of information processing, speed of naming, 
and recognition memory) in a sample of 16 healthy elderly volunteers.
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6.2 Introduction: Ginkgo Biloba
There are a number of compounds that have been implicated as possible 
enhancers o f human cognition, the actions of which either aim to improve 
cerebral blood flow or increase oxygen and glucose availability for the brain.
The Chinese herbal remedy Ginkgo Biloba Extract (GBE) is a potential 
cognitive enhancing drug, improving aspects o f memory and cognition, 
particularly in elderly samples (Israel, Dell’Accio, Martin and Hugonot (1987); 
Dieli, La Mantia, Saetta and Constanzo, (1981); Taillandier, Ammar, 
Rabourdin, Ribeyre, Pichon, Niddam, and Pierart, (1986); Weibrecht and 
Jansen, (1986); Wesnes, Simmons, Rook, and Simpson, (1987); Franco, Cuny 
and Nancy (1991); Rai, Shovlin, and Wesnes , (1991); Le Bars, Katz, Berman, 
Itil, Freedman and Schatzberg (1997) and Maurer, Ihl, Dierks and Frolich 
(1997).
Ginkgo biloba is one of the most widely used natural products o f plant origin 
(Beyreuther, 1991). The tree is regarded as a living fossil, it has been on earth 
for approximately 200, 000, 000 years, has probably existed longer than any 
other tree (Nakanishi, 1988). Treatment with GBE can be traced back to the 
origins o f Chinese herbal medicine approximately 5000 years ago, in the past 
GBE was used to treat bronchitis and asthma. Treatment with the leaves and the 
fruit o f the tree are still recommended for diseases o f the heart and lungs (Chang 
and But, 1987).
Extracts of GBE were introduced into medical practice some 30 years ago, 
where it was used to treat disturbances in cerebral and peripheral blood flow 
(Ambrosi and Bourde, 1975; Courbier, Jauasseran and Reggi, 1977; Bauer, 
1984, Bemdt and Kramer, 1987; Deihm, Heinrich and Mori, 1990). The first 
GBE was registered by German physician-pharmacist Dr Willmar Schwabe in 
1965. GBE has been prescribed as a drug in France for over 20 years. GBE is 
also accepted as a drug in a number o f countries e.g. Germany, Spain,
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Switzerland, Luxembourg, Greece, Italy and Ireland. In the UK GBE is 
considered as a food supplement and hence is readily available over the counter 
in pharmacists, health food stores and supermarkets.
6.3 What is Ginkgo Biloba
GBE contains many different substances including flavonoids, 
proanthocyanidines, ginkgolides and biobalide. The protective effects of GBE 
are probably due to the main constituents the flavonoids (e.g. ginkgo flavone 
glycosides) and the terpeniods (ginkgolides). Ginkgolide B is one of the 
ginkgolides present in the extract (others are ginkgolide A, B, C and J). 
Metabolites o f the ginkgo biloba extract have been found to cross the blood 
brain barrier, when radio-labelled GBE was given to rats traces of the 
compound were found in a number of organs including the brain. Seventy two 
hours post dose the highest concentration o f GBE was found in the 
hypothalamus, striatum and hippocampus (Moreau, Eck, McCabe and Skinner, 
1988).
6.4 The possible mechanisms of action
The pharmacological action o f GBE is often described as ‘polyvalent’, the 
major mechanisms include ‘vaso’ and ‘tissue protective’ and ‘cognitive 
enhancing’ including mood elevating action which makes it beneficial in the 
treatment o f elderly patients suffering from senile dementia. It was first thought 
that the mechanism of action of GBE was via vasoregulation, however, as 
research continued other possible mechanisms o f action have been proposed, 
such as antioxidant properties trapping free radicals therefore protecting cells 
from damage, more recently GBE has been shown to act upon cerebral 
plasticity (Lacour, Ez-Zaher and Raymond, 1991).
GBE has been shown to protect cells by acting as a scavenger of free radicals 
(Pincemail and Deby, 1986) that prevents peroxidation o f membrane lipids by
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oxygen free radicals (Dorman, Cote and Buck, 1992), ginkgolide B has been 
shown to have a protective effect against brain ischemia, this effect might be 
due to an effect on cerebral blood flow and/or brain glucose utilisation. The 
neuroprotective effect o f ginkgolide B due to the specific platelet-activating 
factor receptor antagonist activity. Krieglstein, Beck and Seibert (1986) found 
that the drug increases cerebral blood flow without reducing metabolic demand, 
this was ascertained by giving intravenous injections o f GBE (130 mg/kg) to 
rats 20 minutes before deoxyglucose administration, this had the effect of 
increasing cerebral blood flow by 50-100 % but had no effect on brain glucose 
utilisation. A drug/compound with such a profile would be useful in the 
treatment o f brain ischemia.
Originally it was thought that the mechanism of action was that, GBE was a 
triple vasoregulator, modulating capacity in arteries, veins and capillaries, 
enabling them to dilate or constrict depending on the disease state.
Several mechanisms contribute to the drugs vaso and tissue protective action, 
GBE can act on arterial, venous and capillary components o f the vascular 
system, as well as on formed elements o f the blood. GBE also has anti­
thrombotic, anti-ischaemic and anti-edema properties, the combined action of 
all mechanisms appear to be responsible for the vasoregulatory action of GBE. 
It is postulated that the flavonoids are responsible for GBE ability to relax 
contracted blood vessels.
6.5 Cognitive enhancing and mood enhancing 
properties
The cognition enhancing properties o f GBE appear to be related to a number of 
actions e.g. the anti- ischaemic and anti-edema properties, free radical 
scavenging and enzyme inhibitor activities o f its flavonoid constituents might 
be involved. The cognitive enhancing properties may be due to GBE 
involvement in inhibition of biogenic amine uptake (Auguet, De Feudis and
2 2 1
Clostre, 1982). GBE has also been shown to have a tyramin-like effect, 
releasing noradrenaline. It is possible that certain phenolic compounds (either 
present in GBE or formed after its administration in the intact animal) enhance 
the release o f catecholamines and other important neurotransmitters such as 
acetylcholine from nerve terminals in the brain and it is this mechanism that is 
responsible for the mood enhancing properties of GBE.
Another mechanism that could be responsible for the cognitive enhancing action 
of GBE would be the inhibition of enzymes in particular catechol-0- methyl 
transferase and monoamine oxidase (MAO) by its flavonoid constituents, 
inhibition of the enzymes leads to increases in catecholamines in synaptic clefts. 
The mood elevating effects could be due to protease-inhibitors that GBE 
contain, e.g. Captopril a protease-inhibitor has been shown to improve mood in 
depressed patients (Zubenko and Nixon, 1984). The protease-inhibitor in GBE 
would probably be due to its flavonoid constituents.
Ginkgo Biloba also appears to affect the cholinergic system, by enhancing the 
density of cholinergic muscarinic receptors (Taylor, 1985). GBE has been 
shown to increase glucose consumption in ischaemic areas in both human and 
animal brains (Rapin and Le Poncin Laffitte, 1979); and increase muscarinic 
receptor population in the hippocampus of the aged rat (Taylor, 1986).
Ginkgo biloba is also thought to possess anti-edema and anti-iscahemic 
properties, these are probably due to the actions o f the flavonol glycosides and 
bilobalide.
Studies have assessed the pharmacokinetics o f ginkgo biloba, to determine the 
peak plasma levels and elimination half life o f the compound from the body. 
Wojcicki, Gawro ska-Szklarz, Bieganowski, Patalan, Smulski, Samachowiec 
and Zakrzewski (1995) assessed the pharmacokinetics and bioavailability o f 3 
different formulations of ginkgo biloba (capsule, drops and tablet formats).
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Eighteen healthy subjects aged 18-45 years (mean age 30 years) received the 
three formulations, and blood samples were taken at baseline and after 0.5, 1.0, 
1.5, 2.0, 2.5, 3.0, 4.0, 6.0, 8.0, 12.0 and 24 hours post dose. It was reported that 
peak plasma levels for all formulations appeared approximately 3 hours post 
dose, the drug was rapidly eliminated, and was totally eliminated after 24 hours. 
The drug has a short elimination half life of 2.84 hours and total body clearance 
was achieved after 44.72 hours.
A number of researchers have examined the effects o f ginkgo biloba on aspects 
of cognitive function in healthy adult, elderly and patient populations to assess 
the effects of supplementation on aspects o f attention, memory, the speed of 
information processing and mood.
6.6 The effects of GBE supplementation on attention 
in adult populations
There have been no clinical studies examining the effect o f ginkgo biloba on 
aspects o f attention in healthy elderly subjects. However there have been studies 
in which the effects o f ginkgo have been observed on tasks assessing attention 
in patient populations.
Weibrecht and Jansen (1986) assessed the effect o f ginkgo biloba (120 mg) 
compared with placebo on the digit symbol substitution task (DSST) in 40 
patients with mild to moderate primary degenerative dementia aged 60-80 years 
taken for 3 months. Performance was assessed at baseline, and after 4, 8 and 12 
weeks. It was reported that scores on the DSST in the ginkgo biloba treated 
group increased significantly.
Wesnes, Simmons, Rook and Simpson (1987) assessed the effects o f ginkgo 
biloba on cognitive performance in 44 elderly patients aged 62-85 years. 
Patients were showing mild signs of cognitive impairment as assessed using the 
Crichton Geriatric behavioural rating scale. Patients were treated with ginkgo
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biloba (120 mg) or placebo for 12 weeks. Performance was assessed using the 
DSST and a number matching task at baseline and after 4, 8 and 12 weeks. It 
was reported that there was a non significant trend towards improvement on the 
DSST in the GBE condition during week 12. Following treatment with GBE 
subjects made significantly more correct responses on the number matching task 
after 8 and 12 weeks.
Maurer, Ihl, Dierks and Frolich (1997) assessed the effects o f GBE on 
performance o f the Syndrom Kurtz Task (SKT) and a trail making task in 20 
patients with Alzheimer's disease. Patients were treated with GBE 240 mg or 
placebo for a period o f 3 months. It was reported that following treatment the 
GBE treated group showed a significant improvement on total SKT scores 
(scores fell from 19.67 to 16.78 after 12 weeks) and a non significant trend 
towards improvement on the trail making task.
Kanowski, Herrmann, Stephan, Wierich and Hbrr (1995) assessed performance 
using the SKT task in a sample o f 216 elderly patients with a mean age of 69.5 
years. All patients had a diagnosis o f presenile or senile dementia o f the 
Alzheimer type. Patients were treated with GBE 240 mg or placebo for 2 years. 
Cognitive function was assessed using the SKT task, it was reported that 
following treatment 38% of the GBE group and 18% o f the placebo treated 
group showed overall improvements (of greater than 4 points) on the task.
The results of both Maurer et al. (1997) and Kanowski et al. (1995) are 
interesting, however as the SKT task incorporates tasks o f attention and 
memory, it is not possible to determine whether the beneficial effects were 
observed on tasks of attention or whether the improvements were primarily on 
the memory tasks alone, without separate analyses o f the subtests, then it is not 
possible to determine the specific effects.
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6.6.1 Sum m ary
To date there have been no reported studies examining the effect of ginkgo 
biloba on attention in healthy adult subjects. However there have been a number 
of studies examining the role of ginkgo biloba on aspects of attention in elderly 
patient populations.
A number of researchers have examined the effects o f GBE on aspects of  
attention in patient populations. The results o f which appear somewhat 
inconclusive. Treatment with GBE has resulted in a number o f non significant 
trends towards improvement (Wesnes et al., 1987; Maurer et al., 1997 and 
Weibrecaht and Jansen, 1986) and significant effects on the SKT task (Maurer 
et al., 1997; Kanowski et al., 1997), the number matching task (Wesnes et al., 
1987) and the trail making task (Maurer et al., 1997).
In general beneficial effects have only been observed when patients have been 
supplemented with large daily doses o f GBE 240 mg (Maurer et al, 1997; 
Kanowski et al., 1997).
Based on these rather limited effects, and the fact that in the present study 
healthy subjects will only receive 100 mg daily for 8 weeks, supplementation 
with ginkgo biloba would probably have no effect on the performance of tasks 
assessing attention.
A 100 mg daily dose was selected as the study was designed to assess the 
cognitive enhancing effect of ginkgo biloba in the "real world", hence the 
recommended daily dose was selected.
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6.7 The effects of GBE supplementation on memory in 
adult populations
There have been no studies examining the effects o f ginkgo biloba on memory 
in healthy elderly subjects, although there have been a number of studies 
examining the effect of ginkgo biloba treatment on memory in healthy adult 
populations in patients with senile dementia of the Alzheimer type (SDAT).
Subhan and Hindmarch (1984) assessed the impact of acute dosing of ginkgo 
biloba (120, 240 and 600 mg) on cognitive performance in a sample of 8 
healthy female volunteers aged 25-40 years (mean age 32 years). Performance 
was assessed using the HPRU version of the Sternberg memory task (subjects 
were required to remember digit strings containing 4, 5 and 6 digits, the number 
of correct and incorrect responses were recorded as was reaction time to the 
stimuli) performance was assessed 1 hour post dose. It was found that reaction 
time on the Sternberg memory task was significantly reduced following a single 
600 mg dose of ginkgo biloba. There were no effects reported on the Sternberg 
memory task with either the 120 mg or 240 mg dose.
Parkin, Dawe and Hindmarch (1995) produced a drug-induced cognitive deficit 
in healthy volunteers. Prior to dosing with either GBE or placebo subjects were 
given a single 1 mg dose of flunitrazepam to induce a short term memory 
deficit. The aim of the study was to determine whether a single 600 mg acute 
dose of GBE would prevent a benzodiazepine induced memory impairment.
10 healthy female volunteers aged between 25 and 40 years (mean age 36.2 
years), received an acute 600 mg dose o f GBE and completed the HPRU 
version of the Sternberg memory task (subjects had to memorise memory sets, 
containing 1, 2 and 3 digits) and a word recognition task (much the same as the 
Sternberg memory task, a recognition and response time task for words, 
subjects were required to memorise a list o f 14 words, and had to recognise the 
14 words). Assessments were made at baseline, 1, 2, 4, and 6 hours post dose.
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There were no significant differences reported between GBE and placebo on the 
tasks. It was possible that the deficit induced was too great therefore the 
experiment was repeated using a lower dose of flunitrazepam (0.5 mg). 
Psychometric assessments were made at baseline, 1.5, 3, 4 and 6 hours. There 
were no significant differences between the treatments (GBE/flunitrazepam, and 
placebo/flunitrazepam) on performance o f the Sternberg memory task or the 
word recognition task.
Dawe, Kerr, Yoon and Hindmarch (1995) conducted a pilot study examining 
the effect o f GBE on cognitive and psychomotor function in a sample of young 
healthy volunteers. Eleven young volunteers (mean age 28.6 years) received 
200 mg GBE and placebo daily for a period o f 14 days, in a randomised cross 
over fashion. Psychometric tests were completed at baseline, day 7 and 14, 
performance was assessed using the HPRU Sternberg memory task (subjects 
had to memorise memory sets, containing 1, 3 and 5 digits), and a picture 
memory task (subjects were shown 12 pictures o f objects for a 30 second 
period, they were required to give immediate recall o f the pictures, delayed 
recall 10 minutes later and recognition some 20 minutes later). In the HPRU 
Sternberg memory task an interaction o f drug and visit that approached 
significance was observed (p = 0.051) the interaction resulted in improvements 
over the visits with GBE compared to placebo. There were no effects o f GBE 
on the picture memory task.
Warot, Lacomblez, Danjou, Weiller, Payan and Puech (1991) investigated the 
effects of GBE on memory function in a sample o f 12 healthy female volunteers 
(aged 19-30 mean age 22.3 years). Subjects were randomly allocated to a single 
dose o f GBE 600 mg or placebo. Memory tests including recognition of 
numbers task (a Sternberg memory task subject had to remember 40 sequences 
of number sets containing 4, 5 or 6 stimuli), free recall and recognition of 
images (subjects were shown 40 items, 20 of which they had previously seen), 
subjects had to provide immediate recall and recognition after 30 minutes).
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There were no significant differences observed between the treatments with 
regard the Sternberg Memory Task or the picture recognition task. It was 
reported that treatment with GBE resulted in a stabilising o f free recall of 
images, whereas performance in the placebo condition declined.
Allain, Raoul, Lieury, LeCoz, Gandon and d'Arbigny (1993) assessed the 
effects of 2 doses o f GBE (320 mg and 600 mg) compared to placebo in a 
sample o f 18 healthy elderly subjects aged 60-80 years (69.3 years). 
Performance was assessed using a dual coding task in which subjects had to 
process and recall pictures of drawings and words, which were presented at a 
rate o f 1920 ms through to 120 ms. It was reported that following treatment 
with both doses o f GBE, there was a significant improvement in performance.
Israel, Dell'accio, Martin and Hugonot (1987) assessed the effects o f GBE on 
memory performance in a sample o f 80 geriatric patients (aged 56-83 years, 
mean age 68.4 years). Subjects were randomly allocated to one o f four 
conditions (placebo, placebo plus memory training, GBE 160 mg, or GBE 160 
mg plus memory training exercises). Patients were treated for 3 months. 
Memory was assessed using measures o f short term memory and general 
memory recall. Significant improvements in short term memory were observed. 
There was also a non significant improvement in general recall. The greatest 
improvements were noted in the GBE plus mental exercise condition.
Rai, Shovlin and Wesnes (1991) conducted a double-blind placebo controlled 
study in 31 patients aged 54-89 years presenting mild to moderate memory 
impairment as defined by the NINCDS-ADRDA standard classification. 
Patients received a 120 mg daily does o f GBE for 6 months. Performance was 
assessed using a digit recall task. Assessments were made at baseline, week 12 
and week 24. It was reported that GBE treatment had no effect on the task.
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Wesnes, Simmons, Rook and Simpson (1987) assessed the effect of GBE on 
memory performance in 44 elderly patients aged 62-85 years experiencing mild 
cognitive impairment. Cognitive performance was assessed using the digit span 
task, immediate word recall and recognition o f 10 words. Patients were treated 
with GBE 120 mg or placebo for 12 weeks. Assessments were made at baseline, 
week 4, 8 and 12. It was reported that following treatment with GBE, responses 
on the word recognition task were significantly improved. There was a non 
significant trend towards improvement on the backward digit span during week 
eight.
Weibrecht and Jansen (1985) assessed the effects o f GBE 120 mg daily for 12 
weeks in elderly patients with primary degenerative Dementia. Memory was 
assessed using the digit span task. Performance was assessed at baseline and 
after 4, 8 and 12 weeks. It was reported that digit span was significantly 
improved after 12 weeks of treatment.
Augustin (1979) assessed the effects o f treatment with GBE on memory 
function in a sample of 189 elderly patients. Patients were randomly allocated to 
treatment with GBE 120 mg or placebo for 6 months. Memory was assessed 
using the digit span task, Rey learning task and the Benton Visual retention 
task. It was reported that following treatment with GBE, 61.6% of patients 
showed significant improvements on the tasks compared to 28% o f the placebo 
group.
Maurer, Ihl, Dierks and Fr lich (1997) assessed the effects o f GBE on 
performance o f the SKT task in 20 patients wit Alzheimer’s disease. Patients 
were treated with GBE 240 mg or placebo for a period of 3 months. It was 
reported that following treatment the GBE treated group showed a significant 
improvement on total SKT scores (scores fell from 19.67 to 16.78 after 12 
weeks).
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Similar results were observed by Kanowski et al. (1996) in the study 216 
elderly patients with a mean age o f 69.5 years. All patients had a diagnosis of 
presenile or senile dementia o f the Alzheimer type. Patients were treated with 
GBE 240 mg or placebo for 2 years. Cognitive function was assessed using the 
SKT task, it was reported that following treatment 38% of the GBE group and 
18% of the placebo treated group showed overall improvements (of greater than 
4 points) on the task. These results of these two experiments are interesting, 
however as the SKT task incorporates subtests assessing aspects o f attention as 
well as memory, it is not possible to determine whether the beneficial effects of 
GBE were limited to tasks of memory, attention or whether they are a 
combination o f improvements on both types o f task.
6.7.1 Summary
A number o f studies have examined the effects o f GBE on memory 
performance in healthy adult populations. The results o f which have proved 
fairly inconclusive. In young healthy adults Subhan and Hindmarch (1984) 
reported that an acute 600 mg dose of GBE significantly improved reaction time 
on the Sternberg Memory Task (SMT). This effect was reported as an effect on 
memory, however it is probably an effect on the speed o f information 
processing rather than an effect on memory.
Other researchers examining the effects of GBE supplementation on memory 
performance in healthy adult populations have noted a trend towards 
improvement on the SMT (Parkin and Dawe, 1995; Dawe et al., 1995), and on 
free recall of images (Warot et al., 1991).
It was reported that GBE had no effects on a word recognition task (Parkin and 
Dawe, 1995), a number recognition task (Warot et a l , 1991), immediate recall, 
delayed recall and recognition o f pictures (Dawe et al., 1995). Based on these 
findings, it seems conclusive that GBE has very little effect on memory function 
in healthy adult populations.
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In terms o f patient populations, there have been a number o f researchers who 
have examined the effects o f ginkgo biloba on memory function. The results of 
which seem to indicate that in some patient populations treatment with GBE has 
resulted in a number o f memory improvements. Significant improvements have 
been noted on a recall o f words and pictures task following doses o f 320 mg and 
600 mg (Allain et al., 1993), general memory recall following 120 mg dose for 
3 weeks (Wesnes et al., 1987) and the digit span following 120 mg daily dose 
for 12 weeks (Weibrecht and Jansen, 1985).
Based on the above findings, it is possible that treatment with GBE 100 mg in 
healthy subjects would result in some performance improvements.
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6.8 The effects of GBE supplementation on
information processing in adult populations
There have been no studies examining the effects o f ginkgo biloba on the speed 
of information processing in healthy elderly subjects, however there have been a 
number o f studies examining the effect of ginkgo biloba treatment on the speed 
of information processing in healthy adult populations and in patients 
populations.
Subhan and Hindmarch (1984) assessed the impact o f acute dosing of ginkgo 
biloba (120, 240 and 600 mg) on cognitive performance in a sample of eight 
healthy female volunteers aged 25-40 years (mean age 32 years). Performance 
was assessed using the Critical Flicker Fusion task (CFF) and the Choice 
Reaction Time task (CRT) performance was assessed after one hour post dose. 
Ginkgo biloba had no effect on performance o f the tasks.
Parkin and Dawe (1995) produced a drug-induced cognitive deficit in healthy 
volunteers. Prior to dosing with either GBE or placebo subjects were given a 
single 1 mg dose o f flunitrazepam to produce a benzodiazepine-induced short 
term memory deficit. The aim of the study was to determine whether a single 
600 mg acute dose o f GBE would prevent a benzodiazepine induced memory 
impairment, that in turn would affect other aspects o f cognitive functioning, i.e. 
the speed of information processing. Ten healthy female volunteers aged 
between 25 and 40 years (mean age 36.2 years) were treated with a single 600 
mg dose o f GBE or placebo followed 5 minutes later by a single 1 mg dose of 
flunitrazepam. Cognitive performance was assessed using the Critical Flicker 
Fusion task (CFF) and the Choice Reaction Time task (CRT). Assessments were 
made at baseline, 1, 2, 4, and 6 hours post dose. There were no significant 
differences reported between GBE and placebo on the CFF or CRT tasks. The 
results of this experiments showed that a deficit was induced by the 
flunitrazepam, however the impairment produced was too great to be alleviated 
by a single 600 mg dose of GBE. Therefore a second study was performed
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using a lower dose of flunitrazepam to induce impairment. In the second 
experiment the same methods and techniques from experiment 1 were used in 
experiment 2, except the dose o f flunitrazepam was reduced to 0.5 mg, and 
psychometric assessments were made at baseline, 1.5, 3, 4 and 6 hours. There 
were no significant differences between the treatments (GBE/flunitrazepam, and 
placebo/flunitrazepam).
Dawe, Kerr, Yoon and Hindmarch (1995) conducted a pilot study examining 
the effect o f GBE on cognitive and psychomotor function in a sample o f young 
healthy volunteers. Eleven young volunteers (mean age 28.6 years) received 
200 mg GBE and placebo daily for a period of 14 days, in a randomised cross 
over fashion. Psychometric tests were completed at baseline, day 7 and 14. The 
psychometric assessment included Critical Flicker Fusion task (CFF) and the 
Choice Reaction Time task (CRT). It was reported that GBE had no effect on 
CFF thresholds, but recognition reaction time was improved following 
treatment with GBE.
Warot, Lacomblez, Danjou, Weiller, Payan and Puech (1991) investigated the 
effects o f GBE on memory function in a sample o f 12 healthy female subjects 
(aged 19-30 mean age 22.3 years). Subjects received 600 mg acute dose and 
performance was assessed one hour post dose. Performance was assessed using 
Critical Flicker Fusion (CFF), Choice Reaction Time (CRT). It was reported 
that GBE had no effect on performance o f the CFF or CRT.
Weibrecht and Jansen (1986) assessed the effects o f GBE 120 mg compared to 
placebo on the speed of information processing in patients with mild to 
moderate dementia. Patients aged 60-80 years, (mean age 71.7 years) received 
GBE 120 mg or placebo for 3 months. Performance was assessed using the 
Critical Flicker Fusion task and the Choice Reaction Time task, at baseline, 
week 4, 8 and 12. It was reported that following treatment with ginkgo biloba, 
CFF thresholds increased significantly, and Choice Reaction Times decreased
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significantly, both effects were indicative o f an improvement in the speed of 
information processing.
Wesnes et al. (1987) assessed the effect of 120 mg o f GBE on performance on a 
choice reaction time task in 44 elderly patients exhibiting signs o f cognitive 
decline. Patients were treated with GBE (120 mg) or placebo for 12 weeks. 
Performance was assessed using a Choice Reaction Time task at baseline and 
weeks 4, 8 and 12. It was reported that after 12 weeks o f treatment the GBE 
group had significantly faster reaction times compared to placebo.
6.8.1 Sum m ary
The results o f these experiments would seem to indicate that ginkgo biloba has 
no effect on tasks assessing the speed of information processing in healthy adult 
populations, assessed using the Critical Flicker Fusion and Choice Reaction 
Time tasks (Subhan and Hindmarch, 1984; Parkin and Dawe, 1995; Warot et 
al, 1991).
In the Dawe et al (1995) study, following a daily dose o f ginkgo biloba (200 
mg) for 14 days, improvements in recognition reaction time were observed. 
These effects are possibly not an effect on the speed o f information processing 
but rather an effect on attention or memory, as recognition reaction time 
represents the attentional aspect of the choice reaction time task, and also 
represents the "what do I do" part of the task which relies on memory.
In patient populations it appears that gingko biloba does have beneficial effects 
on the speed of information processing, Weibrecht and Jansen (1986) reported 
that following 120 mg daily dose for 3 months Critical Flicker Fusion 
thresholds in patients with mild to moderate dementia improved and reaction 
times were decreased. Wesnes et al (1987) also reported that following 120 mg 
daily dose for 3 months, reaction times were significantly decreased in patients 
with mild cognitive impairment.
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Based on these findings, it is possible that slight improvements in the speed of 
information processing would be noted in healthy elderly.
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6.9 The effects of GBE supplementation on mood and 
well being in adult populations
There have been no studies examining the effects o f ginkgo biloba on mood and 
general well being in healthy elderly subjects, however there have been a number 
studies examining the effect of ginkgo biloba treatment on mood and general 
wellbeing in healthy young and elderly patient populations.
Subhan and Hindmarch (1984) assessed the impact of acute dosing of ginkgo 
biloba (120, 240 and 600 mg) on cognitive performance in a sample of 8 healthy 
female volunteers aged 25-40 years (mean age 32 years). Subjective mood was 
assessed using line analogue rating scale (LARS) 1 hour post dose. It was reported 
that GBE had no effect on the mood variables.
Parkin and Dawe (1995) induced a benzodiazepine cognitive deficit in healthy 
volunteers with a 1 mg dose of flunitrazepam. Five minutes following the dose, 
subjects received a 600 mg dose o f GBE or placebo. The aim of the study was to 
determine whether a single 600 mg acute dose o f GBE would prevent a 
benzodiazepine induced impairment, and whether this would in turn produce 
changes in mood. Mood was assessed in 10 healthy female volunteers aged 
between 25 and 40 years (mean age 36.2 years) using line analogue rating scale 
(LARS). The LARS assess tiredness, drowsiness and alertness. Assessments were 
made at baseline, 1, 2, 4, and 6 hours post dose. There were no significant 
differences reported between GBE and placebo on any o f the subjective measures. 
The deficit induced by the 1 mg dose of flunitrazepam was too great therefore a 
second experiment was conducted using a lower dose. The second experiment used 
the same methods and techniques from experiment 1, except the dose of 
flunitrazepam was reduced to 0.5 mg, and psychometric assessments were made at 
baseline, 1.5, 3, 4 and 6 hours. It was reported that there were no significant
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differences between the treatments (GBE/flunitrazepam, and 
placebo/flunitrazepam).
Warot et al (1991) investigated the effects of two types o f GBE on mood in a 
sample o f healthy female volunteers (aged 19-30 mean age 22.3 years). Mood was 
assessed using a visual analogue rating scale (VARS). It was reported that ginkgo 
biloba had no effect on variables o f mood.
Franco, Cuny and Nancy (1991) conducted a long term study examining the effects 
of GBE on subjective ratings, in 78 elderly persons aged 60-85 years. Subjects 
received 120 mg GBE daily for 12 months. All subjects were experiencing 
difficulties with the performance o f everyday life, subjective ratings were 
completed using the McNair self assessment scale o f cognitive deficits (CDS). The 
scale assessed cognitive disorders in terms of quality of life assessing components 
of attention, concentration, psychomotor co-ordination, orientation, short term and 
long term memory. It was reported that subjects who received GBE showed 
significant improvements of more than 11.6 points on the scale.
Taillandier, Ammar, Rabourdin, Ribeyre, Pichon, Niddam and Pierart (1989) 
conducted a study in 166 patients with cerebral insufficiency. Patients were 
randomly allocated to treatment with placebo or GBE 160 mg for a period o f 12 
months. Patients were assessed using the Geriatric Clinical Evaluation Scale 
(GCES) which is designed to assess intellectual function, memory, alertness, 
attention, mood, social insertion and neurosensorial disturbances. Assessments 
were made at baseline and after 3, 6, 9 and 12 months. It was reported that GBE 
treated patients, showed a significant improvement in GCES as early as 3 months, 
and the improvement continued throughout the duration o f the trial.
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Weibrecht and Jansen (1986) assessed the effect GBE on the Crichton Geriatric 
Rating Scale. Forty patients aged 60-80 years were randomly allocated to treatment 
with GBE 120 mg or placebo for 3 months. Assessments were made using the 
Crichton Rating Scale (which included 11 items assessing mobility, orientation, 
communication, co-operation, restlessness, dressing, feeding, continence, sleep and 
mood). Performance was also assessed using the Sandoz Clinical Assessment Scale 
(assessing confusion, mental alertness, impairment o f recent memory, 
disorientation, mood, depression, emotional liability, self care, anxiety, motivation, 
irritability, hostility, bothersome, indifference to surroundings, unsociability, 
uncoopertiveness, fatigue, appetite, dizziness and overall impression o f the patient). 
Assessments were made at baseline and after 4, 8 and 12 weeks. It was reported 
that following treatment with GBE after just 8 weeks, patients reported 
improvements in sleep, health score and general well being. Scores on the Sandoz 
Clinical Assessment Scale significantly decreased by week 8.
Wesnes et al. (1987) assessed a double blind study to investigate the effects of 
GBE 120 mg on the quality o f life o f 44 elderly patients aged 62-85 years. All 
patients showed signs o f cognitive impairment in their everyday function as 
assessed with the Crichton Geriatric rating Scale. Quality o f life was measured 
using a behaviour rating scale. The scale was completed at baseline and after 12 
weeks. It was reported that following 12 weeks o f treatment the GBE group 
showed increased interest taken in everyday activities.
Kanowski et al. (1996) assessed the effects o f GBE on ADL and Clinical Global 
Impression (CGI) in 216 elderly patients with SDAT (aged greater than 55 years). 
Patients were treated with GBE 240 mg for 2 years. Assessments were made using 
the Clinical Global Impression (CGI) and the Niimberger Alters-Beobachtungs- 
skala behavioural assessment of activities of daily living (ADL). It was reported 
that the CGI scores were significantly higher following treatment with GBE and
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there was a non significant trend towards improvement on the ADL following 
GBE.
Maurer et al. (1997) assessed the effect o f treatment with GBE on Alzheimer's 
disease progression. Twenty patients aged 50-80 years were treated with GBE 240 
mg or placebo for 3 months. Alzheimer's disease progression was assessed using 
the Alzheimer's Disease Assessment Scale (ADAS) and the Clinical Global 
Impression (CGI) at baseline and at monthly intervals. It was reported that 
treatment with GBE resulted in improvements in CGI scores. There was trend 
towards improvement on the ADAS in the GBE treated group, however this trend 
failed to reach statistical significance.
Vorberg (1985) assessed the effects of GBE treatment in patients with cerebral 
insufficiency. One hundred and twelve patients aged 55-94 years (mean age 70.5 
years) were treated with GBE 120 mg for 12 months. Subjects were required to self 
rate changes in mood and vigilance using a specially designed questionnaire. The 
questionnaire consisted of a four point scale for assessing memory (memory for 
order, occasional memory gaps concerning unimportant recent events, moderate 
memory gaps concerning unimportant recent events and occasional forgetfulness of 
important events or severe memory gaps concerning trivial and important events). 
Patients were also required to assess vigilance using a four point scale (normal 
alertness and vigilance, minor loss of imagination, concentration and speech, 
moderate loss o f imagination, concentration and response, or definite loss o f  
imagination and concentration). It was reported that following treatment with GBE 
disturbances in short term memory and vigilance underwent a significant 
improvement over the treatment period.
Le Bars, Katz, Berman, Itil, Freedman, and Schatzberg (1997) assessed the efficacy 
of GBE on subjective ratings in a sample o f 309 patients with Alzheimer's Disease
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or multi-infarct dementia. Patients were randomly assigned to treatment with GBE 
(120 mg daily) or placebo for a period of 12 months. Assessments were made at 
baseline and after 12, 26 and 52 weeks. Subjective ratings were made using the 
Alzheimer’s Disease Assessment Scale- Cognitive Subscale (ADAS-Cog), the 
Geriatric Evaluation by Relatives Rating Instrument (GERRI) and the Clinical 
Global Impression o f Change (CGI). It was reported that the Ginkgo treated group 
had a 1.4 point higher score on the ADAS-Cog and a 1.4 higher score on the 
GERRI than the placebo treated group. In real terms, this equated to 27% of the 
GBE treated group showing a 4 point improvement on the ADAS-Cog, compared 
to 14% in the placebo condition. 37% of the GBE treated group showed 
improvements on the GERRI compared to 23% of those treated with placebo. 
There were no differences between the 2 groups in terms o f scores on the CGI.
6.9.1 Sum m ary
The results o f these experiments would seem to indicate that ginkgo biloba has no 
effect on mood as assessed using line analogue rating scales, in healthy adult 
populations (Subhan and Hindmarch, 1984; Parkin and Dawe, 1995, Warot et al, 
1991).
In patient populations, there were beneficial effects on subjective ratings following 
treatment with GBE. Treatment with GBE 120 mg for 3 months resulted in 
improvements in sleep and general well being (Weibrecht and Jansen, 1986), 
increased interest in everyday activities expressed on the Crichton Geriatric Rating 
Scale (Wesnes et al., 1987), improvements on the Clinical Global Impressions 
(Maurer et al, 1997), McNair Self Assessment Scale (Franco et a l, 1991), 
Geriatric Clinical Evaluation Scale (Tailandier et a l, 1989), Sandoz Clinical 
Assessment Scale (Weibrecht and Jansen, 1986), Alzheimer's Disease Assessment 
Scale- Cognitive Subscale and the Geriatric Evaluation Rating Scale (LeBars et al,
244
1997) and improvements on the Activity of Daily Living Scale (Kanowski et al., 
1997).
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6.10 Conclusions
To date relatively few studies have been published on the effects o f ginkgo biloba 
extract on cognitive function in healthy elderly subjects. Of the studies that have 
been conducted, very few psychological tests have been utilised. In terms of the 
research to date, it would seem that GBE has little effect on cognitive function in 
healthy adult populations. The effects o f GBE on cognitive function in healthy 
elderly subjects who believe they are experiencing a certain degree o f cognitive 
decline is yet to be revealed. Health food stores in the UK, promote the use of 
ginkgo biloba stating that when used as a supplement ginkgo improves memory 
performance, however it would seem that there is little evidence to support such a 
claim.
6.11 Aims of the present study: Analysis of the effects of 
long term supplementation with Ginkgo Biloba on 
cognitive function in healthy elderly subjects
This experiment aimed to assess the impact o f the recommended daily dose of 
ginkgo biloba (100 mg) in healthy subjects experiencing a mild degree of 
forgetfulness. This study aimed to examine the actions o f GBE on cognitive 
function, the effects o f ginkgo biloba were examined on tasks assessing attention, 
memory recall, the speed o f information processing, speed o f naming, memory 
recall, and cognitive failures in everyday living.
In chapter 4 the effects of age on the tasks was determined on cognitive function in 
healthy drug free elderly subjects. It was reported that main effects o f age were 
reported on the speed of naming objects (SKT I), immediate recall o f objects (SKT 
II), arranging blocks (SKT IV), replacing blocks (SKT V), counting symbols (SKT 
VI), reverse naming (SKT VII) and delayed recall o f objects (SKT VIII).
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The primary aim of this experiment was to assess whether ginkgo biloba would 
help alleviate the age related decline reported on the tasks, as well as assess the 
effects on other memory tasks such as memory for faces, digit span forwards and 
backwards, shopping list task and the object task.
Based on previous research, it was postulated that treatment with GBE in healthy 
elderly subjects would result in improvements in some aspects o f attention, SKT 
VII (reverse naming task), memory,(the HPRU Sternberg memory task and the 
digit span task). Since Maurer et al. (1997) and Kanowski et al (1996) reported 
that treatment with GBE resulted in improvements on the SKT task in patient 
populations, it was questioned whether such improvements would be noted in 
healthy elderly subjects who believed they were experiencing mild cognitive 
decline.
6.12 Methods
6.12.1 Subjects
16 healthy community dwelling elderly subjects (7 males and 9 females) aged 
between 61 and 84 years (mean age 70.18 years) were enrolled in the study. All 
were in physical and mental good health, and were not taking any concomitant 
treatments that would interfere with the test measures. Subjects were recruited from 
the general public via the HPRU database and poster advertisements, all believed 
that they were experiencing problems with their memory functioning.
6.12.2 Treatm ents
The treatments comprised ginkgo biloba 100 mg and placebo, each were taken for a 
period of 8 weeks with a 4 week washout period between treatments. Double-blind 
crossover design was employed therefore subject received both treatments.
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Treatments were administered orally as 1 tablet taken once a day (with breakfast), 
the tablets were identically packaged in blister packs.
6.12.3 Procedure
Prior to participation in the study, subjects were familiarised and trained on all 
psychometric tests, 12 test sessions took place (at baseline, week 2, 4, 6, 7 and 8 for 
each treatment).
Subjects attended the unit at the same time o f day for each o f the test sessions. 
They performed all assessments. Testing took approximately 45 minutes. Tablets 
were dispensed to patients at the baseline visit, and they returned any unused 
tablets after the 8 week period, and were used as a measure o f compliance.
6.12.4 A ssessm en ts
Assessments were made on a regular basis, subjects were assessed on days 1 
(baseline), 14 (week 2), 28 (week 4), 42 (week 6), 49 (week 7) and 56 (week 8). 
Assessments included CFF, CRT, HPRU Sternberg Memory Task (which were 
completed at each visit) SKT and MMT (were completed on alternate visits) and an 
activity o f daily living scale (ADL) which was completed at the beginning and end 
of each treatment.
The psychometric tasks completed by the subjects assessed attention (SKT IV, V, 
VI, VII and SMT); memory (SKT II, VIII, shopping list task, shopping list 
recognition task, object memory task, object recognition task, memory for faces 
task, digit span task); speed of information processing (CFF, CRT); and speed of 
naming (SKT I, III). The study also assessed self reporting o f cognitive failure, 
with an activity of daily living scale (ADL). Table five summarises the testing 
schedule.
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Table 71: Summarising the assessment test schedule at each visit.
Baseline W eek 2 W eek 4 W eek 6 W eek 7 W eek 8
Critical Flicker Fusion * * * * * *
Choice Reaction Time * * * * * *
HPRU Sternberg Memory 
Task
* * * * * *
Syndrom Kurtz Task * * *
Shopping List Task * * *
Object Memory * * *
Facial Memory * * *
Digit Span * * *
Activity o f  Daily Living * *
6.12.5 Critical Flicker Fusion Task (CFF)
The critical flicker fusion task (CFF) is regarded as an index of overall CNS 
activity, the ability of the central nervous system to process discrete 'bits' of 
information. Therefore an increase in CFF thresholds is associated with increased 
alertness and a greater capacity for information processing.
6.12.6 Choice Reaction Time (CRT)
The choice reaction time task (CRT) is used as an indicator o f sensorimotor 
performance, assessing the efficiency o f the attentional and response mechanisms 
in the information processing chain. The task is comprised o f three components 
recognition reaction time (RRT), motor reaction time (MRT) and total reaction 
time (TRT).
6.12.7 HPRU Sternberg Memory Task (SMT)
The HPRU Sternberg memory task is a technique based upon a reaction time 
method where subjects are required to memorise a set o f target digits. In the 
original Sternberg memory task, the ability to scan the memory set was assessed by 
getting subjects to attend to a series of digits, then presenting one digit and asking 
the subjects whether that digit was in the original memory set. In the HPRU version
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of the task, memory scanning ability is assessed with the presentation o f 12 single 
probe digits.
6.12.8 The Syndrom Kurtz Task (SKT)
The SKT task is comprised of 9 subtasks assessing aspects o f attention (SKT 
Rearranging blocks), SKT V (replacing blocks), SKT VI (counting symbols), VII 
(reverse naming)), memory (SKT II (immediate recall) SKT VIII delayed recall) 
and SKT IX (recognition memory)) and the speed o f naming (SKT I (object 
naming), SKT III (numerical naming)).
6.12.9 Milford Object memory task
In the task, subjects are required to memorise 12 photographs o f objects e.g. a car, 
tree, iron and mug etc. (items are presented one item per page). After the subjects 
have seen and named all 12 items they are asked to recall as many o f the 12 items 
as possible.
6.12.10 Milford Object recognition task
In the recognition task, subjects are then required to complete a forced choice task, 
in which they have to recognise the original photograph o f the object from a set of  
24 photographs. The items are presented 2 per page. For example using the above 
example, the subjects would be presented with a photograph o f a car and a train, the 
subject is required to say that the car was in the booklet and the train was not.
6.12.11 Milford Shopping list task
In the shopping list task, subjects are shown a shopping list containing 12 shopping 
items, e.g. sausages, cabbage, toothpaste, lemons, gravy etc. (items are presented 
one item per page). After the subjects have seen and named all 12 items are asked 
to recall as many of the 12 items as possible.
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6.12.12 Milford Shopping list recognition task
The subjects are then required to complete a forced choice task. In this task subjects 
are presented with 24 shopping items, the 12 original shopping items plus 12 
distractor items). The items are presented 2 per page (an original picture and a 
distractor), the subject is required to identify which of the 2 shopping items were on 
their original shopping list. For example using the above shopping list as an 
example, the subjects would be presented with the words sausages or beefburgers, 
the subject is required to say that sausages were on their list and not beefburgers.
6.12.13 Milford Memory For Faces Task
In this task, subjects are presented with named photographs o f faces, the subjects 
are required to memorise the name and face, Subjects are required to memorise sets 
of one, three, five and seven faces.
6.12.14 Milford Digit Span task
Subjects are aurally presented with a series o f numbers (increasing in length form 3 
digits through to 9 digits). Subjects are required to repeat the digit sequence. 
Subjects were only given one chance to correctly repeat the sequence, if  they failed 
to repeat the correct sequence, the task was abandoned. Subjects had to repeat the 
sequence o f digits in the order in which they heard them, starting with 3 digits, 
increasing by 1 digit at a time until the subject failed to repeat the correct sequence, 
or to the end o f the task when the subjects had recalled all 9 digits.
In the second part o f the task, subjects had to repeat a sequence o f digits in reverse 
order. Again subjects were first presented with 3 digits to recall in reverse order 
increasing by 1 digit at a time until the subject failed to repeat the correct sequence, 
or to the end of the task when the subjects had recalled all 9 digits.
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This version o f the digit span was a little different from the standard method 
employed in the Wechsler scale where subjects have 2 attempts in which to 
correctly recall the digit strings.
6.13 Results
The data were analysed using a 2 way analysis o f variance with treatment and visit 
as within subject factors. The performance data were analysed in terms of the 
cognitive groupings that were identified in chapter 4. The groupings included:-
1. Attention ( HPRU Sternberg memory Task, SKT subtests IV, V, VI, and VII).
2. Memory recall (SKT subtest II, VIII, shopping list task, object recall, memory 
for faces task, digit span forward, digit span backward).
3. Speed o f naming (SKT subtest I and III)
4. Speed o f information processing (CFF, TRT, RRT and MRT).
5. Recognition memory (SKT subtest IX, shopping list forced choice task, objects 
forced choice task).
The study also examined the effect o f ginkgo biloba supplementation on an 
Activities of Daily Living (ADL).
6.14 The effect of Ginkgo Biloba on aspects of attention
In chapter 4 the effects o f ageing on tasks that assessed attention were examined, it 
was concluded that there was a main effect of age, as age increases performance on 
orientation tasks declined. The purpose o f this experiment was to assess the effects 
of GBE supplementation on attention tasks. In chapter 4 a number o f tasks were 
classed as assessing attention they included SKT subtests IV, V, VI, VII and the 
HPRU Sternberg Memory Task.
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6.14.1 SKT su b te s t IV (arranging blocks)
In this tasks, subjects were presented with 10 numbered blocks, they were required 
to place the blocks in ascending order as quickly as possible, the time taken to 
complete the task was recorded.
There was no main effect o f treatment (F (i, 29) = 1.99; p>0.05), the time taken to 
arrange blocks was comparable for both treatments (see Table 72).
Table 72: Showing the treatm ent means at each visit (seconds).
Baseline Week 4 Week 7
Ginkgo Biloba 19.18 16.93 16.87
Placebo 21.60 18.20 17.26
There was a main effect of visit (F (2 , 5 8) = 7.56; p<0.001) subjects got faster at 
arranging blocks over time. There was no interaction between treatment and visit (F
(2 , 58) = 0.60; p>0.05).
The main effect o f time was analysed using the Newman Keul’s task. It was 
revealed that performance at weeks 4 and 7 were significantly faster than at 
baseline, perhaps reflecting a practice effect (see Figure 54).
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The main effect of time on arranging blocks (SKT IV)
i -----------------------------------1
Week 4  Week 7
Tim e
Figure 54: The main effect o f tim e on perform ance o f SKT subtest IV  (arranging
blocks).
6.14.2 SKT su b te s t V (replacing blocks)
In this task, subjects had to replace the 10 numbered blocks to their original 
starting position (this was marked on the magnetic board).
There was no main effect o f treatment (F (i, 2 9) = 0.20; p>0.05), the time taken to 
replace blocks was comparable for both treatments (see Table 73).
Table 73: Showing the treatm ent m eans at each visit (seconds).
Baseline Week 4 Week 7
Ginkgo Biloba 15.12 13.43 13.18
Placebo 14.66 13.26 12.66
There was a main effect o f visit (F (2, 58) = 6.78; p<0.001) subjects got faster at 
replacing blocks over time. There was no interaction between treatment and visit (F
(2,58)= 0.05; p>0.05).
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Post hoc testing on the main effect of time with Newman Keul's revealed that 
performance o f the task at weeks 4 and 7 was significantly faster than performance 
at baseline, perhaps reflecting a practice effect (see Figure 55).
The main effect of time on replacing blocks (SKT V)
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Figure 55: The main effect o f tim e on perform ance o f SKT subtest V  (replacing blocks).
6.14.3 SKT su b te s t VI (counting sym bols)
Subjects had to count the number of symbols contained on a sheet, e.g. squares. 
The sheet contained a number of symbols including flowers, circles, and squares. 
Time taken to complete the task was recorded.
There was no main effect o f treatment (F (i, 29) = 0.08; p>0.05), the time taken to 
count symbols was comparable for both treatments (see Table 74).
Table 74: Showing the treatm ent m eans at each visit (seconds).
Baseline Week 4 Week 7
Ginkgo Biloba 2 2 . 0 0 19.62 18.68
Placebo 21.46 18.06 19.40
20 j
S
H  1 0 -  
c
0
Baseline
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There was a main effect of visit (F (2, 58) = 5.99; p<0.005) subjects got faster at 
counting symbols over time. There was no interaction between treatment and visit 
(F (2 , 58) = 0.74; p>0.05).
Post hoc testing o f the main effect o f time with Newman Keul's revealed that 
performance o f the task at weeks 4 and 7 was significantly faster than performance 
at baseline, perhaps reflecting a practice effect (see Figure 56).
The main effect of time on counting symbols (SKT VI)
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Figure 56: The main effect o f tim e on perform ance o f SKT subtest V I (counting
sym bols).
6.14.4 SKT su b te s t VII (reverse naming task)
In this task, subjects had to perform a reverse naming task, subjects were presented 
with 2 rows of letters (e.g. ABBABAB), everytime the subjects read the letter A they 
had to say B had when the read B they had to say A. The time taken to complete the 
task was recorded.
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There was no main effect o f treatment (F (i, 29) = 0.005; p>0.05), the time taken to 
complete the reverse naming task was comparable for both treatments (see Table 
75).
Table 75: Showing the treatm ent m eans at each visit (seconds).
Baseline Week 4 Week 7
Ginkgo Biloba 22.06 20.31 18.81
Placebo 22.33 18.93 20.33
There was a main effect o f visit (F (2 , 58) = 8.04; p<0.001) subjects got faster at 
performing the reverse naming task over time. There was no interaction between 
treatment and visit (F (2 , 58) = 1.88; p>0.05).
Post hoc testing of the main effect o f time revealed that performance o f the task at 
weeks 4 and 7 was significantly faster than performance at baseline, perhaps 
reflecting a practice effect (see Figure 57).
The main effect of time on the reverse naming task 
(SKT VII)
■s-----------------------------------1
Week 4  W eek 7
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Figure 57: The main effect o f tim e on perform ance o f SKT subtest V II (reverse nam ing
task).
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6.14.5 HPRU Sternberg Memory Task (SMT)
In this task, subjects had to memorise a memory set (varying in size from 1, 3 to 5 
digits). Immediately following the memory set, a random series of 12 digits were 
presented, subjects were required to state whether the digit present, was contained 
in the memory set, by pressing the “yes” response button and “no” if it wasn’t. 
Time taken to respond was recorded.
There was no main effect o f treatment (F (i, 24) = 0.60; p>0.05), performance was 
the comparable for both treatments (see Table 76).
Table 76: Showing the treatm ent m eans at each visit (m illiseconds).
Baseline Week 2 Week 4 Week 6 Week 7 Week 8
GBE 798.86 817.81 794.81 782.97 751.73 738.54
Placebo 894.38 850.69 912.80 844.05 772.39 724.00
There was no main effect o f visit (F (5 , 120) -  1.62; p>0.05) there was no change in 
performance across visits. There was no interaction between treatment and visit (F 
(5 ,120)= 0.40; p>0.05).
6.14.6 Sum m ary
There were no main effects of treatment on tasks assessing attention in a healthy 
elderly population. In most cases there are main effects o f time, possibly indicating 
practice effects (even though the subjects were trained on the tasks before 
participation in the study). It is possible that the practice effects hide smaller 
treatment effects.
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6.15 The effect of Ginkgo Biloba on memory recall
In chapter 4 the effects of ageing on tasks that assess memory recall were analysed, 
it was concluded that there was no main effect of age o f performance o f memory 
recall tasks. The purpose o f this experiment was to assess the effects o f GBE 
supplementation on memory recall. In chapter 4 a number o f tasks were classed as 
assessing memory recall they included SKT subtests II, and SKT subtest V III. The 
effects of GBE on memory for a shopping list, object memory, face memory and 
digit span were also examined.
6.15.1 SKT su b te s t II (immediate recall)
The subjects were required to provide immediate recall of 12 previously named 
objects. The number of omissions and time taken to complete the task were 
recorded. Subjects were allocated 60 seconds in which to respond.
There was no main effect o f treatment (F (i, 2 9) = 0.02; p>0.05), the number of 
omissions was comparable for both treatments (see Table 77).
Table 77: Showing the treatm ent m eans at each visit (num ber o f om issions).
Baseline Week 4 Week 7
Ginkgo Biloba 5.00 5.00 4.75
Placebo 4.66 5.06 4.80
There was no main effect o f visit (F (2 , 58) = 0.44; p>0.05) there was no change in 
the number o f omissions across visits. There was no interaction between treatment 
and visit (F (2 , 58) = 0.30; p>0.05).
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6.15.2 SKT su b te s t VIII (delayed recall)
Subjects were required to provide delayed recall of 12 previously named objects, 
recall was required 10 minutes after initial presentation. The number of omissions 
and time taken to complete the task was recorded.
There was no main effect o f treatment (F (i; 2 9) = 0.21; p>0.05), delayed recall was 
the comparable for both treatments (see Table 78).
Table 78: Showing the treatm ent means at each visit (num ber o f om issions).
Baseline Week 4 Week 7
Ginkgo Biloba 5.00 5.06 4.62
Placebo 5.20 4.53 4.13
There was no main effect o f visit (F (2 , 58) = 2.03; p>0.05) there was no change in 
delayed recall across visits. There was no interaction between treatment and visit (F
(2 , 58) = 0.65; p>0.05).
6.15.3 Milford shopping list task
Subjects were required to read and try and remember a list of 12 shopping items 
e.g. sausages, lemons, toothpaste, gravy etc. Immediately following presentation, 
subjects had to recall as many of the 12 items as possible. The number of correct 
items recalled were recorded.
There was no main effect o f treatment (F (i, 2 6) = 1-60; p>0.05), recall o f the 
shopping list task was the comparable for both treatments (see Table 79).
Table 79: Showing the treatm ent m eans at each visit (num ber o f correct responses).
Baseline Week 4 Week 7
Ginkgo Biloba 8.50 7.58 7.58
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Placebo 7.56 7.37 6.93
There was no main effect o f visit (F (2, 52) = 2.01; p>0.05) there was no change in 
shopping list recall across visits. There was no interaction between treatment and 
visit (F (2 , 52) = 0.41; p>0.05).
6.15.4 Milford object memory task
Subjects were required to observe and try and remember 12 pictures of objects e.g. 
a tree, car, iron, mug etc. Immediately following presentation, subjects were 
required to recall as many of the 12 items as possible. The number of correct items 
recalled were recorded.
There was no main effect o f treatment (F (i, 2 6) = 0.18; p>0.05), recall o f objects 
was the comparable for both treatments (see Table 80).
Table 80: Showing the treatm ent m eans at each visit (num ber o f  correct responses).
Week 2 Week 6 Week 8
Ginkgo Biloba 7.33 7.66 7.66
Placebo 7.25 7.75 6.93
There was no main effect o f visit (F (2, 52) = 0.58; p>0.05) there was no change in 
object recall across visits. There was no interaction between treatment and visit (F 
(2 , 52) = 0.47; p>0.05).
6.15.5 Milford memory for faces task
Subjects were presented with named photographs of faces, subjects were required 
to memorise the name and face of each photograph. Photographs were presented in 
series of 1,2, 5 and 7 faces. After subjects had seen all the names and faces in each 
series, they were then presented with just the photographs of the faces, subjects had
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to name the photograph. The number of correct faces identified in each series were 
recorded.
6.15.6 Recall of 1 and 3 faces
There was no main effect o f treatment, time or interaction, as all subjects were able 
to recall one and three faces.
6.15.7 Recall of 5 faces
There was no main effect o f treatment (F (i, 2 6) = 0.00; p>0.05), on recall of 5 faces 
(see Table 81).
Table 81: Showing the treatm ent m eans at each visit (num ber o f correct responses).
Week 2 Week 6 Week 8
Ginkgo Biloba 2.58 2.58 2.58
Placebo 2.75 2.87 2.18
There was no main effect o f visit (F (2 , 52) = 2.38; p>0.05) there was no change in 
face recall across visits. There was no interaction between treatment and visit (F (2 , 
52) = 0.08; p>0.05).
6.15.8 Recall of 7 faces
There was no main effect of treatment (F (i, 2 6) = 0.08; p>0.05), on recall o f 7 faces 
(see Table 82).
Table 82: Showing the treatm ent m eans at each visit (num ber o f correct responses).
Week 2 Week 6 Week 8
Ginkgo Biloba 3.08 2.50 2.83
Placebo 2.75 2.93 2.18
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There was no main effect of visit (F (2 , 52) = 0.67; p>0.05) there was no change in 
face recall across visits. There was no interaction between treatment and visit (F (2 , 
52) =1.27; p>0.05).
6.15.9 Digit Span Forward Task
This task was adapted from the Wechsler adult intelligence task. Subjects were 
aurally presented with a series of numbers (increasing in length from 3 through to 
9 digits) required to recall the strings of numbers in the order in which they were 
presented. Subjects were required to recall as many of the strings as possible, 
subjects were only given one chance in which to correctly repeat the string, when 
an error was made, the task was abandoned. The subjects longest span was 
recorded.
There was no main effect of treatment (F (i, 2 6) = 0.22; p>0.05), on forward digit 
span recall (see Table 83).
Table 83: Showing the treatment means at each visit (longest span).
Week 2 Week 6 Week 8
Ginkgo Biloba 5.83 6.50 6.08
Placebo 6.31 6.56 6 . 1 2
There was no main effect of visit (F (2, 52) = 2.39; p>0.05) there was no change in 
digit recall across visits. There was no interaction between treatment and visit (F (2 , 
52) = 0.55; p>0.05).
6.15.10 Digit Span Backward Task
This task was adapted from the Wechsler adult intelligence task. Subjects were 
aurally presented with a series of numbers (increasing in length from 3 through to 
9 digits) required to recall the strings of numbers in the reverse order in which they
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were presented. Subjects were required to recall as many of the strings as possible, 
subjects were only given one chance in which to correctly repeat the string, when 
an error was made, the task was abandoned. The subjects longest span was 
recorded.
There was no main effect o f treatment (F (i, 2 6) = 0.46; p>0.05), on backward digit 
span recall (see Table 84).
Table 84: Showing the treatment means at each visit (longest span).
Week 2 Week 6 Week 8
Ginkgo Biloba 4.83 5.16 4.66
Placebo 4.31 4.81 4.56
There was no main effect o f visit (F (2 , 52) = 0.81; p>0.05) there was no change in 
digit recall across visits. There was no interaction between treatment and visit (F (2 , 
52) = 0.16; p>0.05).
6.15.11 Sum m ary
There were no main effects of treatment on tasks assessing memory recall in a 
healthy elderly population.
6.16 The effect of Ginkgo Biloba on the speed of naming
In chapter 4 the effects of ageing on tasks assessing the speed o f naming were 
examined, it was concluded that there was no main effect o f age on tasks assessing 
the speed of naming. The purpose o f this experiment was to assess the effects of 
GBE supplementation the speed o f naming. In chapter 4 a number o f tasks were 
classed as assessing speed of naming they included SKT subtests I, and SKT 
subtest 11 1 .
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6.16.1 SKT su b te s t I (object naming)
Subjects were shown a card containing 12 pictures of objects, subjects were 
required to name the objects and try to commit them to memory, as they would be 
asked about them at a later date.
There was no main effect o f treatment (F (i, 2 9) -  0.02; p>0.05), time taken to 
complete the object naming task was the comparable for both treatments (see Table 
85).
Table 85: Showing the treatment means at each visit (seconds).
Baseline Week 4 Week 7
Ginkgo Biloba 18.25 19.12 20.50
Placebo 21.33 17.00 20.73
There was no main effect o f visit (F (2 , 58) = 1.51; p>0.05) there was no change in 
time taken to complete the task across visits. There was no interaction between 
treatment and visit (F (2 , 58) = 1.51; p>0.05).
6.16.2 SKT su b te s t III (naming num erals)
Subjects were required to name 10 numbered blocks, the time taken to name the 
blocks was recorded.
There was no main effect of treatment (F (i, 2 9) = 0.41; p>0.05), the time taken to 
name numerals was comparable for both treatments (see Table 86).
Table 86: Showing the treatment means at each visit (seconds).
Baseline Week 4 Week 7
Ginkgo Biloba 8.00 7.56 7.93
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Placebo 12.60 7.60 7.46
There was no main effect o f visit (F (2 , 58) = 1.33; p>0.05) there was no change in 
the time taken to complete the task across visits. There was no interaction between 
treatment and visit (F (2 , 58) = 1.08; p>0.05).
6.16.3 Sum m ary
There were no main effects o f treatment on tasks assessing the speed o f naming in a 
healthy elderly population.
6.17 The effect of Ginkgo Biloba on the speed of 
information processing
In chapter 4 the effects of ageing on tasks that assessed information processing 
were examined, it was concluded that there was no main effect of age of 
performance o f information processing tasks. The purpose o f this experiment was 
to assess the effects o f GBE supplementation on information processing. In chapter 
4 a number o f tasks were classed as assessing speed o f information processing they 
included the Critical Flicker Fusion Task (CFF), Total Reaction Time (TRT), 
Recognition Reaction Time (RRT) and Motor Reaction Time (MRT).
6.17.1 Critical Flicker Fusion (CFF)
Critical flicker fusion threshold was determined by getting subjects to complete 3 
ascending and 3 descending trials, the mean of all 6 trials was recorded.
There was no main effect o f treatment (F (i, 24) — 1.75; p>0.05), critical flicker 
fusion thresholds were the comparable for both treatments (see Table 87).
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Table 87: Showing the treatment means at each visit (Hz).
Baseline Week 2 Week 4 Week 6 Week 7 Week 8
GBE 29.75 29.85 29.54 30.70 29.66 30.78
Placebo 30.76 30.90 30.67 31.27 31.28 31.55
There was a main effect o f time (F (5 , 120) = 3.23; p<0.05) performance on the task 
improved over time, perhaps reflecting a practice effect (see Figure 58). Post hoc 
testing with Newman Keul's revealed that CFF thresholds were significantly higher 
at week 8  than all other assessments. There was no interaction between treatment 
and visit (F (5 , 120) = 0.58; p>0.05).
The main effect of time on critical flicker fusion task
(CFF)
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The main effect of time on performance of the critical flicker fusion (CFF).Figure 58:
6.17.2 Total Reaction Time (TRT)
In this task, subjects had to place their index finger on a home key and respond to 
stimuli, when a light illuminated, subjects had to remove their finger from the home 
key and extinguish the illuminated light. Total Reaction time was determined by 
taking the mean response time from 20 stimuli.
269
There was no main effect o f treatment (F (i, 2 4) = 0.04; p>0.05), total reaction time 
was the comparable for both treatments (see Table 8 8 ).
Table 88: Showing the treatment means at each visit (milliseconds).
Baseline Week 2 Week 4 Week 6 Week 7 Week 8
GBE 630.09 598.20 613.83 594.87 617.83 609.56
Placebo 621.32 620.04 615.11 604.08 620.15 623.04
There was no main effect o f visit (F (5 , 120) = 1.04; p>0.05) there was no change in 
total reaction times across visits. There was no interaction between treatment and 
visit (F (5j 120) = 0.36; p>0.05).
6.17.3 Recognition Reaction Time (RRT)
In this task, subjects had to place their index finger on a home key and respond to 
stimuli, when a light illuminated, subjects had to remove their finger from the home 
key and extinguish the illuminated light. Recognition reaction time was defined as 
the time taken for the subject to remove their finger from the home key.
There was no main effect o f treatment (F (i, 24) = 0.02; p>0.05), recognition reaction 
time was the comparable for both treatments (see Table 89).
Table 89: Showing the treatment means at each visit (milliseconds).
Baseline Week 2 Week 4 Week 6 Week 7 Week 8
GBE 409.80 386.91 409.87 388.17 409.22 396.41
Placebo 403.04 395.27 407.59 402.52 406.58 408.47
There was no main effect o f visit (F (5 , 120) -  1-12; p>0.05) there was no change in 
recognition reaction times across visits. There was no interaction between treatment 
and visit (F (5) 120) = 0.41; p>0.05).
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6.17.4 Motor Reaction Time (MRT)
In this task, subjects had to place their index finger on a home key and respond to 
stimuli, when a light illuminated, subjects had to remove their finger from the home 
key and extinguish the illuminated light. Motor reaction time was defined as the 
time taken for the subjects to move from the home key to the illuminated light.
There was no main effect o f treatment (F (i, 24) = 0.29; p>0.05), motor reaction time 
was the comparable for both treatments (see Table 90).
Table 90: Showing the treatment means at each visit (milliseconds).
Baseline Week 2 Week 4 Week 6 Week 7 Week 8
GBE 220.28 211.27 203.93 206.70 208.60 300.97
Placebo 215.39 224.76 207.55 201.56 211.27 214.55
There was no main effect o f visit (F (5 , 120) ~ 1-56; p>0.05) there was no change in 
motor reaction times across visits. There was no interaction between treatment and 
visit (F (5, 120) = 1-33; p>0.05).
6.17.5 Sum m ary
There were no main effects o f treatment on tasks assessing the speed o f information 
processing in a healthy elderly population.
6.18 The effect of Ginkgo Biloba on recognition memory
In chapter 4 the effects of ageing on tasks that assess recognition memory were 
assessed, it was concluded that there was no main effect o f age on recognition 
memory. The purpose o f this experiment was to assess the effects o f GBE 
supplementation on recognition memory. In chapter 4 the SKT subtest IX was
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classed as assessing recognition memory. The effects o f GBE were also examined 
on the shopping list forced choice and object forced choice tasks.
6.18.1 SKT su b te s t IX (recognition memory)
In the recognition memory task, subjects had to recognise the 12 original pictures 
of objects (originally seen in subtest I) from a series of 48 pictures. The number of 
omissions were recorded.
There was no main effect o f treatment (F (1,2 9) = 0.04; p>0.05), recognition memory 
was the comparable for both treatments (see Table 91).
Table 91: Showing the treatment means at each visit (number of omissions).
Baseline Week 4 W eek 7
Ginkgo Biloba 0.81 0.56 0.87
Placebo 1.26 0.73 0.46
There was no main effect o f visit (F (2 , 58) = 2.05; p>0.05) there was no change in 
recognition memory performance across visits. There was no interaction between 
treatment and visit (F (2 , 58) = 2.05; p>0.05).
6.18.2 The Milford forced choice shopp ing  list recognition task
In this task, subjects were presented with the word pairs containing the shopping 
list item plus a distractor item, the subjects had to decide which was the original 
shopping list item. The number of correctly recognised words were recorded.
There was no main effect o f treatment (F (i, 2 6) = 0.28; p>0.05), on shopping list 
recognition (see Table 92).
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Table 92: Showing the treatment means at each visit (correct responses).
Week 2 Week 6 Week 8
Ginkgo Biloba 11.25 11.41 11.75
Placebo 11.56 11.37 11.62
There was no main effect o f visit (F (2 , 52) = 0.27; p>0.05) there was no change in 
performance across visits. There was no interaction between treatment and visit (F
(2 ,52) = 2.18; p>0.05).
6.18.3 The Milford forced choice object recognition task
In this task, subjects were presented with the picture pairs containing the original 
picture plus a distractor picture, the subjects had to decide which was the original 
picture. The number of correctly recognised pictures were recorded.
There was no main effect of treatment (F (i, 2 6) = 0.85; p>0.05), on object 
recognition (see Table 93).
Table 93: Showing the treatment means at each visit (correct responses).
Week 2 Week 6 Week 8
Ginkgo Biloba 11.66 11.75 11.58
Placebo 11.56 11.37 11.62
There was no main effect o f visit (F (2 , 52) = 0.03; p>0.05) there was no change in 
performance across visits. There was no interaction between treatment and visit (F
(2 , 52) = 0.57; p>0.05).
6.18.4 Summary
There were no main effects of treatment on tasks assessing recognition memory in 
a healthy elderly population.
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6.19 The effect of Ginkgo Biloba on Subjective Ratings of 
ADL
Subjects completed a shortened version of the Bayer Activity of Daily Living scale, 
consisting of 14 self rating questions, assessing everyday problems with memory, 
perception and failures in attention. (The shortened questionnaire can be seen in 
appendix 5).
There was no main effect o f treatment (F (i, 3 0) = 0.08; p>0.05), total ADL score 
was the comparable for both treatments (see Table 94).
Table 94: Showing the treatment means at each visit.
Baseline Week 8
Ginkgo Biloba 14.24 12.07
Placebo 14.34 13.46
There was no main effect o f visit (F (i, 30) = 2.45; p>0.05) there was no change in 
total ADL score across visits. There was no interaction between treatment and visit 
(F ( i , 30) = 0.31; p>0.05).
6.19.1 Sum m ary
There were no main effects o f treatment on subjective ADL ratings in a healthy 
elderly population.
6.20 Discussion
The hypothesis tested was that treatment with ginkgo biloba would help alleviate 
the age related decline reported on the psychometric tasks (see chapter 4). However 
there were no main effects o f treatment on any o f the aspects o f cognitive
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functioning (attention, memory recall, recognition memory, speed o f information 
processing or the speed of naming) or on subjective ratings o f daily activities.
Main effects o f time, i.e. changes in performance over the testing sessions, were 
observed on some of the tasks (SKT IV, V, VI, VII and the Critical Flicker Fusion 
task). These changes were possibly attributed to practice/learning effects, or simply 
the subjects were beginning to feel more comfortable with the testing situation. It is 
very difficult to eliminate learning effects in an elderly population, even when the 
subjects have been sufficiently trained, as this particular age group, are not familiar 
with computers and the laboratory environment. Prior to participation, all subjects 
were trained on the tasks, completing the tasks at least 6 times (as it was thought 
that subjects reach performance plateau after 6 tests, Parkin et al., 1996). However 
it would appear that subjects were not sufficiently trained.
There have been no studies examining the effect o f long term supplementation with 
ginkgo biloba on tasks assessing attention in health adult populations, and any 
studies that have been conducted in patient populations have revealed 
improvements on the digit symbol substitution task (Weibrecht and Jansen, 1986) 
and the digit copying test (Rai et al., 1991). No improvements were noted on the 
trail making task a test of attentional/executive control (Maurer et a l , 1997). The 
tasks assessing attention in the present study included SKT IV (arranging blocks); 
SKT V (replacing blocks); SKT VI (counting symbols); SKT VII (reverse naming 
task) and the HPRU Sternberg memory task (SMT). SKT IV and V are spatial 
tasks, requiring subjects to arrange and replace numerical blocks into ascending 
order, SKT VI is a simple counting task that places emphasis on attention and 
vigilance, and SKT VII is a complex reverse naming task, in which subjects are 
required to perform a mental reversal of letters, so that when they read the letter A  
they had to say B, and vice versa. This task can be likened to the digit symbol 
substitution task (even though in the DSST task subjects provide a written response
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and the subjects can choose their own pace), and based on the similarity might have 
been expected to report drug effects, however no effects were observed.
The beneficial effects o f ginkgo biloba treatment on memory function seem to be 
limited to patient populations, as results in healthy adult populations seem 
somewhat inconclusive, any effects in healthy adults have been observed when 
large doses o f GBE have been administered, Subhan and Hindmarch, (1984) 
administered a single acute 600 mg dose and reported an improvement on the 
Sternberg memory task, however no improvement was noted at lower doses (120 
and 240 mg). Following 200 mg daily dose for 14 days, a trend towards memory 
improvement on the Sternberg memory task was noted (Dawe et al., 1995). 
However it is possible that these effects are "noise" effects and not true drug 
effects. Since a relatively low dose (the manufacturers recommended daily dose 
100 mg was used in the present study) then no effects on memory could have been 
expected in a healthy population.
As with the effects o f GBE on memory function, the beneficial effects o f GBE on 
the speed o f information processing, seem to be limited to patient populations. 
Results in healthy adult populations revealed that GBE had no effect on such tasks, 
only one pilot study reported improvements on the recognition component o f the 
choice reaction time task, and in this study subjects had received a 200 mg daily 
dose for 14 days (Dawe et al., 1995). Hence based on these findings, treatment with 
a 100 mg daily dose o f GBE would not have been expected to result in significant 
improvements.
There have been no studies examining the effect o f ginkgo biloba on the speed of  
naming, however since these tasks rely heavily on timing, any effects would be 
expected to mirror results obtained on tasks assessing the speed o f information 
processing, therefore since GBE had no effect on tasks assessing the speed of
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information processing (CFF, CRT, SKT total score) then effects on the speed o f  
naming (SKT I, III) would not be expected.
The results of this experiment would seem to indicate that 100 mg ginkgo biloba is 
not beneficial for treating cognition especially in healthy elderly subjects who 
believed they were experiencing problems with their memory. It is possible that 
more dramatic effects may have been demonstrated if  the dose o f GBE had been 
increased to at least 120-200 mg daily or, if  the subjects included in the trial had 
been experiencing definite memory decline. The subjects included in the 
experiment complained of memory problems, however they were very fit and 
healthy, and were probably not experiencing any great degree o f cognitive decline. 
Based on this evidence It was concluded that a 100 mg daily dose o f ginkgo biloba 
had no beneficial effects on cognition in a sample o f healthy elderly subjects.
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7 Chapter Seven: The effects of an acute dose 
of glucose on cognitive and psychomotor 
functioning in an elderly population
7.1 Chapter Outline
The important role of glucose to the brain
What happens once glucose has entered the body
The uptake of glucose to the brain- the glucose transport mechanism
The possible mechanisms for glucose's role in the enhancement of
cognition
The effect of glucose on neurotransmitter synthesis and function 
The effects of ageing on glucose regulation
The effect of glucose administration on performance in elderly 
subjects
The effect of glucose on attention in healthy elderly subjects 
The effect of glucose on memory function in healthy elderly subjects 
The effect of glucose on the speed of information processing in 
healthy elderly subjects
The effect of glucose on mood in healthy elderly subjects 
Assessing the effects of glucose administration on cognitive function and 
mood in a healthy elderly population.
Blood glucose level
The effect of glucose on attention
The effect o f glucose on memory recall
The effect ofglucose on the speed of naming
The effect ofglucose on the speed of information processing
The effect of glucose on recognition memory
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The effect of glucose on subjective mood ratings -  The Profile of 
Mood States
The effect of hypoglycaemia on psychometric test performance
The literature suggests that glucose enhances some aspects of cognitive 
performance especially in aged samples. This study aims to assess the impact of a 
50g glucose drink on cognitive and psychomotor performance in a sample of 24 
healthy elderly volunteers. The effects of glucose administration were examined on 
tasks assessing memory, attention, the speed of information processing and 
subjective ratings of mood.
The chapter reviews the previous literature in terms of the effects of glucose 
administration on aspects of cognitive function and mood in both healthy elderly 
and patient populations.
7.2 The important role of glucose
There a numerous lines o f evidence to suggest that blood glucose levels play an 
important role in cognitive function. Glucose administration has improved various 
aspects of cognition including memory, attention, reaction time and aspects of 
mood. The beneficial effects have been demonstrated in young healthy populations 
(Lapp, 1981; Benton and Owens, 1993; Benton, Owens and Parker, 1994; Craft, 
Murphy and Wemstrom, 1994; Foster, Lidder, and Siinram, 1997) elderly 
populations (Gonder-Frederick, Hall, Vogt, Cox, Green and Gold, 1987; Hall, 
Gonder-Frederick, Chewning, Silveira and Gold, 1989; Manning, Hall and Gold, 
1990; Manning, Parsons and Gold, 1992; Parsons and Gold, 1992) and in patients 
with Alzheimer’s Disease (Craft, Murphy and Wemstrom, 1994; Manning, 
Ragozzino and Gold, 1993; Craft, Newcomer, Kanne, Dagogo-Jack, Cryer, 
Sheline, Luby, Dagogo-Jack and Alderson, 1996).
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The belief that glucose may be responsible for some o f the cognitive enhancing 
effects was noted by Wenk (1989) he reported that many o f the nootropic drugs i.e. 
those that improve memory and attention, produce their effect by increasing the 
availability and uptake o f glucose. He noted that many o f the cognitive enhancing 
drugs do not cross the blood brain barrier, many are effective when injected 
peripherally but not when injected directly into the brain, and a number of 
cognitive enhancing drugs are not effective following adrenalectomy. Based on this 
evidence, it was believed that glucose was directly involved in determining 
cognitive function.
Based upon this evidence, a number o f research teams have supplemented subjects 
with glucose in the belief that it could be used as an alternative method for 
improving/enhancing memory and cognition. It is thought that the available glucose 
would enter the blood stream and be carried to the brain to act as a fuel source for 
brain cells.
The brain is the most metabolically active organ in the human body, it accounts for 
only 2-2.7% o f total body weight, but it consumes approximately 20% o f the bodies 
oxygen supply, 25% o f the bodies glucose supply and 19% of the bodies blood 
supply (Holiday, 1979; Garrow and Blaza, 1982).
The human brain utilises glucose as its primary source o f energy, it uses 
approximately 70 mg o f glucose every minute, it has been calculated that without 
replacement the brains supply would be completely used up in 10-15 minutes 
(Marks and Rose, 1981). It is estimated that the brain consumes approximately 17 
calories per lOOg o f brain tissue (Siebert, Gessner and Klasser, 1986). Glucose is 
the brain's primary source o f fuel, however it can in very extreme conditions such 
as extreme starvation, utilise other fuels mainly ketone bodies (Gottstein, Held,
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Muller and Berghoff, 1970). The brain is also able to utilise glycogen as a fuel, 
however the brain has a limited store o f glycogen (2-4 mmol/g) and it is estimated 
that glycogen would only manage to provide energy for the brain for approximately 
3 minutes (Siesjo, 1978). Alternative fuels do not readily cross the blood brain 
barrier and hence are only used under extreme conditions, and under normal 
conditions the brain is dependant upon a continuous blood supply o f glucose 
(Krassner, 1986).
7.3 What happens to glucose once it has entered the 
body
Before the cognitive effects o f glucose are explored, the fate of glucose in the body 
will be examined. Following a meal or glucose drink, blood glucose levels rise for 
approximately 30 minutes after which they fall and return to baseline levels within 
about 2 hours. When there is an excess supply of glucose in the blood, the liver 
converts the excess glucose into glycogen for storage in the liver cells, and when 
the level of blood glucose falls, the hormone glucagon converts the glycogen into 
glucose and it is released into the blood stream.
Insulin acts in three ways:-
1. It increases glucose utilisation by body cells
2. It suppresses hepatic glucose production
3. It promotes glycogen formation in order to maintain glucose levels within 
narrow limits.
This biological mechanism ensures a continual optimal supply o f glucose for the 
brain (See figure 59).
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Insulin
------------------- ►
Glucose M------------------- Glycogen
Figure 59: Showing the conversion of glucose into glycogen and vice versa with the role
of the glucoregulatory-hormones glucagon and insulin.
7.4 Uptake of glucose to the brain - the glucose 
transport mechanism
At present 5 proteins have been identified as responsible for the transport o f  
glucose across the cell membranes into the brain. With the exception o f the lumen 
in the small intestine and the proximal tube o f the kidney, the transport o f glucose 
across the cell membranes occurs by a process o f facilitated (carrier mediated) 
diffusion (Pessin and Bell, 1992). the 5 proteins are termed:-
1. GLUT! (found in the erythrocytes)
2. GLUT2 (found in the liver)
3. GLUT3 (found in the brain)
4. GLUT4 (found in the muscle/fat)
5. GLUT5 (found in the small intestine)
Proteins GLUT1 and GLUT3 are present in the brain and work together to ensure a 
continual supply o f glucose to the brain cells. GLUT1 is found in endothelial cells 
and appears to be responsible for the transport o f glucose across the blood brain
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barrier and delivery o f glucose to underlying tissues. GLUT3 mediates glucose 
transport across neuronal cell membranes. At present the role o f the other glucose 
proteins is unclear. Once the glucose has crossed the blood brain barrier, it then 
diffuses through the extracellular space and across the neuronal membranes. Once 
glucose enters the cell, it is broken down by a process of glycolysis (see figure 2)
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Figure 60:
GLUCOSE
•I Hexokinase 
Glucose 6 phosphate
-I phosphohexose isomerase 
Fructose 6 phosphate
•I phosphofructokinase 
Fructose 1 , 6 -  Diphosphate 
'I . Aldose 
Glyceraldehyde-3 -phosphate
i- Glyceraldehyde-3-phosphate 
dehydrogenase 
1, 3-Diphosphoglycerate
•I phosphoglyceratekinase 
3 phosphoglycerate
'I phosphoglyceratemutase 
2 phosphoglycerate 
'I enolase 
Phosphonenolpyruvate
J' pymvatekinase 
Pyruvate
Citric Acid Cycle Acetyl-CoA
The breakdown of glucose by glycolysis.
284
7.5 The possible mechanisms for glucose’s role in the 
enhancement of cognition
Two possible routes have been identified to account for glucose’s beneficial effects. 
A number o f lines of evidence have been provided to substantiate the 2 possible 
routes. Enhancement o f glucose can be via a central route (directly in the brain) or 
via a peripheral route.
Researchers who favour the peripheral route, have assessed the effects of fructose 
on memory performance. Fructose (unlike glucose) does not cross the blood-brain 
barrier, therefore if  any memory improvements were evident following ingestion of 
fructose, then it must be via a peripheral route. It was found that 2g/kg fructose 
enhanced memory in much the same way as 2g/kg o f glucose. However, lOOg/kg 
fructose had no effect on memory, whereas lOOg/kg glucose acted to enhance 
memory. This lead researchers to believe that 100 mg/kg glucose exerted its 
positive effects via a central route.
The central route is believed to be attained by glucose acting directly on a substrate 
in the brain, possibly the cells of the hippocampus, to produce the enhancement of 
memory. Messier, Durkin, Mrabet and Destrade (1989) postulated that the 
mechanism could involve an interaction with acetylcholine.
Numerous investigations were taken to identify possible mechanisms for the 
peripheral enhancement o f memory following glucose ingestion. It was first 
thought that insulin release following glucose ingestion was responsible for the 
memory enhancement. However no memory enhancement was observed when 
animals were injected with insulin. The insulin probably promoted the absorption 
of glucose by insulin sensitive tissues, thus reducing glucose availability.
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The second approach was to investigate the role o f the adrenal medulla. There is a 
wealth of evidence that adrenalin has a memory enhancing effect (Gold, and van 
Buskirk, 1975; Gold and Zometzer, 1983). Increases in blood glucose cause the 
adrenal medulla to release adrenalin, therefore if  this mechanism were responsible 
for the memory enhancement, then no memory enhancement would be observed in 
animals who have had their adrenal medullas removed. However it was reported 
that the response in these animals was exactly the same response as “normal” 
animals. Therefore the memory enhancing effect o f glucose could not be mediated 
by adrenalin release from the adrenal medulla.
The peripheral route may be mediated via the organ responsible for glucose 
metabolism, the liver. In order to investigate this, the celiac ganglion was 
destroyed. The celiac ganglion is the route through which the autonomic nerves 
from the liver pass to the CNS. Celiac ganglion lesions eliminated the memory 
enhancing effects o f glucose. This finding suggests that the memory enhancing 
effects o f glucose may be mediated through the liver. A possible mechanism would 
be, a rise in blood glucose is detected by the liver and transduced into neural 
signals which are transmitted to the brain via the autonomic nervous system. 
However this is purely speculative as no information is presently available as to 
how the proposed neural signal from the liver might influence memory when it 
reaches the brain.
7.6 The effect of glucose on neurotransmitters synthesis 
and function
The beneficial effects o f glucose may also be attributed to the interaction o f glucose 
with neurotransmitter synthesis/function particularly acetylcholine, dopamine and 
the opiates.
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Several lines o f evidence have been proposed to suggest that glucose may interact 
with central cholinergic mechanisms. Glucose has been shown to alleviate 
scopolamine induced amnesia (Meisser, Durkin, Mrabet and Destrade, 1990), 
alleviate the depletion o f acetylcholine following treatment with quinuclidinyl 
benzilate (QNB) (Ricny, Tucek, and Novakova, 1992) glucose also helped to 
reduce the loss o f atropine-induced acetylcholine in the caudate nucleus, whereas 
glucose had no effect on acetylcholine content in animals who had not received 
atropine (Dolezal and Tucek, 1982). Glucose also increases extracellular 
acetylcholine following scopolamine injections (Durkin, Messier, de Boer and 
Westerink 1992). The above evidence would seem to indicate that glucose is taken 
into cholinergic presynaptic terminals and transformed into acetylcoenzyme A 
which is then used to synthesize acetylcholine.
Glucose also interacts with a number o f other neurotransmitters. It is possible that 
the memory improving action of peripherally-injected dopamine drugs may be 
mediated by glucose. Animal experiments whereby the rats were pre-trained on two 
radial maze tasks and injected with the D2 receptor agonist quinpirole and D1 
agonist SKF 38393. It was found that performance on the maze tasks were 
improved following treatment with quinpirole and not SKF 38393, interestingly the 
injection o f quinpirole was found to increase blood glucose whilst SKF 38393 did 
not (Clayson, 1971). Peripheral injections o f glucose can supress the firing of 
nigrostriatal dopamine-containing neurons and lower dopamine metabolite content 
(Chance, Cao and Fisher, 1989). Manipulation of blood glucose levels alters the 
response to drugs such as haloperidol and amphetamine.
Glucose has also been shown experimentally to interact with the opiates. Glucose 
has also been shown to reverse the amnesia produced by morphine (Stone, Walker, 
Gold and Gold, 1991). Morphine injections are believed to reduce the hippocampal
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acetylcholine output, and when glucose is administered it attenuates the reduction 
of acetylcholine.
7.7 The effects of ageing on glucose regulation
Ageing is a natural state associated with a number o f changes in cognition such as 
decline in attention and memory performance and a slowing o f information 
processing. It is not known precisely what biological mechanisms are responsible 
for cognitive decline, however it has been postulated that abnormalities in glucose 
metabolism may play a role in this cognitive decline.
Human ageing is associated with a number o f disruptions in glucose regulation and 
utilisation such as elevated blood glucose levels following the ingestion o f a 
glucose drink (O’Sullivan, 1974); decreased peripheral glucose metabolism (Fink, 
Kolterman, Griffen and Olefsky, 1983) and decreased central glucose metabolism 
(Kuhl et al, 1984; Riege et al, 1985).
There are many lines o f evidence that would seem to indicate that the aged human 
brain suffers from reduced cerebral glucose utilisation. Hoyer (1988) notes that 2 
enzymes essential for the breakdown o f glucose (glycolysis) Hexokinase and 
phosphfructokinase are reduced in aged human brains.
A number of studies have provided evidence to support the claim that a reduction 
in cerebral metabolism (a condition commonly noted in an elderly population) 
results in a decline in cognitive function. Riege, Metter, Kuhl and Phelps (1985) 
reported that elderly subjects (aged greater than 48 years) differed from younger 
subjects (aged less than 42 years) on a number o f occasions. 23 healthy adults aged 
27-78 years performed a total o f 18 different memory tests. It was reported that 
elderly subjects with high superior frontal and lower caudate thalmic metabolic
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rates performed better on tests of memory for stories, sentences, complex designs 
and patterns. Beradi, Haxby, Grady and Rapoport, (1991) found that elderly 
subjects with higher verbal memory scores also had a high rate o f glucose 
utilisation in the right hemisphere. However Duara, Grady, Haxby, Sundaram, 
Cutler, Heston, Moore, Schlageter and Larson (1984) Duara, Grady, Haxby, Ingvar, 
Sokoloff, Margolin, Manning, Cutler and Rapoport (1986) failed to report any 
relationship between cognitive function and resting metabolic rate.
Despite the minor inconsistencies there seems to be evidence to indicate that in 
elderly subjects there is a relationship between the ability to metabolise glucose and 
cognitive performance, higher glucose metabolism being associated with superior 
cognitive performance.
Poor glucose regulation and metabolism has been put forward as a risk factor for 
Alzheimer’s disease. Landin, Blennow, Wallin and Gottfries (1993) defined 
Alzheimer’s disease as a “hypometabolic brain disease” disrupted glucose 
regulation and utilisation often seen in Alzheimer’s disease may be responsible for 
the memory disturbances observed in this disorder. Duara et al (1986) notes that 
Alzheimer's patients show more extreme abnormalities o f the glucose system than 
age matched healthy subjects. Hoyer (1992) notes that patients with Alzheimer’s 
disease showed a 44% reduction in glucose utilisation. Foster, Chase, Manis, 
Brooks, Fedio, Patronas and Di Chiro (1984) reported that overall glucose 
utilisation was 10 - 49% lower in a sample o f Alzheimer patients than a control 
group. The areas o f the brain most affected were the parietal lobes (32% reduction) 
and the temporal lobes (34% reduction), whereas the frontal cortex was relatively 
unaffected (19%).
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7.8 The effects of glucose administration on 
performance in elderly subjects
There have been a number of experiments assessing the effects o f glucose on 
cognitive function in samples of elderly subjects, a sector o f the population known 
to exhibit a decline in cognition.
It would seem that as a result of the ageing process, the elderly are more susceptible 
to fluctuations in blood glucose (Kent, 1976). The elderly have been shown to 
suffer a decline in cerebral glucose utilisation, and it is possible that this is 
responsible for the cognitive deficits present in the population. Based on this 
hypothesis it was questioned whether supplementation with glucose would enhance 
aspects o f cognitive functioning.
A review of the literature assessing the role o f glucose in psychometric task 
performance in both diabetic and healthy subjects has lead researchers to believe 
that psychometric test performance deteriorates when blood glucose levels are low 
(< 2.2 mmol/L) and tends to improve when blood glucose levels are raised to 
within normal limits (4.0 -7.0 mmol/L). (Holmes, Hayford, Gonzales and Weydert, 
1983; Cox, Gonder-Frederick, Schroeder, Cryer, and Clarke, 1983; Kerr, 
MacDonald and Tattersall, 1989; Kerr, MacDonald and Tattersall, 1991; 
Perlmutter, Malekeh, Hodgson-Harrington, Ginsberg, Katz, Singer and Nathan, 
1984; Perlmutter, Tun, Sizer, McGlinchey and Nathan, 1987; Maassen, 
Lingenfelser, Gluck, Renn, Eggstein, and Jakober, 1990)
7.9 The effect of glucose on attention in healthy elderly 
subjects
Attention is an aspect of cognitive functioning thought to be susceptible to 
fluctuations in blood glucose levels and which has been shown to improve
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following treatment with glucose in young samples (Benton, Owens and Parker, 
1994).
Research in diabetic subjects would seem to indicate that attention is an aspect of 
cognition that is susceptible to fluctuations in blood glucose level, in particular it 
would seem that low blood glucose levels (or poor glycaemic control) are 
associated with poorer attentional task performance (Maassen, Lingenfelser, Gluck, 
Renn, Eggstein, and Jakober, 1990; Perlmutter, Malekeh, Hodgson-Harrington, 
Ginsberg, Katz, Singer and Nathan, 1984).
There have been five studies to date, that have assessed the effect o f glucose on 
attention in healthy elderly subjects.
Manning, Hall and Gold (1990) examined the effects o f glucose on attention in 17 
healthy elderly volunteers aged 62-84 years, (mean age 73 years). Subjects were 
treated with glucose 50 g or saccharin 23.7 mg and performance was assessed using 
the letter cancellation task . It was reported that supplementation with glucose had 
no effect on performance o f the task.
Craft, Murphy and Wemstrom (1994) conducted a study which assessed the effects 
of glucose on attention in a sample o f 32 elderly subjects aged 58-77 years (mean 
age of 68.5 years). Subjects were treated with glucose (50 g) and saccharin (23.7 
mg). Performance was assessed using the paced auditory serial addition test 
(PASAT) and the Stroop task. In the paced auditory serial addition task subjects 
had to add 60 pairs o f randomised digits presented in a continuous string. In the 
Stroop task subjects had to complete three conditions, in the first condition subjects 
had to read 100 coloured words, in the second condition the subjects had to name 
the colours o f 100 blocks, and finally the subjects were presented with coloured 
words written in discordant colours, subjects were required to ignore the written
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word and name the colour of the ink. It was reported that glucose administration 
had no effect on performance of the either the PAS AT or the Stroop task.
Craft, Newcomer, Kanne, Dagogo-Jack, Cryer, Sheline, Luby, Dagogo-Jack and 
Alderson (1996) questioned whether the improvements in cognitive performance 
were attributable to the glucose or simply due to raised plasma insulin levels as a 
result of the excess glucose intake. To examine this the researchers assessed 
cognitive function in 13 healthy adults (mean age 71 years), under three conditions. 
In condition one, plasma insulin levels were maintained at 6 U/ml and dextrose was 
infused to keep plasma glucose levels o f 90 mg/dl. In the second condition insulin 
levels were allowed to vary naturally and dextrose was infused to maintain plasma 
glucose levels at 225 mg/dl. Finally in the third condition both glucose and insulin 
were maintained at baseline levels (insulin 7 U/ml and glucose 90 mg/dl). 
Cognitive performance was assessed 30 minutes after the blood glucose and insulin 
levels had been adjusted and stabilised for 30 minutes. Cognitive performance was 
assessed using the Stroop task. It was reported that when plasma insulin levels were 
raised and glucose levels remained at baseline there was no effect on performance 
of the Stroop task. Therefore the effect was not just due to the raised insulin levels.
Allen, Gross, Aloia and Billingsley (1996) assessed the effects o f glucose on 
attention in 28 healthy elderly subjects aged 61-87 years (mean age 73 years). 
Subjects were treated with glucose (50 g). Performance was assessed using the trail 
making A and B tests and a dichotic listening task (subjects had to attend to 2 
auditory signals, one to each ear, two triads o f one syllable words were presented 
simultaneously to the right and left ears. Subjects completed 11 trials, and after 
they had heard all the words they had to recall as many o f the words as possible). It 
was reported that subjects with poor glucose control (which was defined as a 
change in blood glucose level greater than 100 mg dl'1 ) had poorer performance on
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the dichotic listening task. Glucose administration had no effect on performance of 
the trail making tasks.
Craft, Zallen and Baker (1992) assessed the effects o f glucose on performance on a 
single and two feature detection task in 14 healthy elderly subjects (mean age 71.4 
years). Subjects were treated with glucose 50 g or saccharin 23.7 mg, following 
treatment subjects completed a single feature detection task (subjects watched a 
computer screen, two rows of geometric shapes (circles and triangles) appeared on 
the screen, subjects were required to respond by pressing the "yes" button if  a 
triangle appeared, and "no" if  it was a circle, subjects had to complete 60 trials. In 
the two feature detection task, the 2 rows o f geometric shapes consisted o f large 
and small circles/triangles were presented, subjects were required to respond to the 
large triangles. It was reported that glucose treatment had no effect on performance 
of the tasks.
A number o f research teams have examined the effects o f supplementation with 
glucose on aspects of attention in patient populations.
Craft, Zallen and Baker (1992) assessed the effects of glucose on performance o f a 
single and two feature detection and localisation task in 21 elderly patients (mean 
age 73.5 years) with very mild, mild and probable Senile Dementia o f the 
Alzheimer Type (SDAT). Subjects were treated with glucose 50 g or saccharin 23.7 
mg, following treatment subjects completed a single feature detection task (subjects 
watched a computer screen, two rows o f geometric shapes (circles and triangles) 
appeared on the screen, subjects were required to respond y pressing the "yes" 
button if  a triangle appeared, and "no" if  it was a circle, subject shad to complete 60 
trials. In the two feature detection task, the 2 rows o f geometric shapes consisted of  
large and small circles/triangles, subjects were required to respond to the large 
triangles. It was reported that treatment with glucose facilitated performance on the
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single feature detection task, glucose had no effect on the two feature detection 
task, this was possibly due to the fact that the two feature detection task was too 
difficult for the SDAT patients.
Craft, Newcomer, Kanne, Dagogo-Jack, Cryer, Sheline, Luby, Dagogo-Jack and 
Alderson (1996) questioned whether the improvements in cognitive performance 
were attributable to the glucose or simply due to raised plasma insulin levels as a 
result o f the excess glucose intake. To examine this, the researchers assessed 
cognitive function in 21 patients with SDAT (mean age 71 years), under three 
conditions. In condition one, plasma insulin levels were maintained at 60U/ml and 
dextrose was infused to keep plasma glucose levels o f 90 mg/dl. In the second 
condition insulin levels were allowed to vary naturally and dextrose was infused to 
maintain plasma glucose levels at 225 mg/dl. Finally in the third condition both 
glucose and insulin were maintained at baseline levels (insulin 7 U/ml and glucose 
90 mg/dl). Cognitive performance was assessed 30 minutes after the blood glucose 
and insulin levels had been adjusted and stabilised for 30 minutes. Cognitive 
performance was assessed using the Stroop task. It was reported that when plasma 
insulin levels were raised and glucose levels remained at baseline there was no 
effect on performance of the Stroop task observed under any o f the 3 conditions.
7.9.1 Summary
The results o f these experiments would seem to indicate that glucose had no effect 
on attention in healthy elderly subjects whether assessed using the letter 
cancellation task (Manning et al, 1990), paced auditory serial addition task (Craft 
et al, 1994), Stroop task (Craft et al., 1994; Craft et a l, 1996), trail making tasks 
(Allen et al, 1996) or feature detection task (Craft et a l, 1992).
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Allen et al (1996) reported that subjects with poor glucose regulation had poorer 
dichotic listening performance. Suggesting that glucose may affect selective 
attention.
The results o f the effects of glucose in patient populations diagnosed with Senile 
Dementia o f the Alzheimer Type (SDAT) would seem to indicate that glucose had 
no effect on the Stroop task (Craft et al., 1996) or two feature detection task (Craft 
et al., 1992). However treatment with glucose facilitated performance on the single 
feature detection task (Craft et a l , 1992) (See table 95).
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7.10 The effect of glucose on memory function in healthy 
elderly subjects
Memory is an aspect o f cognition thought to be susceptible to fluctuations in blood 
glucose level. A number o f researchers have reported that supplementation with 
glucose significantly improved memory performance in healthy young subjects 
(Benton and Owens, 1993; Craft, Murphy and Wemstrom, 1994; Benton, Owens 
and Parker, 1994; Foster, Lidder and Sunram, 1997).
Research in diabetic patients would also seem to implicate the role o f glucose in 
memory function. Diabetes is a disease state in which the pancreas lacks the ability 
to produce insulin, or only produces small amounts o f insulin, rendering the patient 
unable to convert excess glucose into glycogen for storage. Diabetic patients suffer 
from wide fluctuations in blood glucose levels, experiencing both hypoglycaemia 
(low blood glucose level) and hyperglycaemia (high blood glucose level) both hypo 
and hyper glycaemia affect the brain.
During hypoglycaemia (when blood glucose levels fall to levels less than 2.2 
mmol/L) the brain suffers from a decrease in glucose supply which results in a state 
o f confusion, inability to concentrate and memory disturbances (Hepburn, 1992). A 
number o f studies have examined the effects o f hypoglycaemia on memory 
function in both diabetic and non diabetic subjects. All studies reported that during 
hypoglycaemia memory function is disturbed (Perlmutter, Malekeh, Hodgson- 
Harrington, Ginsberg, Katz, Singer, and Nathan, 1984; Perlmutter, Tun, Sizer, 
McGlinchey, Nathan, 1987; Kalmijn, Feskens, Launer, Stijnen and Kromhout, 
1995; Hvidberg, Fanelli, Hershey, Terkamp, Craft and Cryer, 1996)
A number o f studies have assessed the role o f glucose on memory performance in 
healthy elderly subjects.
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Gonder-Frederick, Hall, Vogt, Gox, Green and Gold (1987) assessed the impact o f  
glucose on memory performance in a sample o f 11 healthy elderly persons aged 58- 
76 years. Memory was assessed using 4 scales o f the Wechsler memory task: a 
paired associative word list (10 pairs of words, 6 easy and 4 difficult recall was 
required 24 hours after presentation), paragraph recall (subjects listened to a story 
and were required to recall the story 15 minutes after presentation), digit span 
(immediate recall of digits both forward and backward) and visual memory 
(geometric shapes were presented and subjects were required to give immediate 
recall o f the shapes). A total memory score was calculated for all subjects by 
summing the scores on the 4 subtests. Subjects were supplemented with either 
glucose (50 g) or saccharin (23.7 mg). It was found that performance on the 
paragraph recall and total Wechsler memory scores were significantly improved in 
the glucose condition. Mean scores for the paired associate word list and the visual 
memory were higher in the glucose condition, however these failed to reach 
statistical significance.
Hall, Gonder-Frederick, Chewning, Silveira and Gold (1989) assessed the effects of 
glucose on tests o f memory in 11 subjects aged 58-77 years (mean age 67.4 years). 
Subjects were treated with glucose (50 g) or saccharin (23.7 mg). Memory function 
was assessed using the same tests as Gonder-Frederick et al. (1987) a paired 
associate word list task, paragraph recall, digit span and immediate recall o f a 
visual memory task. In line with Gonder-Frederick et al (1987) it was reported that 
glucose significantly enhanced performance on the paragraph recall and total 
Wechsler memory scores. However Hall et al (1989) reported that glucose 
significantly enhanced performance on the paired associate word list task and the 
visual memory task. Gonder-Frederick et al (1989) reported a non significant trend 
towards improvement on these tasks, this lack o f significance in the Gonder- 
Frederick et al (1987) study, probably suggests that the improvement o f
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performance in the Hall et al (1989) was a weak effect, that failed to reach 
statistical significance using the same method in the Gonder-Frederick et al (1987) 
study.
Manning, Hall and Gold (1990) examined the effects o f glucose on memory 
function in 17 healthy elderly subjects aged 62-84 years, (mean age 73 years). 
Subjects were supplemented with glucose (50 g). Performance was assessed using a 
selective reminding task (a list o f 12 words were read out to subjects, they were 
asked to repeat as many as possible, the subjects then had to re-read all the words 
that they had failed to recall, they had to keep reading and recalling, until all 12 
words had been recalled, or 12 trials had been completed), paragraph recall 
(subjects were required to recall the paragraph immediately after hearing it and 
after 40 minutes) digit span, (immediate recall o f both forward digit and backward 
digit spans) and Rey-Osterrieth complex figures task, (subjects were required to 
give immediate recall o f complex figures). It was reported that glucose significantly 
improved performance on the paragraph recall task and the selective reminding task 
but had no effect on the digit span, or Rey Osterreith complex figures test.
Manning, Parsons and Gold (1992) assessed the effect o f administering glucose 
before and after the presentation o f test material. Twenty two Subjects aged 60-81 
years were given either a drink containing glucose (50 g) or saccharin (23.7 mg) 
before or after hearing the Wechsler paragraph recall task. Recall o f the passage 
was required after 24 hours. Enhanced memory performance was expected when 
subjects had received 50g glucose before hearing the passage, however the authors 
were interested to investigate whether giving glucose after the presentation o f test 
material would result in enhanced memory performance. It was found that glucose 
administration both before and after the presentation o f test material significantly 
improved the recall o f the passage even after 24 hours had elapsed between test 
points.
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Parsons and Gold (1992) assessed the effects of three doses o f glucose (10 g, 25 g 
and 50 g) on memory performance in a sample o f 10 healthy elderly subjects aged 
60-82 years. Memory was assessed using the paragraph recall task (subject had to 
give immediate recall and recall 40 minutes after presentation). Parsons and Gold 
noted that glucose enhanced performance on the paragraph recall task in inverted U  
dose response manner. Memory performance was better when subjects had 
received 25 g glucose, compared to placebo, 10 g and 50 g glucose.
Craft, Murphy and Wenstrom (1994) conducted a study which assessed the effects 
of glucose on memory performance in a sample of 32 elderly subjects aged 58-77 
years (with a mean age o f 68.5 years). The subjects were treated with glucose (50 
g) and saccharin (23.7 mg). Memory performance assessed using the paragraph 
recall task, (subjects were required to recall the story immediately after hearing it 
and after a delay o f 10 minutes), procedural memory (subjects had to complete a 
serial reaction time task, in which they had to keep their middle and index fingers 
on 4 keys, that corresponded to the 4 comers o f the computer screen, subjects had 
to press the corresponding key when an asterix appeared), pattern recall and 
recognition (subjects were presented with 3 patterns for 10 seconds, subjects had to 
reproduce the pictures immediately and after 10 minutes. Subjects were also 
required to perform a recognition task, they had to select the 3 pictures from a 
series o f 12 pictures). It was found that glucose enhanced memory performance on 
the paragraph recall task in male subjects, especially those with good glucose 
tolerance. Glucose was found to have no effect on any other memory measures.
Allen, Gross, Aloia and Billingsley (1996) assessed the effects o f glucose (50g) on 
memory function in 28 healthy elderly subjects aged 61-87 years (mean age 73 
years). Performance was assessed using the Rey/Taylor complex figures test 
(subjects had to copy complex figures from memory and recall the figures after a
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20 minute delay). It was reported that glucose administration resulted in significant 
improvements on the Rey/Taylor complex figures test.
Craft, Newcomer, Kanne, Dagogo-Jack, Cryer, Sheline, Luby, Dagogo-Jack and 
Alderson (1996) questioned whether the improvements in cognitive performance 
was attributable to the glucose or simply due to raised plasma insulin levels as a 
result o f the excess glucose intake. To examine this the researchers assessed 
cognitive function in 13 healthy adults (mean age 71 years), under three conditions. 
In condition one, plasma insulin levels were maintained at 6 U/ml and dextrose was 
infused to keep plasma glucose levels o f 90 mg/dl. In the second condition insulin 
levels were allowed to vary naturally and dextrose was infused to maintain plasma 
glucose levels at 225 mg/dl. Finally in the third condition both glucose and insulin 
were maintained at baseline levels (insulin 7 U/ml and glucose 90 mg/dl). 
Cognitive performance was assessed 30 minutes after the blood glucose and insulin 
levels had been adjusted and stabilised for 30 minutes. Cognitive performance was 
assessed using paragraph recall task (recall was required immediately and after a 10 
minute delay). It was reported that manipulating plasma insulin levels had no effect 
on memory in healthy subjects.
A number o f research teams have examined the effects o f glucose supplementation 
on aspects o f memory in patients with Senile Dementia o f the Alzheimer's Type 
(SDAT).
Craft, Zallen and Baker (1992) examined the effect o f glucose administration on 
memory performance in a sample o f 21 patients with very mild, mild and probable 
senile dementia o f the Alzheimer's type (SDAT). Patients were supplemented with 
glucose (50 g) or saccharin (23.7 mg), following supplementation cognitive 
function was assessed using a paired associate word list task (10 pairs o f words 
were presented subjects were required to provide immediate recall and after a 20
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minute filled gap); paragraph recall (immediate recall and recall after 15 minutes) 
and pattern recall and recognition (subjects were presented with 3 patterns for 15 
minutes, subjects had to reproduce the patterns immediately after seeing them and 
after 20 filled minutes, subjects were also required to perform a recognition task, 
they had to recognise the 3 pictures from a series of 12). It was reported that 
subjects with poor glucose regulation (i.e. those whose blood glucose levels 
initially rose quite rapidly and remained elevated for some time ) showed a 
significant improvement on all tasks.
Craft, Dagogo-Jack, Wiethop, Murphy, Nevins, Fleishman, Rice, Newcomer and 
Cryer (1993) tested memory performance in 22 SDAT patients under 3 glycaemic 
conditions (fasted, raised to 175 mg/ml and 225 mg/ml). Memory was assessed 
using the paragraph recall task (immediate recall and after a 20 minute delay); 
paired associate learning task (8 pairs o f words were presented to subjects, subjects 
had to recall the words immediately and after 20 minutes). It was reported that 
patients with mild SDAT showed better memory performance on the immediate 
paragraph recall task when blood glucose levels were raised to 225 mg/ml.
Manning, Ragozzino and Gold (1993) assessed the effects o f glucose 
administration on memory in a sample of 23 SDAT subjects aged 68-94 years 
(mean age 82 years). Patients received treatment with glucose (75 g) or saccharin 
(34.8 mg). Memory function was assessed using paragraph recall (immediate 
recall); word list (containing 8 words, subjects were required to give immediate 
recall); face recognition task (subjects were presented with a series o f faces, and 
were required to rate the faces as either pleasant or unpleasant, following this, 
subjects were shown a number of faces and they had to decide whether they had 
seen the faces before), and a word recognition task (subjects were presented with a 
list o f words, they had to rate whether they liked the words or not, then they were 
presented with a list o f words, subjects had to decide whether they had previously
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seen the words). It was reported that glucose treatment facilitated performance on 
the paragraph recall task, facial recognition task and the word list task.
Craft, Newcomer, Kanne, Dagogo-Jack, Cryer, Sheline, Luby, Dagogo-Jack and 
Alderson (1996) questioned whether the improvements in cognitive performance 
observed in subjects was attributable to the glucose or simply due to raised plasma 
insulin levels as a result of the excess glucose intake. To examine this the 
researchers examined cognitive function in 21 SDAT patients (mean age 71 years), 
under three conditions. In condition one, plasma insulin levels were maintained at 6 
U/ml and dextrose was infused to keep plasma glucose levels o f 90 mg/dl. In the 
second condition insulin levels were allowed to vary naturally and dextrose was 
infused to maintain plasma glucose levels at 225 mg/dl. Finally in the third 
condition both glucose and insulin were maintained at baseline levels (insulin 7 
U/ml and glucose 90 mg/dl). Cognitive performance was assessed 30 minutes after 
the blood glucose and insulin levels had been adjusted and stabilised for 30 
minutes. Cognitive performance was assessed using paragraph recall task (recall 
was required immediately and after a 10 minute delay). It was reported that when 
plasma insulin levels were raised and glucose levels remained at baseline there was 
a significant improvement in performance on the task.
7.10.1 Sum m ary
The benefits o f glucose supplementation on memory performance in healthy 
elderly subjects seem somewhat inconclusive. It would seem that glucose enhances 
performance on some memory tasks but not others.
In particular it would seem that glucose enhances performance on the paragraph 
recall task, this was true for immediate recall and recall after 10, 20 or 40 minutes 
(Gonder Frederick et a l, 1987; Hall et al., 1989; Parsons and Gold, 1992; Craft et 
al., 1994; Manning et al., 1990).
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There is conflicting evidence from tasks o f immediate memory where forming 
associations between items is crucial for task performance. For instance, Hall et al, 
(1989) noted that performance on a paired associate word list task and an 
immediate recall visual memory task showed an improvement following a glucose 
treatment, whereas Gonder Frederick et al, (1987) only noted non significant 
improvements on these tasks.
Glucose was also found to significantly' improve performance on a selective 
reminding task, much like the previous tasks requires aspects of attention, learning 
and manipulation of information, not just memory (Manning et a l, 1990). To 
conclude, glucose would seem to have beneficial effects on memory tasks that 
require the subjects to actively work on the information, either by making 
associations or learning and constantly monitoring the information.
Glucose supplementation was found to have no effect on the digit span task 
(Gonder-Frederick et al, 1987; Hall et al, 1989; Manning et al, 1990), in the digit 
span task, subjects simply have to remember digit strings in increasing length, 
performance on this task is fairly well maintained with age. Glucose also had no 
effect on the Rey Osterreith complex figures task (Manning et al, 1990), this is 
essentially a copying task, subjects are asked to look at a figure and reproduce it, 
even though some o f the figures are quite complex, all the subjects have to do, is to 
form an image of the figure and hold it in memory long enough to be able to 
reproduce the pattern, contrary findings were reported by Allen et a l, (1996).
Glucose had no effect on the procedural memory task (Craft et a l, 1994) 
essentially a sequence learning task with no verbal component, a task that is not 
expected to show the same decrement or improvement as a verbal task. Allen et al 
(1996) reported that glucose had no effect on a verbal fluency task. Glucose also
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had no effect on performance o f a pattern recall and recognition task, this is a 
highly procedural tasks that incorporates some reliance on spatial memory, and 
performance enhancement would not be expected on procedural tasks (Craft et al., 
1994).
To conclude, it would seem that glucose improves performance in healthy subjects 
on tasks which involve substantial verbal re-coding o f material, or perhaps 
comprehension o f textual material, whereas other types o f memory are not affected 
by glucose treatment.
In patient populations glucose has been shown to improve performance on the 
paragraph recall task (Craft et al., 1993; Manning et al., 1993) Craft et al., (1996) 
reported that when insulin levels were raised and glucose levels were maintained at 
baseline levels, performance on the paragraph recall task was facilitated. Poor 
glucose regulation was also associated with better paragraph recall (Craft et a l ,
1992).
Glucose supplementation has also had beneficial effect on a word list task and 
facial recognition task (Manning et al., 1993).
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7.11 The effect of glucose on the speed of information 
processing in healthy elderly subjects
There have been no studies where the effects of glucose supplementation have been 
examined on tasks assessing the speed of information processing in healthy elderly 
subjects. However, it would be expected that results of such experiments would 
mirror results o f glucose supplementation on aspects o f attention. As tasks that 
assess the speed o f information processing, often involve aspects o f attention.-
Reaction time has been used as a measure o f the speed o f information processing in 
healthy young subjects, generally it has been reported that performance on a choice 
reaction time task is improved following glucose treatment (Benton and Owens,
1993).
Reaction time has been assessed in elderly diabetic subjects, the consensus of 
opinion is that low blood glucose concentration impairs aspects o f reaction time, 
particularly choice reaction time (Kerr, MacDonald and Tattersall 1991; Maasen, 
Lingenfelser, Gluck, Renn, Eggstein, and Jakober, 1990).
Benton, Owens and Parker (1994) assessed the effect o f glucose on performance of 
a rapid information processing task (RIPT) in seventy female subjects with a mean 
age o f 21.4 years. Subjects were treated with either two 50g glucose or placebo 
drinks subjects completed the RIPT for 20 minutes. The rapid information 
processing task required the subjects to monitor a computer screen, in which 
numbers were randomly flashed, subjects had to press the space bar when 3 odd or 
3 even numbers appeared consecutively, response times and the number o f correct 
and incorrect responses were recorded. It was found that reaction times on the RIPT 
were faster in subjects who had received the glucose drink or had higher blood 
glucose levels.
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Moser, Plum and Buckman (1983) assessed the effects o f glucose supplementation 
(25 g and 50 g) on reaction time in a sample o f 21 subjects aged 19-31 years. 
Subjects completed the reaction time task for 45 minutes, it was reported that 
glucose enhanced reaction times.
Owens and Benton (1993) assessed the effects o f glucose on reaction time in 96 
young adults (mean age 21.2 years). Subjects were treated with glucose (50 g) or 
placebo. Performance was assessed using a choice reaction time task. It was 
reported that glucose facilitated performance on the task, in particular it was 
reported that subjects with increasing blood glucose levels had faster decision times 
than subjects with falling blood glucose levels.
7.11.1 Sum m ary
There have been no studies examining the effect o f glucose supplementation on 
tasks assessing the speed o f information processing in healthy elderly subjects. 
However there have been studies examining the effects o f glucose on reaction time 
in healthy young populations. These have reported that reaction times have 
improved following treatment with glucose.
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7.12 The effect of glucose on mood in elderly subjects
There is some evidence to suggest that glucose can affect subjective mood ratings, 
this is primarily based on the fact that glucose interacts with the synthesis and 
functions o f a number of neurotransmitters namely acetylcholine, dopamine and the 
opiates. It is generally assumed that low blood glucose levels are associated with 
increased ratings of tiredness, tension and irritability (Gold, MacLeod, Frier and 
Dreary, 1995).
There have been no studies conducted, examining the effects o f glucose on mood in 
healthy elderly subjects. However three studies have examined the effects in 
healthy young subjects. Benton and Sargent (1982) assessed blood glucose and 
mood in a sample of young healthy males with no previous history o f aggressive 
behaviour. It was found that the subjects reported higher self ratings o f aggression 
when blood glucose levels were less than 2.2 mmol/L.
Owens, Parker and Benton (1997) assessed the effect o f glucose on mood in 96 
young healthy subjects aged 17-27 years. It was reported that subjects with falling 
blood glucose levels had lower energy scores than subjects with rising blood 
glucose levels. Benton and Owens (1993) assessed the effect o f glucose on mood in 
354 subjects with a mean age of 21.7 years. Mood was assessed using the 
Activation-Deactivation check list (AD-ACL). It was reported that subjects with 
rising blood glucose levels reported higher energy scores and lower tension scores 
than subjects with falling blood glucose levels.
7.12.1 Summary
In healthy adult populations it has been reported that low blood glucose is 
associated with higher ratings of aggression (Benton and Sargent, 1982) lower
311
energy scores (Owens, Parker and Benton, 1997) and higher tension scores (Benton 
and Owens, 1993).
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7.13 Conclusions
To summarise it would seem that aspects o f cognition and mood can be 
enhanced following the intake o f a glucose drink. In elderly subjects glucose 
appears to facilitate aspects o f memory function to a greater extent than non­
memory tasks.
7.14 Aims of the present study: Assessing the effects 
of glucose administration on cognitive function 
and mood in a healthy elderly population
The aim o f this study was to examine the effect o f a single 50 g dose of glucose 
on cognitive and psychomotor performance in a sample o f 24 healthy elderly 
subjects aged 64-84 years. Cognitive function was assessed prior to and 
following the administration o f glucose and saccharin drinks. Tasks assessing 
attention included (HPRU SMT, SKT IV, V, VI, VII), memory recall (word list 
SKT II, VIII,), recognition memory (SKT IX), speed of information processing 
(CFF, RRT, MRT, and TRT), speed o f naming (SKT I, III), and mood (Profile 
of Mood States).
On the basis o f previous findings we would expect glucose to improve 
performance on verbal memory tasks requiring subjects to actively work on the 
information i.e. perform substantial verbal re-coding, or comprehension o f  
textual materials. In terms o f the tasks included in the present study glucose was 
expected to enhance performance on the word list task, SKT II (immediate 
recall), SKT VIII (delayed recall) and SKT IX (recognition memory). In terms 
of mood, it was expected that when supplemented with glucose, subjects would 
feel more energetic and less tense than when supplemented with saccharin.
Based on previous literature, significant improvements would not expected on 
SKT V (arranging blocks), SKT V (replacing blocks) SKT VI (counting 
symbols), SKT VII (reverse naming task), SKT I (object naming) and SKT III
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(numerical naming) or the HPRU Sternberg Memory Task (SMT). Glucose was 
expected to induce improvements on the Critical Flicker Fusion task (CFF ), 
Choice Reaction Time (CRT).
7.15 Method
7.15.1 Subjects
24 healthy volunteers (12 male and 12 female) aged 64-84 (mean age 69.66 
years) participated in the study. Subjects were in good mental and physical 
health, and were not taking any concomitant medication that would affect 
performance on the test measures. Subjects were recruited from the general 
public via the HPRU subject database and poster advertisements.
7.15.2 Treatm ents
The treatments were in the form a 16 fl oz caffeine-free fruit flavoured drink 
sweetened with either glucose (50 g) or saccharin (23.7 mg). A double-blind 
crossover design was adopted, therefore subjects received both treatments. Both 
drinks were identical in colour, taste and mouth feel. Treatments were separated 
by at least 48 hours.
7.15.3 Procedure
Subjects attended the unit for a period of 3 visits, a training/familiarisation visit 
and 2 experimental visits (glucose and saccharin). Subjects entered the unit 
fasted (for a minimum of 3 hours) underwent a baseline test assessment 
comprising the Critical Flicker Fusion Task (CFF), Choice Reaction time 
(CRT), HPRU Sternberg Memory Task (SMT), The Syndrom Kurtz Task 
(SKT), 15 item word list (WLT) and Profile o f Mood States (POMS).
Following the baseline testing, subjects received a fruit flavoured drink 
sweetened with either 50 g glucose or saccharin 23.7 mg, following a break of 
30 minutes in which time the subject sat quiet waiting for the glucose to enter
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the bloodstream, subjects then underwent another test battery (consisting o f the 
same tasks used in the baseline tests battery, using different forms o f the SKT 
and a different word list, the order was counterbalanced).
Three blood glucose measures were taken, at baseline, 30 minutes post dose, 
and at the end of the experimental psychometric assessment (50 minutes post 
dose).
The same procedure was conducted for both glucose and placebo treatments.
7.15.4 A ssessm en ts
7.15.5 Critical Flicker Fusion Task (CFF)
The critical flicker fusion task (CFF) is regarded as an index o f overall CNS 
activity, the ability of the central nervous system to process discrete 'bits' o f 
information Hindmarch (1980). Therefore an increase in CFF threshold is 
associated with increased alertness and a greater capacity for information 
processing.
7.15.6 Choice Reaction Time Task (CRT)
The choice reaction time task (CRT) is used as an indicator o f sensorimotor 
performance, assessing the efficiency o f the attentional and response 
mechanisms in the information processing chain. The task is comprised o f three 
components recognition reaction time (RRT), motor reaction time (MRT) and 
total reaction time (TRT).
7.15.7 HPRU Sternberg Memory Task (SMT)
The HPRU Sternberg memory task is a technique based upon a reaction time 
method where subjects are required to memorise a set o f target digits. In the 
HPRU version of the task subjects had to attend to the stimulus set (consisting
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of sets o f 1, 3 and 5 digit strings) memory scanning ability is assessed with the 
presentation of 12 single probe digits.
7.15.8 Syndrom Kurtz Task (SKT)
The SKT task is comprised o f 9 subtasks assessing aspects o f attention, memory 
and the speed o f information processing. Attention is assessed using SKT 
Rearranging blocks), SKT V (replacing blocks), SKT VI (counting symbols) 
and SKT VII (reverse naming). Memory is assessed using SKT II (immediate 
recall), SKT VIII (delayed recall), SKT IX (recognition memory). The speed of 
naming assessed using SKT I (object naming) and SKT III (numerical naming).
7.15.9 Word List Task (WLT)
In the word list task, subjects were required to memorise a list o f 15 words each 
having 6 letters and 2 syllables. Words were presented aurally (via headphones) 
at the rate o f 1 per second. Immediately after hearing the list, subjects were 
required to write down the names o f as many famous people as possible (e.g. 
film stars, authors, politicians, heads o f state etc) in a 30 second period. 
Immediately after this, subjects were required to recall as many words as 
possible.
7.15.10 Profile of Mood S tates (POMS)
The Profile o f Mood States was designed by McNair, Lorr and Droppleman, 
(1992) as a subjective assessment o f mood. The scale assesses six affective 
states, tension-anxiety, depression-dejection, anger-hostility, vigour-activity, 
fatigue-inertia, confusion-bewilderment. Subjects are presented with a list o f 65 
mood adjectives, subjects are required to rate each item, as to how they have felt 
over the past week, using a 5 point scale.
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7.15.11 Blood G lucose A ssessm en t
Blood glucose was measured using an Accutrend blood glucose meter. The 
meter uses an enzymatic sensor to assess the level o f glucose in the blood. A 
single pin prick o f blood is used to obtain a measurement o f peripheral blood 
glucose level which is believed to reflect the glucose concentration in the brain 
(Lund-Anderson, 1979). Blood glucose was assessed at the beginning o f the 
experiment, 30 and 50 minutes after the glucose drink.
7.16 Results
The data were analysed using a two way analysis o f variance (ANOVA) with 
treatment and visit as a within subject factors
7.16.1 Blood g lucose level
Blood glucose concentration was assessed at baseline, 30 minutes and 50 
minutes post dose. The blood data were analysed to determine the main effects 
of treatment and time.
There was a main effect o f treatment (F (i, 23) = 23.38; p<0.0001) blood glucose 
levels in the glucose treated group were significantly higher than blood glucose 
measurements in the placebo group. There was a main effect o f time (F (i, 2 3 ) =  
4.03; p <0.05) blood glucose measurements changed significantly over the three 
test points (baseline, post 30 minutes and post 50 minutes). There was a 
significant treatment and time interaction (F (2 ,4 6) = 5.79; p <0.005).
Post hoc testing of the drug time interaction using the Newman Keul's task 
revealed that there were no significant differences between the blood glucose 
measurements at baseline, however at post treatment 30 and 50 minutes, the 
glucose treated group had significantly higher blood glucose levels (p<0.05). 
(See Figure 61)
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The change in blood glucose level
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Figure 61: The change in blood glucose level over tim e (* p<0.05).
7.17 The effect of glucose on psychometric task 
performance
The effect o f treating subjects with a glucose drink resulted in a significant 
increase in blood glucose level. What is o f importance is, whether an increase in 
blood glucose level has an effect on psychometric performance. It was 
postulated that higher blood glucose levels would result in superior 
psychometric performance compared to lower blood glucose levels, hence 
performance following the glucose treatment was expected to be superior than 
performance following the placebo treatment.
The data were analysed using a 2 way analysis o f variance with treatment and 
visit as within subjects factors.
The performance data were analysed in terms of the cognitive groupings 
identified in chapter 4. The groupings included:-
1. Attention (HPRU Sternberg memory task (SMT), SKT subtests IV, V, VI 
and VII)
2. Memory Recall (SKT subtests II and VIII)
3. Speed of naming (SKT subtests I, III)
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4. Speed of information processing (CFF, TRT, RRT, and MRT)
5. Recognition memory (SKT subtest IX)
The study also examined the effect of glucose on mood assessed using the 
Profile o f mood states (POMS). Six mood states were assessed these included 
(tension, depression, anger, vigour, fatigue and confusion).
7.18 The effect of glucose on attention
In chapter 4 the effects o f ageing were examined on tasks that assessed 
attention, it was concluded that as age increases performance on the tasks 
declined. In chapter 4 tasks classed as assessing attention included SKT subtests 
IV, V, VI, VII and the HPRU Sternberg Memory Task (SMT).
7.18.1 SKT su b te s t IV (arranging blocks)
In this task subjects had to arrange 10 random numbered blocks into ascending 
order, the time taken to complete the task was recorded.
There was no main significant effect of treatment (F (i, 23) = 0.83; p > 0.05), time 
taken to arrange blocks was comparable for both the glucose and placebo 
treatments (see Table 99).
Table 99: Showing treatm ent m eans (seconds).
Baseline Post dose
Glucose 19.28 19.08
Placebo 18.70 18.70
There was no significant time effect (F (i, 23) = 0.04; p > 0.05) there was no 
significant change in performance over time. There was no interaction between 
treatment and time (F (i, 23) = 0.03; p > 0.05).
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7.18.2 SKT su b te s t V (replacing blocks)
In this task, subjects had to replace the 10 blocks to their original starting 
position, (which was marked on the magnetic board).
There was no main significant effect of treatment (F (i, 23) = 4.22; p = 0.05) time 
taken to replace the blocks was comparable for both the glucose and placebo 
treatments (see Table 100).
Table 100: Showing treatm ent m eans (seconds).
Baseline Post dose
Glucose 14.91 14.33
Placebo 13.58 14.08
There was no significant time effect (F (i, 23) = 0.01; p > 0.05) there was no 
significant change in performance over time. There was no interaction between 
treatment and time (F (1, 23) = 1-42; p > 0.05).
7.18.3 SKT su b te s t VI (counting sym bols)
In this task, subjects had to count the number of circles on a sheet which 
consisted of a number of symbols (e.g. circles, flowers etc.) time taken to 
complete this task was recorded.
There was no main significant effect of treatment (F (1, 2 3) = 3.37; p = 0.07), time 
taken to count symbols was comparable for both the glucose and placebo 
treatments (see Table 101).
Table 101: Showing treatm ent m eans (seconds).
Baseline Post dose
Glucose 19.25 19.00
Placebo 19.79 20.16
321
There was no significant time effect (F (i, 23) = 0.03; p > 0.05) there was no 
significant change in performance over time. There was no interaction between 
treatment and time (F (1, 23) = 1-09; p > 0.05).
7.18.4 SKT su b te s t VII (reverse naming task)
In this task, subjects had to perform a reverse naming task, in which they were 
presented with 2 rows of letters (e.g. abbaabaab) every time the subjects read 
the letter A they had to say B and when they read B they had to say A. Time 
taken to complete the task was recorded.
There was no main significant effect o f treatment (F (i, 23) = 0.03; p > 0.05), time 
taken to perform a reverse naming task was comparable for both the glucose 
and placebo treatments (see Table 102).
Table 102: Showing treatm ent m eans (seconds).
Baseline Post dose
Glucose 21.45 21.50
Placebo 21.45 21.75
There was no significant time effect (F (i, 2 3) = 0.13; p > 0.05) there was no 
significant change in performance over time. There was no interaction between 
treatment and time (F (i, 23) = 0.06; p > 0.05).
7.18.5 HPRU Sternberg Memory Task (SMT)
In this task subjects had to memorise a memory set (varying in size from 1 digit, 
3 digits and 5 digits). Following the memory set, a random series of 12 digits 
were presented, subjects were required to state whether the digit presented was 
a part of the memory set, by pressing the "yes" response button and "no" if it 
wasn't. The time taken to respond was recorded.
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There was no main effect o f treatment (F (i, 23) = 0.59; p >0.05) performance on
the Sternberg memory task was comparable in both the glucose and placebo
treatments (see Table 103).
Table 103: Showing treatment means (milliseconds).
Baseline Post dose
Glucose 1036.37 1006.58
Placebo 1062.58 1005.20
There was a main effect of time (F (i, 23) = 15.08; p<0.001) performance of the 
task significantly improved over time, possibly reflecting a learning/familiarity 
effect. (See Figure 62) There was no interaction between treatment and time (F 
(1,2 3) = 1-03; p>0.05).
The Effect Of Time On Performance Of The Sternberg 
Memory Task
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Figure 62: The main effect of time on performance of the Sternberg Memory Task
(SMT).
7.18.6 Sum m ary
In line with the previous research examining the effect o f glucose on attention 
in healthy elderly subjects, there were no beneficial effects reported on tasks 
assessing attention, following glucose administration.
Baseline Post dose
Time
0  Baseline
7.19 The effect of glucose on memory recall
In chapter 4 the effects o f ageing on tasks that assess memory recall were 
assessed, it was concluded that there was no main effect o f age o f performance 
of memory recall. In chapter 4 tasks classed as assessing memory recall 
included SKT subtests II (immediate recall), and SKT subtest VIII (delayed 
recall) and recall of a 15 item word list was also examined.
7.19.1 SKT su b te s t II (immediate recall)
Subjects were required to provide immediate recall of 12 previously named 
objects, the number of forgotten items and time taken to complete the task were 
recorded (maximum time allocated was 1 minute).
There was no main significant effect of treatment (F (i, 23) = 0.15; p > 0.05), 
there was no significant difference in immediate memory for glucose or placebo 
treatments (see Table 104).
Table 104: Showing treatment means (number of omissions).
Baseline Post dose
Glucose 4.66 5.83
Placebo 4.79 5.50
There was a significant time effect (F (i, 23) = 11.37; p < 0.005) there was a 
significant change in performance over time, performance on the task 
deteriorated over time, so that subjects forgot more items in the post dose 
assessment this was possibly attributable to interference from the baseline 
assessment (see Figure 63).There was no interaction between treatment and 
time (F (1, 23) = 0.71; p > 0.05).
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The effect of time on immediate recall
Baseline 30 minutes post
dose
Time
Figure 63: The main effect of time on immediate recall of 12 objects.
7.19.2 SKT su b te s t VIII (delayed recall)
Subjects were required to provide delayed recall of 12 previously named 
objects, some 10 minutes after initial presentation. The number of forgotten 
items and time taken to complete the task were recorded.
There was a significant main effect o f treatment (F (i, 23) = 5.92; p < 0.05), there 
was a significant difference in delayed memory performance between the 
glucose and placebo treatments. Subjects in the glucose group forgot more 
items/objects than subjects in the placebo condition. There was a significant 
time effect (F (i, 23) = 20.31; p < 0.0001) there was a significant change in 
performance over time, subjects forgot more objects in the post treatment 
assessment, this was possibly attributable to interference from the baseline 
assessment, as a different set of pictures had been presented at the baseline test 
point. With baseline mean equal to 4.60 items forgotten, and post dose mean 
equal to 6.04 items forgotten. There was no interaction between treatment and 
time (F (i;2 3) = 2.98; p > 0.05).
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The main effect of treatment on a delayed recall task
Placebo Glucose
Treatment
Figure 64: The main effect of treatment on delayed recall of 12 pictures.
7.19.3 Word list recall
Subjects were presented aurally with 15 six lettered words, the words were 
presented 1 per second. Following presentation, to prevent rehearsal, subjects 
had 1 minute in which to write down the names of famous people (e.g. 
politicians, actors, authors etc.). Following this the subjects had to write down 
as many of the 15 words as possible, recall time was not restricted. The number 
of words recalled were recorded.
There was no main effect o f treatment (F (i, 2 3) = 1.17; p >0.05), word list recall 
was comparable in both the glucose and placebo treatments (see Table 105).
Table 105: Showing treatment means (correct responses).
Baseline Post dose
Glucose 3.91 3.33
Placebo 3.37 3.08
There was no main effect o f time (F (i, 23) = 2.00; p>0.05) there was no change 
in performance over time. There was no interaction between treatment and time 
(F (1,23) = 2.53; p>0.05).
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7.19.4 Sum m ary
There were no effects of glucose administration on performance o f the word list 
task, or on immediate recall o f the 12 pictures. In terms o f delayed recall (SKT 
subtest VIII), glucose had a negative impact, subjects forgot more pictures when 
they were treated with glucose, these negative effects are possibly due to 
interference from previously presented pictures, this is backed up by the fact 
that subjects forgot more items over time.
7.20 The effect of glucose on the speed of naming
In chapter 4 the effects o f ageing on tasks that assess the speed o f naming were 
assessed, it was concluded that there was no main effect o f age on tasks 
assessing the speed o f naming. In chapter 4 tasks classed as assessing speed of 
naming included SKT subtests I (object naming), and SKT subtest III 
(numerical naming).
7.20.1 SKT su b te s t I (object naming)
Subjects were presented with 12 pictures of objects, they had to name the 
objects and try to commit them to memory, as they were to be recalled at a later 
date.
There was no main significant effect o f treatment (F (i, 23) = 1-07; p > 0.05), time 
taken to complete the object naming task was comparable for both the glucose 
and placebo treatments (see Table 106).
Table 106: Showing treatment means (seconds).
Baseline Post dose
Glucose 14.00 14.87
Placebo 14.58 15.54
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There was no significant time effect (F (i, 23) = 2.78; p > 0.05) there was no
significant change in performance over time. There was no interaction between
treatment and time (F (1,23) = 0.0007; p > 0.05).
7.20.2 SKT su b te s t III (naming num erals)
Subjects were required to name 10 numbered blocks, the time taken to name the 
blocks were recorded.
There was no main significant effect of treatment (F (1, 2 3) = 0.15; p > 0.05), time 
taken to name numerals was comparable for both the glucose and placebo 
treatments (see Table 107).
Table 107: Showing treatment means (seconds).
Baseline Post dose
Glucose 7.20 6.70
Placebo 7.37 7.25
There was no significant time effect (F (i; 23) = 1.66; p < 0.05) there no 
significant change in performance over time. There was no interaction between 
treatment and time (F (i; 23) = 0.71; p > 0.05).
7.20.3 Sum m ary
There were no effects o f glucose on the speed o f naming, assessed using the 
SKT subtests I (object naming) and III (numerical naming).
7.21 The effect of glucose on the speed of information 
processing
In chapter 4 the effects o f ageing on tasks that assessed information processing 
were assessed, it was concluded that there was no main effect o f age o f  
performance o f information processing tasks. In chapter 4 tasks classed as 
assessing speed of information processing included the Critical Flicker Fusion
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Task (CFF), Total Reaction Time (TRT), Recognition Reaction Time (RRT) 
and Motor Reaction Time (MRT).
7.21.1 Critical Flicker Fusion (CFF)
Critical flicker fusion threshold was determined by subjects completing 3 
ascending and 3 descending trials, the mean of all 6 presentations were 
recorded.
There was no main effect o f treatment (F (i, 22) = 0.00; p>0.05) performance of 
the critical flicker fusion task was comparable in both the glucose and placebo 
treatments (see Table 108).
Table 108: Showing treatment means (Hz).
Baseline Post dose
Glucose 29.71 28.93
Placebo 29.60 29.22
There was a main effect o f time (F (i, 23) = 11.56; p<0.01) there was a significant 
change in performance over time performance on the task decreased in the post 
treatment assessment, possibly reflecting a fatigue/boredom effect (see figure 
65). There was no interaction between treatment and time (F (i, 2 3) = 2.78; 
p>0.05).
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The main effect of time on the Critical Flicker Fusion Task
(CFF)
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Figure 65: The main effect of time on the critical flicker fusion task (CFF).
7.21.2 Total Reaction Time (TRT)
Subjects completed the choice reaction time task, subjects placed their index 
finger on a home key, and the task was to extinguish illuminated lights, by 
moving their finger from the home key to press a button placed directly under 
the illuminated light, subjects were required to respond to 20 stimuli 
illuminating 1 of 6possible lights. Total reaction time was defined as the sum of 
both recognition and motor reaction time.
There was no main effect of treatment (F (i, 2 0) = 1-37; p>0.05) total reaction 
time was comparable in both the glucose and placebo treatments (see Table 
109).
Table 109: Showing treatment means (milliseconds).
Baseline Post dose
Glucose 682.35 674.25
Placebo 704.97 721.10
There was no main effect o f time (F (i, 20) = 0.21; p>0.05) there was no 
significant change in performance over time. There was no interaction between 
treatment and time (F (i, 20) = 0.27; p>0.05).
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7.21.3 Recognition Reaction Time (RRT)
Recognition reaction time was defined as the time taken for the subjects to 
realise that a light was illuminated, and lift their finger from the home key.
There was no main effect o f treatment (F (i, 2 0) = 0.14; p>0.05) recognition 
reaction time was comparable in both the glucose and placebo treatments (see 
Table 110).
Table 110: Showing treatment means (milliseconds).
Baseline Post dose
Glucose 460.31 439.48
Placebo 449.69 471.37
There was no main effect o f time (F (i, 2 0) = 0.07; p>0.05) there was no 
significant change in performance over time. There was no interaction between 
treatment and time (F (1, 20) = 1-09; p>0.05).
7.21.4 Motor Reaction Time (MRT)
Motor reaction time was defined as the time taken for the subjects to move their 
finger from the home key, to touch the button placed directly under the 
illuminated light.
There was no main effect o f treatment (F (i, 2 0) = 2.38; p>0.05) motor reaction 
time was comparable in both the glucose and placebo treatments (see Table 
in).
Table 111: Showing treatment means (milliseconds).
Baseline Post dose
Glucose 233.66 234.77
Placebo 271.81 249.73
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There was no main effect o f time (F (i, 20) = 0.46; p>0.05) there was no
significant change in performance over time. There was no interaction between
treatment and time (F (1,20) = 0.04; p>0.05).
7.21.5 Sum m ary
Glucose administration was found to have no effect on tasks assessing the speed 
of information processing (CFF, TRT, RRT or MRT).
7.22 The effect of glucose on recognition memory
In chapter 4 the effects of ageing on tasks that assess recognition memory were 
assessed, it was concluded that there was no main effect o f age on recognition 
memory. In chapter 4 the SKT subtest IX was classed as assessing recognition 
memory.
7.22.1 SKT su b te s t IX (recognition memory)
In the recognition memory test, subjects had to recognise the 12 original 
pictures (presented in subtest I) from a series of 48 pictures. The number of 
omissions were recorded.
There was no main effect o f treatment (F (i, 2 3) — 0.07; p>0.05) recognition 
memory was comparable in both the glucose and placebo treatments (see Table 
112).
Table 112: Showing treatment means (number of omissions).
Baseline Post dose
Glucose 1.00 1.08
Placebo 0.87 1.33
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There was no main effect o f time (F (i, 23) = 1-68; p>0.05) there was no
significant change in performance over time. There was no interaction between
treatment and time (F (1,23) = 0.92; p>0.05).
7.22.2 Sum m ary
Glucose had no effect on recognition memory.
7.23 The effect of glucose on subjective mood ratings - 
The Profile of Mood States (POMS)
Subjective mood is an aspect o f human functioning that is thought particularly 
susceptible to fluctuations in blood glucose concentration. Diabetic subjects 
often experience feelings of tension, confusion and fatigue, when blood glucose 
concentrations fall to less than 2.2 mmol/L. This experiment assessed the 
impact o f glucose on subjective ratings o f tension, depression, anger, vigour, 
fatigue, confusion.
7.23.1 Tension
There was no main effect o f treatment, however it approached significance (F (i, 
2 3) = 3.84; p = 0.06) tension scores were comparable between glucose and 
placebo treatments (see Table 113).
Table 113: Showing tension treatment means.
Baseline Post dose
Glucose 7.33 5.50
Placebo 5.54 4.75
There was a main effect of time (F (i, 23) = 0.92; p <0.05) there was a significant 
change in tension scores over time, tension scores were lower in the post 
treatment assessment, possibly due to the fact that the subjects had adapted to 
the testing situation at the post treatment assessment. (See figure 6 6 ). There was 
no interaction between treatment and time (F (i, 23) = 0.92; p>0.05).
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Figure 66: The main effect of time on subjective ratings of tension.
7.23.2 Depression
There was no main effect o f treatment (F (i, 23) =2.62; p > 0.05) depression 
scores were comparable between glucose and placebo treatments (see Table 
114).
Table 114: Showing depression treatment means.
Baseline Post dose
Glucose 6.87 5.25
Placebo 4.20 3.87
There was no main effect of time (F (i, 2 3) = 3.69; p = 0.06) there was no 
significant change in depression scores over time. There was no interaction 
between treatment and time (F (i,23) = 1-65; p>0.05).
7.23.3 Anger
There was no main effect o f treatment (F (i, 23) = 0.36; p > 0.05) anger scores 
were comparable between glucose and placebo treatments (see Table 115).
The main effect of time on ratings of tension
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Table 115: Showing anger treatment means.
Baseline Post dose
Glucose 2 . 0 0 1.54
Placebo 1.62 1.33
There was no main effect o f time (F (i, 2 3) = 0.85; p > 0.05) there was no 
significant change in anger scores over time. There was no interaction between 
treatment and time (F (i, 23) = 0.04; p>0.05).
7.23.4 Vigour
There was a main effect of treatment (F (i, 2 3) = 6.37; p < 0.01) there was a 
significant difference in vigour scores between glucose and placebo treatments 
vigour scores were higher following the placebo treatment (see Figure 67). 
There was no main effect o f time (F (i, 2 3) -  0.30; p > 0.05) there was no 
significant change in vigour scores over time. There was no interaction between 
treatment and time (F (i, 23) = 0.00; p>0.05).
The main effect of treatment on ratings of vigour
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Figure 67: The main effect of treatment on vigour scores.
7.23.5 Fatigue
There was no main effect of treatment (F (i, 2 3) = 3.22; p > 0.05) fatigue scores 
were comparable between glucose and placebo treatments (see Table 116).
Glucose Placebo
Treatment
■  Glucose 
EQ Placebo
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Table 116: Showing fatigue treatment means.
Baseline Post dose
Glucose 5.70 6.37
Placebo 4.70 4.87
There was no main effect o f time (F (i, 2 3) = 0.47; p >0.05) there was no 
significant change in fatigue scores over time. There was no interaction between 
treatment and time (F (i, 2 3 ) = 0.11; p>0.05).
7.23.6 Confusion
There was no main effect o f treatment (F (i, 23) = 1.05; p > 0.05) confusion 
scores were comparable between glucose and placebo treatments (see Table 
117).
Table 117: Showing confusion treatm ent means.
Baseline Post dose
Glucose 7.66 8.08
Placebo 7.41 6.83
There was no main effect o f time (F (i, 2 3) = 0.02; p > 0.05) there was no 
significant change in confusion scores over time. There was no interaction 
between treatment and time (F (i, 23) = 0.95; p>0.05).
7.23.7 Sum m ary
Overall higher blood glucose levels did not result in performance 
improvements. Glucose administration had no effect on attention, memory, 
speed of naming, information processing or subjective ratings o f mood, contrary 
to previous research.
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7.24 The effect of blood glucose level on psychometric 
performance
There is some evidence to suggest that the beneficial effects o f treatment with 
glucose is often dependant on the person's ability to tolerate glucose. For 
example Allen et al (1996) reported that elderly subjects with poor glucose 
control (which was defined as a change in blood glucose following a glucose 
drink o f greater than 1 0 0  mg dLi) had poorer performance on a dichotic 
listening task. Benton and Owens (1993) it was reported that subjects with 
rising blood glucose levels remembered more words on a word list than subjects 
with falling blood glucose levels.
Based on these results, it was questioned whether there would be differences 
between performance in subjects whose blood glucose rose or fell between the 
second and third blood glucose assessments (30 and 50 minutes post dose). All 
subjects in the glucose condition were classified as either risers (n = 15) or 
fallers (n = 9). Data was analysed using a two way ANOVA with change in 
blood glucose level (rising or falling) and task performance as variables.
It was reported that there was a significant difference between the Sternberg 
memory task performance in terms o f the change in blood glucose levels. It 
was reported that performance in subjects with falling blood glucose levels had 
superior performance to subjects with rising blood glucose level (F (1,2 3) = 6.47; 
p<0.05). (See table 118)
Table 118: The effect o f blood glucose level (rising or falling) on Sternberg M em ory
perform ance.
Blood Glucose Rising Blood Glucose Falling
Sternberg Memory Task 1034.35 967.7
There were no significant differences between risers and fallers on any o f the 
other psychometric tasks.
337
In terms of mood, there was a significant difference between the subjective 
ratings of vigour and fatigue. It was reported that subjects with falling blood 
glucose levels felt more vigorous (F (i, 2 3) = 5.46; p<0.05) and less fatigued (F (i, 
23) = 6.49; p<0.05) than subjects with rising blood glucose levels (see table 119).
Table 119: Showing the mean fatigue and vigour ratings for subjects w ith  rising or
falling blood glucose levels.
Blood Glucose Rising Blood Glucose Falling
Fatigue 24.0 4.0
Vigour 15.70 16.00
7.25 The effect of hypoglycaemia on psychometric 
performance
Previous researchers, examined the level of blood glucose and its effect on 
performance. It is generally assumed that low blood glucose levels have a 
detrimental effect on cognitive functioning. To explore this claim, psychometric 
test performance and mood measures were compared in subjects with blood 
glucose levels less than 2.2 mmol/L with psychometric test measures and mood 
scores from subjects with blood glucose levels greater than 2.2 mmol/L.
The baseline data were analysed using a 2 way analysis o f variance with blood 
level (blood levels less than 2.2 mmol/L compared with blood levels greater 
than 2.2 mmol/L) and test performance as variables (CFF, CRT, SMT, and word 
list)
It was found that hypoglycaemic subjects were significantly slower at the 
Sternberg memory task than subjects with normal blood glucose concentrations 
(F (i, 19) = 8.21; p<0.05). Performance on the immediate recall task (SKT subtest 
n) was poorer in subjects with hypoglycaemic blood glucose levels. 
Performance on all other memory tasks was also worse for subjects with 
hypoglycaemic blood glucose levels, however these failed to reach statistical
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significance. There were no significant differences between the two groups of 
subjects on any of the other psychometric tests (See Tables 120-123).
7.25.1 The effect of blood glucose level on attention
Table 120: Showing the effect o f blood glucose level on attention.
Psychometric 
test score
Hypoglycaemic Normal blood 
glucose level
Level of Significance
SMT 1145.22 ms 1018.83 ms F (i, 19) = 8.21 p<0.05
SKT IV 19.33 seconds 18.33 seconds F (1 ,2 2 )= 0.41 p>0.05
SKT V 14.55 seconds 13.00 seconds F (1 ,2 2 )= 2.62 p>0.05
SKT VI 19.77 seconds 19.80 seconds F (1 ,2 2 )= 0.00 p>0.05
SKT VII 21.22 seconds 21.60 seconds F (i,2 2 )= 0.03 p>0.05
7.25.2 Summary
Low blood glucose levels was associated with significantly slower reaction 
times on the Sternberg Memory Task, low blood glucose levels had no effect on 
any other measures of attention (SKT, IV, V, VI, VII).
7.25.3 The effect of blood g lucose level on m em ory
Table 121: Showing the effect o f blood glucose level on m em ory recall and
recognition.
Psychometric 
test score
Hypoglycaemic Normal blood 
glucose level
Level of Significance
Word List 
(delayed)
2.55 words 3.75 words F (i, i9)= 0.25; p>0.05
SKT II 6.00 omissions 4.06 omissions F (1 ,2 2 )= 10.29 p<0.05
SKT VIII 4.88 omissions 3.53 omissions F (i, 2 2) = 3.21 p>0.05
SKT IX 1.22 omissions 0.66 omissions F (1 ,2 2 )= 1.42 p>0.05
7.25.4 Summary
Low blood glucose levels were associated with significantly poorer 
performance on immediate recall o f 12 pictures, low blood glucose levels were 
associated with poorer memory performance on all other measures word list,
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delayed recall or recognition memory, however the differences failed to reach 
statistical significance.
7.25.5 The effects of blood g lucose on the speed  of information 
processing
Table 122: The effect o f blood glucose level on the speed o f inform ation processing.
Psychometric 
test score
Hypoglycaemic Normal blood 
glucose level
Level of Significance
CFF 29.47 Hz 29.70 Hz F (i, 19) = 0.03; p>0.05
RRT 416.20 ms 478.71 ms F (i, 19) = 1.76; p>0.05
MRT 267.85 ms 273.59 ms F a, 19) = 0 .0 1 ; p>0.05
TRT 684.06 ms 721.98 ms F a, 19)= 0.63; p>0.05
SKT Total 0 . 8 8  total score 0.60 total score F (i, 2 2 )= 0.71 p>0.05
7.25.6 Sum m ary
There were no significant differences between performance o f tasks assessing 
the speed o f information processing for subjects with low or high blood glucose 
level.
7.25.7 The effect of blood g lucose on the speed  of naming
Table 123: Showing the effect o f blood glucose level on the speed o f nam ing
Psychometric 
test score
Hypoglycaemic Normal blood 
glucose level
Level of Significance
SKT I 13.55 seconds 15.20 seconds F ci, 2 2 )= 1 -29 p>0.05
SKT III 7.22 seconds 7.46 seconds F d ,  2 2 )= 0.06 p>0.05
7.25.8 Summary
Blood glucose levels did not affect performance on tasks assessing the speed of  
naming.
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7.26 The effects of blood glucose level on mood
Mood data were also analysed using a two way analysis o f variance with blood 
level (baseline blood glucose levels less than 2.2 mmol/L compared with blood 
glucose levels greater than 2.2 mmol/L) and self ratings o f mood (tension, 
depression, anger, vigour, fatigue, confusion and overall mood score).
There were no significant differences between the 2 groups o f subjects (low 
blood glucose versus high blood glucose level) on any o f the subjective self 
ratings (See table 124).
Table 124: Showing the effect o f hypoglycaem ia on m ood.
Subjective 
Mood Rating
Blood 
Glucose < 
2.2 mmol/L
Blood 
Glucose > 
2.2 mmol/L
Level of Significance
Tension 6.77 5.58 F (i, 19 ) = 0.25; p>0.05
Depression 6.11 3.58 F n, 19) = 1-05; p>0.05
Anger 1.44 2.16 F (i, 19 ) = 0.17; p>0.05
Vigour 17.22 18.75 F a, 19) = 0.23; p>0.05
Fatigue 7.11 4.00 F (i, 1 9 ) = 1.48; p>0.05
Confused 8.00 7.58 F n, 19) = 0.07; p>0.05
Overall Mood 46.66 41.66 F (i, 19 ) = 0.56; p>0.05
7.26.1 Sum m ary
Blood glucose level did not affect subjective ratings o f mood.
7.27 Conclusion
Subjects with hypoglycaemic blood glucose concentrations showed 
significantly poorer performance on the HPRU Sternberg Memory Task and 
made significantly more omissions on the immediate recall task than subjects 
with normal blood glucose concentrations. However task performance on all 
other measures were comparable to subjects with blood glucose concentrations
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greater than 2.2 mmol/L. Self ratings o f mood were also similar for all subjects 
regardless o f blood glucose level.
7.28 Discussion
This study demonstrated that treatment with glucose resulted in significantly 
higher blood glucose assessments than when treated with placebo/saccharin. 
However this raise in blood glucose level had no effect on any aspects of  
performance, namely attention, memory recall, recognition memory, the speed 
of information processing, the speed of naming or subjective ratings o f mood.
Attention was assessed using SKT subtests IV, V, VI, VII and the HPRU 
Sternberg Memory Task. SKT Rearranging blocks), SKT V (replacing blocks), 
are spatial tasks, requiring the subjects to place blocks into ascending order, and 
then replace the blocks to their initial start place, that is clearly marked on the 
board. SKT subtest VI is a attention/vigilance task and as previously found 
glucose had no effect on tasks assessing attention, hence improvements 
following treatment with glucose would not be expected on the task. SKT 
subtest VII is a reverse naming task, requiring the subjects to read a letter and 
respond verbally with another letter e.g. read A and say B, this task is similar in 
some respects to the Stroop and Digit symbol substitution tasks relying heavily 
on attentional processes to perform the task. As the previous studies have 
demonstrated, glucose had no effect on tasks assessing attention. Glucose also 
had no effect on the HPRU Sternberg memory task, this task does not assess 
verbal memory, and is much like the digit span task, where subjects are required 
to hold small amounts of information in memory for a short time, and then 
perform a scanning procedure, hence with such similarity to the digit span task, 
improvements following glucose would not be expected. These findings 
replicate previous studies, where glucose had no effect on tasks assessing 
attention.
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The memory tasks included in this study did not require the subjects to perform 
associations, substantial verbal re-coding, or comprehension o f textual 
materials, hence and best glucose would only have been expected to induce 
mild non significant trends towards improvement on SKT subtest II (immediate 
recall of 12 objects), SKT VIII (delayed recall of 12 objects), SKT IX 
(recognition memory of 12 objects), and the word list containing 15 words. The 
word list task only included single verbal items, in the previous literature with 
research in elderly subjects, it would seem that beneficial effects o f glucose 
treatment would only be expected when subjects were required to perform 
complex verbal memory tasks such as in the paired associative word list, and 
the selective reminding task. As expected glucose had no effect on any 
measures of memory.
There were no studies conducted that assessed the role o f glucose on tasks 
assessing the speed of information processing in healthy elderly subjects. In 
young healthy subjects improvements were noted on reaction time tasks 
following glucose treatment (Benton and Owens, 1993). However this study 
would seem to suggest that like attention, and aspects of memory, glucose has 
no effect on tasks assessing the speed of information processing in healthy 
elderly subjects (CFF, RRT, MRT, TRT).
There have been no studies that assessed the role o f glucose on tasks the speed 
of naming, however in line with the findings on the speed of information 
processing, performance improvements following glucose treatment would not 
be expected.
Results supported this, glucose had no effect on SKT subtest I (naming objects) 
or SKT subtest III (numerical naming).
To conclude, it would seem that in healthy elderly subjects the benefits of 
glucose supplementation would seem to be specialised to verbal memory tasks,
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or memory tasks requiring subjects to perform associations, substantial verbal 
re-coding, or comprehension of textual materials. In the present study, glucose 
has no effect on attention, non verbal memory tasks, the speed of information 
processing, or the speed of naming.
There have been no studies that have examined the role o f glucose on aspects of  
mood in healthy elderly subjects. Research in young subjects would seem to 
indicate that higher blood glucose levels are associated with improved feelings 
of vigour, and lower ratings o f tension and anxiety (Benton and Owens, 1993; 
Reid and Hammersly, 1995). The present study failed to replicate any findings, 
the only effects reported, seemed to indicate that subjects felt more vigorous 
following the placebo treatment, the opposite o f what was expected. From this 
study it was concluded that glucose had no effect on mood in healthy elderly 
subjects.
In terms of the effect of the change in blood glucose level, it was questioned 
whether there would be a difference in performance in subjects whose blood 
glucose levels rose between the second and third assessments compared with 
subjects whose blood glucose levels fell between the second and third 
assessments. It was reported that subjects with falling blood glucose levels 
showed superior performance on the Sternberg memory task than subjects with 
rising blood glucose levels. Subjects with falling blood glucose levels also 
reported feeling more vigorous and less fatigued than subjects with rising blood 
glucose levels.
The main differences between the present study, and previous studies, are the 
tasks used, (however as shown above, some similarities can be drawn between 
tasks), and the numbers of subjects included in the studies. In the Gonder- 
Frederick et al., (1987) study, it was stated that only small numbers o f elderly 
subjects were needed to demonstrate the beneficial effects o f glucose on 
cognitive function, however in the present study, the numbers included
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exceeded those used in previous studies, (with the exception o f Craft et al., 
1994 and Allen et al., 1996) and reported null results. It is possible that the 
small numbers of subjects included in the previous studies were not truly 
representative of the population as a whole, and if  the numbers were increased, 
then the weak results would be diluted, (see Table 125)
Table 125: Showing Age and num ber o f subjects included in the previous studies.
Author Number of 
subjects
Age of subjects
Gonder-Frederick et al, (1987) 11 58-76 years
Hall et al, (1989) 11 58-76 years
Manning et al, (1990) 17 62-84 years
Manning et al, (1992) 22 60-81
Craft et al, (1996) 13 mean age 71 years
Parsons and Gold (1992) 10 60-82 years
Allen et al, (1996) 28 61-87 years
Craft et al, (1994) 32 58-77 years
A number o f studies have examined the effect o f glucose on attention in young 
healthy subjects. Benton et al (1994) assessed performance using the Stroop 
task in young healthy subjects and unlike Craft et al. (1994; 1996) reported that 
glucose enhanced performance o f the Stroop task. This contradicts findings in 
healthy elderly subjects, where no beneficial effects were reported. The 
differences between the two studies could reflect true age effects, or could be a 
result o f different sample sizes. It could be argued that the effects on attention 
may be age specific, enhancing performance in young subjects, and not 
affecting elderly subjects. Another difference between these studies, relates to 
sample sizes, in the Craft et al. (1994) study, 32 subjects were supplemented, 
and in the Benton et al. (1994) study 50 young subjects were supplemented. 
Perhaps, larger elderly sample sizes may result in observed improvements.
Previous literature with young healthy subjects would seem to indicate that 
glucose does have a beneficial effect on recall performance o f the word list task, 
contrary to the findings of this study. Benton, Owens and Parker, (1993)
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reported that glucose facilitated memory recall of 30 nouns. In Benton and 
Owens (1993) subjects were presented with 15 item word list, following 
presentation, subjects had 30 seconds in which to write down as many US 
capitals as possible, following this, subjects were given 1 minute to recall the 15 
words. It was reported that subjects with rising blood glucose levels 
remembered more words than subjects with falling blood glucose levels. The 
present study was conducted in much the same way as the Benton and Owens 
(1993) study, however instead of writing down US capitals, subjects had 30 
seconds in which to write down the names o f famous people. The different 
results between the age groups could represent true age differences, healthy 
elderly subjects may have been impaired by performing the distractor task 
(writing down the names o f famous people) to a greater degree than young 
healthy subjects. It is possible that the differences could be a result of 
differences in task procedure, the differences in the distractor task, may help to 
produce differences in the results.
The tests themselves may be a factor that may have lead to a failure to produce 
any effects, it is possible that the tests used may not have placed the subjects 
under enough cognitive demand. In previous studies, tasks that have been 
enhanced by an increased availability o f blood glucose either required a rapid 
response or had time constraints. For example glucose was found to improve 
performance on a choice reaction time task (reaction to a number o f stimuli) and 
not a simple reaction time task (reaction to one stimuli) (Owens and Benton, 
1994). Also increased glucose availability was shown to affect Stroop 
performance on the incongruent condition (difficult task whereby subjects are 
presented with colour names written in conflicting coloured ink for example the 
word red written in blue ink, the subjects has to tell the experimenter the colour 
of the in k ) and not the congruent condition (a colour word written in the same 
coloured ink e.g. the word red written in red ink, subjects have to give the 
colour of the ink). Beneficial effects o f glucose have often only been observed 
after long periods o f time during prolonged testing periods. For example Keul
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(1982) found that glucose improved performance on a driving simulator task 
only after the subjects had travelled a long distance (70-110 Km), and 
performance on the rapid information processing task was found to be improved 
following glucose administration towards the end o f the test session- after great 
cognitive demand had been placed on the subject.
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8 Chapter Eight: The Discussion
The trend for an ever ageing population is associated with increased incidence 
of illness and the demand for treatment. The elderly as a group represent the 
highest users o f medication in the population (Whittington and Petersen, 1979) 
and with an increase in population size coupled with an improved standard of 
living, the demand for treatment is expected to escalate in future years.
One of the greatest problems experienced by elderly populations is a decline in 
cognitive function. This decline is a consequence o f ageing even before the 
elderly begin to encounter degenerative diseases and polypharmacy. An ageing 
society is at an increased risk of polypharmacy, multiple medication use is not 
only inconvenient for the patient, but can have hazardous effects, increasing the 
potential for adverse side effects, such as accidents both in and around the 
home.
The elderly suffer cognitive decline as a consequence o f increased age, 
therefore if  society can take steps to limit the decline in cognitive function 
experienced by elderly persons, then this could lead to improvements in an 
elderly persons quality of life. One method for doing this, is to try and limit the 
use of drugs for the treatment of disorders and identify alternative compounds 
which may help to alleviate cognitive decline.
The search for alternative therapies for the treatment o f aged diseases is not 
new, at present Pharmaceutical companies are developing and testing hundreds 
of potential nootropic products, however to date, the only available treatments 
are very expensive and are associated with a number o f side effects, which 
substantially limit their utility. With problems in the search for drugs which 
posses nootropic properties, a number o f research teams have assessed the
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effects of a number of readily available over the counter preparations in terms 
of their ability to enhance cognitive function.
Researchers who have taken steps to identify potential nootropic compounds 
have noted that there are a number o f variables that affect human cognitive 
function, these include current state of health, medication use and nutritional 
status etc. There is some debate concerning whether poor nutritional status 
could adversely affect cognitive function. If this is true, then improved 
nutritional status should result in improved cognitive function. In chapter two 
the importance of vitamins in the diet was discussed, it would seem that 
vitamins are required by the body for the production of neurotransmitters, for 
the release o f energy from foods and for their antioxidant properties. Since 
vitamins play such an important role in the body, then it is likely that a vitamin 
deficiency would result in noticeable changes in behaviour.
The search for potential nootropic compounds, and the measurement o f the 
effects o f vitamin deficiency on cognitive function is meaningless without 
firstly understanding the types of changes the elderly experience as a result of 
age, and secondly identifying valid and reliable test methods for assessment of  
human cognitive function. It is vitally important that researchers develop norms 
in terms o f the types of age related changes one would expect on psychometric 
tasks, before they go on to assess the effect of a potential nootropic on human 
cognitive functioning.
There are two main methods available for the assessment o f cognitive change in 
elderly subjects, it can be done via subjective rating scales or with the use o f  
psychometric/performance type tasks. In terms o f ease o f applicability, 
subjective ratings are easier to conduct, cheaper as they do not require 
specialised facilities and trained staff to operate them, and can generate vast 
amounts of data in a short amount o f time. However the main drawbacks with
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subjective rating scales are that subjects may misinterpret what is being asked of 
them and hence the data collected may not be credible.
In this thesis, to test whether subjects we able to reliably report changes in 
cognitive function, 160 healthy elderly subjects aged 60-85 years completed an 
Activity o f Daily Living Scale (ADL). The scale consisted o f 159 questions 
assessing aspects o f attention, memory, orientation and the speed of processing. 
Subjects were required to rate performance o f daily activities in terms of the 
number o f problems they had experienced over the previous month. Analysis of 
the data reported that the elderly were not aware o f any problems with the 
performance o f daily activities. The ADL scale did not identify any aspects of 
cognitive function that were proving difficult for an aged population. These 
results at first may seem surprising, however Rabbitt and Abson (1991) noted 
that self rating is very difficult for an aged population as reflections of self 
rating usually strongly reflect changes in general confidence and attitudes 
towards themselves rather than information on cognitive ability. Nisbett and 
Wilson (1977) report that individuals have difficulty inspecting their cognitive 
processes and can only make inferences about them from received social 
opinion, or by observing the overt effects of their behaviour on the external 
world. Hence it comes as little surprise that the elderly are not accurate at self 
rating changes in cognitive function. Based on these findings, it was concluded 
that the more preferred way to accurately measure cognitive decline in healthy 
elderly subjects was with the use o f performance tasks.
In chapter four the effects and age and gender were determined on a battery of 
cognitive tasks that measures aspects o f attention, memory and the speed of 
information processing. The test battery consisted of the Critical Flicker Fusion 
task (CFF), the Choice Reaction Time Task (CRT), HPRU Sternberg Memory 
Task (SMT) and the Syndrom Kurtz Task (SKT).
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It was concluded that age related decrements in performance were expected on 
SKT II (immediate recall), SKT IV (arranging blocks), SKT V (replacing 
blocks), SKT VI (counting symbols), SKT VII (reverse naming), SKT VIII 
(delayed recall), HPRU Sternberg Memory Task (SMT), Critical Flicker Fusion 
Task (CFF) and the Choice Reaction Time Task (CRT).
In terms o f analysis it was reported that age effects were reported on SKT II 
(immediate recall), SKT IV (arranging blocks), SKT V (replacing blocks), SKT 
VI (counting symbols), SKT VII (reverse naming), and SKT VIII (delayed 
recall). However no age related decrements were noted on the Critical Flicker 
Fusion Task (CFF), Choice Reaction Time (CRT) or the HPRU Sternberg 
Memory Task (SMT). However it must be stated that even when there were age 
effects, they were quite idiosyncratic i.e. performance didn't simply decline 
steadily with age. The lack o f effect may be a result specific to the sample 
tested, it is possible that they were not experiencing an age related decrement on 
the tasks, however it is more likely that the actual tasks are not in fact age 
sensitive. In terms of age related declines on CFF, the majority o f studies 
reported an age related decrement were published in the 1940's and 1950's and it 
is possible that age related declines are no longer evident on the task, whether 
this is due to changes in technology or methodology remains unknown. The 
lack of effect on the Choice Reaction Time task (CRT) may be due to a 
methodological flaw in the design, in the present task, subjects were only 
required to respond to one of six lights, it is possible that the task was too 
simple, and age related decrements may have been noted if  the number of 
stimuli had been increased. The lack of effect on the HPRU Sternberg Memory 
Task (SMT) is also quite likely to be due to a flaw in the methodology. In the 
original Sternberg Memory Task subjects memory scanning ability was 
assessed with a single digit probe, and age related decrements were noted on 
this version o f the task (Sternberg, 1966). However in the HPRU version o f the 
task, memory scanning ability was assessed by presenting the subjects with 12 
single digit probes, the subjects task was to determine whether the probe, a
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single item presented after the main list, had been presented as part of a list. 
Hence this version of the task was assessing a different aspect o f memory to the 
original Sternberg Memory Task. It would appear that the present HPRU 
version of the task is not sensitive to the effects of age.
Having identified the effects of age on the test battery, it was speculated that 
treatment with potential nootropic compounds may help to alleviate the age 
related decrement in performance. To test this hypothesis elderly subjects were 
treated with multivitamins, ginkgo biloba and glucose and performance was 
assessed on the test battery.
In chapter five, 239 healthy elderly volunteers aged 60-80 years were treated 
with either placebo or multivitamins for a period of 36 weeks. Cognitive 
function and blood samples were assessed at baseline, and after 12, 24 and 36 
weeks. Based on previous research it was hypothesised that treatment with 
multivitamins would result in improved performance on SKT subtests II 
(immediate recall), SKT IV (arranging blocks), SKT V (replacing blocks), SKT 
VIII (delayed recall), the Ravens Standard Progressive Matrices (RSPM) and 
the Cognitive Failures Questionnaire (CFQ). It was also hypothesised that 
multivitamin supplementation would lower anxiety and depression scores on the 
Hospital Anxiety and Depression Scale (HADS). It was reported that long term 
multivitamin supplementation had no effect on the tasks. The lack o f effect in 
the present study was possibly a result o f the sample selection process, as 
subjects were volunteers, the large majority o f subjects were well educated, 
wealthy health conscious individuals. The majority o f whom were unlikely to be 
suffering from nutritional deficiency or any degree o f cognitive decline. Indeed 
only 30% of the sample were at a high risk of deficiency o f vitamin B6 and only 
10% at a high risk of deficiency o f vitamin B2 . The data was also analysed 
taking into account the subjects risk o f deficiency, it was reported that risk of  
deficiency had no effect on performance of the tasks. Risk o f deficiency did 
however affect mood ratings, it was reported that subjects with a moderate risk
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of deficiency had higher anxiety levels following supplementation. In terms of 
supplementation subjects supplemented with placebo with a high risk of 
deficiency reported greater depression rates over time compared to those with a 
low risk of deficiency who reported that they felt less depressed over time. 
Therefore the effects o f vitamin deficiency may have more effects subjectively 
rather than objectively.
In chapter six, 16 healthy elderly volunteers aged 60-85 years were treated with 
ginkgo biloba 100 mg and placebo daily for 8 weeks in a randomised cross over 
design, with a 4 week washout period. Cognitive function was assessed at 
baseline and at weeks 2, 4, 6, 7 and 8. It was hoped that treatment with GBE 
would improve performance on the HPRU Digit Span Task, HPRU Sternberg 
Memory Task and aspects o f the SKT especially SKT II (immediate recall), 
SKT VII (reverse naming) SKT VIII (delayed recall) and SKT IX (recognition 
memory). However it was reported that treatment with ginkgo biloba had no 
effect on performance of any tasks. The lack o f effect o f ginkgo biloba on 
cognitive function in the present study was possibly due to dosing of GBE. A 
100 mg daily dose was selected as this was the recommended daily dose, and it 
was felt that it would be interesting to see if  a recommended daily dose would 
induce positive beneficial effects on cognitive function. It is quite possible that 
if  the daily dose was increased, more beneficial effects would have been 
observed.
In chapter seven, 24 healthy volunteers were treated with acute doses o f glucose 
(50 g) and placebo (saccharin 23.7 mg) in a randomised cross over design. 
Blood glucose measurements were assessed at baseline, 30 and 50 minutes post 
dose. Cognitive function was assessed at baseline and 30 minutes post drink. 
Based on previous research it was hypothesised that treatment with glucose 
would improve performance on the word list task, SKT II (immediate recall), 
SKT VIII (delayed recall) SKT IX (recognition memory) would increase energy 
ratings and decrease tension ratings. It was reported that following the glucose
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treatment blood glucose levels were significantly increased compared to 
placebo, however this increase in blood glucose had no effect on cognitive task 
performance. There are numerous studies that have reported benefits effects of 
glucose on cognitive function in elderly populations, however in the present 
study even though glucose levels were significantly higher following the 
glucose drink, the elevation in blood glucose had no observable effect on task 
performance. There is some evidence that a persons ability to tolerate glucose 
may have an effect on task performance, poor glucose tolerance is usually 
associated with poor task performance (Allen et al, 1996). In this sample it was 
reported that subjects with falling blood glucose (between the second and third 
samples) reported improved performance on the Sternberg memory task and felt 
more vigorous and less fatigued than subjects with rising blood glucose levels, 
possibly suggesting that the subjects were utilising the excess glucose and hence 
were reporting beneficial effects. There were no other reported differences. The 
main differences between the present study, and previous research lies in the 
number o f subjects sampled. In previous studies, sample sizes ranged between 
10 and 17 subjects (with the exception o f Allen et al., 1996 and Craft et al, 
1994). it is possible that the small sample sizes were not truly representative of 
the population as a whole and if  numbers were increased the results may have 
been diluted. The test battery used in the present study was unique, none o f the 
tasks had been used for the assessment o f cognitive function following a 
glucose drink. It is possible that the tasks did not measure the correct aspects of 
cognitive function. In terms of future research it would be interesting to assess 
the effect of glucose on cognitive function in larger samples o f healthy elderly 
subjects and incorporate some o f the previously reported sensitive tasks into the 
test battery.
In terms of the experimental supplement chapters, it would appear that 
treatment with multivitamins, ginkgo biloba and glucose had no effect on any 
aspect o f cognitive function in healthy elderly volunteers. However examination 
of the previous research would seem to indicate that performance improvements
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have been noted in healthy adult, elderly and patient populations. In many cases 
the effects o f supplementation are more dramatic in patient populations, but are 
still evident in healthy samples. These results would seem to be at odds with 
previous literature, however there are a number o f reasons to account for the 
lack of treatment effect.
Firstly, it is possible that the samples included in the present studies, were not 
experiencing any form of cognitive decline (despite the fact they believed that 
they were experiencing difficulties with memory attention and slowness of 
thought). In terms o f their baseline cognitive performance measures, their 
performance was almost comparable to healthy young subjects in many cases. 
Examination o f the baseline scores reveal that the elderly subjects reported 
scores that corresponded with scores obtained by young samples. It is possible 
that the effects of supplementation with multivitamins, ginkgo biloba and 
glucose may be more dramatic in elderly subjects with definite cognitive 
decline. In terms o f future experiments, it may be useful to pre-screen subjects 
in terms o f cognitive decline, and only enrol subjects with definite degrees of 
cognitive decline, as the present analyses would seem to indicate that 
supplementation has no effect on cognitive performance in healthy elderly 
volunteers.
Analysis of the subjects age, may also help to account for the lack o f effect, in 
many o f the previous studies, the mean age o f subjects were in the 70's. 
However in the present studies, despite the large age range 60-85 years, the 
mean age of subjects was approximately 65 years, which in aged research is 
considered as "young". The sample only contained small numbers o f subjects 
who were aged over 70 years. In terms of future studies, it may be beneficial to 
include a larger sample o f older subjects (aged 75+).
The recruitment procedure may also have contributed to the lack o f effect. This 
was particularly true in the multivitamin study as volunteers responded to
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advertisements in local papers and doctor's surgeries or were obtained from the 
HPRU database. People who volunteer for clinical trials via advertisements tend 
to be highly motivated and health conscious, therefore the selection process 
meant that only highly motivated healthy volunteers were available. The result 
is that the samples were probably not representative o f the elderly population as 
a whole. In terms o f future studies, it may be better to obtain volunteers from 
more varied sources, i.e. referrals from GP practices, health visitors and social 
workers as well as via advertisements.
The lack of effect may also be a result o f inappropriate test measures. In chapter 
four the assessment methods were assessed in terms o f their ability to detect age 
related changes. Despite the fact that a number o f the tasks were age sensitive 
(SKT II (immediate recall), SKT IV (arranging blocks), SKT V (replacing 
blocks), SKT VI (counting symbols), SKT VII (reverse naming), and SKT VIII 
(delayed recall)). Supplementation with either multivitamins, ginkgo biloba or 
glucose did not remove this age related decrement. It is possible that the effects 
of supplementation were limited to aspects of cognitive function that were not 
addressed in the present analyses.
The SKT task is a short symptom task for use in elderly subjects experiencing 
cognitive decline, it is possible that the task is not suitable for use in healthy 
elderly subjects, and would appear that the task is not pharmacosensitive in 
healthy elderly subjects. However more research is warranted before such a 
conclusion is reached.
Analysis o f age related effects on the Critical Flicker Fusion, Choice Reaction 
Time and the HPRU Sternberg Memory Task would seem to indicate that these 
tasks are not age sensitive and further analysis o f the effects o f supplementation 
on performance o f the tasks would seem to indicate that the tasks are not 
pharmacosensitive in healthy elderly subjects. Perhaps the effects o f treatment
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on such tasks is limited to drugs that impair rather than improve performance, or 
rather the effects are specific to patient populations.
The results of this thesis raise a number o f questions, they raise doubts on the 
credibility o f the tasks used in this thesis, they raise doubts on the methodology 
of the tasks used in the thesis and they raise a number o f questions o f the 
laboratory versus real life tests. Chapter Four outlined the tasks used in the 
thesis and aimed to identify similarities between the present tests and other tasks 
used for the assessment of cognitive function, in order to understand and 
classify what aspects o f cognitive function the tasks assess. It would appear that 
in many instances, it was quite difficult to identify similarities between the 
present tasks and currently valid and reliable methods. Examination of the 
methodology of the present tasks revealed that many o f the tests were unique. In 
the HPRU version o f the Sternberg Memory Task, memory scanning ability was 
assessed by presenting 12 single digit probes. The methodology employed by 
the HPRU does not parallel the method in the original Sternberg Memory Task, 
therefore it was not possible to make a direct comparison between the 2 tasks, 
and it was not possible to easily identify what aspect of cognitive function the 
task measured. Similar criticisms can be made o f a number o f subtests of the 
Syndrom Kurtz Task (SKT) and the Milford Memory Task. In the SKT both 
delayed and recognition memory were assessed. These aspects o f memory are 
commonly assessed in psychopharmacological studies, as it is interesting to 
determine whether a particular drug adversely affects memory. The 
methodology o f the SKT delayed and recognition tasks were quite unique. In 
the delayed recall task, subjects had 2 attempts to remember the information 
(information was first looked at before the immediate recall and straight after 
immediate recall subjects were given 5 seconds to refresh their memory o f the 
information), normally delayed recall is assessed by allowing only one attempt 
at remembering. In this task, it is not possible to tell whether the subjects were 
recalling items that they recalled before, which you might hypothesise were 
easier items, or recalling from the original list. A similar argument can be used
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for the recognition memory task, generally recognition tasks are tested 
exclusively (i.e. without previously testing immediate and delayed recall).
The methodology in the Milford Memory Task was also quite unique. The 
Milford digit span task was dramatically different from the original digit span 
task. In the Milford version, subjects were only given one chance to correctly 
recall the digit span, whereas in the original task, subjects were given two 
chances to recall the digit spans. Such dramatic differences between the present 
tasks and other tasks mean that cross comparisons are almost impossible and the 
task of identifying what aspects o f cognitive function the task is assessing is 
also very difficult.
There are a number o f variables that can affect performance on tasks, in the 
laboratory there are a number o f steps scientists can take to limit the variance 
induced by the variables such as testing in the same environment with the same 
equipment, same experimenter and at the same time o f the day. Practice effects 
are one o f the greatest problems posed in psychopharmacology, if  a subject is 
not fully trained on the task their performance will improve over time and can 
be misinterpreted as drug improvements. Parkin et al., (1996) assessed training 
needs for subjects, in particular how many times a subjects would need to 
complete the CFF and CRT tasks in order to reach performance plateau. 14 
young healthy naive subjects completed the CFF and CRT tasks it was 
concluded that after just 6 sessions all subjects had reached performance 
plateau. This experiment was repeated in 26 elderly subjects aged 61-84 years 
(unpublished data) and much the same as the young subjects, the elderly had 
reached performance plateau after just 6 test sessions. Based on this evidence, 
prior to participation in clinical trials, all HPRU subjects are trained on the tasks 
(complete 6 sessions). Therefore in terms o f HPRU criteria all elderly subjects 
were fully trained and had reached performance plateau. However analysis of 
the data within this thesis would seem to indicate that practice effects were 
evident despite the fact subjects were considered fully trained. Practice effects
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were observed on the Critical Flicker Fusion, Choice Reaction Time and 
Sternberg Memory Tasks. These practice effects pose a number o f questions on 
how should subjects be trained on tasks, should they have a practice before each 
visit, or even a number o f practices before each visit.
Practice effects were noted on the Critical Flicker Fusion task in two o f the 
experiments (glucose and ginkgo biloba experiments). The Critical Flicker 
Fusion task is a physiological measure of brain efficiency and as such, is a task 
that should have no learning curve and hence no practice effects. However 
practice effects were noted on the task, this indicates that the task in its present 
format probably does not measure what it is intended to measure.
These methodological differences may reflect the fact that many o f the tasks 
used were designed in the 1970's when knowledge o f the cognitive system was 
less advanced than what we know today. Therefore for these reasons, it can be 
argued that the tasks have limited utility as science and technology advances 
towards the millennium.
Finally the lack o f effect with the three compounds (multivitamins, ginkgo 
Biloba and glucose) may be due to the low dosage given. This is unlikely to be 
true in the vitamin study as the dose given was equal to ten times the US 
recommended daily allowance. However the low dose may be responsible for 
the lack o f effect in the Ginkgo Biloba and glucose studies. In the Ginkgo 
Biloba study a daily dose of 100 mg was given to subjects for 8 weeks. 100 mg 
is the recommended daily dose specified by the manufacturers (Pharma Nord), 
and as this thesis aimed to assess cognitive function and change in the "real life" 
setting, this dose was selected. From examination o f the present Ginkgo Biloba 
study and the previous literature it would appear that a higher dose o f Ginkgo 
Biloba would probably result in more favourable effects.
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In the glucose study a 50 g dose o f glucose was given to all subjects. A number 
of studies have previously reported effect on cognitive function in the elderly 
with this dose. To help resolve this issue, it may have been better to design the 
studies using a dose range including both lower and higher doses o f glucose e.g. 
25 g, 50g and 75 g. In the Ginkgo Biloba study perhaps it would have been 
better to assess the cognitive effects using GBE 100 mg and a 200 mg dose. 
Perhaps dose ranging studies would have found more effects.
In summary, the effects o f improved nutritional status with multivitamins, 
Ginkgo Biloba or glucose failed to induce any beneficial reported effect on 
cognitive function in a healthy elderly population. Further research is needed to 
ascertain whether the null results are specific to the population sampled or are a 
true reflection of a lack of effect following dosing with over the counter 
nutritional supplements. In order to do this, larger sample sizes need to be 
included in such studies. For example, rather than rely on volunteers for such 
studies, perhaps local GP's and health visitors could help with the recruitment 
process. This would help eliminate the problem of only including fit, healthy, 
eager elderly subjects, making the sample more varied and representative o f the 
population as a whole.
It would also be beneficial to conduct dose ranging studies, as it is possible that 
the dose selected in the present studies were either not potent enough or were 
too potent. It is quite possible that cognitive function is enhanced in an inverted 
U manner, so the dose of ginkgo biloba and glucose may have been to low and 
the dose o f multivitamin too high. Dose ranging studies would help to provide 
answers to such questions.
The fact that the results o f these studies do not reflect previously reported 
findings would seem to indicate that future research needs to be conducted in 
order to help determine whether nutritional supplements can have beneficial 
effects on human cognitive functioning.
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Appendix One: Abbreviations
ADAS Alzheimer Disease Assessment Scale
ADAS-Cog Alzheimer's Disease Assessment Scale Cognitive 
Subscale
AD-ACL Activation Deactivation Check List
ADL Activity of Daily Living Scale
ANOVA Analysis of Variance
BDI Beck Depression Inventory
CDS Cognitive Difficulties Scale
CERAD Consortium to Establish a Registry for Alzheimer’s 
Disease
CES-D The Center for Epidemiological Studies Depression 
Scale
CFF Critical Flicker Fusion Task
CFQ Cognitive Failures Questionnaire
CGI Clinical Global Impression
CNS Central Nervous System
CoA Coenzyme A
CRT Choice Raection Time
DISS Disability Impairment Interview Schedule
DSST Digit Symbol Substitution Task
EAQ Everyday Attention Questionnaire
EMQ Everyday Memory Questionnaire
EPQ Eysenk Personality Questionnaire
FPI Freiberger Personality Inventory
GERRI Geriatric Evaluation by Relatives Rating Scale
GCES Geriatric Clinical Evaluation Scale
GBE Ginkgo Biloba Extract
HADS Hospital Anxiety and Depression Scale
HPRU Human Psychopharmacology Research Unit
IADL Instrumental Activities o f Daily Living
LARS Line Analogue Rating Scale
LF Lost and Found Questionnaire
MAO Monoamine Oxidise
MFQ Memory Failures Questionnaire
MID Multi-infacrt Dementia
MMSE Mini Mental State Examination
NAD Nicotinamide adenine dinucleotide
NART National Adult Raeding Test
NINCDS-ADRDA Workingroup for the auspices o f Department of Health
and Human Services Task Force on Alzheimer’s 
Disease
POMS Profile of Mood States
QOL Quality of Life
RDA Recommended Daily Allowance
RIPT Rapid Information Processing Task
RSPM Ravens Standard Progressive Matrices
SDAT Senile Dementia o f the Alzheimer Type
SKT Syndrom Kurtz Task
SMT HPRU Sternberg Memory Task
VARS Visual Analogue Rating Scale
WAIS Wechsler Adult Intelligence Scale
WLT W ord List T ask
WMS Wechsler Memory Scale
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Appendix Two: Principal components
analysis -18 factor solution
The 59 items from the Activities o f Daily Living Scale (ADL) was subject to a 
principal components analysis using Statistica. Factors with Eigenvalues equal 
to or greater than one, were retained for an oblimin rotation. When test items 
loaded on more than one factor, they were included in a factor according to their 
maximal weighting. There was pairwise deletion to missing data.
Factor 1
1. When driving an auto, do you have problems recognising landmarks that 
would help you know where to turn?
2. When driving an auto, do you have problems recalling landmarks that would 
help you know where to turn?
3. When travelling to new places do you sometimes become overwhelmed with 
new information?
4. When driving an auto, do you become unsure about which exit(s) to take to 
get to a familiar place?
5. Do you have difficulty reading the newspaper thoroughly?
6. When going on a vacation or to visit friends, do you have difficulty 
organising the trip yourself?
7. Do you have difficulty touring an unfamiliar city or place on your own? 
Factor 2
1. Although you know your personal identification number- or you have it on a 
piece o f paper- do you find you have difficulty operating an automatic teller 
machine for a simple transaction (e.g. withdrawal)?
2. Do you have difficulty making a transaction (i.e. take out money) at an 
automated bank machine?
Factor 3
1. While counting something up do you need to recount it several times?
3. Do you forget to turn of the stove, turn out the lights, or lock the door when 
you should?
Factor 4
1. When you look up an unfamiliar telephone number, do you have to refer 
back to it when dialling?
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2. Do you forget names of people who have just been introduced to you?
3. Do you have difficulty remembering telephone numbers which you 
frequently dial?
Factor 5
1. Do you forget anniversaries or birthdays you have always observed in the 
past?
2. Do you have problems remembering important dates and events?
3. Do you buy greetings cards, birthday or anniversary cards for close 
relatives/friends and then forget to mail them?
Factor 6
1. If you are interrupted while speaking, do you tend to forget what you were 
going to say?
2. If you have to wait your turn to speak, do you have trouble keeping in mind 
what you want to say while listening to someone else to talk?
3. Do you experience difficulty “doing two things at the same time”?
4. If you have a new and or important idea do you have difficulty remembering 
it 5 minutes later if  you don’t write it down immediately?
Factor 7
1. Do you experience problems concentrating on reading leisure material?
2. Are you easily distracted when reading leisure material?
3. After reading a chapter or a few pages in a book or in an article do you have 
difficulty describing what you read?
4. Do you need to read the same passage or part o f a book (or other reading 
material) several times in order to remember it?
Factor 8
1. Do you experience problems playing card games (e.g. gin rummy, canasta 
etc.)?
2. Do you lose important things?
3. If you are interrupted doing an activity or shore do you have difficulty 
continuing where you left-off?
4. Is it difficult for you to keep your mind on a task when several other things 
are going on around you?
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5. Do you repeatedly go from one room into another in order to do or get 
something but then forget what you wanted to do?
Factor 9
1. Do you have little to say in a conversation because o f lack o f thoughts or 
ideas?
2. Have you started to avoid discussions/conversations because o f difficulty 
finding the correct words to use?
3. Do you have difficulty participating in hobbies?
4. Do you become confused while performing several simple activities around 
the home, at the same time?
Factor 10
1. Do you have difficulty driving from one familiar spot to another without 
preparation i.e. without carefully going over the route?
2. Do you experience difficulty understanding your bank statement?
3. When walking or hiking do you find that you have to concentrate more on 
landmarks and signposts in order to find the way back?
Factor 11
1. Do you forget about what you have just done (e.g. locking the door, pulling 
out a plug on an appliance)?
2. Have you had difficulty remembering where you’ve parked your car?
Factor 12
1. Do you forget a point in the middle o f a conversation?
2. Have you become less certain about how to correctly spell words that you 
know?
3. Do you purchase tickets for an event only to find that you have bought 
tickets for a wrong date or time?
Factor 13
1. Do you experience difficulty learning new directions regarding how to use 
simple household appliances (e.g. coffee maker, iron, toaster)?
2. Do you experience difficulty learning new directions regarding how to use 
complex household appliances (e.g. microwave oven, vacuum cleaner, 
washing machine)?
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Factor 14
1. Do you begin an activity or chore and then forget the steps or the sequences 
of behaviours necessary for the completion of the activity?
2. If you use public transport for a route you’ve never taken before, do you feel 
uneasy and uncertain about what to do?
3. Do you have trouble following a map to a new place?
4. Do you have difficulty reading a map of an unfamiliar city or place?
Factor 15
1. Are you uninterested in daily political events?
2. Do you find it difficult to complete forms?
3. Do you put off doing things because you have difficulty getting them 
organised?
Factor 16
1. Do you go to social/cultural events on the wrong day or at the wrong time?
2. Do you invite friends or relatives for a visit and then you find that you forgot 
that you invited them?
Factor 17
1. Do you have difficulty giving directions to a place that you used to go to 
frequently?
2. If asked for directions, do you have difficulty giving detailed information? 
Factor 18
1. Do you have difficulty finding the correct word to use when speaking?
2. Do you search for personal belongings (e.g. spectacles)?
3. Do you have problems concentrating on conversations?
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Appendix Three: Principal components
analysis two factor solution
The 59 items from the Activities of Daily Living Scale (ADL) was subject 
to a principal components analysis using Statistica. Factors with 
Eigenvalues equal to or greater than one, were retained for an oblimin 
rotation. When test items loaded on more than one factor, they were 
included in a factor according to their maximal weighting. There was 
pairwise deletion to missing data.
Factor 1
Do you experience difficulty “doing two things at the same time”?
Do you have problems remembering important dates and events?
Do you put off doing things because you have difficulty getting them 
organised?
Do you have problems concentrating on conversation?
Do you need to read the same passage or part o f a book (or other reading 
material) several times in order to remember it?
If you have to wait your turn to speak, do you have trouble keeping in mind 
what you want to say while listening to someone else talk?
If you are interrupted whilst speaking, do you tend to forget what you were 
going to say?
After reading a chapter or a few pages in a book or in an article do you have 
difficulty describing what you just read?
Do you lose important things?
Is it difficult for you to keep your mind on a task when several other things are 
going on around you?
Do you have difficulty finding the correct words to use when speaking?
If you have a new and/or important idea do you have difficulty remembering it 
5 minutes later if  you don’t write it down immediately?
Do you search for personal belongings?
Have you started to avoid discussions/conversations because o f difficulty 
finding the correct word to use?
Are you easily distracted when reading leisure material?
Do you experience problems concentrating on reading leisure material?
Do you forget a point in the middle o f a conversation?
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Do you become confuse while performing several simple activities around the 
home at the same time?
Do you forget anniversaries or birthdays you have always observed in the past?
Do you buy greetings cards, birthday or anniversary cards for close 
relatives/friends and then forget to mail them?
If asked for directions do you have difficulty giving detailed information?
Do you have difficulty reading the newspaper thoroughly?
Do you experience problems playing card games (e.g. gin rummy, canasta etc.)?
Do you repeatedly go from one room to another, in order to do, or get 
something, but then forget what you wanted to do?
Do you go from social/cultural events on the wrong day or at the wrong time?
Do you forget to turn off the stove, turn out the lights, or lock the door when 
you should?
Do you forget about what you have just done (e.g. locking the door, or pulling 
out a plug on an appliance?
Do you invite friends or relatives for a visit and then find that you forgot that 
you invited them?
Do you have difficulty giving detailed directions to a place that you used to 
frequently go?
Do you forget names of people who have just been introduced to you?
When making telephone calls do you dial the wrong number?
Do you have little to say in a conversation because o f lack o f thoughts or ideas?
Do you begin an activity/chore and then forget the steps or sequences of 
behaviours necessary for the completion o f the activity?
Do you have difficulty remembering telephone numbers which you frequently 
dial?
Have you had difficulty remembering where you have parked your car?
While counting something up do you need to recount it several times?
When you look up an unfamiliar telephone number, do you have to refer back to 
it while dialling?
Factor 2
Do you have difficulty touring an unfamiliar city or place on your own?
Do you have trouble following a map to a new place?
When travelling to new places do you sometimes become overwhelmed with 
new information?
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When driving an auto, do you become unsure or uncertain about which exits to 
take to get to a familiar place?
When walking or hiking do you find that you have to concentrate more on 
landmarks and signposts in order to find the way back?
Do you have difficulty reading a map of an unfamiliar city or place?
When driving an auto, do you have problems recognising landmarks that would 
help you know where to turn?
When driving an auto, do you have problems recalling landmarks that would 
help you know where to turn?
Do you experience difficulty learning new directions regarding how to use 
simple household appliances (e.g. coffeemaker, iron, toaster)?
Have you become less certain about how to correctly spell words that you 
know?
If you are interrupted during an activity or chore do you have difficulty 
continuing where you left off?
Do you experience difficulty learning new directions regarding how to use 
complex household appliances (e.g. microwave oven, vacuum cleaner, washing 
machine)?
Do you have difficulty driving from one familiar spot to another without
preparation- i.e. without carefully going over the route?
When going on a vacation or to visit friends, do you have difficulty organising 
the trip yourself?
If you use public transportation for a route you’ve never taken before, do you 
feel uneasy and uncertain about what to do?
Do you find it difficult to complete forms?
Do you have difficulty making a transaction (i.e. take money out) at an
automated bank machine?
Although you know your personal identification number- or you have it on a 
paper- do you have difficulty operating an automatic teller machine for a simple 
transaction (e.g. withdrawal)?
Do you experience difficulty understanding your bank statement?
Do you purchase tickets for an event only to find that you bought tickets for a 
wrong date or time?
Do you have difficulty participating in hobbies?
Are you uninterested in daily political events?
When making telephone calls do you dial the wrong number?
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Appendix Four: Principal components
analysis four factor solution
The 59 items from the Activities o f Daily Living Scale (ADL) was subject to a 
principal components analysis using Statistica. Factors with Eigenvalues equal 
to or greater than one, were retained for an oblimin rotation. When test items 
loaded on more than one factor, they were included in a factor according to their 
maximal weighting. There was pairwise deletion to missing data.
Factor 1
Do you have problems concentrating on conversation?
Do you have little to say in a conversation because o f lack o f thoughts or ideas?
Do you become confused while performing several simple activities around the 
home at the same time?
Do you experience difficulty “doing two things at the same time”?
When going on vacation or to visit friends, do you have difficulty organising the 
trip yourself?
Is it difficult for you to keep your mind on a task when several other things are 
going on around you?
If you have to wait your turn to speak, do you have trouble keeping in mind 
what you want to say while listening to someone else talk?
If you are interrupted while speaking, do you tend to forget what you were 
going to say?
After reading a chapter or a few pages in a book or in an article, do you have 
difficulty describing what you just read?
Do you experience problems concentrating on reading leisure material?
have you started to avoid discussions/conversations because of difficulty 
finding the correct word to use?
Are you easily distracted when reading leisure material?
Do you have difficulty reading the newspaper thoroughly?
Do you put off doing things because you have difficulty getting them 
organised?
Factor 2
Do you need to read the same passage or part o f a book (or other reading 
material) several times in order to remember it?
Do you have difficulty participating in hobbies?
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Do you forget point in the middle of a conversation?
Do you have difficulty finding the correct words to use when speaking?
Are you uninterested in daily political events?
Do you have difficulty touring an unfamiliar city or place on your own?
When travelling to new places do you sometimes become overwhelmed with 
new information?
Do you experience difficulty learning new directions regarding how to use 
complex household appliances (e.g. microwave oven, vacuum cleaner, washing 
machine)?
When driving an auto, do you become unsure or uncertain about which exits to 
take to get to a familiar place?
Do you experience difficulty learning new directions regarding how to use 
simple household appliances (e.g. coffeemaker, iron, toaster )?
When driving an auto, do you have problems recognising landmarks that would 
help you know where to turn?
When driving an auto, do you have problems recalling landmarks that would 
help you know where to turn?
Although you know your personal identification number- or you have it on a 
piece o f paper- do you have difficulty operating an automatic teller machine for 
a simple transaction (e.g. withdrawal)?
Do you have difficulty reading a map o f an unfamiliar city or place?
Do you have difficulty making a transaction (i.e. take money out) at an 
automated bank machine?
When walking or hiking to you find that you have to concentrate more on 
landmarks and sign posts in order to find the way back?
If you are interrupted during an activity or chore do you have difficulty 
continuing where you left off?
Factor 3
Do you have difficulty following a map to a new place?
Do you forget to turn off the stove, turn out the lights, or lock the door when 
you should?
Do you invite friends or relatives for a visit and then find that you forgot that 
you invited them?
have you had difficulty remembering where you have parked your car?
Do you go to social/cultural events on the wrong day or at the wrong time?
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Do you buy greetings cards, birthday or anniversary cards for close friends or 
relatives and then find that you forgot to mail them?
If asked for directions, do you have difficulty giving detailed information?
If you have a new and/or important idea, do you have difficulty remembering it 
5 minutes later if  you don’t write it down immediately?
Do you forget about what you have just done (e.g. locking the door, pulling out 
a plug on an appliance)?
Have you become less certain about how to spell words that you know?
Do you find it difficult to complete forms?
If you use public transportation for a route you’ve never taken before, do you 
feel uneasy and uncertain about what you do?
Do you have difficulty giving directions to a place that you used to frequently 
go?
Do you have difficulty driving from one familiar spot to another without 
preparation i.e. without carefully going over the route?
Do you experience difficulty understanding your bank statement?
When making telephone calls do you dial the wrong number?
Do you forget anniversaries or birthdays you have always observed in the past?
Do you begin an activity/chore and then forget the steps or sequences of 
behaviours necessary for the completion of the activity?
Factor 4
Do you have difficulty remembering telephone numbers which you frequently 
dial?
Do you have problems remembering important dates and events?
Do you search for personal belongings?
When you look up an unfamiliar telephone umber, do you have to refer back to 
it while dialling?
Do you repetitively go from one room into another in order to do or get 
something but then forget what you wanted to do?
Do you forget names o f people who have just been introduced to you?
Do you lose important things?
Do you experience problems playing card games (e.g. gin rummy, canasta etc.)?
While counting something up do you need to recount it several times?
Do you purchase tickets for an event only to find that you bought tickets for a 
wrong date or time?
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Appendix Five: Shortened ADL Scale
(14 Items)
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Please complete the following questionnaire
Age Sex
(Please indicate your age and sex)
0 = never (no problems) 3 = most of the time
1 = occasionally 4 = always (on every occasion)
2 = some of the time
Question / Item Your Answer
If you have an important idea and don’t write it down immediately 
do you have difficulty remembering it 5 minutes later? 0 1 2 3 4
Do you have problems learning new information? 0 1 2 3 4
Do you find you forget what you have just done (e.g. locking the 
door, turning the fire off etc.)? 0 1 2 3 4
Do you have difficulty travelling from one familiar spot to another 
without preparation (i.e. without carefully planning your route)? 0 1 2 3 4
Do you forget the names of people who have just been introduced 
to you? 0 1 2 3 4
Do you have problems remembering important dates/events? 0 1 2 3 4
Do you need help completing household tasks, even though 
physically capable of doing them? 0 1 2 3 4
Do you have difficulty finding the correct word to use when 
speaking? 0 1 2 3 4
Do you have problems concentrating on conversations? 0 1 2 3 4
Do you go from one room to another in order to get something (e.g. 
your spectacles) and then forget what you wanted? 0 1 2 3 4
Do you become confused whilst performing more than one 
household activity at the same time? 0 1 2 3 4
If you are interrupted whilst performing an activity, do you have 
difficulty continuing where you left off? 0 1 2 3 4
Do you have difficulty following a map to a given destination? 0 1 2 3 4
Do you have difficulty remembering what you have just read? 0 1 2 3 4
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STUDY REFERENCE 
HPRU/RO/COOl
VOLUNTEER INITIALS  ______
VOLUNTEER N U M B E R _______
VISIT NUMBER _  OPERATOR_
SKT
A short cognitive performance test 
for assessing memory and attention
CQ
o
DATE
r ^ r 7
- ■ s > ;  ' •
Tester
Name Age
Date o f birth Occupation
IQ group 1 < 9 0 90-110 >110
Diagnosis
Remarks
Date Time
RAW NORM
SCORES VALUES
Naming objects Seconds
immediate recall Confabulations:
Apple Feather House Leaf
Cock Car Dice Peg
Pol M ouse Spoon Clock Tick objects named
Om issions
SH O W  TABLEAU AGAIN FOR 5 SECONDS ONLY
Naming numerals Seconds
Arranging blocks Seconds
Replacing blocks Seconds
Counting symbols 0 ( 4 3 ) Seconds
Reversal naming Correct sequence
G F G F G F F G G F G F G F G F G
F F G F G F F G F G F G G G F G F Seconds
Delayed recall Confabulations:
Apple Feather House Leaf
Cock Car Dice Peg
Pot M ouse Spoon Clock Tick objects named
Omissions
Recognition memory Confabulations:
Apple Feather House Leaf
Cock Car Dice Peg
Pot M ouse Spoon Clock Tick objects named
Omissions
Overall assessment o f clinical degree o f severity TOTAL
<;c o r f
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